2019 Annual Meeting | P2 - Poster Session 2

Date Monday 05/06/19

Time 11:30 AM - 06:30 PM EDT Add To Calendar

Session Format This program will be presented both in-person and online

On Demand This program is not expected to be available in the meeting's On Demand product.

Event Type Scientific Poster Session

Topic(s) Neuro Trauma, Critical Care, and Sports Neurology, Aging, Dementia, and Behavioral Neurology, Autoimmune Neurology, Cerebrovascular Disease and Interventional Neurology, Child Neurology and Developmental Neurology, Epilepsy/Clinical Neurophysiology (EEG), General Neurology, Global Health and Neuroepidemiology, Headache, Movement Disorders, Multiple Sclerosis, Neuromuscular and Clinical Neurophysiology (EMG), Neuro-oncology, Pain, Research Methodology, ��ɫ��, and History

CME Available 0.00 credit

Program Materials Program Evaluations

Event Timeline
05:30 PM - 06:30 PM EDT	Abstract	9-001 - Incidence and trends of Frontotemporal Disorders in Olmsted County: a population based study (1995-2010). Pierpaolo Turcano, MD
05:30 PM - 06:30 PM EDT	Abstract	9-002 - Absence of Embarrassability Distinguishes Frontotemporal Dementia from Alzheimer's Disease and Healthy Controls Oleg Y. Yerstein, MD
05:30 PM - 06:30 PM EDT	Abstract	9-003 - Hemispheric Asymmetry Contributing to Socioemotional Behavior in Frontotemporal Dementia Leila Parand, MD
05:30 PM - 06:30 PM EDT	Abstract	9-004 - The Cognitive Aspects of Sexual Intimacy in Dementia Patients: A Neurophysiological Review and Insights for Diagnosis and Treatment Anna S. Nordvig, MD
05:30 PM - 06:30 PM EDT	Abstract	9-005 - Intrinsic amygdala connectivity as an endophenotype for social behavior: A novel SNP affecting CSMD1 increases amygdala connectivity and prosocial behavior in a GWAS meta-analysis. Kevin Bickart, MD, PhD
05:30 PM - 06:30 PM EDT	Abstract	9-006 - Phenotypic Complexity and the Likelihood of a Diagnostic Result in a Sequencing Test of 2,300+ Genes Associated with Autism Spectrum Disorders and/or Intellectual Disability Tracy Brandt, PhD
05:30 PM - 06:30 PM EDT	Abstract	9-007 - Exploring functional connectivity correlates of problem solving under stress David Q. Beversdorf, MD, FAAN
05:30 PM - 06:30 PM EDT	Abstract	9-008 - Delirium Assessment for Acute Ischemic Stroke Patients at UNMC Hae Young Baang, MD
05:30 PM - 06:30 PM EDT	Abstract	9-009 - Allopregnanolone improves neuropsychiatric symptoms in elderly men with Fragile X-associated tremor/ataxia syndrome (FXTAS): Results from an open label study Aditi Trivedi, MD
05:30 PM - 06:30 PM EDT	Abstract	9-010 - Altered Brain Metabolism Associated With Functional Motor Disorder: Preliminary Results Of The HYCORE Study.
05:30 PM - 06:30 PM EDT	Abstract	9-011 - Corticolimbic Fast-Tracking: Enhanced Multimodal Integration in Functional Neurological Disorder
05:30 PM - 06:30 PM EDT	Abstract	9-012 - Do Anxiety and Depression Levels Interfere with Cognitive Performance in Ecuadorian Multiple Sclerosis Patients? – a Case-Control Study
05:30 PM - 06:30 PM EDT	Abstract	9-013 - Reflexia Alternans in the Setting of Electroconvulsive Therapy Shayan A. Gates, DO
05:30 PM - 06:30 PM EDT	Abstract	9-014 - Impact of Antipsychotic Treatment Switching in Patients With Schizophrenia, Bipolar Disorder, And Major Depressive Disorder Benjamin Carroll
05:30 PM - 06:30 PM EDT	Abstract	9-015 - Safety, Pharmacokinetics (PK), and Pharmacodynamics (PD) of TAK-831, a Selective D-amino Acid Oxidase Inhibitor, in Healthy Volunteers Lin Xu, PhD
05:30 PM - 06:30 PM EDT	Abstract	9-016 - Individual Differences in Social Network Size Linked to Nucleus Accumbens and Hippocampal Volumes in Motor Functional Neurological Disorders Juan Pablo Ospina Botero, MD
05:30 PM - 06:30 PM EDT	Abstract	9-017 - Event Related Potentials as a possible Traumatic Brain Injury (TBI) biomarker in older patients at risk of neurodegenerative disorders Katherine Turk, MD
05:30 PM - 06:30 PM EDT	Abstract	9-018 - “Paroxysmal Symptoms and Correlated EEG findings in Dementia with Lewy Bodies” Deepmala Nandanwar, MD
05:30 PM - 06:30 PM EDT	Abstract	9-019 - The Role of Neuroimaging in a Fragile X Carrier with only Dementia and Perypheral Neuropathy André Luiz Guimarães de Queiroz
05:30 PM - 06:30 PM EDT	Abstract	9-020 - Primary Familial Brain Calcification Yazan Radaideh, MD
05:30 PM - 06:30 PM EDT	Abstract	9-021 - The Cognitive Phenotyping of McCune-Albright Syndrome: A Case Series
05:30 PM - 06:30 PM EDT	Abstract	9-022 - Compound heterozygous C9ORF72 hexanucleotide repeat expansions causing FTD Daniel Anderson, DO
05:30 PM - 06:30 PM EDT	Abstract	9-023 - A Novel PRNP-G131R Mutation Associated with Familial Prion Disease Jumana T. Alshaikh, MD
05:30 PM - 06:30 PM EDT	Abstract	9-024 - CSF1R Mutation-negative Adult-onset Leukoencephalopathy with Axonal Spheroids and Pigmented Glia (ALSP): Genotypic Heterogeneity in an Important Cause of Early-onset Dementia Benjamin P. Trewin, MBBS, PhD, FRACP
05:30 PM - 06:30 PM EDT	Abstract	9-025 - Distinctive Clinical Features of Cerebral Amyloid Angiopathy Related Inflammation: the Vanderbilt University Medical Center Experience James E. Eaton III, MD
05:30 PM - 06:30 PM EDT	Abstract	9-026 - Morphometric correlation of parkinsonian signs in different primary progressive aphasia syndromes
05:30 PM - 06:30 PM EDT	Abstract	9-027 - Saccadic Eye Movements: A Glimpse into Cognitive Impairment
05:30 PM - 06:30 PM EDT	Abstract	9-028 - Early in vivo signatures of neurodegeneration at individual level in isolated REM behaviour disorder
05:30 PM - 06:30 PM EDT	Abstract	9-029 - The UCSF Memory and Aging Center: Early Developmental History Screening Questionnaire
05:30 PM - 06:30 PM EDT	Abstract	9-030 - Cognitive Profiles in Amyloid-Positive Mild Cognitive Impairment and Alzheimer’s Disease with and without Tau Lauren McCollum, MD
05:30 PM - 06:30 PM EDT	Abstract	9-031 - Cognitive Decline Over 18 Months in Patients With Mild Cognitive Impairment or Dementia due to Alzheimer’s Disease
05:30 PM - 06:30 PM EDT	Abstract	9-032 - Prosodic Impairment as a Marker of apoE4 Status in logopenic variant Primary Progressive Aphasia with AD Pathology Naomi Nevler, MD
05:30 PM - 06:30 PM EDT	Abstract	9-033 - Creutzfeldt-Jakob Disease Masquerading as Autoimmune Encephalitis Sushma Kola, MD
05:30 PM - 06:30 PM EDT	Abstract	9-034 - Elevation of 14-3-3 and Unique MRI findings in a Case of Logopenic Variant Primary Progressive Aphasia Yazan Al-Hasan, MD, PhD
05:30 PM - 06:30 PM EDT	Abstract	9-035 - An Atypical Presentation of Prion Disease with Alien Limb, Apraxia, and Intact Cognition Saima Chaudhry, MD
05:30 PM - 06:30 PM EDT	Abstract	15-001 - Quantifying CSF Biomarkers of Neuronal Injury, Neuroinflammation and Synaptic Integrity in Antibody-Mediated Encephalitis Gregory S. Day, MD, MSc, FAAN
05:30 PM - 06:30 PM EDT	Abstract	15-002 - Sensitivity of Cell Count and Protein in Cerebrospinal Fluid for the Diagnosis of Autoimmune Encephalitis Julien Hebert, MD
05:30 PM - 06:30 PM EDT	Abstract	15-003 - Autoimmune encephalitis in children: A case series from a tertiary care center Alice Edwards, DO
05:30 PM - 06:30 PM EDT	Abstract	15-004 - Determining the Prevalence of Sleep Disturbances in Autoimmune Encephalitis Margaret Blattner, MD
05:30 PM - 06:30 PM EDT	Abstract	15-005 - Autoimmune Encephalitis in the Neurologic Intensive Care Unit: Clinical Characteristics, Complications, and Outcomes. Shailee S. Shah, MD
05:30 PM - 06:30 PM EDT	Abstract	15-006 - Clinical, radiological and laboratory comparison between autoantibody-negative and autoantibody-positive Autoimmune Encephalitis patients. Antonino Giordano
05:30 PM - 06:30 PM EDT	Abstract	15-007 - Imaging and Pathologic Findings in an Adult and Pediatric Case of Anti-GABA-A Receptor Encephalitis Neena Cherayil, MD
05:30 PM - 06:30 PM EDT	Abstract	15-008 - NMDAR encephalitis associated with HIV "CNS escape" Patrick B. Moloney, MBBS
05:30 PM - 06:30 PM EDT	Abstract	15-009 - Improving Utilization of Neurological Autoantibody Testing at a Public Hospital: A Quality Improvement Project Kyle M. Blackburn, MD
05:30 PM - 06:30 PM EDT	Abstract	15-010 - Need for ICD Code for Suspected Autoimmune Encephalitis as Demonstrated by Retrospective Ten Year Analysis of Unspecified Autoimmune Encephalitis Treated with Immunoglobulin or Plasma Exchange
05:30 PM - 06:30 PM EDT	Abstract	15-011 - What Does a Positive Neuronal Antibody Titer Mean? Fajun Wang, MD
05:30 PM - 06:30 PM EDT	Abstract	15-012 - Cerebral FDG-PET Findings in a Patient with Limbic Encephalitis: an Important Aid to Localize the Affected Region and Support the Diagnosis of Autoimmune Encephalitis. Dhara Murray-Frank, MD
05:30 PM - 06:30 PM EDT	Abstract	15-013 - Coexisting Anti-Ma and Anti-NMDA-R Antibody Syndromes in a Case of Brainstem and Limbic Encephalitis Ryan Kammeyer, MD
05:30 PM - 06:30 PM EDT	Abstract	15-014 - An unusual late presentation of anti-NMDA Receptor (NMDA-R) Autoimmune Encephalitis following Herpes Simplex Virus (HSV) Encephalitis Amr H. Ewida, MD
05:30 PM - 06:30 PM EDT	Abstract	15-015 - Anti-N-Methyl-D-Aspartate (NMDA) Encephalitis Associated with Tall-cell Variant Papillary Thyroid Carcinoma Ahmad Mahadeen, MD
05:30 PM - 06:30 PM EDT	Abstract	15-016 - When Autoimmune Encephalitis masquerades as an Eating Disorder, two case reports on unique presentation of anti - NMDAR Encephalitis. Akash Virupakshaiah, MD
05:30 PM - 06:30 PM EDT	Abstract	15-017 - A case of CSF NMDA antibody negative NMDA encephalitis! Khaled Abdalla, MD
05:30 PM - 06:30 PM EDT	Abstract	15-018 - Diffuse White Matter Disease and Rapidly Progressive Dementia Secondary to Non-Paraneoplastic Voltage-Gated Calcium Channels Antibody
05:30 PM - 06:30 PM EDT	Abstract	15-019 - A challenging case of intractable seizures in a pediatric patient with anti-GAD65 encephalitis Supriya Kairamkonda, MD
05:30 PM - 06:30 PM EDT	Abstract	15-020 - Anti-GAD Antibody Associated Encephalitis: A Child with Epilepsia Partialis Continua and Ataxia Isaac Molinero, MD
05:30 PM - 06:30 PM EDT	Abstract	15-021 - Anti-GAD65 Antibody: a Possible Link to Encephalopathy, Aphasia, Seizures and Lateralized Weakness Gabriela Tantillo, MD
05:30 PM - 06:30 PM EDT	Abstract	15-022 - Drug-Resistant Status Epilepticus Associated with GAD-65 Autoimmune Limbic Encephalitis Rafia Shafqat, MD
05:30 PM - 06:30 PM EDT	Abstract	15-023 - GAD 65 Antibody Encephalitis Presenting as New Onset Refractory Status Epilepticus (NORSE) Amin Sanei Moghaddam, MD
05:30 PM - 06:30 PM EDT	Abstract	15-024 - Evaluation of the Malignancy Risk Associated With Paraneoplastic Antibodies Robert J. Marquardt, DO
05:30 PM - 06:30 PM EDT	Abstract	15-025 - An Atypical Presentation of Anti-Hu Receptor Meningoencephalitis Brittany L. Heckel, MD
05:30 PM - 06:30 PM EDT	Abstract	15-026 - Post-Herpes Autoimmune Encephalitis Luay Mrad, MD
05:30 PM - 06:30 PM EDT	Abstract	15-027 - Voltage-Gated Potassium Channel Antibody-Mediated Encephalitis in Siblings Kiel Woodward, MD
05:30 PM - 06:30 PM EDT	Abstract	15-028 - A Report on LGI1 Encephalitis in association with Squamous Cell Carcinoma of the Lung Akash Virupakshaiah, MD
05:30 PM - 06:30 PM EDT	Abstract	15-029 - Refractory LGI-1 Limbic Encephalitis and Secondary Mesial Temporal Lobe Epilepsy: A Case Report Tahsin Khan, MD
05:30 PM - 06:30 PM EDT	Abstract	15-030 - Presence of Systemic Autoantibodies and Associated Comorbid Conditions in a Large Cohort of Stiff Person Syndrome Michael Comisac III
05:30 PM - 06:30 PM EDT	Abstract	15-031 - F/M Wave Area And F-Wave Duration Quantify Spinal Hyperexcitability in Glutamic Acid Decarboxylase (GAD) Antibody Positive Patients with Stiff Person Syndrome. Mahmood Shbeb, MD
05:30 PM - 06:30 PM EDT	Abstract	15-032 - Coexistence of neuromyelitis optica and stiff person syndrome in a single patient: a case report Amanda Thuringer, DO
05:30 PM - 06:30 PM EDT	Abstract	15-033 - Long-term Rituximab Use Benefits Patients with Stiff Person Syndrome Salman Aljarallah, MD
05:30 PM - 06:30 PM EDT	Abstract	15-034 - Anti Glutamic Acid Decarboxylase Antibody Syndromes Occur At An Earlier Age In African Americans. Shitiz K. Sriwastava, MBBS
05:30 PM - 06:30 PM EDT	Abstract	15-035 - Double Hit and Excellent Treatment Response: AMPA and GAD-65 Receptor Antibodies in a Young Woman with Stiff Person Plus Syndrome Misdiagnosed as Acute Scoliosis and Bipolar Disorder Natalie P. Witek, MD
05:30 PM - 06:30 PM EDT	Abstract	15-036 - GAD65 and Glycine Receptor-Associated Neurologic Autoimmunity and Stiff-Person Syndrome within the University of Utah Health Care System Jonathan R. Galli, MD
05:30 PM - 06:30 PM EDT	Abstract	15-037 - Bortezomib for the Treatment of Refractory Stiff Person Spectrum Disorder Khalil Husari, MD
05:30 PM - 06:30 PM EDT	Abstract	15-038 - Isolated Dysarthria due to Immune-mediated Brainstem Encephalitis Associated with Anti-Glutamate Acid Decarboxylase 65 antibodies Sara Dawit, MD
05:30 PM - 06:30 PM EDT	Abstract	15-039 - Anti- Tr antibodies in autoimmune cerebellar ataxia: Serial antibody testing and response to immunotherapy Chrysanthi Barba
05:30 PM - 06:30 PM EDT	Abstract	15-040 - Steroid therapy in probable cerebellar-type Hashimoto's encephalopathy Masako Kinoshita, MD, PhD
05:30 PM - 06:30 PM EDT	Abstract	15-041 - A Previously Undescribed Case of an Autoimmune Cerebellar Ataxia (ACA) Associated with a Novel Antibody Against Mouse Cerebellum. Sabeena I. Malik, MD
05:30 PM - 06:30 PM EDT	Abstract	15-042 - Bilateral Horizontal Gaze Paralysis - Case Series Poonam Bansal, MD
05:30 PM - 06:30 PM EDT	Abstract	15-043 - Anti-GAD 65 Antibody Mediated Cerebellar hemiataxia Abdul Rahman Alchaki, MD
05:30 PM - 06:30 PM EDT	Abstract	15-044 - A Rare Case of Non-Neoplastic Anti-GAD Positive Cerebellar Ataxia and Progressive Encephalomyelitis with Rigidity and Myoclonus (PERM), Responsive to IVIG Therapy Noushin Jazebi, MD
05:30 PM - 06:30 PM EDT	Abstract	15-045 - Paraneoplastic cerebellar degeneration in a woman with gastric adenocarcinoma Jonathan Lauritsen, DO
05:30 PM - 06:30 PM EDT	Abstract	15-046 - Autoimmune dystonia – a group of patients responsive to immunotherapy Firas Sioufi, MD
05:30 PM - 06:30 PM EDT	Abstract	15-047 - Chronic Lymphocytic Inflammation with Pontine Perivascular Enhancement not Responsive to Steroids – Management Decisions in a Situation of Diagnostic Uncertainty Buse Sengul, MD
05:30 PM - 06:30 PM EDT	Abstract	15-048 - The Hand that Danced: A Case of Seronegative NMO presenting with Pseudoathetosis Aditya V. Boddu, MD
05:30 PM - 06:30 PM EDT	Abstract	15-049 - Paraneoplastic Syndrome with a Progressive Supranuclear Palsy phenotype Abdallah O. Amireh, MD
05:30 PM - 06:30 PM EDT	Abstract	15-050 - A Young Woman with Palatal Myoclonus, Memory loss and Seizures Shawn Allen, MD
05:30 PM - 06:30 PM EDT	Abstract	15-051 - Discovering Context-dependent Whole Blood Gene Expression Quantitative Trait Loci (eQTL) In Relapsing Remitting Multiple Sclerosis
05:30 PM - 06:30 PM EDT	Abstract	15-052 - Distribution and Efficacy of Ofatumumab and Ocrelizumab in Humanized-CD20 Mice following Subcutaneous or Intravenous Administration
05:30 PM - 06:30 PM EDT	Abstract	15-053 - IL-11 Induces Encephalitogenic Th17 cells in Experimental Autoimmune Encephalomyelitis Nazanin Kiapour, MD
05:30 PM - 06:30 PM EDT	Abstract	15-054 - Effect of Fumarates on Human iPSC Derived Neural Progenitor Cells and Human Primary Neurons
05:30 PM - 06:30 PM EDT	Abstract	15-055 - Cladribine modulates the expression of ICAM-1 and VCAM-1 on human brain endothelium; relevance to multiple sclerosis (MS) Simon Hawke
05:30 PM - 06:30 PM EDT	Abstract	15-056 - Evaluating the Effect of Cladribine on Marmoset B- and T-Cell Proliferation and Survival
05:30 PM - 06:30 PM EDT	Abstract	15-057 - High Dose Biotin, MD1003, Protects Axons in a Mouse Model of Chronic Spinal Cord Demyelination Arthur E. Warrington, PhD
05:30 PM - 06:30 PM EDT	Abstract	15-058 - The Role of Cyclophilin A in Immune-mediated CNS Inflammation Unsong Oh, MD
05:30 PM - 06:30 PM EDT	Abstract	15-059 - Paracrine Modulation of Microglial Activation and Oligodendroglial Differentiation as Potential Therapeutic Mechanisms of Mesenchymal Stem Cell-Derived Neural Progenitors (MSC-NPs) Cellular Therapy in MS
05:30 PM - 06:30 PM EDT	Abstract	15-060 - Serum Exosomes from Multiple Sclerosis subjects express EBV-derived proteins and activate Monocyte-Derived Macrophages Samia J. Khoury, MD, FAAN
05:30 PM - 06:30 PM EDT	Abstract	15-061 - Thalamic Energy Dysregulation Drives Microstructural Changes Of Thalamo-Cortical Projections In Multiple Sclerosis Vito A. Ricigliano
05:30 PM - 06:30 PM EDT	Abstract	15-063 - Inhibition of Bruton’s Tyrosine Kinase Selectively Prevents Antigen-Activation of B cells and Ameliorates B-Cell-Mediated Experimental Autoimmune Encephalomyelitis
05:30 PM - 06:30 PM EDT	Abstract	15-064 - Novel Mouse Model to Study Cerebellar Dysfunction in Multiple Sclerosis Natalie Favret
05:30 PM - 06:30 PM EDT	Abstract	15-065 - Characterization of Myelin-reactive CD8+ T cells in Multiple Sclerosis Joseph J. Sabatino, Jr., MD
05:30 PM - 06:30 PM EDT	Abstract	15-066 - Pharmacokinetic/Pharmacodynamic Characterization of Siponimod (BAF312) in Blood versus Brain in Experimental Autoimmune Encephalomyelitis Mice Marc Bigaud
05:30 PM - 06:30 PM EDT	Abstract	15-067 - Oligodendroglial FGFR1 gene targeting protects against cerebellar demyelination and axonal degeneration in MOG35-55 induced chronic EAE Ranjithkumar Rajendran
05:30 PM - 06:30 PM EDT	Abstract	15-068 - Single Cell Analysis of Acute Inflammatory Demyelinating Syndromes Identify Cell States Enriched for MS Susceptibility Claudiu I. Diaconu, MD
05:30 PM - 06:30 PM EDT	Abstract	15-069 - Dimethyl Fumarate Exerts Selective Effects on Key B Cell Subsets and IgG Levels Which May Contribute to its Therapeutic Benefit in MS While Maintaining Protective Humoral Immunity Amit Bar-Or, MD, FRCPC
05:30 PM - 06:30 PM EDT	Abstract	15-070 - Single-Cell Genomics Reveals Spatial and Stage-Associated Diversity in Multiple Sclerosis Lucas Schirmer, MD
05:30 PM - 06:30 PM EDT	Abstract	15-071 - Dimethyl Fumarate (DF) Suppresses GMCSF-producing Th1 cells in EAE and human CD4 T cells. Farinaz Safavi, MD, PhD
05:30 PM - 06:30 PM EDT	Abstract	15-072 - Flotillin-1/2 autoantibodies in patients with inflammatory disorders of the CNS Sara Mariotto, MD, PhD
05:30 PM - 06:30 PM EDT	Abstract	15-073 - Intrathecal Injections of Primary Progressive Multiple Sclerosis Derived Antibodies Result in Motor Deficits and CNS Pathology in Mice Suggesting Leading Role of Antibodies in CSF Effects Francesca M. Cali
05:30 PM - 06:30 PM EDT	Abstract	15-074 - Establishment of Neurofilament Light Chain (NfL) SIMOA assay as well as a conversion factor to enable comparison to historical results using Bovine calibrators. Robert Hendricks
05:30 PM - 06:30 PM EDT	Abstract	15-075 - The Role of Pericytes in the Pathophysiology of Multiple Sclerosis Erdem Tuzun
05:30 PM - 06:30 PM EDT	Abstract	15-076 - Regulatory T cells Modulate B-cell Calcium Fluctuation
05:30 PM - 06:30 PM EDT	Abstract	15-077 - Inhibition of Bruton’s Tyrosine Kinase Prevents Inflammatory Macrophage Differentiation: A Potential Role in Multiple Sclerosis
05:30 PM - 06:30 PM EDT	Abstract	15-078 - Microarray Analysis Indicates Altered Expression Levels of B Cell Genes in Benign Multiple Sclerosis Recai Turkoglu
05:30 PM - 06:30 PM EDT	Abstract	15-079 - A Study of Long Noncoding RNAs Expression Levels in the CSF of Multiple Sclerosis Patients
05:30 PM - 06:30 PM EDT	Abstract	15-080 - Analyzing Normal and Multiple Sclerosis Brain Cells Using Single-Nucleus RNA Sequencing: Transcriptome Analyses of Normal and Diseased Cells Expressing S1P Receptors and Related Enzymatic Genes
05:30 PM - 06:30 PM EDT	Abstract	15-081 - Effect of Route of Administration on the Biodistribution of a Novel Anti-CD20 Antibody in Experimental Autoimmune Encephalomyelitis-Variant Mice
05:30 PM - 06:30 PM EDT	Abstract	15-082 - NfL Levels in CSF, Serum, and Plasma of RRMS and PPMS Patients in a Cross-sectional UCSF Cohort Christopher Harp
05:30 PM - 06:30 PM EDT	Abstract	15-083 - Cross-talk between Multiple Sclerosis (MS)-relevant B cell subsets and myeloid cells: potential contribution to the CNS-compartmentalized inflammation associated with disease progression Hanane Touil, PhD
05:30 PM - 06:30 PM EDT	Abstract	15-084 - CD39/CD73 Implication In Neuro-immunological Inflammatory Disorders
05:30 PM - 06:30 PM EDT	Abstract	15-085 - Melanoma cell adhesion molecule-expressing memory helper T cells in CNS-demyelinating diseases Ryotaro Ikeguchi
05:30 PM - 06:30 PM EDT	Abstract	15-086 - Axons Exposed to an Inflammatory Stimulus are Vulnerable to Damage by CD8+ Cytotoxic T Cells Implicated in Axon Injury William F. Schmalstieg, MD
05:30 PM - 06:30 PM EDT	Abstract	15-087 - Longitudinal Expression of Gluco- and Mineralocorticoid Receptors and their Targets in Multiple Sclerosis Clemens Goedel, MD
05:30 PM - 06:30 PM EDT	Abstract	15-088 - Effect of Subcutaneous Treatment With Anti-CD20 Antibody on B-cell Depletion in a Lipopolysaccharide-Induced Inflammatory Mouse Model
05:30 PM - 06:30 PM EDT	Abstract	15-089 - Human MAIT Cell Response Shows Subset Diversity in Multiple Sclerosis Jorge D. Correale, MD
05:30 PM - 06:30 PM EDT	Abstract	15-090 - Transcriptional Profiling of Autologous Bone Marrow Mesenchymal Stem Cell-Derived Neural Progenitors (MSC-NPs) from Patients with Multiple Sclerosis
05:30 PM - 06:30 PM EDT	Abstract	15-091 - Co-existence of Multiple Sclerosis and Anti-NMDA Receptor Encephalitis: What We Can Learn From It? Bade Gulec
05:30 PM - 06:30 PM EDT	Abstract	15-092 - Cerebrospinal Fluid of Primary Progressive MS Patients Impairs Remyelination in an Experimental Model of Multiple Sclerosis
05:30 PM - 06:30 PM EDT	Abstract	15-093 - Nilotinib-associated Demyelinating Disease Casey J. Judge, DO
05:30 PM - 06:30 PM EDT	Abstract	15-094 - Longitudinal Changes in the Expression of IL-33 in Relapsing Remitting Multiple Sclerosis Subramaniam Sriram, MD
05:30 PM - 06:30 PM EDT	Abstract	15-095 - Neuroblastoma Cell Line and Lymphocytes Talk for Cladribine Influenced Apoptosis and Inflammation Pathways in Multiple Sclerosis (MS): An “In Vitro” Study
05:30 PM - 06:30 PM EDT	Abstract	15-096 - Gene Expression Profiles of Proteins Involved in Cladribine Metabolism and their Possible Correlation with Epstein-Barr Virus Variants
05:30 PM - 06:30 PM EDT	Abstract	15-097 - A novel mouse model of demyelinated lysolecithin lesions at different stages of remyelination Jonpaul Bonsignore
05:30 PM - 06:30 PM EDT	Abstract	15-098 - From Mouse to Man – Translational Aspects of Serum Neurofilament Light Chain in Multiple Sclerosis Frauke Zipp, MD
05:30 PM - 06:30 PM EDT	Abstract	15-099 - Peripheral Nerve Hyperexcitability Syndromes: a Single Center Experience. Gregorio Spagni
05:30 PM - 06:30 PM EDT	Abstract	15-100 - Prevalence of Axonal sensory neuropathy with IgM binding to Trisulfated heparin disaccharide (TS-HDS) in patients with Fibromyalgia Asma Malik, MD
05:30 PM - 06:30 PM EDT	Abstract	15-101 - Calcineurin Inhibitors Can Be Safely Reduced in Most Patients with Well-controlled Myasthenia Gravis. Yuko Takahashi
05:30 PM - 06:30 PM EDT	Abstract	15-102 - Comparison of the Quantitative Myasthenia Gravis (QMG) and Myasthenia Gravis Activities of Daily Living (MG-ADL) scores in the MGTX Randomized Trial Tarrant McPherson
05:30 PM - 06:30 PM EDT	Abstract	15-103 - Bilateral sixth nerve cranial palsy: Should we think of Myasthenia Gravis? Lithey Poveda
05:30 PM - 06:30 PM EDT	Abstract	15-104 - CIDP Disease Burden: Results of a US Nationwide Patient Survey Todd D. Levine, MD
05:30 PM - 06:30 PM EDT	Abstract	15-105 - Does CIDP Increase The Risk of Acquiring Other Autoimmune Disorders? A New York State Planning and Research Cooperation System Database Analysis (1998-2014) Sanjila Islam, MD
05:30 PM - 06:30 PM EDT	Abstract	15-106 - First Report of Confirmed CIDP in a Patient with Neuromyelitis Optica Spectrum Disorder (NMOSD) Maitreyi Murthy, MD
05:30 PM - 06:30 PM EDT	Abstract	15-107 - Refractory Contactin-1-seropositive chronic inflammatory demyelinating polyneuropathy with involvement of cranial nerves: A case report. Emilio R. Garrido Sanabria, MD, PhD
05:30 PM - 06:30 PM EDT	Abstract	15-108 - Serological and Clinical Profile of Antibody Positive Autoimmune Gastrointestinal Dysmotility Patients Receiving IVIg Chen Yan, MD
05:30 PM - 06:30 PM EDT	Abstract	15-109 - Miller-Fisher Syndrome Presenting in an Air Force Recruit with Extensive Maxillary Sinus Disease as Unilateral Ophthalmoplegia Morgan Jordan, DO
05:30 PM - 06:30 PM EDT	Abstract	15-110 - Novel Findings in Hereditary Sensory and Autonomic Neuropathy Type IV Aditi V. Varma-Doyle, MD
05:30 PM - 06:30 PM EDT	Abstract	3-001 - The Oldest Strokes in the Oldest State: Experience of Acute Stroke at Maine Medical Center Michael P. Stanley, MD
05:30 PM - 06:30 PM EDT	Abstract	3-002 - Differences in Presenting Symptoms of Acute Stroke Among Young and Older Adults Haley Huggins, MD
05:30 PM - 06:30 PM EDT	Abstract	3-003 - Do Older stroke patients with higher NIHSS scores have increased DTN time? Nidhi Kasatwar, MD
05:30 PM - 06:30 PM EDT	Abstract	3-004 - The relationship between individual risk factors and likelihood to list modifiable stroke risk factors amongst racial/ethnic minority seniors in Los Angeles Demelio A. Urbano
05:30 PM - 06:30 PM EDT	Abstract	3-005 - Mechanical Thrombectomy is effective and safe on elderly stroke patients Marwa A. Elnazeir, MD
05:30 PM - 06:30 PM EDT	Abstract	3-006 - Characteristics and Outcomes of Mechanical Thrombectomy in Nonagenarians Sishir Mannava, MD
05:30 PM - 06:30 PM EDT	Abstract	3-007 - Clinical Outcomes following Endovascular Therapy and/or Thrombolysis in Elderly with Large Vessel Occlusion Strokes: A “Real World” Experience Tamra I. Ranasinghe, MD
05:30 PM - 06:30 PM EDT	Abstract	3-008 - Not all Strokes in the Young are Vasculitis: A Challenging Case of Thrombotic Thrombocytopenic Purpura Steven C. Swavely, MD
05:30 PM - 06:30 PM EDT	Abstract	3-009 - Hypercoagulable States in Young Adults with Ischemic Stroke in a Stroke Belt State Sarah R. Durica, MD
05:30 PM - 06:30 PM EDT	Abstract	3-010 - Focal Cerebral Arteriopathy in Young Adult Stroke Patients Mary Clare McKenna, MB BCh BAO PhD
05:30 PM - 06:30 PM EDT	Abstract	3-011 - Angiomatosis Cerebri Meghan Purohit, DO
05:30 PM - 06:30 PM EDT	Abstract	3-012 - Associations Between Risk Factors and Stroke Mechanisms in Young Adult Stroke
05:30 PM - 06:30 PM EDT	Abstract	3-013 - Impact of race in ischemic stroke affecting young adults Haitham Hussein, MD, FAAN
05:30 PM - 06:30 PM EDT	Abstract	3-014 - Establishing Criteria for Triage of Primary Intracerebral Hemorrhage Patients: Optimizing ICH Care Across Health Care Systems Katie Alex
05:30 PM - 06:30 PM EDT	Abstract	3-015 - Outcomes in Transferred Stroke Patients with Large Vessel Occlusion (LVO) after IV rt-PA Nikil Swamy, MD
05:30 PM - 06:30 PM EDT	Abstract	3-016 - Interfacility Transfer for Mechanical Thrombectomy – Direct to Neuroangiography or CT Angiography First? Kelley Humbert, MD
05:30 PM - 06:30 PM EDT	Abstract	3-017 - Transfer to Nearest Primary Stroke Center Portends Significant Delays and Poorer Outcomes in LVOs. Audrey Arango, RN
05:30 PM - 06:30 PM EDT	Abstract	3-018 - Gender Disparities in Misdiagnosis of Ischemic Stroke or TIA During Telestroke Consultation Tara D. Von Kleist, MBBS
05:30 PM - 06:30 PM EDT	Abstract	3-019 - Complicated Migraines treated with Thrombolysis as an Ischemic Stroke mimic via Telestroke Ravyn Cash, NP
05:30 PM - 06:30 PM EDT	Abstract	3-020 - Telestroke Technology Decreases Time to Neurologist Evaluation for Emergent Stroke Treatment During After Hours Andrew J. Zhang, MD
05:30 PM - 06:30 PM EDT	Abstract	3-021 - Telestroke Sub-events and their Contribution to Door-to-Needle Time in a Telestroke Network Rahul H. Rahangdale, MD
05:30 PM - 06:30 PM EDT	Abstract	3-022 - Implementation of Secure Messaging System Reduces Response to Page in Telestroke Network Chris Hackett, MA
05:30 PM - 06:30 PM EDT	Abstract	3-023 - Differences in Door-to-Needle Times and Functional Outcomes between Primary Stroke Centers and Non-Primary Stroke Centers in a Telestroke Network Among Patients Receiving Intravenous Tissue Plasminogen Activator Shaun Ajinkya, MD
05:30 PM - 06:30 PM EDT	Abstract	3-024 - Extending Telestroke Call Window to 24 Hours Increases Call Volume and Acute Stroke Treatments Chris Hackett, MA
05:30 PM - 06:30 PM EDT	Abstract	3-025 - C3FIT (Coordinated, Collaborative, Comprehensive, Family-Based, Integrated, and Technology-Enabled Care): A Randomized Controlled Comparative Effectiveness Trial on Stroke Health Care Delivery. William D. Freeman, MD, FAAN
05:30 PM - 06:30 PM EDT	Abstract	3-026 - Intra-arterial mesenchymal stem cell therapy modulates inflammasome to confer neuroprotection in animal model of ischemic stroke Pallab Bhattacharya, PhD
05:30 PM - 06:30 PM EDT	Abstract	3-027 - Utilizing Single Cell Immune Profiling to Identify Serum-based Biomarkers for Transient Ischemic Attacks Kate E. Therkelsen, MD
05:30 PM - 06:30 PM EDT	Abstract	3-028 - Neuroprotection by Non Steroidal Anti-Inflammatory Drugs Against an In Vivo & In Vitro Ischemic Stroke via Downregulating Intrinsic Apoptosis Pathways.
05:30 PM - 06:30 PM EDT	Abstract	3-029 - Glutamate Induces Synthesis of Thrombogenic Peptides and Extracellular Vesicle Release from Human Platelets Deepa Gautam
05:30 PM - 06:30 PM EDT	Abstract	3-030 - Serum Troponin Level In Acute Ischemic Stroke Identifies Patients with Concomitant Visceral Infarcts Aidan Azher, MD
05:30 PM - 06:30 PM EDT	Abstract	3-031 - Low Holotrancobalamin- A Risk Factor And Better Marker Than Cobalamin And Homocysteine In Acute Stroke. Yatin Sagvekar
05:30 PM - 06:30 PM EDT	Abstract	3-032 - The Relationship Between Serum Highly Sensitive C-Reactive Protein, Severity And Short-Term Outcome In Acute Stroke At The Lagos University Teaching Hospital, Lagos, Nigeria. Oguntunde F. Olapeju, MBBS
05:30 PM - 06:30 PM EDT	Abstract	3-033 - Utility of D-dimer for oncologic disease suspicion in patients with cryptogenic ischemic stroke.
05:30 PM - 06:30 PM EDT	Abstract	3-034 - Thromboelastography with Platelet Mapping(TEG-PM) is a Sensitive Indicator of Radiographically Confirmed Ischemic Stroke: A Retrospective Analysis. Niraj A. Arora, MD
05:30 PM - 06:30 PM EDT	Abstract	3-035 - Differences in Admission Electrolyte Concentrations among Stroke Etiologies Rachel Forman, MD
05:30 PM - 06:30 PM EDT	Abstract	3-036 - Design of a Phase III Study of Intravenous Glibenclamide (BIIB093) for Large Hemispheric Infarction: the CHARM Study Kevin N. Sheth, MD, FAAN
05:30 PM - 06:30 PM EDT	Abstract	3-037 - Prediction of Malignant Edema in Anterior Circulation Stroke: Validation of the EDEMA Score and Added Value of Stroke Severity Yajun Cheng
05:30 PM - 06:30 PM EDT	Abstract	3-038 - Neuro-Checks and the National Institute of Health Stroke Scale in Acute Stroke
05:30 PM - 06:30 PM EDT	Abstract	3-039 - Early mobilization after 12 hours post thrombolysis is feasible and safe in minor stroke patients Muhib Khan, MD, FAAN
05:30 PM - 06:30 PM EDT	Abstract	3-040 - Fast-track versus Long-term Hospitalizations for Patients with Non-disabling Acute Ischaemic Stroke Joachim Fladt, MD
05:30 PM - 06:30 PM EDT	Abstract	3-041 - Understanding the Environment of Care for Hospitalized Stroke Patients Alyssa Chao
05:30 PM - 06:30 PM EDT	Abstract	3-042 - Disparities in the effect of atrial fibrillation on discharge destination and length of stay in patients hospitalized for ischemic stroke: the Florida Puerto Rico Atrial Fibrillation Stroke Study Nicole B. Sur, MD
05:30 PM - 06:30 PM EDT	Abstract	3-043 - Practice Alert: Generalized Tonic-Clonic Seizures Associated with Intra-arterial Administration of High Doses of Verapamil in Treatment of Cerebral Vasospasm
05:30 PM - 06:30 PM EDT	Abstract	3-044 - Triage of Acute Strokes Using an EMS-driven Rapid Arterial Occlusion Evaluation (RACE) Protocol: a Longitudinal Study. Ehad Afreen, MD
05:30 PM - 06:30 PM EDT	Abstract	3-045 - Improving field Identification of Large vessel occlusion: A retrospective review analysis Parneet K. Grewal, MD
05:30 PM - 06:30 PM EDT	Abstract	3-046 - A Prehospital Los Angeles motor scale (LAMS) score of 4 or more predicts intervention for acute stroke. Tej Stead
05:30 PM - 06:30 PM EDT	Abstract	3-047 - Improvement in Stroke Survey Scores for Rural EMS Providers Eric J. Seachrist, MD
05:30 PM - 06:30 PM EDT	Abstract	3-048 - Reasons for Prehospital Delay in Acute Ischemic Stroke: a Prospective Cohort Study Joachim Fladt, MD
05:30 PM - 06:30 PM EDT	Abstract	3-049 - RAcial Disparities in Ich After iv-tpA and Neurointerventional Treatment (RADIANT) Chia-Chun Chiang, MD
05:30 PM - 06:30 PM EDT	Abstract	3-050 - Cerebral Oximetry in Acute Ischemic Stroke Patients According to Brain Area and Recanalization Status
05:30 PM - 06:30 PM EDT	Abstract	3-051 - A Life Saving Treatment in an Adolescent Girl Presenting with Headache and Stupor Vishal Mandge, MD
05:30 PM - 06:30 PM EDT	Abstract	3-052 - Clinical Presentation, Neuroimaging Characteristics and Long-term Outcome in Pediatric Cerebral Venous Sinus Thrombosis: A Retrospective Study Cemal Karakas, MD
05:30 PM - 06:30 PM EDT	Abstract	3-053 - Retrospective Cohort Analysis in Neonatal Cerebral Sinus Venous Thrombosis Cemal Karakas, MD
05:30 PM - 06:30 PM EDT	Abstract	3-054 - Endovascular Reconstruction of Intracranial Aneurysms with Pipeline in Pediatric Patients Peyman Shirani, MD
05:30 PM - 06:30 PM EDT	Abstract	3-055 - Utility of Routine Neck MRA in a Pediatric MRI Stroke Protocol Austin Baltensperger, MD
05:30 PM - 06:30 PM EDT	Abstract	3-056 - Screening Tool to Provide Early Stroke Detection after Cardiac Catheterization in Children Catherine Salussolia, MD, PhD
05:30 PM - 06:30 PM EDT	Abstract	3-057 - Monogenic Causes of Cerebrovascular Disease in Childhood Bridget L. Ostrem, MD, PhD
05:30 PM - 06:30 PM EDT	Abstract	3-058 - Spontaneous Consecutive Four Vessel Cervicocephalic Dissections and Flow-Limiting Ischemic Stroke Anvi Gadani, MD
05:30 PM - 06:30 PM EDT	Abstract	3-059 - Gene Expression Profile of Cervical Artery Dissection by Time of Event Ilana Green, MD
05:30 PM - 06:30 PM EDT	Abstract	3-060 - Recurrent Cervicocephalic Dissections are Associated with Variants in Connective Tissue Disease Genes Mohammad Ridha, MD
05:30 PM - 06:30 PM EDT	Abstract	3-061 - IV Thrombolysis for Stroke Due to Cervicocephalic Arterial Dissection: What Is The Right Practice? Owais Khadem Alsrouji, MD
05:30 PM - 06:30 PM EDT	Abstract	3-062 - VZV-Induced Central Nervous System Vasculopathy: Clinical, Imaging and Biological Features Jean Khoury, MD
05:30 PM - 06:30 PM EDT	Abstract	3-063 - Treatment and Follow-up of VZV-Induced Central Nervous System Vasculopathy Jean Khoury, MD
05:30 PM - 06:30 PM EDT	Abstract	3-064 - Two Cases of Transient Global Amnesia in Marfan Syndrome Kenneth A. Morris, MD, PhD
05:30 PM - 06:30 PM EDT	Abstract	3-065 - A unique case of Turner syndrome with spontaneous intracranial artery dissection Aman Deep, MD
05:30 PM - 06:30 PM EDT	Abstract	3-066 - Clinicoradiographic Course of Focal Intracranial Arteriopathy in Young Adults Adam MacLellan, MD, BSch
05:30 PM - 06:30 PM EDT	Abstract	3-067 - Racial disparities in moyamoya disease in a North American cohort Khadija Irshad, MD
05:30 PM - 06:30 PM EDT	Abstract	3-068 - Is there a distinct phenotype for non-Asian moyamoya patients? Hajere Gatollari
05:30 PM - 06:30 PM EDT	Abstract	3-069 - Moyamoya Disease and Associated Risk Factors: Analysis of a National Database Animesh Gupta, MD
05:30 PM - 06:30 PM EDT	Abstract	12-001 - A Prospective Study of Patients with Chronic Inflammatory Demyelinating Polyneuropathy (CIDP): Identifying Ultrasonographic Features for Diagnosis and Prognosis Nicholas Crump, MD
05:30 PM - 06:30 PM EDT	Abstract	12-002 - Serum Cytokines and Chemokines in Chronic Inflammatory Demyelinating Polyneuropathy Compared to Diabetic Neuropathy, Idiopathic Neuropathy and Other Inflammatory Neuropathies Jeffrey Z. Shije, MD
05:30 PM - 06:30 PM EDT	Abstract	12-003 - Guillain- Barré Syndrome following Influenza Vaccination in the United States: A CDC/FDA Vaccine Adverse Event Reporting System Study, 1990-2016 Kevin Nolasco
05:30 PM - 06:30 PM EDT	Abstract	12-004 - Trends In Outpatient And Hospitalization Charges Relevant To the Management of Chronic Inflammatory Demyelinating Polyneuropathy: A Statewide Planning and Research Cooperative System (SPARCS) Study 2002-2014 Anil Thatikonda
05:30 PM - 06:30 PM EDT	Abstract	12-005 - A Case Series of Patients with Neurofascin Associated Peripheral Neuropathies Angela Aziz-Donnelly, MD
05:30 PM - 06:30 PM EDT	Abstract	12-006 - Clinical and Electrophysiological Features of Chronic Inflammatory Demyelinating Polyneuropathy in Chile. Jose G. Cea Munoz, MD
05:30 PM - 06:30 PM EDT	Abstract	12-007 - Long Term Differential Outcomes of CIDP Patients After Using IVIG, Plasmapheresis, Or Corticosteroids: A Statewide Planning and Research Cooperative System (SPARCS) Study 2002-2014 Anil Thatikonda
05:30 PM - 06:30 PM EDT	Abstract	12-008 - Vasculitic Peripheral Neuropathy, differences between Systemic and Non-Systemic etiologies.
05:30 PM - 06:30 PM EDT	Abstract	12-009 - Acute Inflammatory Demyelinating Polyneuropathy following Pembrolizumab infusion Anand Venkatraman, MBBS
05:30 PM - 06:30 PM EDT	Abstract	12-010 - Rituximab for the treatment of chronic inflammatory demyelinating polyradiculoneuropathy: A retrospective chart review Matthew Varon, MD
05:30 PM - 06:30 PM EDT	Abstract	12-011 - Acute Immune Sensory Polyradiculopathy (AISP): A Challenging Diagnosis Rocio Vazquez Do Campo, MD
05:30 PM - 06:30 PM EDT	Abstract	12-012 - The prevalence, severity and risk factors for chemotherapy induced peripheral neuropathy at 0 and 2 years after the completion of paclitaxel therapy Noah A. Kolb, MD
05:30 PM - 06:30 PM EDT	Abstract	12-013 - Proximal Median Neuropathy with Brachial Plexitis After PICC Placement; a Case Study and Review of Neurologic Complications Associated with Central Venous Catheter Placement Christa Seligman, NP
05:30 PM - 06:30 PM EDT	Abstract	12-014 - Inflammatory Ischemic Nerve Injury Can Cause CIDP-like Neuropathy Pariwat Thaisetthawatkul, MD, FAAN
05:30 PM - 06:30 PM EDT	Abstract	12-015 - Acute Motor And Sensory Axonal Neuropathy following Diarrheal Illness with Concomitant Dry Beri Beri following Bariatric Surgery Hesham T. Ghonim, MD
05:30 PM - 06:30 PM EDT	Abstract	12-016 - Nivolumab induced neurological syndrome mimicking acute inflammatory demyelinating polyneuroradiculopathy responding to infliximab Supriya Kairamkonda, MD
05:30 PM - 06:30 PM EDT	Abstract	12-017 - Multifocal motor neuropathy: a rare and complex disease - an university center’s experience. Caroline L. Medeiros, Jr., MD
05:30 PM - 06:30 PM EDT	Abstract	12-018 - Guillain Barre Syndrome Variant with Facial Diplegia and Paresthesias presenting with Bulbar Weakness Bhavesh Trikamji, MD
05:30 PM - 06:30 PM EDT	Abstract	12-019 - Clinical and Epidemiological Profile of a Brazilian’s cohort of patients with Chronic Inflammatory Demyelinating Polyradiculoneuropathy Viviane T. Carvalho, MD
05:30 PM - 06:30 PM EDT	Abstract	12-020 - Severe Subacute Motor Neuronopathy Associated with Non-Hodgkin B Cell Lymphoma Nucike Khezri
05:30 PM - 06:30 PM EDT	Abstract	12-021 - Miller Fischer Syndrome after Vaccination in the United States: A CDC/FDA Vaccine Adverse Event Reporting System Study, 1999-2017
05:30 PM - 06:30 PM EDT	Abstract	12-022 - Different Effects of Selective Phosphodiesterase Inhibitors on Experimental Autoimmune Neuritis. Toshiki Fujioka, MD
05:30 PM - 06:30 PM EDT	Abstract	12-023 - Acute Motor-Sensory Axonal Variant of GBS with Cranial Nerve Involvement (Dysphagia) in a Patient with Acute Cervical Myelopathy Masking Upper Motor Neuron Signs Jenny Argudo Luzuriaga, MD
05:30 PM - 06:30 PM EDT	Abstract	12-024 - Is Alcoholic Neuropathy Selective ? Natarajan Visvanathan, MD, DM, FAAN
05:30 PM - 06:30 PM EDT	Abstract	12-025 - 2 cases of hypertrophic CIDP associated to other autoimmune neurological disorders: Myasthenia Gravis and Multiple Sclerosis. Victor Mantelatto Bonsi
05:30 PM - 06:30 PM EDT	Abstract	12-026 - Safety of Therapeutic Plasma Exchange for the Treatment of Guillain-Barré Syndrome in Polycythemia Vera Rory Abrams, MD
05:30 PM - 06:30 PM EDT	Abstract	12-027 - Readmissions after Guillain-Barré Syndrome: Nationally Representative Data Mallory N. Luckey, MD
05:30 PM - 06:30 PM EDT	Abstract	12-028 - Prospective, Open-Label Study Evaluating the Safety and Tolerability of Higher Infusion Rates of Intravenous Immunoglobulin in Patients with Chronic Inflammatory Demyelinating Polyneuropathy. Interim analyses. Yue Jiang, MD
05:30 PM - 06:30 PM EDT	Abstract	12-029 - The Recovery of Severe Foot Drop in Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) in relation to Electrodiagnostic Findings of the Affected Tibialis Anterior (TA) Muscle Dinushi Weerasinghe, MBBS
05:30 PM - 06:30 PM EDT	Abstract	12-030 - A 65 year old man with MADSAM associated with neurosarcoidosis Yohei Harada, MD
05:30 PM - 06:30 PM EDT	Abstract	12-031 - Role of Cerebrospinal Fluid Protein and Laboratory Testing in Guillain Barre Syndrome Kasser Saba, MD
05:30 PM - 06:30 PM EDT	Abstract	12-032 - The effect of L-Arginine on mitochondrial function, nitric oxide synthesis and nitrative stress Celia H. Tengan, MD
05:30 PM - 06:30 PM EDT	Abstract	12-033 - A novel Biological (FOX-115) improves endurance of motor performances in old mice Ruggero G. Fariello, MD
05:30 PM - 06:30 PM EDT	Abstract	12-034 - Chilaiditi syndrome and radiological sign in myotonic dystrophy type 1 Shinei Kato, MD
05:30 PM - 06:30 PM EDT	Abstract	12-035 - Aliskiren and cytokine's expression in mdx mice
05:30 PM - 06:30 PM EDT	Abstract	12-036 - New Insights About Myofibrillar Myopathies: The Role Of Metalloproteinases 2 And 9 In The Pathogenesis Alzira A. Carvalho, MD
05:30 PM - 06:30 PM EDT	Abstract	12-037 - Axial Weakness as the Presenting Manifestation of Myopathy Andrea Parks, MD
05:30 PM - 06:30 PM EDT	Abstract	12-038 - Paraspinal Atrophy Suggesting Underlying Genetic Etiology Daniel Schwartz
05:30 PM - 06:30 PM EDT	Abstract	12-039 - Nitrative Stress In Skeletal Muscle Of Patients With Mitochondrial DNA Mutation Jomenica D. Livramento
05:30 PM - 06:30 PM EDT	Abstract	12-040 - A patient with Late onset Pompe Disease presenting with prominent muscle cramps, proximal lower extremities muscle weakness, and widespread myotonic discharges seen in electromyography. Amr H. Ewida, MD
05:30 PM - 06:30 PM EDT	Abstract	12-041 - Exome sequencing reveals novel candidate genes and potential oligogenic inheritance in patients with the complex trait arthrogryposis Davut Pehlivan, MD
05:30 PM - 06:30 PM EDT	Abstract	12-042 - A unique myopathic phenotype of novel SPTAN1 mutation without encephalopathy in siblings Arayamparambil Anilkumar, MD, FAAN
05:30 PM - 06:30 PM EDT	Abstract	12-043 - Molecular link between insulin resistance and skeletal muscle atrophy in myotonic dystrophies Giovanni Meola, MD, FAAN
05:30 PM - 06:30 PM EDT	Abstract	12-044 - Low Dose Dantrolene Treatment Reduced Pain in Patients with Strongman Syndrome. Ludivine Chamard Witkowski
05:30 PM - 06:30 PM EDT	Abstract	12-045 - Novel missense mutation in CAPN3 gene detected in a tunisian family with limb girdle muscular dystrophy type 2
05:30 PM - 06:30 PM EDT	Abstract	6-001 - Discontinuation Rates for Hormonal Contraception on Enzyme Inducing versus Other Antiepileptic Drug Categories: Interim Analysis of the Epilepsy Birth Control Registry Andrew G. Herzog, MD, MSc, FAAN
05:30 PM - 06:30 PM EDT	Abstract	6-002 - Catamenial epilepsy: prevalence in a heterogenous cohort of women with epilepsy
05:30 PM - 06:30 PM EDT	Abstract	6-003 - Trends In The Anti-Epileptic Drug Usage During Pregnancy And Malformation Outcomes Over Two Decades In Kerala Registry Of Epilepsy And Pregnancy Ravish Keni
05:30 PM - 06:30 PM EDT	Abstract	6-004 - Is Pre-conceptional counselling for Women with Epilepsy (WWE) beneficial: Experience from Kerala Registry of Pregnancy and Epilepsy, India
05:30 PM - 06:30 PM EDT	Abstract	6-005 - Increased Lamotrigine Clearance and Decreased Levels with Non-oral Hormonal Contraceptive Use Alexa M. King, MD
05:30 PM - 06:30 PM EDT	Abstract	6-006 - Adherence of Saudi women with epilepsy to folic acid intake in pre-conceptional period in Riyadh, Saudi Arabia. Ahmed A. Alqahtani
05:30 PM - 06:30 PM EDT	Abstract	6-007 - Malformation Risk Of Newer AEDs In Women With Epilepsy Sanjeev V. Thomas, MD, FAAN
05:30 PM - 06:30 PM EDT	Abstract	6-008 - STXBP1 is associated with bruxism in awake patients
05:30 PM - 06:30 PM EDT	Abstract	6-009 - Outcome of Genetic Testing for Patients with Epilepsy is Associated with Age of Seizure Onset, Presence of Other Neurological Features and Concurrent Testing of Parents Dianalee McKnight, PhD
05:30 PM - 06:30 PM EDT	Abstract	6-010 - FRRS1L gene Homozygous Mutation (p.Gly246del) in Puerto Rican Families With Epileptic Encephalopathy and Dyskinetic Movements Imane Abdelmoumen, MD
05:30 PM - 06:30 PM EDT	Abstract	6-011 - Genetic Characterization and Prognosis of Adult Patients with Lennox-Gastaut Syndrome: A Prospective Case-Series Study Robert De Santis, MD
05:30 PM - 06:30 PM EDT	Abstract	6-012 - Will You Get Stuck? Predicting Trafficking Deficient SCN1B Mutations from Localization and Amino Acid Change Rachel J. Saban, MD
05:30 PM - 06:30 PM EDT	Abstract	6-013 - Seizures, dystonia and progressive cerebellar degeneration in homozygous DNAJC19 mutation without dilated cardiomyopathy or 3-methylglutaconic aciduria Marta Ruiz Lopez, MD
05:30 PM - 06:30 PM EDT	Abstract	6-014 - Progressive Myoclonus Epilepsy of Lafora First Diagnosed in El Salvador
05:30 PM - 06:30 PM EDT	Abstract	6-015 - Differential Methylation Profiles of BDNF Promoters I and IV in Patients with Temporal Lobe Epilepsy Thais Secchi
05:30 PM - 06:30 PM EDT	Abstract	6-016 - Adenosine Deaminase (ADA1) Gene Variants are Associated with Mood Disorders in Patients with Temporal Lobe Epilepsy
05:30 PM - 06:30 PM EDT	Abstract	6-017 - The Risk of Seizure Recurrence in Patients with Status Epilepticus Requiring Anesthetic Treatment Angela Parsons, DO
05:30 PM - 06:30 PM EDT	Abstract	6-018 - Outcomes of Status Epilepticus in Elderly: a systematic review. Mahsa Sadeghi, MD
05:30 PM - 06:30 PM EDT	Abstract	6-019 - Clinical Features and Outcomes of Patients with Status Epilepticus Caused by Neuroinflammation Makoto Hara, MD
05:30 PM - 06:30 PM EDT	Abstract	6-020 - Quantitative EEG Burst Suppression Ratio and Patient Outcome in Refractory Status Epilepticus Neil Mehdiratta, MD
05:30 PM - 06:30 PM EDT	Abstract	6-021 - Benefits of Extended Targeted Temperature Management (TTM) in the Management of Super-Refractory Status Epilepticus Secondary to anti-NMDAR encephalitis Ausaf Ahmed, MD
05:30 PM - 06:30 PM EDT	Abstract	6-022 - Cefepime-induced Non-convulsive Status Epilepticus Chris Hollen, MD
05:30 PM - 06:30 PM EDT	Abstract	6-023 - Implementation of Seizure and Status Epilepticus Protocols in the Emergency Department of a large Academic Hospital Kyna Schreiber, MD
05:30 PM - 06:30 PM EDT	Abstract	6-024 - Increased Risk of Status Epilepticus in Post-stroke Epilepsy Patients on Coumadin Magdalena Stepien, MD
05:30 PM - 06:30 PM EDT	Abstract	6-025 - Pharmacological treatment of status epilepticus at UNMC: assessment of seizure outcomes Hae Young Baang, MD
05:30 PM - 06:30 PM EDT	Abstract	6-026 - Cessation of Intrathecal Tranexamic Acid Induced Status Epilepticus with Pentobarbital Devin E. Prior, MD
05:30 PM - 06:30 PM EDT	Abstract	6-027 - Using Data Mining Tools, Microservices Architecture And Artificial Intelligence Modules For The "Juvenile Myoclonic Epilepsy JME-1000 Project" David A. Discua
05:30 PM - 06:30 PM EDT	Abstract	6-028 - Improving Lennox-Gastaut Syndrome from Diagnosis to Management through Online Continuing ��ɫ��: Changes in Patient Experience, Clinical Practice, and Provider Knowledge and Competence
05:30 PM - 06:30 PM EDT	Abstract	6-029 - Predictors of 30-day readmission after index hospitalization for epilepsy: a 5-year national estimate using the Nationwide Readmission (NRD) database Chirag N. Savani, MD
05:30 PM - 06:30 PM EDT	Abstract	6-030 - How Common Are Idiopathic Seizures in the Elderly? A Retrospective Review. Louis M. Beers, MD
05:30 PM - 06:30 PM EDT	Abstract	6-031 - Differential diagnosis of epileptic seizure and syncope using machine learning algorithms
05:30 PM - 06:30 PM EDT	Abstract	6-032 - Long-term Follow up of Epilepsy Patients After a Single Neurologist Visit Chintan Prajapati
05:30 PM - 06:30 PM EDT	Abstract	6-033 - Differentiation of Epileptic Seizures from Dissociative Attacks, an Ongoing Dilemma. Fiona Chan, MBBS
05:30 PM - 06:30 PM EDT	Abstract	6-034 - A Survey of Health Care Professionals' Perceptions of Convulsive Seizure Freedom and Antiepileptic Drug Adherence Elizabeth Rappa
05:30 PM - 06:30 PM EDT	Abstract	6-035 - Pediatric Focal Epilepsy: Patient Characteristics, Treatment Choices, Healthcare Resource Use and Costs by Developmental Delay and Behavioral Disorders Comorbidity Subgroups: A US Claims Database Analysis
05:30 PM - 06:30 PM EDT	Abstract	6-036 - Implementation of the Liverpool Adverse Events Profile in Patients with Epilepsy at the University of Puerto Rico Epilepsy Clinics
05:30 PM - 06:30 PM EDT	Abstract	7-001 - Central Meningioma Necrosis after CAR T-Cell Therapy Seth N. Levin, MD
05:30 PM - 06:30 PM EDT	Abstract	7-002 - A Case of Extracranial Metastatic Spread of a PTCH1- and TP53-mutated, Cerebellar Desmoplastic/Nodular Medulloblastoma in a Patient with Li-Fraumeni Syndrome Mary Jane Lim-Fat, MD, FRCPC
05:30 PM - 06:30 PM EDT	Abstract	7-003 - Presentation of High Grade Glioma Resembling Like Acute Disseminated Encephalomyelitis Yash Shah, MD, MBBS, MPH
05:30 PM - 06:30 PM EDT	Abstract	7-004 - Leptomeningeal Carcinomatosis in a patient with Waldenstrom Macroglobulinemia. Sania Atta, MBBS
05:30 PM - 06:30 PM EDT	Abstract	7-005 - A Rare Case of Primary Neurolymphomatosis in Natural Killer T-Cell Lymphoma Mallory N. Luckey, MD
05:30 PM - 06:30 PM EDT	Abstract	7-006 - A protean case of neurolymphomatosis David Valentine, MD
05:30 PM - 06:30 PM EDT	Abstract	7-007 - A rare case of Isolated Neurolymphomatosis of Multiple Cranial Nerves Palsy Marjorie Ho, MD
05:30 PM - 06:30 PM EDT	Abstract	7-008 - Superficial Siderosis Associated with Central Neurocytoma Mina Lobbous, MD
05:30 PM - 06:30 PM EDT	Abstract	7-009 - Successful Treatment of CNS Involvement in Cutaneous T-Cell Lymphoma Mycosis Fungoides Shreya Nayak, MD
05:30 PM - 06:30 PM EDT	Abstract	7-010 - Intraventricular lipids: A clue to early diagnosis of asymptomatic spinal dural teratoma rupture Aparna Vaddiparti, MD
05:30 PM - 06:30 PM EDT	Abstract	7-011 - Multifocal Cerebral Infarction and Status Epilepticus as a Result of 3-bromopyruvate Toxicity for Treatment of Ocular Melanoma Abigail M. Taylor, PA
05:30 PM - 06:30 PM EDT	Abstract	7-012 - An Uncommon Cause of Subcortical Low Intensity T2 Lesion Sonia M. Caraballo-Cartagena, MD
05:30 PM - 06:30 PM EDT	Abstract	7-013 - Glioblastoma multiforme that present with radiographic dural tails. Questioning the prognosis paradigm with case-based evidence of greater than average length of survival Nara Michaelson, MD
05:30 PM - 06:30 PM EDT	Abstract	7-014 - Isolated CNS Blastic Plasmacytoid Dendritic Cell Neoplasm in a Patient with AML Nicholas Metrus, MD
05:30 PM - 06:30 PM EDT	Abstract	7-015 - Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) manifesting in the Course of Treatment of Hodgkin’s Lymphoma with Brentuximab Jessica Frey, MD
05:30 PM - 06:30 PM EDT	Abstract	7-016 - Pilocytic Astrocytoma in an Elderly Patient with Eleven Years of Follow-up: A Case Report and Commentary on Management of PA in An Elderly Patient Lucas Cofer
05:30 PM - 06:30 PM EDT	Abstract	7-017 - Glioblastoma and Disseminated Intravascular Coagulation: Literature Review and Illustrative Case
05:30 PM - 06:30 PM EDT	Abstract	7-018 - To Biopsy or Not to Biopsy? A case of primary intramedullary spinal cord lymphoma presenting as longitudinally extensive transverse myelitis within cervical cord Sammita Satyanarayan, MD
05:30 PM - 06:30 PM EDT	Abstract	7-019 - Unusual case of recurrent SMART (stroke-like migraine attacks after radiation therapy) syndrome Ninad Desai, MBBS
05:30 PM - 06:30 PM EDT	Abstract	7-020 - An Unusual Cause of Longitudinal Extensive Transverse Myelitis (LETM) in an Anti-Aquaporin-4 Antibody Positive Case Steven C. Yang, DO
05:30 PM - 06:30 PM EDT	Abstract	7-021 - Atypical radiographic appearance of anaplastic ependymoma that mimics arteriovenous malformation: a case report Annie L. Hsieh, MD, PhD
05:30 PM - 06:30 PM EDT	Abstract	7-022 - Small RNA Deep Sequencing Identifies Unique Extracellular-derived Bioactive Noncoding RNA Cargos in Pediatric Brain Tumors Setty M. Magana, MD, PhD
05:30 PM - 06:30 PM EDT	Abstract	7-023 - Combined Pharmacologic Inhibition of MEK-ERK and PI3K/mTOR Signaling in Glioblastoma Models Enhances Therapeutic Antitumor Activity Karisa C. Schreck, MD, PhD
05:30 PM - 06:30 PM EDT	Abstract	7-024 - Inflammatory signaling supports cancer cell growth within the leptomeninges Adrienne Boire, MD, PhD, FAAN
05:30 PM - 06:30 PM EDT	Abstract	7-025 - Selective Activation of PIK3CB in Glioblastoma Multiforme
05:30 PM - 06:30 PM EDT	Abstract	7-026 - Stearoyl CoA Desaturase is an essential regulator of fatty-acid-induced ER stress and a therapeutic target in gliomablastoma Arsalan Hashemi Aghdam, MD
05:30 PM - 06:30 PM EDT	Abstract	7-027 - Genomic Signatures From Bench to Bedside - a Protocol for Translation: sigQC Andrew Dhawan, MD
05:30 PM - 06:30 PM EDT	Abstract	7-028 - Using PIK3CB and Connexin-43 Inhibition to Sensitize Glioblastoma Cells to Temozolomide Farah Shah
05:30 PM - 06:30 PM EDT	Abstract	7-029 - Comparative Analysis of Tumor Treating Fields Using Conventional versus Alternative Transducer Array Placement for Posterior Fossa Glioblastoma Eric T. Wong, MD, FAAN
05:30 PM - 06:30 PM EDT	Abstract	7-030 - Impact of EGFR Amplification in Newly Diagnosed Glioblastoma Treated with Adjuvant Temozolomide: Four-year experience of a single major tertiary care institution
05:30 PM - 06:30 PM EDT	Abstract	7-031 - Factors Associated with Tumour Recurrence in WHO Grade II Meningiomas
05:30 PM - 06:30 PM EDT	Abstract	7-032 - Radiographic Appearance of Leptomeningeal Disease in Patients with EGFR Mutated Non-Small Cell Lung Carcinoma Treated with Tyrosine Kinase Inhibitors – A Case Series Ugur Sener, MD
05:30 PM - 06:30 PM EDT	Abstract	7-033 - Neuropsychological and resting state fMRI changes with Spiritual Practice
05:30 PM - 06:30 PM EDT	Abstract	7-034 - 3-D Brain Tumor Modeling for Improved Patient Health Literacy and Trainee ��ɫ�� Na Tosha N. Gatson, MD, PhD, FAAN
05:30 PM - 06:30 PM EDT	Abstract	7-035 - Efficacy of Extended Adjuvant Temozolomide Cycle Duration in Newly Diagnosed Glioblastoma: Four-year experience of a single major tertiary care institution
05:30 PM - 06:30 PM EDT	Abstract	7-036 - Clinical presentation, management, and biomarkers of neurotoxicity after adoptive immunotherapy with CAR T-cells Philipp Karschnia
05:30 PM - 06:30 PM EDT	Abstract	7-037 - Developing an Inpatient Neurology Registry To Understand Neurological Disease Burden in Zambia Aparna Nutakki, MD
05:30 PM - 06:30 PM EDT	Abstract	7-038 - Neurocysticercosis and HIV Among Zambian Youth: A Geographic Approach Alexandra Buda
05:30 PM - 06:30 PM EDT	Abstract	7-039 - GBS after the Zika-outbreak in Colombia: The newcomer is gone but the problem continues! Carlos A. Pardo-Villamizar, MD
05:30 PM - 06:30 PM EDT	Abstract	7-040 - A Comparison of the Full Outline of Unresponsiveness (FOUR) and Glasgow Coma Scale (GCS) Scores in Predicting Mortality Among Patients with Altered Level of Consciousness in Uganda. Amir A. Mbonde, MD
05:30 PM - 06:30 PM EDT	Abstract	7-041 - Jellyfish Envenomation causing Irukandji Syndrome Presenting as Generalized Muscle Spasms in a Young Adult Male in Laiya, Batangas, Philippines- A Case Report. Alexandria E. Matic, MD
05:30 PM - 06:30 PM EDT	Abstract	7-042 - Diagnosis and Treatment of Neuromyelitis Optica in Ethiopia Katherine E. Heaton, MD
05:30 PM - 06:30 PM EDT	Abstract	7-043 - Neurology International Residents Videoconference and Exchange (NIRVE) Sanskriti Sasikumar, MD
05:30 PM - 06:30 PM EDT	Abstract	7-044 - Global Health ��ɫ�� in Child Neurology and Neurodevelopmental Disabilities Training Programs: A National Survey Andres Jimenez Gomez, MD
05:30 PM - 06:30 PM EDT	Abstract	7-045 - Global Teleneurology Service: First Insights Riley Bove, MD, FAAN
05:30 PM - 06:30 PM EDT	Abstract	7-046 - Task-shifting to Optimize Outpatient Neurological Care in Zambia Ana C. Villegas
05:30 PM - 06:30 PM EDT	Abstract	7-047 - Stroke surveillance and Establishment of Acute Stroke Care Pathway in Rural Northwest India using Community Health Workers: data from Ludhiana rural population-based stroke registry Jeyaraj D. Pandian, MD, DM
05:30 PM - 06:30 PM EDT	Abstract	7-048 - Challenges Faced in Semi Urban & Rural Rehabilitation Center: A single Center Prospective Study from India Devashish D. Ruikar, MD
05:30 PM - 06:30 PM EDT	Abstract	7-049 - Electronic Fetal Monitoring as a Remedy for Cerebral Palsy in Africa: First Do No Harm James C. Johnston, MD, JD, FAAN
05:30 PM - 06:30 PM EDT	Abstract	7-051 - Modes of death of hospitalized patients with Parkinson’s disease: a 12-year retrospective analysis
05:30 PM - 06:30 PM EDT	Abstract	7-052 - Psychological Attachment Styles of Surrogate Decision Makers and Neuro ICU Goals-of-Care Decisions Prerak Juthani
05:30 PM - 06:30 PM EDT	Abstract	7-053 - Advance directives of treatment in ALS patients: The Piedmont and Valle d’Aosta register experience in the 2008-2013 period. Cristina Moglia
05:30 PM - 06:30 PM EDT	Abstract	7-054 - Outcomes of Patients with Cancer Related Pain Who Use Cannabis: Trends and Data from the Nationwide Inpatient Sample Database Martin A. Myers, MD
05:30 PM - 06:30 PM EDT	Abstract	7-055 - Hospitalizations for Opioid Overdoses in the United states from 2003-2014. Trends from the Nationwide Inpatient Sample and Predictors of Mortality. Sahil Gupta, MD
05:30 PM - 06:30 PM EDT	Abstract	7-056 - Multivariate Pattern Analysis of Emotion Regulation in Opioid-Dependent and Opioid-Naïve Chronic Pain Patients Behnaz Jarrahi, PhD
05:30 PM - 06:30 PM EDT	Abstract	7-057 - Diffusion Tensor Tractography of Brainstem Fibers and Application to Combat-Related Pain Yu Zhang, PhD
05:30 PM - 06:30 PM EDT	Abstract	7-058 - Subjective Mental and Physical Wellbeing Correlates with Pain in Military Personnel with Trans-tibial Amputations Igal Mirman, MD
05:30 PM - 06:30 PM EDT	Abstract	7-059 - Pain Compounding Pain: Fibromyalgia and Migraine Comorbidity
05:30 PM - 06:30 PM EDT	Abstract	7-060 - Nerve-Specific Local and Systemic Analgesic Effects of Acupuncture in Healthy Adults, Measured by Quantitative Sensory Testing (QST) Alexandra Dimitrova, MD
05:30 PM - 06:30 PM EDT	Abstract	7-061 - Predictors of 30-day Readmissions and Prolonged Length of Stay Following Hospitalization for Complex Regional Pain Syndrome Type 1 - A 5-year National Estimate Charles W. Brock, MD
05:30 PM - 06:30 PM EDT	Abstract	7-062 - “Burning Foot Syndrome” due to Acute Copper Deficiency Myeloneuropathy after Bariatric Surgery Paul M. Elsbernd, MD
05:30 PM - 06:30 PM EDT	Abstract	7-063 - Comparison of the firing pattern of superficial dorsal horn neurons evoked by robotic and human manual brushing. Dongchul Lee
05:30 PM - 06:30 PM EDT	Abstract	7-064 - Retrospective Diagnosis of Painful Diabetic Polyneuropathy from Electronic Abstraction of Medical Records Brittany Lapin
05:30 PM - 06:30 PM EDT	Abstract	7-065 - A Prospective Clinical Trial to Assess High Frequency Spinal Cord Stimulation (HF-SCS) at 10 kHz in the Treatment of Chronic Intractable Pain from Peripheral Polyneuropathy
05:30 PM - 06:30 PM EDT	Abstract	7-066 - High Frequency Spinal Cord Stimulation (HF-SCS) at 10 kHz for the Treatment of Neuropathic Limb Pain from Painful Diabetic Neuropathy Charles E. Argoff, MD
05:30 PM - 06:30 PM EDT	Abstract	7-067 - Dorsal Root Ganglion Stimulation: A Potentially Effective Treatment for Painful Hereditary and Idiopathic Axonal Polyneuropathy Kwo Wei David Ho, MD, PhD
05:30 PM - 06:30 PM EDT	Abstract	7-068 - CONVEY, A Phase 2 Placebo-Controlled, Double-Blind, Enriched Enrollment Randomized Withdrawal Study Design of Vixotrigine for the Treatment of Pain in Participants With Confirmed Small Fiber Neuropathy Leslie Shinobu, MD, PhD
05:30 PM - 06:30 PM EDT	Abstract	7-069 - Electrical Impedance Myography for Assessing Patients with Low Back Pain Seward B. Rutkove, MD, FAAN
05:30 PM - 06:30 PM EDT	Abstract	7-070 - Jumping as a Strategy to Overcome Freezing of Gait while Turning in Parkinson’s Disease Karlo J. Lizarraga, MD, MS, FAAN
05:30 PM - 06:30 PM EDT	Abstract	7-071 - Association of Inflammation and Neurocognitive Impairment in Older Hispanics Living with HIV Monica M. Diaz, MD, MS
05:30 PM - 06:30 PM EDT	Abstract	7-072 - Witnessed Apneas During Sleep are Associated with Elevated Tau-PET Signal in the Entorhinal Cortex in Cognitively Unimpaired Elderly Diego Z. Carvalho, MD
05:30 PM - 06:30 PM EDT	Abstract	7-073 - Prevalence and Prognosis of Atrial Fibrillation Among Hospitalized Ischemic Stroke Patients with Comobid Seizures in the United States Alain Z. Lekoubou Looti, MD
05:30 PM - 06:30 PM EDT	Abstract	7-074 - Seizure Comorbidity Increases Odds Of 30-Day Readmission After an Index Hospitalization for Sepsis Alain Z. Lekoubou Looti, MD
05:30 PM - 06:30 PM EDT	Abstract	7-075 - Recruitment of Minority Populations with Parkinson's disease at an Urban Hospital Chantale O. Branson, MD, MSCR, FAAN
05:30 PM - 06:30 PM EDT	Abstract	7-076 - Assessing the social determinants of health in Tourette Syndrome Marisela E. Dy-Hollins, MD, MSCR, FAAN
05:30 PM - 06:30 PM EDT	Abstract	7-077 - Chronic episodic cortical spreading depressions induce trigeminal allodynia and anxiety behavior Andrea Harriott, MD
05:30 PM - 06:30 PM EDT	Abstract	1-001 - Metformin Use and Stroke Risk in Hispanic and Non-Hispanic Diabetic Male Veterans Eliana Vasquez
05:30 PM - 06:30 PM EDT	Abstract	1-002 - Intra-arterial tPA administration during Mechanical Thrombectomy is Associated with Increased Risk of Subarachnoid Hemorrhage Vasu Saini, MD
05:30 PM - 06:30 PM EDT	Abstract	1-003 - “Sacral Vein Sign” on MRI with Typical Findings of Spinal Arteriovenous Fistula Suggests a Pelvic Arteriovenous Fistula with Retrograde Spinal Venous Drainage Rohit Swarnkar, MD
05:30 PM - 06:30 PM EDT	Abstract	1-004 - Atypical presentation of Neurologic complications of Osler-Weber-Rendu Syndrome: A case series Faddi G. Saleh Velez, MD
05:30 PM - 06:30 PM EDT	Abstract	1-005 - Cocaine- induced Vasospasm During Mechanical Thrombectomy in Acute Ischemic Stroke Patients: A Report of Two Cases Marina Kushnirsky, MD
05:30 PM - 06:30 PM EDT	Abstract	1-006 - Artificial Intelligence in Acute Stroke Diagnostics: Application in Large Vessel Occlusions
05:30 PM - 06:30 PM EDT	Abstract	1-007 - Moyamoya Disease Associated with Autoimmune Hemolytic Anemia: A Case Report Shreya Agarwal
05:30 PM - 06:30 PM EDT	Abstract	1-008 - Diagnosis and Treatment of Steroid Responsive Cerebral Amyloid Angiopathy Related Inflammation without Brain Biopsy Kavneet Kaur, MD
05:30 PM - 06:30 PM EDT	Abstract	1-009 - A case of prosopagnosia with the retained ability to recognize caricatures Melissa Cook, MD
05:30 PM - 06:30 PM EDT	Abstract	1-010 - 'At a Loss for Words’: POEMS syndrome complicated by Acute Ischemic Stroke Sneha Jacob, MD
05:30 PM - 06:30 PM EDT	Abstract	10-001 - Automatic Scoring of Parkinson’s Disease Motor Symptoms Using a Smartwatch Nicholas L. Shawen
05:30 PM - 06:30 PM EDT	Abstract	10-002 - Continuous Monitoring of Orthostatic Hypotension and Instability Events in Parkinson Disease Aaron Hadley
05:30 PM - 06:30 PM EDT	Abstract	10-003 - Continuous Objective Monitoring in Parkinson’s Disease: A description of over 25,000 Parkinson’s symptom scores across the world using the Personal KinetiGraph (PKG) wearable monitoring device Peter Lynch
05:30 PM - 06:30 PM EDT	Abstract	10-004 - Activity-independent detection of mediation states in individuals with Parkinson’s disease using wearable sensors Murtadha Hssayeni
05:30 PM - 06:30 PM EDT	Abstract	10-005 - An Investigation of Tracking Technology in the Setting of an Established Exercise Program for Individuals with Parkinson’s Disease: A 10-Month Program Sarah Ingersoll, RN, PHN
05:30 PM - 06:30 PM EDT	Abstract	10-006 - Wearable sensor (Parkinson’s Kinetigraph) and dopamine transporter imaging as potential biosignature for constipation in Parkinson’s Daniel van Wamelen
05:30 PM - 06:30 PM EDT	Abstract	10-007 - The Feasibility of Using Smart Gloves to Quantify Hand Movements in Parkinson’s Disease
05:30 PM - 06:30 PM EDT	Abstract	10-008 - Patient-Centered Clinical Trial Design: A Case Study in Parkinson’s Disease Katrina A. Gwinn, MD, FAAN
05:30 PM - 06:30 PM EDT	Abstract	10-009 - Self-Reported and Objective Monitoring of Physical Activity in Parkinson Disease Sneha Mantri, MD, MS, FAAN
05:30 PM - 06:30 PM EDT	Abstract	10-010 - Critical Path for Parkinson’s: Catalyzing Innovation for Parkinson’s Clinical Trials through Data Sharing and Regulatory Science Diane Stephenson
05:30 PM - 06:30 PM EDT	Abstract	10-011 - Assessing Tele-Health Outcomes in Multiyear Extensions of Parkinson's Disease Trials (AT-HOME PD): Initiation of a Long-Term Observational Study Ruth Schneider, MD, FAAN
05:30 PM - 06:30 PM EDT	Abstract	10-012 - A Virtual Cohort Study of LRRK2 G2019S Carriers: A Novel Model for Long-Term Observation Ruth Schneider, MD, FAAN
05:30 PM - 06:30 PM EDT	Abstract	10-013 - Can Art Therapy improve signs and symptoms of Parkinson's Disease? Preliminary Results from the "ExplorArtPD Study" Alberto Cucca, MD
05:30 PM - 06:30 PM EDT	Abstract	10-014 - Effect of Balanced Based Torso Weighting on Gait in Parkinsonism. Delaram Safarpour, MD, MSCE, FAAN
05:30 PM - 06:30 PM EDT	Abstract	10-015 - KICK-OUT PD: Mobility, Quality of Life, and Feasibility Outcomes in a Pilot Study of a PD-Specific Karate Intervention Brianna J. Sennott, MD
05:30 PM - 06:30 PM EDT	Abstract	10-016 - Medical Cannabis in the Treatment of Parkinson’s Disease Bennett H. Myers, MD
05:30 PM - 06:30 PM EDT	Abstract	10-017 - KICK-OUT PD: Qualitative Analysis of Expectations and Outcomes in a Pilot Study of a Parkinson’s Disease Karate Intervention Jori Fleisher, MD, MSCE, FAAN
05:30 PM - 06:30 PM EDT	Abstract	10-018 - The effect of metronome and music on gait variability in people with Parkinson’s disease Amy Hellman, MD, FAAN
05:30 PM - 06:30 PM EDT	Abstract	10-019 - Determining the Efficacy of a Vibration Induced Intervention on Improving Arm Swing and Subsequent Gait Stability in Parkinsonian Patients William F. Taber
05:30 PM - 06:30 PM EDT	Abstract	10-020 - Clinical Experience in Over 100 Using Pimavanserin for Parkinson’s Disease Psychosis Gupta V. Harsh, MD
05:30 PM - 06:30 PM EDT	Abstract	10-021 - Physical Activity and Rates of Cognitive Decline in Early Parkinson Disease Sneha Mantri, MD, MS, FAAN
05:30 PM - 06:30 PM EDT	Abstract	10-022 - The Effect of High-Intensity Exercise on Objective Sleep Outcomes in Parkinson’s Disease Amy W. Amara, MD PhD
05:30 PM - 06:30 PM EDT	Abstract	10-023 - Transcranial Direct Current Stimulation for Limb-Kinetic Apraxia in Parkinson's Disease – a Randomized, Double-blinded, Sham-controlled Trial Jung E Park, MD, PhD
05:30 PM - 06:30 PM EDT	Abstract	10-024 - How Parkinson’s Disease Affects Value-Based Decisions Leila Montaser-Kouhsari, MD, PhD
05:30 PM - 06:30 PM EDT	Abstract	10-025 - Suicidal Behavior in Parkinson Disease Brian Koo, MD
05:30 PM - 06:30 PM EDT	Abstract	10-026 - Alzheimer’s Disease Genetic Risk Variants Predict Cognitive Decline in Parkinson’s Disease Laura Baratta
05:30 PM - 06:30 PM EDT	Abstract	10-027 - Determinants of Weight Change in Parkinson's Disease John H. Herndon, MD
05:30 PM - 06:30 PM EDT	Abstract	10-028 - Mild Cognitive Impairment changes Natural Reading in Parkinson‘s Disease Josefine Waldthaler, MD
05:30 PM - 06:30 PM EDT	Abstract	10-029 - Impulse Control Disorders in Parkinson’s disease – a cross-sectional and longitudinal study of severity Fahd Baig, MBBS
05:30 PM - 06:30 PM EDT	Abstract	10-030 - Neural Correlates of Impaired Motivation in Parkinson’s Disease Lauren M. Massimo, PhD
05:30 PM - 06:30 PM EDT	Abstract	10-031 - Anxiety and depression are associated with levodopa-responsive, but not levodopa-unresponsive, freezing of gait in Parkinson’s disease Johnathan L. McKay, PhD
05:30 PM - 06:30 PM EDT	Abstract	10-032 - Heart Rate Variability And Sympathetic Skin Response In Idiopathic And Leucine-Rich Repeat Kinase 2-Associated Parkinson's Disease Amina Nasri, MD
05:30 PM - 06:30 PM EDT	Abstract	10-033 - Rapid Picture Naming in Parkinson’s Disease Using the Mobile Universal Lexicon Evaluation System (MULES) Test Jenna Conway, MD
05:30 PM - 06:30 PM EDT	Abstract	10-034 - Genomic variants associated with cognitive impairment in Parkinson's disease: Ethnicity-specific genome-wide association study Sun Ju Chung, MD, PhD, FAAN
05:30 PM - 06:30 PM EDT	Abstract	10-035 - Cognitive Improvement After Six-Week Action Observation and Motor Imagery Training in Patients with Parkinson’s Disease Elisa Canu
05:30 PM - 06:30 PM EDT	Abstract	10-036 - Non-motor phenotypes in Parkinson’s disease patients with metabolic syndrome.
05:30 PM - 06:30 PM EDT	Abstract	10-037 - Pimavanserin versus quetiapine for the treatment of psychosis in Parkinson’s disease and dementia with Lewy bodies Sarah Horn, MD
05:30 PM - 06:30 PM EDT	Abstract	10-038 - Diminished fMRI global signal differences between eyes closed and eyes open resting state in REM behavior disorder (RBD) and Parkinson’s disease Jessika Suescun, MD
05:30 PM - 06:30 PM EDT	Abstract	10-039 - Olfactory Hallucinations as a Non-motor sign of Parkinson’s disease – A Single Center Experience Shivika Chandra, MD, FAAN
05:30 PM - 06:30 PM EDT	Abstract	10-040 - Kickboxing and Cognition in Parkinson's Disease Colin McLeod, MD
05:30 PM - 06:30 PM EDT	Abstract	10-041 - Usefulness of the Stroke Drivers Screening Assessment (SDSA) in patients with Parkinson’s syndrome Nobutoshi Morimoto
05:30 PM - 06:30 PM EDT	Abstract	10-042 - “Incomplete Design” Errors Distinguish Design Fluency Performance in Parkinson’s Disease Patients with Left Motor Onset Symptoms
05:30 PM - 06:30 PM EDT	Abstract	10-043 - Comparison of EEG Connectivity measures and Frequency analysis for identification of patients with Mild Cognitive Impairment in Parkinson´s disease – a Random Forest Analysis Menorca Chaturvedi
05:30 PM - 06:30 PM EDT	Abstract	10-044 - Longitudinal Cortical Changes Associated With Apathy in Parkinson’s Disease
05:30 PM - 06:30 PM EDT	Abstract	10-045 - Profile of Non-motor Symptoms and Impact on Quality of Life of Parkinson Disease Patients in a Neurology Clinic in Lagos Nigeria Babawale Arabambi, MBBS
05:30 PM - 06:30 PM EDT	Abstract	10-046 - Cholinesterase Inhibitor Taper Worsens Symptoms in Patients with Parkinson’s Disease Lauren R. Moo, MD, FAAN
05:30 PM - 06:30 PM EDT	Abstract	10-047 - Results of a Phase 1 Dose-Ranging Trial, and Design of a Phase 2 Trial, of K0706, a Novel C-Abl Tyrosine Kinase Inhibitor for Parkinson’s Disease. Andrew M. Goldfine, MD
05:30 PM - 06:30 PM EDT	Abstract	10-048 - Efficacy results of a 12-month, dose-level blinded study of CVT-301 (levodopa inhalation powder) in patients with Parkinson’s disease Eric S. Farbman, MD, FAAN
05:30 PM - 06:30 PM EDT	Abstract	10-049 - Preclinical Development of a Novel Precision Olfactory Delivery (POD®) - L-dopa Drug-Device Combination Product for the Treatment of OFF Episodes in Parkinson’s Disease Kelsey Satterly
05:30 PM - 06:30 PM EDT	Abstract	10-050 - Gastric Retention of the Accordion Pill™: Results From MRI Studies With Parkinson’s Disease Patients and Healthy Volunteers
05:30 PM - 06:30 PM EDT	Abstract	10-051 - ITI-214, A Novel Phosphodiesterase I Inhibitor for the Treatment of Parkinson's Disease: Results from A Phase I/II Clinical Study Robert Davis
05:30 PM - 06:30 PM EDT	Abstract	10-052 - Efficacy of ND0612 for nocturnal problems and early morning OFF: A blinded rater study of 2 dosing regimens Alberto J. Espay, MD, FAAN
05:30 PM - 06:30 PM EDT	Abstract	10-053 - Efficacy and Safety of Apomorphine Sublingual Film for The Treatment of “OFF” Episodes in Patients With Parkinson’s Disease: Phase 3, Double-Blind, Placebo-Controlled Trial Stewart A. Factor, DO, FAAN
05:30 PM - 06:30 PM EDT	Abstract	4-001 - Enhancing Skills in Serious Illness Communication in Neurology Residents Using Simulation- A Pilot Study Marcey L. Osgood, DO
05:30 PM - 06:30 PM EDT	Abstract	4-002 - The Implementation and Assessment of a Comprehensive Simulation-Based Curriculum in Treating Acute Neurological Emergencies at UC San Diego: Preliminary Results and Findings Victoria L. Wu, MD
05:30 PM - 06:30 PM EDT	Abstract	4-003 - Application of Non-Mydriatic Retinal Photography in the Outpatient Neurology Setting Nataliya Pyatka, MD
05:30 PM - 06:30 PM EDT	Abstract	4-004 - Judgements of Competence: Negotiated Meaning Making in Resident Evaluations Douglas P. Larsen, MD
05:30 PM - 06:30 PM EDT	Abstract	4-005 - Using Smartphone Mindfulness Apps to Increase Trainee Resilience and Reduce Burnout Crystal J. Yeo, MD, PhD
05:30 PM - 06:30 PM EDT	Abstract	4-006 - Making Well Neurologists: A Multifaceted Program for Neurology Trainee and Faculty Wellbeing Rebecca K. Miller-Kuhlmann, MD
05:30 PM - 06:30 PM EDT	Abstract	4-007 - Real-Time Assessment of Residents’ Perceptions of Inappropriate Neurology Consults Caroline Gentile Kruse, MD
05:30 PM - 06:30 PM EDT	Abstract	4-008 - Childbearing and parenthood during residency and fellowship. Khadija Irshad, MD
05:30 PM - 06:30 PM EDT	Abstract	4-009 - Brain Death Determination Skills Workshop for Neurology Residents Roshni A. Patel, MD
05:30 PM - 06:30 PM EDT	Abstract	4-010 - Brain Death Exam and Breaking the News; Simulation Based training for Neurology Residents; a need for Standardization Muhammad Niazi, MD
05:30 PM - 06:30 PM EDT	Abstract	4-011 - Flipped Classrooms as a Learning Tool for Neurology Noon Conference Curriculum
05:30 PM - 06:30 PM EDT	Abstract	4-012 - The Use of Standardized Patients versus Mannequin-Simulation for Training in Neurologic Emergencies – How “Real” is Real Enough? A Pilot Study Casey S. Albin, MD, FAAN
05:30 PM - 06:30 PM EDT	Abstract	4-013 - A Medical Legal Curriculum for Residents to Increase Physician Comfort in Patient Interactions Kate E. Therkelsen, MD
05:30 PM - 06:30 PM EDT	Abstract	4-014 - The Impact of a Dedicated Emergency Department Neurology Resident on the Inpatient Neurology Service Shuja Sheikh, MD
05:30 PM - 06:30 PM EDT	Abstract	4-015 - Enhancing Neurology Resident ��ɫ�� Utilizing Prehospital Stroke Telemedicine to Shorten Time to Acute Stroke Intervention Philip W. Tipton, MD
05:30 PM - 06:30 PM EDT	Abstract	4-016 - Advocacy education in neurology residency: A survey of U.S. neurology residency program directors Kara Stavros, MD, FAAN
05:30 PM - 06:30 PM EDT	Abstract	4-017 - Outcomes of a “Boot Camp” for incoming neurology residents David Valentine, MD
05:30 PM - 06:30 PM EDT	Abstract	4-018 - An Interactive, Video-Based, Online Curriculum in Movement Disorders for Neurology Housestaff: A Pilot Study Lina Vadlamani
05:30 PM - 06:30 PM EDT	Abstract	4-019 - Burnout Rate Among Iraqi Neurology Residents Omar M. Al-Janabi, MD, PhD, MSc
05:30 PM - 06:30 PM EDT	Abstract	4-020 - Effect on the Clinical Learning Environment after Expansion of the Thrombectomy Time Window Elizabeth M. Aradine, MD
05:30 PM - 06:30 PM EDT	Abstract	4-021 - The?Impact of?a 24-hour?Thrombectomy?Window on Resident ��ɫ�� Rachel Aubert, DO
05:30 PM - 06:30 PM EDT	Abstract	4-022 - Improving Neurology Resident Well-Being Through Appreciative Inquiry: Results of a Pilot Session Jeffrey Dewey, MD, MHS, FAAN
05:30 PM - 06:30 PM EDT	Abstract	4-023 - Medicolegal Considerations Influence Neurology Residents’ Perception of Inappropriate Consults Emma M. Loebel, MD
05:30 PM - 06:30 PM EDT	Abstract	4-024 - Resident Tele-education using the Zeriscope Device Nicholas Milano, MD
05:30 PM - 06:30 PM EDT	Abstract	4-025 - Assessment of Resident Opinions and Knowledge of Neurology Subspecialty Fellowship Application Sarah R. Ahmad
05:30 PM - 06:30 PM EDT	Abstract	4-026 - The Past, Present, and Future of the Clinical Neurophysiology Fellowship: A Survey of Program Directors Kalea L. Colletta, DO
05:30 PM - 06:30 PM EDT	Abstract	4-027 - Surveying the Clinical Learning Environment in Terms of Wellness, Burnout, Psychological Safety, and Mistreatment in a Neurology Residency Program at an Academic Medical Centre Jeffrey B. Schachter, MD
05:30 PM - 06:30 PM EDT	Abstract	4-028 - Osler Apprenticeship Program: Impact of peer advising on medical student preparedness and experience in the Neurology Clerkship Christine Shrock, MD
05:30 PM - 06:30 PM EDT	Abstract	4-029 - The Effects of Residents’ teaching on Medical Students’ Neurology Experience and Interest Zafer Keser, MD
05:30 PM - 06:30 PM EDT	Abstract	4-030 - Empowering residents to enhance Medical Students' ��ɫ�� during their Neurology Clerkship Yvo A. Rodriguez-Linares, MD
05:30 PM - 06:30 PM EDT	Abstract	4-031 - Can students help bridge the great divide? Student perceptions of neurology and psychiatry clerkship integration Justin J. Mowchun, MD
05:30 PM - 06:30 PM EDT	Abstract	4-032 - Student Satisfaction and NBME Outcomes with Team Based Learning on the Neurology Clerkship, a Pilot Study Steven R. Dunham, Jr., MD
05:30 PM - 06:30 PM EDT	Abstract	4-033 - Validity of Neurology Core Clinical Experience Score Tafline Kao, MD
05:30 PM - 06:30 PM EDT	Abstract	4-034 - Assessment of Medical Student Clinical Skills during Neurology Clerkship: A Quality Improvement Study Erin Barnes, MD
05:30 PM - 06:30 PM EDT	Abstract	4-035 - How am I really doing in Neuro Small Group? Student Perceptions of Feedback in Neurology Case-Based Learning Sessions Claire P. Hogue
05:30 PM - 06:30 PM EDT	Abstract	4-036 - Development of the Summer NeuroImaging Research Program (SNIRP) for Undergraduates: Novel Research to Engage Students and Enhance the Academic Mission John R. Absher, MD, FAAN
05:30 PM - 06:30 PM EDT	Abstract	4-037 - Top 5 Reasons Not to Choose Neurology as a Career Okeanis Vaou, MD, FAAN
05:30 PM - 06:30 PM EDT	Abstract	4-038 - Effect of a faculty-led comprehensive mentorship program on medical student recruitment and research productivity in neurology Shuhan Zhu, MD
05:30 PM - 06:30 PM EDT	Abstract	4-039 - Assessment of a Movement Disorders Video Curriculum for Neurology Clerkships Sagari R. Bette, MD
05:30 PM - 06:30 PM EDT	Abstract	4-040 - Can Interactive Case-Based Modules Improve Medical Student Shelf Examination Performance? Leighton Mohl, MD
05:30 PM - 06:30 PM EDT	Abstract	4-041 - Medical Student Assessment Across Multiple Clinical Campuses: Are We Consistent? Sherri A. Braksick, MD, FAAN
05:30 PM - 06:30 PM EDT	Abstract	4-042 - You Never Forget Your First? Impact of Interview Timing on Final Rank Order Fallon Schloemer, DO
05:30 PM - 06:30 PM EDT	Abstract	4-043 - Disclosure of Medical Errors in Stroke Patients: A Randomized Controlled Trial in a Simulation Curriculum Diana M. Barratt, MD, MPH, FAAN
05:30 PM - 06:30 PM EDT	Abstract	4-044 - The Addition of Virtual Reality into the Neurology Curriculum John P. Holton-Burke, MD
05:30 PM - 06:30 PM EDT	Abstract	4-045 - Patterns of Brain Volume Loss in Traumatic Brain Injury Somayeh Meysami, MD
05:30 PM - 06:30 PM EDT	Abstract	4-046 - Exosomal and Plasma Protein Biomarkers of Neuronal Injury and Inflammation in Chronic Mild TBI: A Chronic Effects of Neurotrauma Consortium (CENC) Biomarker Discovery Project Kimbra L. Kenney, MD, FAAN
05:30 PM - 06:30 PM EDT	Abstract	4-047 - Highly Sensitive Single Molecular Array Immunoassay Measurement of t-Tau, NF-L, GFAP, and UCH-L1 Biomarkers in Acute Concussion/Mild Traumatic Brain Injury (mTBI) Patient Serum and Saliva Samples Ahmed Chenna, PhD
05:30 PM - 06:30 PM EDT	Abstract	4-048 - CTE Pathology Absent in Former Military Services Members: A Preliminary Study Demonstrating No Increase in Neurodegenerative Proteinopathy Following TBI Arushi Tripathy
05:30 PM - 06:30 PM EDT	Abstract	4-049 - Chronic Neurobehavioral Symptoms in Retired Athletes and Military Veterans with a History of Head Trauma Adam J. Darby, MD
05:30 PM - 06:30 PM EDT	Abstract	4-050 - Ice Hockey Head Impact Kinematics Are Not Associated with Changes in Clinical Concussion Measures Thomas A. Buckley, PhD
05:30 PM - 06:30 PM EDT	Abstract	4-051 - Use of a Novel Clinically Relevant Symptom Scale for Acute Concussion Matthew T. McCarthy, MD
05:30 PM - 06:30 PM EDT	Abstract	4-052 - Abnormal Levels of Expired End-Tidal Carbon Dioxide (ETCO2) are Associated with Severity of Injury in Adults with Mild to Moderate Traumatic Brain Injury at a Level I Trauma Center
05:30 PM - 06:30 PM EDT	Abstract	4-053 - MULES on the Sidelines: A Vision-Based Assessment Tool for Sports-Related Concussion Samuel Fallon
05:30 PM - 06:30 PM EDT	Abstract	4-054 - Increased Optic Nerve Sheath Diameter after Mild Traumatic Brain Injury in a High-Risk Population Chloe E. Super, MD
05:30 PM - 06:30 PM EDT	Abstract	4-055 - Discordance of Cardiovascular Autonomic Discharge after Concussion is related to ChrM2 Gene Receptor Subtypes Michael F. La Fountaine, EdD, ATC
05:30 PM - 06:30 PM EDT	Abstract	4-056 - Astroglial activation and altered amyloid metabolism in human repetitive concussion Pashtun Shahim, MD, PhD
05:30 PM - 06:30 PM EDT	Abstract	4-057 - Plasma NF-L, tau, GFAP and advanced MRI imaging in the evaluation of mild Traumatic Brain Injury in a prospective cohort of active rugby players Etienne Laverse, MBBS, BSc, MRCP(Neurol), AICSM
05:30 PM - 06:30 PM EDT	Abstract	4-058 - The Effect of Repetitive Head Impact Exposure on Response Inhibition in Contact Sport Athletes Kelsey Bryk, MSc
05:30 PM - 06:30 PM EDT	Abstract	4-059 - The National Institute of Neurological Disorders and Stroke (NINDS) Updates to the Spinal Cord Injury (SCI) Common Data Element Recommendations Robin S. Feldman
05:30 PM - 06:30 PM EDT	Abstract	4-060 - The Life time risk after NFL, A Retrospective study Suresh Kumar, MD
05:30 PM - 06:30 PM EDT	Abstract	4-061 - ENIGMA Military Brain Injury: Altered Subcortical Volume in Chronic TBI Revealed by Mega-Analysis
05:30 PM - 06:30 PM EDT	Abstract	4-062 - Exosome Proteins as Prognostic and Diagnostic Biomarkers for Mild Traumatic Brain Injury Miranda Flamholz
05:30 PM - 06:30 PM EDT	Abstract	4-063 - Relationship between Rapid Number and Picture Naming Tests of a Concussion Assessment Battery Melissa S. DiFabio
05:30 PM - 06:30 PM EDT	Abstract	4-064 - The Impact of Traumatic Brain Injury on Arterial Compliance and Cerebral Blood Flow
05:30 PM - 06:30 PM EDT	Abstract	4-065 - Neurological Outcomes in Cardiac Arrest Patients with Non-shockable vs. Shockable Rhythm Treated With Targeted Temperature Management Gopika Hari
05:30 PM - 06:30 PM EDT	Abstract	4-066 - Evidence of Late Cognitive Recovery after Cardiac Arrest with Anoxia and Extended Coma Ryka Ashenden, MD
05:30 PM - 06:30 PM EDT	Abstract	4-067 - Efficacy of Early Neurological Examination in Determining Survival in Post Cardiac Arrest Patients who Underwent Hypothermia Protocol Rajanigandhi Hanumanthu, MD
05:30 PM - 06:30 PM EDT	Abstract	4-068 - NeuroCardiac Comprehensive Care Clinic Seeks to Define and Detect Neurological, Psychiatric, and Functional Sequelae in Cardiac Arrest Survivors Danish Ghazali, MD
05:30 PM - 06:30 PM EDT	Abstract	4-069 - Is Therapeutic Hypothermia For Cardiac Arrest Changing Outcomes: A National Inpatient Sample Analysis 2008-2014 Mohammad Rauf A. Chaudhry, MD
05:30 PM - 06:30 PM EDT	Abstract	4-070 - National Trends in Utilization of Therapeutic Hypothermia for Cardiac Arrest: National Inpatient Sample Study 2008-2014
05:30 PM - 06:30 PM EDT	Abstract	4-071 - Ischemic stroke after targeted temperature management for out-of-hospital cardiac arrest: A MRI findings Minyoul Baik, Jr., MD
05:30 PM - 06:30 PM EDT	Abstract	4-072 - High Motor Glascow Coma Scale score is associated with Survival to Discharge in Cardiac Arrest Patients: Retrospective Data from the MOCHA Study Jonathan Duskin, MD
05:30 PM - 06:30 PM EDT	Abstract	4-073 - Variability in post-arrest prognosis knowledge by healthcare providers Adarsh Menon
05:30 PM - 06:30 PM EDT	Abstract	4-074 - Racial Differences In Hospital Utilization Of Therapeutic Hypothermia Among Cardiac Arrest Patients In United States Mohammad Rauf A. Chaudhry, MD
05:30 PM - 06:30 PM EDT	Abstract	4-075 - Safe and effective use of prolonged, 4-week therapeutic hypothermia for super-refractory status epilepticus. Jae Eun Lee, MD
05:30 PM - 06:30 PM EDT	Abstract	4-076 - Impact of Early Treatment on Duration and Outcomes in Status Epilepticus Christine E. Yeager, MD
05:30 PM - 06:30 PM EDT	Abstract	4-077 - Treatment Comparison of Critically Ill Patients with Non-Convulsive Seizures or Non-Convulsive Status Epilepticus Receiving Levetiracetam Prophylaxis Safa Kaleem, MD
05:30 PM - 06:30 PM EDT	Abstract	4-078 - Racial Disparity in the Development of Seizure as a Delayed Complication of Subdural Hematoma Stacy C. Brown, MD
05:30 PM - 06:30 PM EDT	Abstract	4-079 - Incidence of Seizures with Fat Embolism Syndrome and Impact on Outcome: An Analysis of National Inpatient Sample Database Ephrem Teklemariam, MD
05:30 PM - 06:30 PM EDT	Abstract	4-080 - Ketamine does not affect Intracranial Pressure in patients with brain injury but effectively suppresses Cortical Spreading Depolarization Mohammad Abbas, MD
05:30 PM - 06:30 PM EDT	Abstract	4-081 - Association of rhythmic and periodic EEG patterns in ICU patients and in-hospital mortality Carlos F. Muniz, MD
05:30 PM - 06:30 PM EDT	Abstract	4-082 - Synaptic Organization of the Reciprocal Circuit Linking the Prefrontal Cortex and the Basolateral Amygdala Laura McGarry, MD, PhD
05:30 PM - 06:30 PM EDT	Abstract	4-083 - Intensive Blood Pressure Treatment in Deep Intracerebral Hemorrhage Audrey Leasure
05:30 PM - 06:30 PM EDT	Abstract	4-084 - The Civil War Soldier as the Model for Treating Hysterical Women in the 19th Century Stephanie M. Roses, MD
05:30 PM - 06:30 PM EDT	Abstract	4-085 - Predicting benign brachial monomelic amyotrophy: factors at presentation that differentiate from amyotrophic lateral sclerosis Sona Mistry, MD, MBBS
05:30 PM - 06:30 PM EDT	Abstract	13-001 - Impact of Fremanezumab on Response Rates, Acute Medication Use, and Disability in Patients With Episodic Migraine Who Have Failed at Least One Prior Migraine Preventive Medication Paul Winner, DO, FAAN
05:30 PM - 06:30 PM EDT	Abstract	13-002 - Reduction in the Severity of Headache in Patients With Chronic and Episodic Migraine With Fremanezumab Treatment Messoud Ashina, MD, PhD
05:30 PM - 06:30 PM EDT	Abstract	13-003 - Single Therapeutic and Supratherapeutic Doses of Ubrogepant Do Not Affect Cardiac Repolarization in Healthy Adults Abhijeet Jakate, PhD
05:30 PM - 06:30 PM EDT	Abstract	13-004 - ACT for Migraine: Effect of Acceptance and Commitment Therapy (ACT) for High Frequency Episodic Migraine without Aura: A phase-II, multicentric, randomized, open-label study Licia Grazzi, MD
05:30 PM - 06:30 PM EDT	Abstract	13-005 - Pharmacokinetics, safety, and tolerability of DFN-02, an intranasal sumatriptan spray containing a permeation enhancer, compared with intranasal sumatriptan in healthy adults
05:30 PM - 06:30 PM EDT	Abstract	13-006 - Eptinezumab for Prevention of Chronic Migraine: Results of 2 Infusions in the Phase 3 PROMISE-2 (Prevention of Migraine via Intravenous Eptinezumab Safety and Efficacy?2) Trial David B. Kudrow, MD
05:30 PM - 06:30 PM EDT	Abstract	13-007 - Eptinezumab Meaningfully Improves Quality of Life (QoL) in Patients with Episodic or Chronic Migraine Within 1 Month After Treatment Egilius L. Spierings, MD, PhD
05:30 PM - 06:30 PM EDT	Abstract	13-008 - Reduction in the Number of Headache Hours in Chronic and Episodic Migraine With Fremanezumab
05:30 PM - 06:30 PM EDT	Abstract	13-009 - Long-Term Safety Evaluation of Ubrogepant for the Acute Treatment of Migraine Jessica Ailani, MD, FAAN
05:30 PM - 06:30 PM EDT	Abstract	13-010 - One-Year Treatment with Galcanezumab in Patients with Chronic Migraine: Results from the Open-Label Phase of the REGAIN Study Holland Detke
05:30 PM - 06:30 PM EDT	Abstract	13-011 - How Adverse Events Are Collected and Reported: Differences Between Randomized Phase 2 and Phase 3 Clinical Trials for Lasmiditan David B. Kudrow, MD
05:30 PM - 06:30 PM EDT	Abstract	13-012 - Improved Functionality, Pain Relief, and Satisfaction in Patients Treated With Ubrogepant vs Placebo: Results from 2 Single-Attack Phase 3 Studies, ACHIEVE I and II Hema Viswanathan
05:30 PM - 06:30 PM EDT	Abstract	13-013 - Quarterly Administration of Fremanezumab Does Not Show “Wearing Off” Effect During Third Month After Injection Cory Blaiss
05:30 PM - 06:30 PM EDT	Abstract	13-014 - Safety from Phase 3 Clinical Studies Comparing Galcanezumab and Placebo in Patients with Episodic and Chronic Migraine
05:30 PM - 06:30 PM EDT	Abstract	13-015 - Long-Term Impact of Fremanezumab on Response Rates, Acute Headache Medication Use, and Disability in Patients With Chronic Migraine: Results of a 1-Year Study Peter J. McAllister, MD, FAAN
05:30 PM - 06:30 PM EDT	Abstract	13-016 - OnabotulinumtoxinA Is Safe and Effective in Patients Who Discontinue Topiramate: Results of the FORWARD Study John F. Rothrock, MD
05:30 PM - 06:30 PM EDT	Abstract	13-017 - Cardiovascular Profile of Dihydroergotamine Mesylate (DHE) Delivered by the POD® Device Compared to D.H.E. 45® for Injection from the INP104-101 Clinical Trial Karen Craig
05:30 PM - 06:30 PM EDT	Abstract	13-018 - Early and Sustained Effect of OnabotulinumtoxinA for Chronic Migraine Treatment: Pooled Analysis of PREEMPT Data Aubrey Adams, PhD
05:30 PM - 06:30 PM EDT	Abstract	13-019 - A Multi-Center, Randomized, Placebo-Controlled, Double-Blind, Crossover Study Evaluating DFN-15, a Liquid Celecoxib Formulation, for the Acute Treatment of Migraine with or without Aura in Adults
05:30 PM - 06:30 PM EDT	Abstract	13-020 - Early Migraine Response by Month 1 and Clinically Meaningful Improvements in Health-Related Quality of Life (HRQoL) in Patients with Migraine in Phase 3 Trials of Eptinezumab Stewart J. Tepper, MD
05:30 PM - 06:30 PM EDT	Abstract	13-021 - Effect of Age on Efficacy and Safety of Galcanezumab Treatment in Adult Patients with Migraine
05:30 PM - 06:30 PM EDT	Abstract	13-022 - Precision Olfactory Delivery (POD®) of Drugs for Neurological Disease: A Safety, Tolerability and Comparative Bioavailability Study of POD Dihydroergotamine Mesylate (INP104) to Approved IV D.H.E. 45® and Migranal® Nasal Spray. Stephen B. Shrewsbury, MD
05:30 PM - 06:30 PM EDT	Abstract	13-023 - Long-Term Impact of Fremanezumab on Headache-Related Disability, Quality of Life, and Patient Satisfaction in Episodic Migraine and Chronic Migraine
05:30 PM - 06:30 PM EDT	Abstract	13-024 - Multiple, Once-Daily, Oral Doses of 150 mg Ubrogepant Administered for 28 Days Are Generally Well Tolerated, With No Clinically Significant Elevation of Alanine Aminotransferase in Healthy Adult Males
05:30 PM - 06:30 PM EDT	Abstract	13-025 - Efficacy of Erenumab in Chronic Migraine Patients With and Without Allodynia

Faculty Disclosures
Kevin N. Sheth, MD, FAAN	Dr. Sheth has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ceribell. Dr. Sheth has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Zoll. Dr. Sheth has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for NControl. Dr. Sheth has received stock or an ownership interest from Astrocyte. Dr. Sheth has received stock or an ownership interest from Alva. The institution of Dr. Sheth has received research support from Biogen. The institution of Dr. Sheth has received research support from Novartis. The institution of Dr. Sheth has received research support from Bard. The institution of Dr. Sheth has received research support from Hyperfine. Dr. Sheth has received intellectual property interests from a discovery or technology relating to health care.
Richard B. Lipton, MD, FAAN	Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Allergan/Abbvie. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Amgen. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biohaven. Dr. Lipton has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Eli Lilly. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Lundbeck. Dr. Lipton has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for GlaxoSmithKline. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Teva. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Vedanta. Dr. Lipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Grifols. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Pfizer. Dr. Lipton has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Axon. Dr. Lipton has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Satsuma. Dr. Lipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Dr. Lipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cool Tech. Dr. Lipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BDSI. Dr. Lipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Linpharma. Dr. Lipton has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Axsome. Dr. Lipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Clexio. Dr. Lipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Shiratronics. Dr. Lipton has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Allergan/Abbvie. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biohaven. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eli Lilly. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lundbeck. Dr. Lipton has or had stock in Biohaven.Dr. Lipton has or had stock in Manistee.Dr. Lipton has or had stock in Axon.Dr. Lipton has or had stock in CoolTech. The institution of Dr. Lipton has received research support from Teva. The institution of Dr. Lipton has received research support from Amgen. The institution of Dr. Lipton has received research support from Allergan/Abbvie. The institution of Dr. Lipton has received research support from Gammacore. The institution of Dr. Lipton has received research support from Axsome. The institution of Dr. Lipton has received research support from Charleston Labs. The institution of Dr. Lipton has received research support from Eli Lilly. The institution of Dr. Lipton has received research support from Satsuma. The institution of Dr. Lipton has received research support from NIH . The institution of Dr. Lipton has received research support from Veterans Administration. Dr. Lipton has received publishing royalties from a publication relating to health care.
Roy L. Freeman, MD	Dr. Freeman has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Cutaneous Diagnostic Life Sciences. Dr. Freeman has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Vertex. Dr. Freeman has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Theravance. Dr. Freeman has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for Inhibikase. Dr. Freeman has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier. The institution of Dr. Freeman has received research support from NIH. The institution of Dr. Freeman has received research support from Theravance. The institution of Dr. Freeman has received research support from Biohaven. The institution of Dr. Freeman has received research support from Lundbeck. Dr. Freeman has received research support from Regeneron.
Bruce I. Ovbiagele, MD, MSc, FAAN	Dr. Ovbiagele has received personal compensation in the range of $50,000-$99,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Stroke Association. Dr. Ovbiagele has received research support from National Institutes of Health. Dr. Ovbiagele has a non-compensated relationship as a President with Society for Equity Neuroscience that is relevant to AAN interests or activities. Dr. Ovbiagele has a non-compensated relationship as a Board Member with World Stroke Organization that is relevant to AAN interests or activities.
Egilius L. Spierings, MD, PhD	Dr. Spierings has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Manistee. Dr. Spierings has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Lundbeck. Dr. Spierings has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Lilly. Dr. Spierings has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Abbvie.
Tanya Fischer, MD, PhD	No disclosure on file
Shitiz K. Sriwastava, MBBS	Dr. Sriwastava has nothing to disclose.
Ivan Da Silva, MD	Dr. Da Silva has nothing to disclose.
Julien Hebert, MD	Dr. Hebert has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Paladin Labs. Dr. Hebert has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Gowling WLG. The institution of Dr. Hebert has received research support from Praxis Precision Medicine.
Aaron F. Struck, MD	The institution of Dr. Struck has received research support from Ceribell.
Cumara B. O'Carroll, MD, FAAN	Dr. O'Carroll has nothing to disclose.
David T. Jones, MD	Dr. Jones has stock in Cephlodyne Neurotechnologies, Inc.. Dr. Jones has received intellectual property interests from a discovery or technology relating to health care.
Maria M. Zak, NP	No disclosure on file
Ansgar Furst, PhD MS	No disclosure on file
John A. Hardy, PhD	No disclosure on file
	No disclosure on file
Nicolas Saikali, MD	Dr. Saikali has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for AbbVie. Dr. Saikali has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Lilly. Dr. Saikali has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Teva. Dr. Saikali has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Upsher-Smith. Dr. Saikali has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Axsome. The institution of Dr. Saikali has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Lundbeck.
Melissa R. Ortega, MD	An immediate family member of Dr. Ortega has received personal compensation for serving as an employee of Aptitude. An immediate family member of Dr. Ortega has received personal compensation for serving as an employee of Oncocyte. An immediate family member of Dr. Ortega has received personal compensation for serving as an employee of Total Health Information.
Shufang Wang	No disclosure on file
David C. Reutens, MD	The institution of Dr. Reutens has received research support from Australian Research Council. The institution of Dr. Reutens has received research support from Siemens Health Care. The institution of Dr. Reutens has received research support from Vivazone Pty Ltd. Dr. Reutens has received intellectual property interests from a discovery or technology relating to health care.
Joy R. Esterlitz	No disclosure on file
Silvia Basaia	Silvia Basaia has nothing to disclose.
Alfonso Fasano, MD, PhD, FAAN	Dr. Fasano has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Abbott. Dr. Fasano has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Abbvie. Dr. Fasano has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ipsen. Dr. Fasano has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Medtronic. Dr. Fasano has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Boston Scientific. Dr. Fasano has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abbott. Dr. Fasano has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Medtronic. Dr. Fasano has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Ceregate. Dr. Fasano has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Inbrain Neuroelectronics. Dr. Fasano has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Syneos Health. Dr. Fasano has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Annovis. Dr. Fasano has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for CADTH. Dr. Fasano has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for International Parkinson and Movement Disorders Society. The institution of Dr. Fasano has received research support from Boston Scientific. The institution of Dr. Fasano has received research support from Medtronic. The institution of Dr. Fasano has received research support from Abbvie. The institution of Dr. Fasano has received research support from Canadian Institutes of Health Research (CIHR). The institution of Dr. Fasano has received research support from Michael J Fox Foundation. The institution of Dr. Fasano has received research support from Bluerock Therapeutics. Dr. Fasano has received publishing royalties from a publication relating to health care. Dr. Fasano has a non-compensated relationship as a Medical Advisory Committee with CenteR for Advancing Neurological Innovation to Application (CRANIA) that is relevant to AAN interests or activities. Dr. Fasano has a non-compensated relationship as a Medical Advisory Committee with HopeNET that is relevant to AAN interests or activities. Dr. Fasano has a non-compensated relationship as a Medical Advisory Committee with International Essential Tremor Foundation that is relevant to AAN interests or activities. Dr. Fasano has a non-compensated relationship as a Member with Tremor Research Group that is relevant to AAN interests or activities. Dr. Fasano has a non-compensated relationship as a Co-Chair with Tremor Study Group of the IPMDS that is relevant to AAN interests or activities. Dr. Fasano has a non-compensated relationship as a Vice-Chair with NPH Study Group of the IPMDS that is relevant to AAN interests or activities. Dr. Fasano has a non-compensated relationship as a Vice-Chair with Industry Committee of the IPMDS that is relevant to AAN interests or activities.
David S. Knopman, MD, FAAN	Dr. Knopman has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for DIAN TU study. The institution of Dr. Knopman has received research support from NIH.
Anthony E. Lang, MD, FAAN	Dr. Lang has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for AbbVie, Amylyx, Aprinoia, Biogen, BioAdvance, Biohaven, BioVie, BlueRock, BMS, Denali, Janssen, Lilly, Pharma 2B, Sun Pharma, and UCB. Dr. Lang has received personal compensation in the range of $50,000-$99,999 for serving as an Expert Witness for medicolegal cases related to paraquat. The institution of Dr. Lang has received research support from AbbVie. Dr. Lang has received intellectual property interests from a discovery or technology relating to health care. Dr. Lang has received publishing royalties from a publication relating to health care.
James Conners, MD	The institution of Dr. Conners has received research support from nih.
Kiwon Lee, MD	No disclosure on file
Ji Hoe Heo, MD, PhD	No disclosure on file
Edward Pan, MD	No disclosure on file
Mudassir Farooqui, MD	Dr. Farooqui has nothing to disclose.
Michael C. Smith, MD, FAAN	Dr. Smith has received personal compensation in the range of $500-$4,999 for serving as a Consultant for SK Lifesciences. Dr. Smith has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for SK Lifesciences .
Deepak Madhavan, MD	No disclosure on file
Sakir H. Gultekin, MD	No disclosure on file
Mark Frasier	No disclosure on file
Shelly K. Weiss, MD	No disclosure on file
Joseph M. Savitt, MD, PhD	The institution of Dr. Savitt has received research support from Bial. The institution of Dr. Savitt has received research support from UCB.
Paula P. Warren, MD	No disclosure on file
Thomas J. Shoemaker, MD	Dr. Shoemaker has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Biogen. Dr. Shoemaker has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for AMGEN. Dr. Shoemaker has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for EMD Serono.
Amanda Thuringer, DO	Dr. Thuringer has nothing to disclose.
Rachel Marie E. Salas, MD, MEd, FAAN	Dr. Salas has received personal compensation for serving as an employee of HMPGlobal. Dr. Salas has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurology Learning Network. Dr. Salas has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for PRIME. Dr. Salas has received publishing royalties from a publication relating to health care.
Steven Frucht, MD	Dr. Frucht has nothing to disclose.
John W. Rose, MD, FAAN	The institution of Dr. Rose has received research support from National Multiple Sclerosis Society. The institution of Dr. Rose has received research support from Guthy Jackson Charitable Foundation. The institution of Dr. Rose has received research support from NIH . The institution of Dr. Rose has received research support from VA. The institution of Dr. Rose has received research support from Biogen. The institution of Dr. Rose has received research support from Friends of MS. Dr. Rose has received intellectual property interests from a discovery or technology relating to health care.
Sankara Sarma	No disclosure on file
Rudolph Castellani	No disclosure on file
Kathleen B. Digre, MD, FAAN	Dr. Digre has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for American Headache Society. The institution of Dr. Digre has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Journal of Neuro-ophthalmology. The institution of Dr. Digre has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Utah Womens Health Review. Dr. Digre has received intellectual property interests from a discovery or technology relating to health care. Dr. Digre has received intellectual property interests from a discovery or technology relating to health care. Dr. Digre has received intellectual property interests from a discovery or technology relating to health care. Dr. Digre has received publishing royalties from a publication relating to health care. Dr. Digre has received publishing royalties from a publication relating to health care.
Sarah Song, MD, MPH, FAAN	Dr. Song has received personal compensation in the range of $50,000-$99,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for AAN.
Omar Siddiqi, MD	The institution of Dr. Siddiqi has received research support from NIH.
Roy E. Strowd III, MD, FAAN	Dr. Strowd has received personal compensation for serving as an employee of Kaplan. Dr. Strowd has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Monteris Medical, Inc. Dr. Strowd has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novocure. The institution of Dr. Strowd has received personal compensation in the range of $500-$4,999 for serving as a Consultant for SpringWorks . Dr. Strowd has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for ��ɫ��. The institution of Dr. Strowd has received research support from Southeastern Brain Tumor Foundation. The institution of Dr. Strowd has received research support from Jazz Pharmaceuticals. The institution of Dr. Strowd has received research support from National Institutes of Health. The institution of Dr. Strowd has received research support from Alpha Omega Alpha. The institution of Dr. Strowd has received research support from American Board of Psychiatry and Neurology. Dr. Strowd has received publishing royalties from a publication relating to health care. Dr. Strowd has received publishing royalties from a publication relating to health care.
Steven Galetta, MD, FAAN	Dr. Galetta has nothing to disclose.
David F. Tang-Wai, MD, FRCPC	Dr. Tang-Wai has nothing to disclose.
Suzanne Powell, MD	Dr. Powell has nothing to disclose.
Katrina A. Gwinn, MD, FAAN	No disclosure on file
Barbara Voetsch, MD, PhD	The institution of Dr. Voetsch has received research support from NIH StrokeNet . Dr. Voetsch has received publishing royalties from a publication relating to health care. Dr. Voetsch has received personal compensation in the range of $500-$4,999 for serving as a International Stroke Conference attendee (travel-related expenses) with AHA/ASA. Dr. Voetsch has a non-compensated relationship as a member of the Massachusetts Systems of Care Workgroup with AHA/ASA that is relevant to AAN interests or activities.
Paul J. Eslinger, PhD	No disclosure on file
Tara Cook, MD	No disclosure on file
Kevin M. Barrett, MD, FAAN	Dr. Barrett has nothing to disclose.
James C. Johnston, MD, JD, FAAN	Dr. Johnston has a non-compensated relationship as a Director with Global NeuroCare that is relevant to AAN interests or activities.
Deepti Anbarasan, MD	Dr. Anbarasan has nothing to disclose.
Carol Mathews	The institution of Carol Mathews has received research support from NIH.
Andrea Harriott, MD	Dr. Harriott has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Theranica. Dr. Harriott has received personal compensation in the range of $5,000-$9,999 for serving as an officer or member of the Board of Directors for Headache Cooperative of New England. The institution of Dr. Harriott has received research support from Electrocore. Dr. Harriott has a non-compensated relationship as a Author agreement with Abbvie that is relevant to AAN interests or activities. Dr. Harriott has a non-compensated relationship as a Researcher/Receipt of drug with Praxis that is relevant to AAN interests or activities.
Mitesh P. Lotia, MD	Dr. Lotia has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. Lotia has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Orphalan. Dr. Lotia has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Abbott.
Sean C. Rose, MD, FAAN	Dr. Rose has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Summit Experts. The institution of Dr. Rose has received research support from Dale Earnhardt Jr Foundation.
Nara Michaelson, MD	The institution of Dr. Michaelson has received research support from Biogen. The institution of Dr. Michaelson has received research support from the National Multiple Sclerosis Society (NMSS). Dr. Michaelson has received research support from Sanofi.
Lironn Kraler, MD	Dr. Kraler has nothing to disclose.
Sonia M. Caraballo-Cartagena, MD	Dr. Caraballo-Cartagena has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. Dr. Caraballo-Cartagena has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenx. Dr. Caraballo-Cartagena has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Caraballo-Cartagena has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for UCB. Dr. Caraballo-Cartagena has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Alexion. Dr. Caraballo-Cartagena has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Takeda. Dr. Caraballo-Cartagena has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Alnylam. Dr. Caraballo-Cartagena has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Argenx.
Gupta V. Harsh, MD	No disclosure on file
David Valentine, MD	No disclosure on file
Aristide Merola, MD, PhD	Dr. Merola has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Abbvie. Dr. Merola has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Abbott. Dr. Merola has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Frontiers in Neurology.
Christa Seligman, NP	No disclosure on file
W. C. LaFrance, Jr., MD, MPH, FAAN	Dr. LaFrance has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for medico-legal work.. The institution of Dr. LaFrance has received research support from Department of Defense. Dr. LaFrance has received publishing royalties from a publication relating to health care. Dr. LaFrance has received publishing royalties from a publication relating to health care. Dr. LaFrance has a non-compensated relationship as a Steering Committee Member with Xenon that is relevant to AAN interests or activities.
Eric L. Logigian, MD, FAAN	Dr. Logigian has nothing to disclose.
Sunil Sheth, MD	Dr. Sheth has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Penumbra. Dr. Sheth has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cerenovus. Dr. Sheth has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Imperative Care.
Jeffrey S. Kutcher, MD, FAAN	Dr. Kutcher has nothing to disclose.
Sara M. Schaefer, MD, FAAN	Dr. Schaefer has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Movement Disorders Journal. The institution of Dr. Schaefer has received research support from American Parkinson Disease Association. Dr. Schaefer has received personal compensation in the range of $500-$4,999 for serving as a RITE Section Lead with ��ɫ��. Dr. Schaefer has received personal compensation in the range of $500-$4,999 for serving as a QOD Question Writer with ��ɫ��.
Waqar Waheed, MD, MBBS	Dr. Waheed has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB.
Brian Stephens, MD	No disclosure on file
Joseph C. McCall, MD	No disclosure on file
Carlos Santiago Claverie, MD	No disclosure on file
Scott D. Newsome, DO, FAAN	Dr. Newsome has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Newsome has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Newsome has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics. The institution of Dr. Newsome has received research support from Biogen. The institution of Dr. Newsome has received research support from Genentech/Roche. The institution of Dr. Newsome has received research support from Department of Defense. The institution of Dr. Newsome has received research support from Patient Centered Outcomes Research Institute. The institution of Dr. Newsome has received research support from National MS Society. The institution of Dr. Newsome has received research support from Lundbeck. The institution of Dr. Newsome has received research support from Sanofi. The institution of Dr. Newsome has received research support from Kyverna Therapeutics. Dr. Newsome has received personal compensation in the range of $10,000-$49,999 for serving as a Lead PI for Clinical Trial with Roche.
H. E. Hinson, MD, MCR, FAAN	Dr. Hinson has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurology. Dr. Hinson has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Heart Association.
Jeffrey L. Saver, MD, FAAN	Dr. Saver has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Medtronic. Dr. Saver has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Stryker. Dr. Saver has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cerenovus. Dr. Saver has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Boehringer Ingelheim (prevention only). Dr. Saver has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Medical Association. Dr. Saver has received stock or an ownership interest from Rapid Medical.
David B. Kudrow, MD	Dr. Kudrow has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AbbVie. Dr. Kudrow has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for AbbVie.
MaryKay A. Pavol, PhD	Dr. Pavol has nothing to disclose.
Michelle Burack, MD, PhD	No disclosure on file
Aravindhan Veerapandiyan, MD	Dr. Veerapandiyan has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biogen, Novartis,Edgewise Therapeutics, Pfizer, PTC Therapeutics, Sarepta Therapeutics, Inc., UCB Pharma, Catalyst, Entrada, Lupin, Percheron, ITF. Dr. Veerapandiyan has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for MedLink Neurology. Dr. Veerapandiyan has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Muscle and Nerve. The institution of Dr. Veerapandiyan has received research support from AMO Pharma, Capricor Therapeutics, Edgewise Therapeutics, FibroGen, Muscular Dystrophy Association, Novartis, Parent Project Muscular Dystrophy, Pfizer, RegenxBio, SolodBio and Sarepta Therapeutics. Dr. Veerapandiyan has received personal compensation in the range of $5,000-$9,999 for serving as a MD with PPMD, MDA.
Prahlad Kumar Sethi, MD, FAAN	No disclosure on file
Eric J. Seachrist, MD	Dr. Seachrist has or had stock in Medtronic.Dr. Seachrist has or had stock in Pfizer. The institution of Dr. Seachrist has received research support from Bristol Myers Squibb. Dr. Seachrist has a non-compensated relationship as a Topic Group, QOD Committee, and Wellness Program Committee with ��ɫ�� that is relevant to AAN interests or activities.
Sneha Jacob, MD	Dr. Jacob has nothing to disclose.
Patrick B. Moloney, MBBS	No disclosure on file
Negar Moheb, MD	Dr. Moheb has nothing to disclose.
Nabila Dahodwala, MD, FAAN	Dr. Dahodwala has received personal compensation in the range of $0-$499 for serving as a Consultant for Genetech. Dr. Dahodwala has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Mediflix. Dr. Dahodwala has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Acadia. Dr. Dahodwala has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Post and Schell. Dr. Dahodwala has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for O'Brien & Ryan, LLP. Dr. Dahodwala has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for MotleyRice. The institution of Dr. Dahodwala has received research support from AbbVie. The institution of Dr. Dahodwala has received research support from Medtronic.
Rana Hanna AL-Shaikh, MD	Dr. Hanna AL-Shaikh has nothing to disclose.
Pezhman Roohani, MD	No disclosure on file
Nikil Swamy, MD	No disclosure on file
Alain Z. Lekoubou Looti, MD	Dr. Lekoubou Looti has nothing to disclose.
Gustavo Da Prat de Magahlaes	Gustavo Da Prat de Magahlaes has nothing to disclose.
Sarah Horn, MD	Dr. Horn has received personal compensation in the range of $500-$4,999 for serving as a Consultant for AbbVie. The institution of Dr. Horn has received research support from Alzheimer's Association.
Gil D. Rabinovici, MD, FAAN	Dr. Rabinovici has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Eli Lilly. Dr. Rabinovici has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alector. Dr. Rabinovici has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Merck. Dr. Rabinovici has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Rabinovici has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Dr. Rabinovici has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novo Norodisk. Dr. Rabinovici has received personal compensation in the range of $500-$4,999 for serving as a Consultant for C2N. Dr. Rabinovici has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Johnson & Joihnson. Dr. Rabinovici has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Peerview. Dr. Rabinovici has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Medscape. Dr. Rabinovici has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for JAMA Neurology. Dr. Rabinovici has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for JAMA. The institution of Dr. Rabinovici has received research support from NIH. The institution of Dr. Rabinovici has received research support from American College of Radiology. The institution of Dr. Rabinovici has received research support from Alzheimer's Association. The institution of Dr. Rabinovici has received research support from Rainwater Charitable Foundation. Dr. Rabinovici has received personal compensation in the range of $500-$4,999 for serving as a Topic Chair, Course Director and teacher with AAN. Dr. Rabinovici has received personal compensation in the range of $500-$4,999 for serving as a Grant reviewer with NIH. Dr. Rabinovici has received personal compensation in the range of $500-$4,999 for serving as a Invited speaker with ANA.
Mark Hallett, MD, FAAN	Dr. Hallett has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen. Dr. Hallett has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurocrine. Dr. Hallett has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Brainsway. Dr. Hallett has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for VoxNeuro. Dr. Hallett has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for QuantalX. Dr. Hallett has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier. Dr. Hallett has received intellectual property interests from a discovery or technology relating to health care. Dr. Hallett has received publishing royalties from a publication relating to health care. Dr. Hallett has received publishing royalties from a publication relating to health care. Dr. Hallett has received publishing royalties from a publication relating to health care. Dr. Hallett has received publishing royalties from a publication relating to health care. Dr. Hallett has received personal compensation in the range of $500-$4,999 for serving as a Speaker with International Parkinson and Movement Disorder Society. Dr. Hallett has a non-compensated relationship as a Past-President with Functional Neurological Disorder Society that is relevant to AAN interests or activities.
Michael R. Wilson, MD, FAAN	Dr. Wilson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Pfizer. Dr. Wilson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ouro Medicines. Dr. Wilson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Vertex Pharmaceuticals. Dr. Wilson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Indapta Therapeutics. Dr. Wilson has received personal compensation in the range of $50,000-$99,999 for serving as an officer or member of the Board of Directors for Delve Bio. Dr. Wilson has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Cambridge Medical Experts. Dr. Wilson has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Dunham Hallmark. Dr. Wilson has stock in Delve Bio. The institution of Dr. Wilson has received research support from Genentech / Roche. The institution of Dr. Wilson has received research support from NIH. The institution of Dr. Wilson has received research support from Novartis. The institution of Dr. Wilson has received research support from National Multiple Sclerosis Society. The institution of Dr. Wilson has received research support from Fanconi Anemia Research Foundation. The institution of Dr. Wilson has received research support from Department of Defense. The institution of Dr. Wilson has received research support from Chan Zuckerberg Initiative. The institution of Dr. Wilson has received research support from Kyverna Therapeutics. Dr. Wilson has received intellectual property interests from a discovery or technology relating to health care. Dr. Wilson has received intellectual property interests from a discovery or technology relating to health care. Dr. Wilson has received personal compensation in the range of $10,000-$49,999 for serving as a Expert Witness with US Dept of Justice.
Jason J. Sico, MD, FAAN	Dr. Sico has nothing to disclose.
Salvador Cruz-Flores, MD, FAAN	The institution of Dr. Cruz-Flores has received research support from University of Texas System.
Rabia Choudry, MD	Dr. Choudry has nothing to disclose.
Alzira A. Carvalho, MD	No disclosure on file
Aparna M. Prabhu, MD	Dr. Prabhu has nothing to disclose.
Eytan Raz	No disclosure on file
S. A. Josephson, MD, FAAN	Dr. Josephson has received personal compensation in the range of $50,000-$99,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for JAMA Neurology. Dr. Josephson has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for McGraw Hill---Harrison's Principles of Internal Medicine. Dr. Josephson has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for various legal firms. The institution of Dr. Josephson has received research support from NINDS. Dr. Josephson has received publishing royalties from a publication relating to health care. Dr. Josephson has received publishing royalties from a publication relating to health care.
Elan D. Louis, MD, MS, FAAN	Dr. Louis has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Wolters Kluwer - Merritt's Textbook of Neurology. Dr. Louis has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Legal Firm. The institution of Dr. Louis has received research support from National Institutes of Health. Dr. Louis has received publishing royalties from a publication relating to health care. Dr. Louis has a non-compensated relationship as a Board of Directors with International Essential Tremor Foundation that is relevant to AAN interests or activities. Dr. Louis has a non-compensated relationship as a Medical Advisory Board with HopeNET that is relevant to AAN interests or activities.
Rashmi B. Halker Singh, MD, FAAN	Dr. Halker Singh has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pfizer. Dr. Halker Singh has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AbbVie. Dr. Halker Singh has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lundbeck. Dr. Halker Singh has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Current Neurology & Neuroscience Reports. Dr. Halker Singh has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Headache Journal. Dr. Halker Singh has received publishing royalties from a publication relating to health care. Dr. Halker Singh has received personal compensation in the range of $5,000-$9,999 for serving as a CME speaker with Pri-med. Dr. Halker Singh has received personal compensation in the range of $500-$4,999 for serving as a CME speaker with Medscape.
Christopher Goetz, MD, FAAN	The institution of Dr. Goetz has received research support from Michael J. Fox Foundation. The institution of Dr. Goetz has received research support from NIH. The institution of Dr. Goetz has received research support from Department of Defense. Dr. Goetz has received publishing royalties from a publication relating to health care. Dr. Goetz has received publishing royalties from a publication relating to health care. Dr. Goetz has received publishing royalties from a publication relating to health care.
Elizabeth Slow, MD, PhD	Dr. Slow has nothing to disclose.
Melissa Mercado, MD	No disclosure on file
Jerold Chun	No disclosure on file
David W. Dodick, MD, FAAN	Dr. Dodick has received personal compensation for serving as an employee of Mayo Clinic. Dr. Dodick has received personal compensation for serving as an employee of Atria Health. Dr. Dodick has received personal compensation for serving as an employee of Thomas Jefferson University . Dr. Dodick has received personal compensation for serving as an employee of Norwegian University of Science and Technology. Dr. Dodick has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Amgen. Dr. Dodick has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Allergan. Dr. Dodick has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Abbvie. Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biohaven. Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biopharm Communications. Dr. Dodick has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Lundbeck. Dr. Dodick has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Eli Lilly. Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Teva. Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Inside Practice Australia. Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Clinical ��ɫ�� Alliance. Dr. Dodick has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genentech. Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Headache Cooperative of the Pacific . Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medica Communications. Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for MJ Healthcare. Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Nocira. Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Praxis. Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Revance . Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Synapse Medical Communications. Dr. Dodick has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Vector Psychometrics. Dr. Dodick has received personal compensation in the range of $0-$499 for serving as a Consultant for Ayya Biosciences. Dr. Dodick has received personal compensation in the range of $0-$499 for serving as a Consultant for Theranica. Dr. Dodick has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Atria. Dr. Dodick has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for WebMD. Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Thomas Jefferson University. Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medforce. Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Precision HEOR. Dr. Dodick has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Genentech. Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Canadian Headache Society. Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Headache Cooperative of New England. Dr. Dodick has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Amgen Japan. Dr. Dodick has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for KingDevick Technologies. Dr. Dodick has received personal compensation in the range of $1,000,000+ for serving as an officer or member of the Board of Directors for Precon Health. Dr. Dodick has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Ontologics. Dr. Dodick has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Matterhorn. Dr. Dodick has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Axon Therapeutics. Dr. Dodick has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Cephalgia Group. Dr. Dodick has stock in Healint. Dr. Dodick has stock in Theranica. Dr. Dodick has stock in Aural Analytics . Dr. Dodick has stock in Epien. Dr. Dodick has stock in Matterhorn. Dr. Dodick has stock in Ontologics. Dr. Dodick has stock in Precon Health. Dr. Dodick has stock in King Devick Technologies. Dr. Dodick has stock in Nocira. Dr. Dodick has stock in Exsano. Dr. Dodick has stock in Palion. Dr. Dodick has stock in AYYA Biosciences. Dr. Dodick has stock in Perfood. Dr. Dodick has stock in Cephalgia Group. Dr. Dodick has stock in Atria Health. Dr. Dodick has stock in Man and Science. Dr. Dodick has stock in Eigenlyfe. An immediate family member of Dr. Dodick has stock in ScotiaLyfe. Dr. Dodick has stock in Axon Therapeutics. The institution of Dr. Dodick has received research support from Department of Defense. The institution of Dr. Dodick has received research support from Patient Centered Outcomes Research Institute. The institution of Dr. Dodick has received research support from Henry Jackson Foundation. Dr. Dodick has received intellectual property interests from a discovery or technology relating to health care. Dr. Dodick has received intellectual property interests from a discovery or technology relating to health care. Dr. Dodick has received intellectual property interests from a discovery or technology relating to health care. Dr. Dodick has received publishing royalties from a publication relating to health care. Dr. Dodick has received publishing royalties from a publication relating to health care. Dr. Dodick has received publishing royalties from a publication relating to health care. Dr. Dodick has a non-compensated relationship as a Chair with American Brain Foundation that is relevant to AAN interests or activities. Dr. Dodick has a non-compensated relationship as a Committee member/Course Director with ��ɫ�� that is relevant to AAN interests or activities. Dr. Dodick has a non-compensated relationship as a Chair/Immediate Past Chair with American Migraine Foundation that is relevant to AAN interests or activities. Dr. Dodick has a non-compensated relationship as a Chair Global Patient Advocacy Coalition with International Headache Society that is relevant to AAN interests or activities.
Lauren R. Moo, MD, FAAN	Dr. Moo has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Pilltrax. An immediate family member of Dr. Moo has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Taylor and Francis. Dr. Moo has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Smith Mirabella Blake. The institution of Dr. Moo has received research support from VA HSR&D. The institution of Dr. Moo has received research support from VA Office of Rural Health. Dr. Moo has received research support from NIH.
Joseph J. Melvin, DO	Dr. Melvin has received personal compensation in the range of $100,000-$499,999 for serving as a Physican with Tower health.
Marco T. Medina, MD, FAAN	Dr. Medina has nothing to disclose.
Yomi A. Ogun, MD, FAAN	Dr. Ogun has nothing to disclose.
Satoshi Kuwabara	Satoshi Kuwabara has nothing to disclose.
Mark F. Gordon, MD, FAAN	Dr. Gordon has received personal compensation for serving as an employee of Teva. Dr. Gordon has stock in Teva.
David J. Sharp, MD	No disclosure on file
Maxwell A. Greene, MD	Dr. Greene has received personal compensation in the range of $500-$4,999 for serving as a Advisory Board Member with Dysimmune Diseases Foundation .
Hanane Touil, PhD	No disclosure on file
Joseph J. Sabatino, Jr., MD	The institution of Dr. Sabatino has received research support from Roche/Genentech.
Khadija Irshad, MD	No disclosure on file
Michael Potchen	Michael Potchen has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Jackson & Campbell, P.C.. Michael Potchen has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Rotezel & Andress.
Jayashree Sundararajan, MD	Dr. Sundararajan has nothing to disclose.
Joshua Z. Willey, MD, FAAN	Dr. Willey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbott. Dr. Willey has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Edwards Scientific. Dr. Willey has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for RECARDIO. Dr. Willey has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abbott. Dr. Willey has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for BrainQ. Dr. Willey has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Journal of the American College of Cardiology. Dr. Willey has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Uptodate. The institution of Dr. Willey has received research support from NIH. Dr. Willey has received personal compensation in the range of $500-$4,999 for serving as a Review chapter author, MKSAP 16-20 with American College of Physicians.
Daniel M. Togasaki, MD, PhD	No disclosure on file
Charlene Gamaldo, MD, FAAN	Dr. Gamaldo has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for johns hopkins. Dr. Gamaldo has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Jazz. Dr. Gamaldo has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Takeda. Dr. Gamaldo has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Apnimed. The institution of Dr. Gamaldo has received research support from NIH/NIMH/NIDA/NINDS. Dr. Gamaldo has received publishing royalties from a publication relating to health care.
Todd D. Levine, MD	Dr. Levine has received personal compensation for serving as an employee of CND life sciences . Dr. Levine has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Nufactor. Dr. Levine has received personal compensation in the range of $50,000-$99,999 for serving as an Expert Witness for PNA. Dr. Levine has or had stock in CND Life Sciences.Dr. Levine has or had stock in Corinthian reference lab.
Gregory S. Day, MD, MSc, FAAN	Dr. Day has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Arialys Therapeutics. Dr. Day has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for DynaMed (EBSCO Health). Dr. Day has or had stock in ANI Pharmaceuticals. The institution of Dr. Day has received research support from National Institutes of Health / NIA. The institution of Dr. Day has received research support from National Institutes of Health / NINDS. The institution of Dr. Day has received research support from Amgen Pharmaceuticals. The institution of Dr. Day has received research support from AVID Radiopharmaceuticals. Dr. Day has received personal compensation in the range of $500-$4,999 for serving as a Presenter at Annual Meeting (CME) with ��ɫ��. Dr. Day has received personal compensation in the range of $500-$4,999 for serving as a Content Development (CME) with PeerView, Inc. Dr. Day has received personal compensation in the range of $5,000-$9,999 for serving as a Content Development (CME) with Continuing ��ɫ��, Inc. Dr. Day has received personal compensation in the range of $5,000-$9,999 for serving as a Content Development (CME) with Ionis Pharmaceuticals. Dr. Day has received personal compensation in the range of $500-$4,999 for serving as a ��ɫ��al Case Development + Presentation (video) with PeerDirect (P\S\L Group). Dr. Day has received personal compensation in the range of $500-$4,999 for serving as a Content Development / Presentation (non-CME) with MJH Life Sciences (NeurologyLive). Dr. Day has a non-compensated relationship as a Clinical Director with Anti-NMDA Receptor Encephalitis Foundation that is relevant to AAN interests or activities.
Rani A. Sarkis, MD, MSc	The institution of Dr. Sarkis has received research support from NINDS.
Claude Steriade, MD	The institution of Dr. Steriade has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for The Epilepsy Study Consortium. Dr. Steriade has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Dynamed. Dr. Steriade has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for DOJ. The institution of Dr. Steriade has received research support from NIH. Dr. Steriade has received personal compensation in the range of $500-$4,999 for serving as a Consultant with Epitel. Dr. Steriade has received personal compensation in the range of $500-$4,999 for serving as a Consultant with Jazz Pharmaceuticals. Dr. Steriade has received personal compensation in the range of $10,000-$49,999 for serving as a Speakers Bureau with SK Life Sciences. Dr. Steriade has received personal compensation in the range of $5,000-$9,999 for serving as a Speakers Bureau with Neurelis. Dr. Steriade has received personal compensation in the range of $5,000-$9,999 for serving as a Advisory Board with Xenon Pharmaceuticals.
Atif Zafar, MD	Dr. Zafar has nothing to disclose.
Vivien H. Lee, MD, FAAN	Dr. Lee has nothing to disclose.
Janice F. Wiesman, MD, FAAN	No disclosure on file
Stewart A. Factor, DO, FAAN	Dr. Factor has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Neurocrine. Dr. Factor has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Factor has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Takeda. The institution of Dr. Factor has received research support from Biohaven. The institution of Dr. Factor has received research support from Neurocrine. The institution of Dr. Factor has received research support from Supernus. The institution of Dr. Factor has received research support from Sun Pharmaceuticals Advanced Research Company. The institution of Dr. Factor has received research support from Aspen. The institution of Dr. Factor has received research support from RHO. Dr. Factor has received publishing royalties from a publication relating to health care. Dr. Factor has received publishing royalties from a publication relating to health care. Dr. Factor has received publishing royalties from a publication relating to health care. Dr. Factor has received publishing royalties from a publication relating to health care.
Bradley F. Boeve, MD, FAAN	Dr. Boeve has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for Rainwater Charitable Foundation. The institution of Dr. Boeve has received research support from Alector. The institution of Dr. Boeve has received research support from EIP Pharma. The institution of Dr. Boeve has received research support from Transposon. The institution of Dr. Boeve has received research support from Cognition Therapeutics. Dr. Boeve has received publishing royalties from a publication relating to health care.
Ralph L. Sacco, MD, MS, FAHA	Dr. Sacco has received personal compensation in the range of $100,000-$499,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Heart Association. The institution of Dr. Sacco has received research support from NIH, NINDS, NCATS, NIMHD. The institution of Dr. Sacco has received research support from FL Department of Health. Dr. Sacco has received research support from University of Washington, Seattle. Dr. Sacco has received publishing royalties from a publication relating to health care.
Jori Fleisher, MD, MSCE, FAAN	The institution of Dr. Fleisher has received research support from Parkinson's Foundation. The institution of Dr. Fleisher has received research support from NIH/NINDS. The institution of Dr. Fleisher has received research support from NIH/NINDS. The institution of Dr. Fleisher has received research support from NIA/NINDS. The institution of Dr. Fleisher has received research support from NIA/NINDS. Dr. Fleisher has received publishing royalties from a publication relating to health care. Dr. Fleisher has received personal compensation in the range of $0-$499 for serving as a Speaker with Parkinson's Foundation. Dr. Fleisher has received personal compensation in the range of $500-$4,999 for serving as a Speaker with Lewy Body Dementia Association. Dr. Fleisher has received personal compensation in the range of $500-$4,999 for serving as a Speaker with Davis Phinney Foundation. Dr. Fleisher has a non-compensated relationship as a Editorial Board Member with AAN Brain & Life Magazine that is relevant to AAN interests or activities.
Alexandra Dimitrova, MD	Dr. Dimitrova has nothing to disclose.
Gary D. Clark, MD	The institution of Dr. Clark has received research support from Greewich pharmaceuticals. The institution of Dr. Clark has received research support from Novartis.
David Seder, MD	No disclosure on file
Margaret Adler, MD	Dr. Adler has nothing to disclose.
Marie F. Grill, MD	Dr. Grill has nothing to disclose.
Gil I. Wolfe, MD, FAAN	Dr. Wolfe has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Grifols. Dr. Wolfe has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Alexion. Dr. Wolfe has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for ArgenX. Dr. Wolfe has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for UCB/Ra. Dr. Wolfe has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen. Dr. Wolfe has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Cartesian. Dr. Wolfe has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Grifols. The institution of Dr. Wolfe has received research support from UCB/Ra. The institution of Dr. Wolfe has received research support from Immunovant. The institution of Dr. Wolfe has received research support from Roche. Dr. Wolfe has received personal compensation in the range of $0-$499 for serving as a Advisor with FDA Advisory Panel for Cellular, Tissue and Genetic Therapies.
Erin Furr-Stimming, MD, FAAN	Dr. Furr-Stimming has received personal compensation for serving as an employee of Help4HD International. Dr. Furr-Stimming has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medscape. Dr. Furr-Stimming has received personal compensation in the range of $500-$4,999 for serving as a Consultant for MedPage. Dr. Furr-Stimming has received personal compensation in the range of $500-$4,999 for serving as a Consultant for PTC Therapeutics. Dr. Furr-Stimming has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Wave Life Sciences. Dr. Furr-Stimming has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Latus Bio. Dr. Furr-Stimming has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Atalanta Therapeutics. Dr. Furr-Stimming has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Furr-Stimming has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for SkyHawk Therapeutics. Dr. Furr-Stimming has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis . Dr. Furr-Stimming has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Atalanta Therapeutics. The institution of Dr. Furr-Stimming has received research support from Roche/Genetech. The institution of Dr. Furr-Stimming has received research support from Uniqure. The institution of Dr. Furr-Stimming has received research support from CHDI. The institution of Dr. Furr-Stimming has received research support from Huntington Study Group/Neurocrine Bioscienes. The institution of Dr. Furr-Stimming has received research support from NIH/University of Iowa. The institution of Dr. Furr-Stimming has received research support from Sage Therapeutics. The institution of Dr. Furr-Stimming has received research support from HDSA. The institution of Dr. Furr-Stimming has received research support from Prilennia. Dr. Furr-Stimming has received publishing royalties from a publication relating to health care. Dr. Furr-Stimming has received publishing royalties from a publication relating to health care. Dr. Furr-Stimming has a non-compensated relationship as a Committee member with AAN UES Committee that is relevant to AAN interests or activities.
William S. Burgin, MD	Dr. Burgin has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for VuEssence. Dr. Burgin has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Burgin has stock in VuEssence. The institution of Dr. Burgin has received research support from VuEssence. The institution of Dr. Burgin has received research support from Bristol-Myers Squibb. The institution of Dr. Burgin has received research support from ReNeuron.
Jennifer A. Tracy, MD	Dr. Tracy has nothing to disclose.
Leah R. Hanson, PhD	The institution of Dr. Hanson has received research support from NIA. The institution of Dr. Hanson has received research support from Merck Foundation. The institution of Dr. Hanson has received research support from Eagle Pharmaceuticals. The institution of Dr. Hanson has received research support from Research Grow Lab. The institution of Dr. Hanson has received research support from State of Minnesota. Dr. Hanson has received intellectual property interests from a discovery or technology relating to health care.
Jessika Suescun, MD	Dr. Suescun has nothing to disclose.
Michael Stanton, MD, FAAN	Dr. Stanton has nothing to disclose.
Hooman Kamel, MD	Dr. Kamel has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for JAMA Neurology. Dr. Kamel has received personal compensation in the range of $50,000-$99,999 for serving as a Endpoint adjudication committee with Boehringer-Ingelheim.
Sarah Lee, MD	Dr. Lee has nothing to disclose.
Nicholas Metrus, MD	Dr. Metrus has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for dotdash / Verywell Health.
Philip W. Tipton, MD	Dr. Tipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for AbbVie. Dr. Tipton has received personal compensation in the range of $500-$4,999 for serving as a Speaker with Alzheimer's Tennessee. Dr. Tipton has received personal compensation in the range of $500-$4,999 for serving as a Speaker with Charlotte County Medical Society, Inc.
Chia-Chun Chiang, MD	Dr. Chiang has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Satsuma. Dr. Chiang has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Aruene Corporation . Dr. Chiang has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Pfizer. Dr. Chiang has received personal compensation in the range of $500-$4,999 for serving as a Consultant for AbbVie. Dr. Chiang has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amneal. The institution of Dr. Chiang has received research support from American Heart Association. The institution of Dr. Chiang has received research support from Lundbeck. The institution of Dr. Chiang has received research support from Pfizer.
Kyle M. Blackburn, MD	Dr. Blackburn has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Argenx.
Jamie Wong, PhD	Dr. Wong has nothing to disclose.
Noah A. Kolb, MD	Dr. Kolb has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abalone Medical. Dr. Kolb has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Disarm Therapeutics. Dr. Kolb has received personal compensation in the range of $0-$499 for serving as a Consultant for Eisana corporation. Dr. Kolb has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion Pharmaceuticals. Dr. Kolb has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for NINDS. Dr. Kolb has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Dr. Kolb has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Locks Law. Dr. Kolb has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for walk up law office . Dr. Kolb has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for ralston, pope, diehl. The institution of Dr. Kolb has received research support from National Cancer Institute.
Jonathan Cahill, MD, FAAN	The institution of Dr. Cahill has received research support from Roche / Genentech. Dr. Cahill has received publishing royalties from a publication relating to health care.
Adarsh Bhimraj, MD	Dr. Bhimraj has nothing to disclose.
Ursula Boschert Shafaatian	Ursula Boschert has nothing to disclose.
Chantale O. Branson, MD, MSCR, FAAN	Dr. Branson has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Supernus. Dr. Branson has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB.
Shiao-Pei Weathers, MD	No disclosure on file
Sarah Barnard	Sarah Barnard has nothing to disclose.
Matthew T. McCarthy, MD	No disclosure on file
Summer Karafiath, MD	No disclosure on file
Paul M. George, MD, PhD, MSE, FAAN	Dr. George has received personal compensation in the range of $0-$499 for serving as a Consultant for ConductiveBio. Dr. George has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Law firms. The institution of Dr. George has received research support from Conductive Bio. The institution of Dr. George has received research support from NIH. Dr. George has received intellectual property interests from a discovery or technology relating to health care. Dr. George has received personal compensation in the range of $10,000-$49,999 for serving as a Adjudicator with Baim Insititute. Dr. George has a non-compensated relationship as a Board Member with ��ɫ�� that is relevant to AAN interests or activities. Dr. George has a non-compensated relationship as a International Stroke Council Program committee member with American Heart Association that is relevant to AAN interests or activities.
Jeffrey Dewey, MD, MHS, FAAN	Dr. Dewey has received personal compensation in the range of $500-$4,999 for serving as a Expert Medication Request Reviewer with Megallan.
Giuseppe Lauria, MD	No disclosure on file
Ruggero G. Fariello, MD	No disclosure on file
Gregory A. Elder, MD	No disclosure on file
Sarah Zubkov, MD	No disclosure on file
Shawna Feely	Shawna Feely has nothing to disclose.
Pooja SirDeshpande, MBBS	No disclosure on file
Dhara Murray-Frank, MD	Dr. Murray-Frank has nothing to disclose.
Vaibhav Goswami, MD	Dr. Goswami has nothing to disclose.
Hesham T. Ghonim, MD	No disclosure on file
Shayan Ul Haque, MD, MBBS	No disclosure on file
Viviane T. Carvalho, MD	Dr. Carvalho has nothing to disclose.
Freddy Escobar-Montealegre	No disclosure on file
R. Michael Gendreau	No disclosure on file
Travis Turner	No disclosure on file
Andrew M. Goldfine, MD	No disclosure on file
Stacey Clardy, MD, PhD, FAAN	Dr. Clardy has received personal compensation for serving as an employee of Veterans Health Administration (VHA). Dr. Clardy has received personal compensation for serving as an employee of University of Utah Health. Dr. Clardy has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AstraZeneca/Alexion. Dr. Clardy has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amgen/Horizon. Dr. Clardy has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Arialys. Dr. Clardy has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Kyverna. Dr. Clardy has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurology/AAN Publications. The institution of Dr. Clardy has received research support from NIH/NINDS. The institution of Dr. Clardy has received research support from SRNA. The institution of Dr. Clardy has received research support from Alexion/AstraZeneca. Dr. Clardy has received personal compensation in the range of $500-$4,999 for serving as a AAN Summer Meeting CoDirector Travel and Lodging with AAN. Dr. Clardy has received personal compensation in the range of $500-$4,999 for serving as a Grand Rounds Travel/Lodging/Honoraria with U of Iowa, Miami, Stanford, Barrow, Beaumont Health, CCF, Emory, Penn State, Mayo Clinic, Walter Reed.
Deborah H. Hall, MD, PhD, FAAN	Dr. Hall has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for ��ɫ��. Dr. Hall has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier - Parkinsonism and Related Disorders. Dr. Hall has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Annals of Neurology. The institution of Dr. Hall has received research support from Parkinson's Foundation. The institution of Dr. Hall has received research support from CHDI. The institution of Dr. Hall has received research support from Uniqure. The institution of Dr. Hall has received research support from NIH.
Dileep R. Yavagal, MD, FAAN	Dr. Yavagal has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Vascular Dynamics. Dr. Yavagal has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Guidepoint. The institution of Dr. Yavagal has received personal compensation in the range of $500-$4,999 for serving as a Consultant for GLG. Dr. Yavagal has received personal compensation in the range of $0-$499 for serving as a Consultant for Medtronic. Dr. Yavagal has received personal compensation in the range of $0-$499 for serving as a Consultant for Cerenovus/Johnson & Johnson. Dr. Yavagal has received personal compensation in the range of $0-$499 for serving as a Consultant for Stryker. Dr. Yavagal has received personal compensation in the range of $0-$499 for serving as a Consultant for Poseydon. Dr. Yavagal has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Athersys. Dr. Yavagal has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Gravity Medical Technology. Dr. Yavagal has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Poseydon. Dr. Yavagal has stock in Poseydon. Dr. Yavagal has stock in Galaxy Therapeutics. Dr. Yavagal has stock in Stentrode. Dr. Yavagal has stock in Gravity Medical. Dr. Yavagal has stock in Gravity Medical Technology. Dr. Yavagal has stock in Athersys. Dr. Yavagal has stock in Rapid Medical . Dr. Yavagal has received intellectual property interests from a discovery or technology relating to health care. Dr. Yavagal has received personal compensation in the range of $5,000-$9,999 for serving as a Medicolegal Expert with Royal Carribean Cruise Line. Dr. Yavagal has received personal compensation in the range of $5,000-$9,999 for serving as a Medicolegal Consultant with Carnival Cruise Line.
Laura J. Balcer, MD, MSCE, FAAN	An immediate family member of Dr. Balcer has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Children's Hospital of Philadelphia.
Michel T. Torbey, MD, MPH, FAAN	Dr. Torbey has nothing to disclose.
Victor H. Patterson, MD	No disclosure on file
Carlos T. Moraes, MD	No disclosure on file
Patrick Hecht, PhD	Dr. Hecht has received personal compensation for serving as an employee of AbbVie. Dr. Hecht has stock in AbbVie.
Michelle P. Kvalsund, DO	Dr. Kvalsund has nothing to disclose.
Kiel Woodward, MD	Dr. Woodward has nothing to disclose.
Jason H. Margolesky, MD, FAAN	Dr. Margolesky has nothing to disclose.
Zafer Keser, MD	Dr. Keser has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier Practice Update.
Michael P. Stanley, MD	Dr. Stanley has received personal compensation in the range of $0-$499 for serving as a Consultant for Roon. Dr. Stanley has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Annals of Neurology. Dr. Stanley has stock in Roon. Dr. Stanley has received personal compensation in the range of $0-$499 for serving as a writer at large with WBUR/Cognoscenti . Dr. Stanley has received personal compensation in the range of $0-$499 for serving as a Poet with Writing the Land. Dr. Stanley has received personal compensation in the range of $0-$499 for serving as a writer at large with Psyche. Dr. Stanley has received personal compensation in the range of $0-$499 for serving as a Writer at large with Wall Street Journal.
Viet-Huong Nguyen, PharmD, MPH, MS	Dr. Nguyen has nothing to disclose.
Pallab Bhattacharya, PhD	Dr. Bhattacharya has nothing to disclose.
Ihtesham A. Qureshi, MD	No disclosure on file
Jean Khoury, MD	Dr. Khoury has nothing to disclose.
Jenna Conway, MD	Dr. Conway has nothing to disclose.
Akio Kimura, MD	Dr. Kimura has nothing to disclose.
David Blas-Boria, MD, FAAN	Dr. Blas-Boria has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novocure.
Steven C. Yang, DO	Dr. Yang has nothing to disclose.
Vishal Mandge, MD	Dr. Mandge has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EMD Serono.
Rachel J. Saban, MD	Dr. Saban has nothing to disclose.
Jomenica D. Livramento	No disclosure on file
Vito A. Ricigliano	Mr. Ricigliano has received personal compensation in the range of $500-$4,999 for serving as a Expert with M3 global research, Biogen and Atheneum Partners.
Pashtun-Poh Shahim, MD, PhD	Pashtun-Poh Shahim has nothing to disclose.
Dorothy Schafer	No disclosure on file
Jawad F. Kirmani, MD	Dr. Kirmani has nothing to disclose.
Omid Omidvar, MD	No disclosure on file
Sharjeel Panjwani, MD	No disclosure on file
Shuja Sheikh, MD	No disclosure on file
Omar M. Al-Janabi, MD, PhD, MSc	Dr. Al-Janabi has nothing to disclose.
Rachel Aubert, DO	Dr. Aubert has nothing to disclose.
Andres Jimenez Gomez, MD	Dr. Jimenez Gomez has nothing to disclose.
Christopher Oakley, MD	Dr. Oakley has nothing to disclose.
Aparna Nutakki, MD	Ms. Nutakki has received research support from UJMT Fogarty Global Health Fellowship Program. Ms. Nutakki has received research support from AAN Medical Student Research Scholarship. Ms. Nutakki has received research support from Gold Humanism Student Summer Fellowship.
Sara Marelli	No disclosure on file
Alejandro A. Rabinstein, MD, FAAN	Dr. Rabinstein has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Boston Scientific. Dr. Rabinstein has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Shionogi . Dr. Rabinstein has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Chiesi. Dr. Rabinstein has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Ceribell. Dr. Rabinstein has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurocritical care/NCS-Springer. Dr. Rabinstein has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Wolters/UptoDate. Dr. Rabinstein has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for EBSCO/DynaMed. Dr. Rabinstein has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for AHA. Dr. Rabinstein has received publishing royalties from a publication relating to health care. Dr. Rabinstein has received publishing royalties from a publication relating to health care. Dr. Rabinstein has received publishing royalties from a publication relating to health care. Dr. Rabinstein has received publishing royalties from a publication relating to health care.
Ignacio L. Pita Garcia, MD	Dr. Pita Garcia has nothing to disclose.
Andrew Satlin	No disclosure on file
Brian J. Copeland, MD	Dr. Copeland has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Teva Neurosciences. The institution of Dr. Copeland has received research support from Ipsen Biopharmaceuticals.
Neil Masangkay, MD, FAAN	Dr. Masangkay has nothing to disclose.
Justin J. Mowchun, MD	No disclosure on file
Benjamin Williams	No disclosure on file
Peter J. McAllister, MD, FAAN	Dr. McAllister has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for pfizer. Dr. McAllister has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for lilly. Dr. McAllister has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for abbvie. Dr. McAllister has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for lundbeck.
J. R. Singleton, MD	Dr. Singleton has received research support from NIH.
A. Gordon Smith, MD, FAAN	Dr. Smith has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. Smith has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Argenx. Dr. Smith has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merz. Dr. Smith has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sangamo. Dr. Smith has received personal compensation in the range of $500-$4,999 for serving as a Consultant for US Department of Justice. Dr. Smith has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen. Dr. Smith has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Eidos. Dr. Smith has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Lexicon. Dr. Smith has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion. The institution of Dr. Smith has received research support from NIH (NINDS, NIDDK). Dr. Smith has received publishing royalties from a publication relating to health care. Dr. Smith has received personal compensation in the range of $0-$499 for serving as a Study Section with NIH.
Sona Narula, MD	Dr. Narula has received personal compensation in the range of $0-$499 for serving as a Consultant for Medscape .
Saima Siddiqui, MD	Dr. Siddiqui has nothing to disclose.
Unsong Oh, MD	Dr. Oh has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Horizon Therapeutics. Dr. Oh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech.
Marcey L. Osgood, DO	Dr. Osgood has nothing to disclose.
Kimberly Vanover, PhD	No disclosure on file
Ali Mahta, MD	Dr. Mahta has received research support from Brown University Health.
Stephen H. Tisch, MBBS	No disclosure on file
Felicia Chow, MD	Dr. Chow has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Medicolegal consulting. The institution of Dr. Chow has received research support from NIH.
Na Tosha N. Gatson, MD, PhD, FAAN	Dr. Gatson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for GT Medical Technologies. Dr. Gatson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Menarini Silicon Biosystems. Dr. Gatson has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for NuvOx Pharmaceuticals. Dr. Gatson has received publishing royalties from a publication relating to health care. Dr. Gatson has a non-compensated relationship as a Board Member with Society for Equity in Neurosciences (SEQUINS) that is relevant to AAN interests or activities.
Riley Bove, MD, FAAN	Dr. Bove has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Alexion. Dr. Bove has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Amgen. Dr. Bove has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genzyme-Sanofi. Dr. Bove has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for TG Therapeutics. Dr. Bove has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for EMD-Serono. Dr. Bove has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cadenza. The institution of Dr. Bove has received research support from Biogen. The institution of Dr. Bove has received research support from Eli Lilly. The institution of Dr. Bove has received research support from Novartis. The institution of Dr. Bove has received research support from Roche Genentech.
Seema Nagpal, MD, FAAN	Dr. Nagpal has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Servier. Dr. Nagpal has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Daiichi-Sankyo. Dr. Nagpal has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Springworks. Dr. Nagpal has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Enclear. Dr. Nagpal has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Plus Therapuetics/Biocept. Dr. Nagpal has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novocure.
Anil Thatikonda	No disclosure on file
Paul B. Rizzoli, MD, FAAN	Dr. Rizzoli has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Axsome. Dr. Rizzoli has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Theranica. Dr. Rizzoli has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Axsome. Dr. Rizzoli has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for Headache Cooperative of New England. Dr. Rizzoli has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Harvard Health Publishing. The institution of Dr. Rizzoli has received research support from Abbvie. Dr. Rizzoli has received publishing royalties from a publication relating to health care.
Tapan R. Kavi, MD	No disclosure on file
Selim R. Benbadis, MD, FAAN	Dr. Benbadis has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Stratus. Dr. Benbadis has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for SK Lifesciences. Dr. Benbadis has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Jazz. Dr. Benbadis has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Catalyst. Dr. Benbadis has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Neurelis. Dr. Benbadis has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Sunovion. Dr. Benbadis has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Livanova. Dr. Benbadis has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for UCB.
Maria Luisa Gorno Tempini, MD, PhD	The institution of Dr. Gorno Tempini has received research support from the NIH.
Mazen M. Dimachkie, MD, FAAN	Dr. Dimachkie has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi. Dr. Dimachkie has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Octapharma. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for ArgenX. Dr. Dimachkie has received personal compensation in the range of $0-$499 for serving as a Consultant for Catalyst. Dr. Dimachkie has received personal compensation in the range of $0-$499 for serving as a Consultant for Takeda. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medlink. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for CSL Behring. Dr. Dimachkie has received personal compensation in the range of $0-$499 for serving as a Consultant for Astellas. Dr. Dimachkie has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Janssen. Dr. Dimachkie has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Dianthus. Dr. Dimachkie has received personal compensation in the range of $0-$499 for serving as a Consultant for TACT / Treat NMD. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cabaletta Bio. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Clinical Neurological Society of America, Inc . Dr. Dimachkie has received personal compensation in the range of $0-$499 for serving as a Consultant for Ig Society, Inc. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abcuro. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amicus. Dr. Dimachkie has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Horizon/Immunovant. Dr. Dimachkie has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for EMD Serono. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ipsen. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Nuvig. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for ��ɫ�� (AAN). Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for American Association of Neuromuscular and Electrodiagnostic Medicine (AANEM). Dr. Dimachkie has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Annexon Biosciences. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for AstraZeneca. Dr. Dimachkie has received personal compensation in the range of $0-$499 for serving as a Consultant for Candid Therapeutics. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Creyon Bio, Inc.. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Nuvig Therapeutics. Dr. Dimachkie has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for UCB Biopharma. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Vertex Pharmaceuticals. Dr. Dimachkie has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Fortrea. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Kriya Therapeutics. The institution of Dr. Dimachkie has received research support from NIH. The institution of Dr. Dimachkie has received research support from The Myositis Association. The institution of Dr. Dimachkie has received research support from Biosensics. Dr. Dimachkie has received intellectual property interests from a discovery or technology relating to health care. Dr. Dimachkie has received intellectual property interests from a discovery or technology relating to health care. Dr. Dimachkie has received intellectual property interests from a discovery or technology relating to health care. Dr. Dimachkie has received publishing royalties from a publication relating to health care. Dr. Dimachkie has received publishing royalties from a publication relating to health care.
Rebecca K. Miller-Kuhlmann, MD	Dr. Miller-Kuhlmann has nothing to disclose.
Eliza C. Miller, MD	Dr. Miller has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for medical malpractice cases. The institution of Dr. Miller has received research support from National Institutes of Health. Dr. Miller has a non-compensated relationship as a member of ASA Advisory Council with American Heart Association/American Stroke Association that is relevant to AAN interests or activities.
Patricio Brand, MD	Dr. Brand has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen.
Ahmad A. Shawagfeh, MD	No disclosure on file
Patrick Y. Wen, MD, FAAN	Dr. Wen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Astra Zeneca . Dr. Wen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Black Diamond . Dr. Wen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Celularity. Dr. Wen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Chimerix. Dr. Wen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Day One Bio . Dr. Wen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genenta. Dr. Wen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Glaxo Smith Kline . Dr. Wen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Dr. Wen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Mundipharma. Dr. Wen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis . Dr. Wen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Nuvation Bio . Dr. Wen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novocure. Dr. Wen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Prelude Therapeutics . Dr. Wen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sagimet. Dr. Wen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sapience. Dr. Wen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Servier. Dr. Wen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Vascular Biogenics . Dr. Wen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for VBI Vaccines . Dr. Wen has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Astra Zeneca . Dr. Wen has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Black Diamond . Dr. Wen has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Celularity. Dr. Wen has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Chimerix. Dr. Wen has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Day One Bio . Dr. Wen has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genenta. Dr. Wen has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Glaxo Smith Kline . Dr. Wen has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Dr. Wen has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Mundipharma. Dr. Wen has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Wen has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Nuvation Bio. Dr. Wen has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novocure. Dr. Wen has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Prelude Therapeutics. Dr. Wen has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sagimet. Dr. Wen has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sapience. Dr. Wen has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Servier. Dr. Wen has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Vascular Biogenics . Dr. Wen has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for VBI Vaccines . Dr. Wen has received research support from Astra Zeneca . Dr. Wen has received research support from Black Diamond . Dr. Wen has received research support from Bristol Meyers Squibb . Dr. Wen has received research support from Celgene. Dr. Wen has received research support from Chimerix. Dr. Wen has received research support from Eli Lily . Dr. Wen has received research support from Erasca. Dr. Wen has received research support from Genentech/Roche . Dr. Wen has received research support from Kazia . Dr. Wen has received research support from MediciNova. Dr. Wen has received research support from Merck. Dr. Wen has received research support from Novartis. Dr. Wen has received research support from Nuvation Bio . Dr. Wen has received research support from Servier. Dr. Wen has received research support from Vascular Biogenics . Dr. Wen has received research support from VBI Vaccines . Dr. Wen has received publishing royalties from a publication relating to health care.
Andrew M. Southerland, MD, FAAN	Dr. Southerland has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Plaintiffs and Defense Cases related to Stroke and Vascular Neurology.. The institution of Dr. Southerland has received research support from American Heart Association. The institution of Dr. Southerland has received research support from NIH. The institution of Dr. Southerland has received research support from Abbvie Pharmaceuticals, Inc.. Dr. Southerland has received intellectual property interests from a discovery or technology relating to health care. Dr. Southerland has received intellectual property interests from a discovery or technology relating to health care.
Stephen Krieger, MD, FAAN	Dr. Krieger has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biogen. Dr. Krieger has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for EMD Serono. Dr. Krieger has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Genentech. Dr. Krieger has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Krieger has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for TG Therapeutics. Dr. Krieger has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi. Dr. Krieger has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cycle. The institution of Dr. Krieger has received research support from Novartis. The institution of Dr. Krieger has received research support from Bristol Myers Squibb. The institution of Dr. Krieger has received research support from Biogen. The institution of Dr. Krieger has received research support from Sanofi.
Brian Koo, MD	Dr. Koo has received personal compensation in the range of $500-$4,999 for serving as a Consultant for American Regent. Dr. Koo has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Speckhals Law. The institution of Dr. Koo has received research support from Department of Defense.
Deborah Forst, MD	Dr. Forst has stock in Eli Lilly. Dr. Forst has received research support from Conquer Cancer Foundation of the American Society of Clinical Oncology. Dr. Forst has received research support from Palliative Care Research Cooperative Group. Dr. Forst has received research support from American Cancer Society Institutional Research Grant.
David Y. Hwang, MD, FAAN	The institution of Dr. Hwang has received research support from NIH. The institution of Dr. Hwang has received research support from Neurocritical Care Foundation. Dr. Hwang has received personal compensation in the range of $10,000-$49,999 for serving as a Associate Medical Director with New England Donor Services.
William D. Freeman, MD, FAAN	Dr. Freeman has nothing to disclose.
Firas Sioufi, MD	Dr. Sioufi has nothing to disclose.
Sung Y. Yu	Sung Y. Yu has received personal compensation for serving as an employee of Abbvie. Sung Y. Yu has received stock or an ownership interest from Abbvie.
Harvey S. Levin, PhD	No disclosure on file
Yujie Wang, MD	Dr. Wang has received personal compensation in the range of $500-$4,999 for serving as a Consultant for TG Therapeutics. The institution of Dr. Wang has received research support from Genentech. The institution of Dr. Wang has received research support from uniQure. The institution of Dr. Wang has received research support from NIH/NINDS.
Larry B. Goldstein, MD, FAHA, FAAN	The institution of Dr. Goldstein has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Janssen. The institution of Dr. Goldstein has received research support from NIH. The institution of Dr. Goldstein has received research support from NIH. Dr. Goldstein has received intellectual property interests from a discovery or technology relating to health care. Dr. Goldstein has received publishing royalties from a publication relating to health care.
Benjamin M. Greenberg, MD, FAAN	Dr. Greenberg has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Greenberg has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. Greenberg has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for EMD Serono. Dr. Greenberg has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Amgen. Dr. Greenberg has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Sanofi/Genzyme. Dr. Greenberg has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genentech/Roche. Dr. Greenberg has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Signant. Dr. Greenberg has received personal compensation in the range of $500-$4,999 for serving as a Consultant for IQVIA. Dr. Greenberg has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sandoz. Dr. Greenberg has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Clene. Dr. Greenberg has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for TG Therapeutics. Dr. Greenberg has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for IQVIA. Dr. Greenberg has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abcuro. Dr. Greenberg has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Siegel Rare Neuroimmune Association. Dr. Greenberg has or had stock in GenrAb.Dr. Greenberg has or had stock in Clene.Dr. Greenberg has received intellectual property interests from a discovery or technology relating to health care. Dr. Greenberg has received publishing royalties from a publication relating to health care.
Meagan O. Bailey, MD	Dr. Bailey has nothing to disclose.
Adam Rizvi, MD	No disclosure on file
Erica S. Westphal	The institution of Ms. Westphal has received personal compensation in the range of $500-$4,999 for serving as a Consultant for McKesson Coorporation. The institution of Ms. Westphal has received research support from Dent Neurologic Institute.
Shuhan Zhu, MD	Dr. Zhu has nothing to disclose.
Fang-Chi Hsu	No disclosure on file
Guillermo Gonzalez-Manrique	Guillermo Gonzalez-Manrique has nothing to disclose.
Sherif Elwan, MD, MBBCh	No disclosure on file
Nobutoshi Morimoto	No disclosure on file
Elizabeth M. Aradine, MD	No disclosure on file
Jose R. Rodriguez, MD	No disclosure on file
Nazanin Kiapour, MD	Dr. Kiapour has nothing to disclose.
Fanny Guillerminet, PhD	No disclosure on file
Daniela Perani	No disclosure on file
Anna S. Nordvig, MD	The institution of Dr. Nordvig has received research support from National Institute on Aging. Dr. Nordvig has received publishing royalties from a publication relating to health care.
Cyrus A. Raji, MD, PhD	Prof. Raji has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Brainreader ApS. Prof. Raji has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Apollo Health . Prof. Raji has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Neurevolution Medicine.
Stephen A. VanHaerents, MD, FAAN	An immediate family member of Dr. VanHaerents has received personal compensation for serving as an employee of AbbVie. Dr. VanHaerents has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Atheneum Group. Dr. VanHaerents has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for legal firm. An immediate family member of Dr. VanHaerents has stock in AbbVie. The institution of Dr. VanHaerents has received research support from NIH.
Shivika Chandra, MD, FAAN	The institution of Dr. Chandra has received research support from American Board of Psychiatry and Neurology Faculty Innovation in ��ɫ�� Award. The institution of Dr. Chandra has received research support from Michael J Fox Foundation.
Anita Shanmugham, MS, MPH	No disclosure on file
Eliana Vasquez	Ms. Vasquez has nothing to disclose.
Kye Won Park, MD	Dr. Park has nothing to disclose.
Emilio Herrera, Jr.	No disclosure on file
Nicholas M. Murray, MD	Dr. Murray has nothing to disclose.
Barbara Schaeffler	No disclosure on file
Davut Pehlivan, MD	Dr. Pehlivan has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ionis Pharmaceuticals.
Daniel Anderson, DO	No disclosure on file
Enrique Urrea-Mendoza, MD	Dr. Urrea-Mendoza has nothing to disclose.
Kristen Fisher, DO	Dr. Fisher has nothing to disclose.
Luiz De Souza, MD	No disclosure on file
Lin Xu, PhD	No disclosure on file
Lee Birnbaum, MD	Dr. Birnbaum has nothing to disclose.
Claudiu I. Diaconu, MD	No disclosure on file
Ronald C. Petersen, MD, PhD, FAAN	Dr. Petersen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Petersen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Dr. Petersen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eli Lilly and Co.. Dr. Petersen has received personal compensation in the range of $0-$499 for serving as a Consultant for Eisai, Inc.. Dr. Petersen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novo Nordisk. Dr. Petersen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Petersen has received publishing royalties from a publication relating to health care. Dr. Petersen has received publishing royalties from a publication relating to health care. Dr. Petersen has received publishing royalties from a publication relating to health care. Dr. Petersen has a non-compensated relationship as a Board of Directors with American Brain Foundation that is relevant to AAN interests or activities.
David Irwin, MD	The institution of Dr. Irwin has received research support from NIH. The institution of Dr. Irwin has received research support from Prevail. The institution of Dr. Irwin has received research support from Passage Bio. The institution of Dr. Irwin has received research support from Alector. The institution of Dr. Irwin has received research support from Transposon. The institution of Dr. Irwin has received research support from Denali. The institution of Dr. Irwin has received research support from Cervo Med.
Alex Baeta	Alex Baeta has nothing to disclose.
Vinod Metta, MBBS	No disclosure on file
Anne C. Roc, PhD	No disclosure on file
Mary C. Rickard, MD	Dr. Rickard has nothing to disclose.
Geetanjali S. Rathore, MD, FAAN	Dr. Rathore has nothing to disclose.
Alicia C. Castonguay, PhD	Dr. Castonguay has nothing to disclose.
Nataliya Pyatka, MD	Dr. Pyatka has nothing to disclose.
Suyog U. Pol, PhD	Dr. Pol has nothing to disclose.
Siddharth Gupta, MD	No disclosure on file
Jenny Argudo Luzuriaga, MD	Dr. Argudo Luzuriaga has nothing to disclose.
Emilio R. Garrido Sanabria, MD, PhD	Dr. Garrido Sanabria has nothing to disclose.
Giana Dawod, MD	Ms. Dawod has nothing to disclose.
Paul H. Berg, MS	No disclosure on file
Miranda Flamholz	Miss Flamholz has nothing to disclose.
Chintan Prajapati	Chintan Prajapati has nothing to disclose.
Priyank Khandelwal, MD	Dr. Khandelwal has nothing to disclose.
Vanessa K. Hinson, MD, PhD, FAAN	The institution of Dr. Hinson has received research support from Biogen. The institution of Dr. Hinson has received research support from Scion Neurostim. The institution of Dr. Hinson has received research support from PPD Development/Takeda Development. The institution of Dr. Hinson has received research support from Parexel Biopharma. The institution of Dr. Hinson has received research support from Impax Laboratories.
Arnold R. Kriegstein, MD, PhD	No disclosure on file
Diego Z. Carvalho, MD	Dr. Carvalho has nothing to disclose.
Sagari R. Bette, MD	Dr. Bette has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Amneal. Dr. Bette has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amneal. Dr. Bette has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Kyowa Kirin. Dr. Bette has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merz. Dr. Bette has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Supernus. Dr. Bette has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AbbVie. Dr. Bette has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Merz. Dr. Bette has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Supernus.
Rachel Forman, MD	Dr. Forman has nothing to disclose.
Kevin Bickart, MD, PhD	Dr. Bickart has nothing to disclose.
Michael D. Gregory, MD	No disclosure on file
Meredith A. Bryarly, MD	The institution of Dr. Bryarly has received research support from Theravance.
Fajun Wang, MD	Dr. Wang has nothing to disclose.
Immaculada Aban	No disclosure on file
Alexis Alvarado Arias, MD	Dr. Alvarado Arias has nothing to disclose.
André Luiz Guimarães de Queiroz	André Luiz Guimarães de Queiroz has nothing to disclose.
Sara Mariotto, MD, PhD	Dr. Mariotto has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Biogen, Sanofi, Alexion, Roche, TSF, Dynamics, UCB, Novartis, Amgen, AAN. The institution of Dr. Mariotto has received research support from Ministero della Salute Italiano. The institution of Dr. Mariotto has received research support from TSF. The institution of Dr. Mariotto has received research support from GJF. The institution of Dr. Mariotto has received research support from Lundbeck. The institution of Dr. Mariotto has received research support from Euroimmun. The institution of Dr. Mariotto has received research support from FISM.
Kevin F. O'Connor, Jr., MD	Dr. O'Connor has nothing to disclose.
Yash Shah, MD, MBBS, MPH	Dr. Shah has nothing to disclose.
Laura Segala, PhD	No disclosure on file
Johnathan L. McKay, PhD	The institution of Dr. McKay has received research support from NIH. The institution of Dr. McKay has received research support from the McCamish Foundation.
Mashina Chomba, MBChB	Dr. Chomba has nothing to disclose.
Barry S. Oken, MD, PhD, FAAN	Dr. Oken has nothing to disclose.
John E. Greenlee, MD, FAAN	Dr. Greenlee has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Medlink. Dr. Greenlee has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Zeigler Cohen Roche. Dr. Greenlee has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Sommers Schwartz PC. Dr. Greenlee has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for St Francis Hospital. Dr. Greenlee has received publishing royalties from a publication relating to health care. Dr. Greenlee has received publishing royalties from a publication relating to health care.
Sebastian Koch, MD	Dr. Koch has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Multiple Legal Matters. Dr. Koch has received stock or an ownership interest from Cerepeutics. Dr. Koch has received intellectual property interests from a discovery or technology relating to health care. Dr. Koch has received intellectual property interests from a discovery or technology relating to health care.
Mamta B. Singh, MD, MBBS, DM, FAAN	Dr. Singh has nothing to disclose.
Benedetta Bodini, MD	Dr. Bodini has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche . Dr. Bodini has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi Genzyme. Dr. Bodini has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Novartis. The institution of Dr. Bodini has received research support from Biogen.
Amanda L. Piquet, MD, FAAN	The institution of Dr. Piquet has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Genentech/Roche. The institution of Dr. Piquet has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Alexion. The institution of Dr. Piquet has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Kyverna . The institution of Dr. Piquet has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech/Roche. The institution of Dr. Piquet has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Kyverna. The institution of Dr. Piquet has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Piquet has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Sands Anderson PC. Dr. Piquet has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Joe Jones Law Firm. Dr. Piquet has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Cortez & Associates. Dr. Piquet has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Falk Waas. The institution of Dr. Piquet has received research support from Rocky Mountain MS Center. The institution of Dr. Piquet has received research support from Roche/Genentech. The institution of Dr. Piquet has received research support from NYU. The institution of Dr. Piquet has received research support from Anokion. The institution of Dr. Piquet has received research support from UCB . The institution of Dr. Piquet has received research support from Foundation for Sarcoidosis. The institution of Dr. Piquet has received research support from Kyverna . Dr. Piquet has received publishing royalties from a publication relating to health care. Dr. Piquet has received publishing royalties from a publication relating to health care. Dr. Piquet has received personal compensation in the range of $10,000-$49,999 for serving as a Litigative Consultant with US-Dept HHS/DICP. Dr. Piquet has a non-compensated relationship as a Medical Advisory Board Member with Autoimmune Encephalitis Alliance (AEA) that is relevant to AAN interests or activities. Dr. Piquet has a non-compensated relationship as a Medical Advisory Board Member with Stiff Person Syndrome Research Foundation (SPSRF) that is relevant to AAN interests or activities.
Padma V. Hadakasira, MD	Dr. Hadakasira has nothing to disclose.
Robert Starke	Robert Starke has nothing to disclose.
Anas Ahmed Moahmmed Saeed Bamashmos, MD	No disclosure on file
David C. Preston, MD, FAAN	Dr. Preston has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for FBI, US Attorney, Insurance Fraud Investigative Units. Dr. Preston has received publishing royalties from a publication relating to health care.
Clifford R. Jack, Jr., MD	The institution of Dr. Jack has received research support from NIH. The institution of Dr. Jack has received research support from Alexander Family Alzheimer's Disease Research Professorship of the Mayo Clinic.
Adriano Chio, MD, FAAN	Dr. Chio has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cytokinetics. Dr. Chio has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Mitsubishi. Dr. Chio has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Chio has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Corcept.
Sara Dawit, MD	Dr. Dawit has nothing to disclose.
Cemal Karakas, MD	Dr. Karakas has nothing to disclose.
Natalie Favret	No disclosure on file
Ramin Farzaneh-Far	No disclosure on file
Sanjila Islam, MD	Dr. Islam has nothing to disclose.
Jeffrey Gluckstein, MD	Dr. Gluckstein has nothing to disclose.
Michael A. Castellano, MD	No disclosure on file
Rosario Vasta, MD	Dr. Vasta has nothing to disclose.
Tanya Simuni, MD, FAAN	Dr. Simuni has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for cadia, AcureX, Adamas, AskBio, Amneal, Blue Rock Therapeutics, Caraway Therapeutics, Critical Path for Parkinson's Consortium (CPP), Denali, Michael J Fox Foundation, Neuroderm, Sanofi, Sinopia, Roche, Takeda and Vanqua Bio. Dr. Simuni has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for of Koneksa, Neuroderm, Sanofi, UCB, AcureX, Adamas, AskBio, Biohaven, Denali, GAIN, Neuron23 and Roche. Dr. Simuni has received research support from Amneal, Biogen, Neuroderm, Prevail, Roche, and UCB and an investigator for NINDS, MJFF, Parkinson's Foundation.
Cenk Ayata, MD	Dr. Ayata has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Quris. Dr. Ayata has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Neurelis. The institution of Dr. Ayata has received research support from NIH. The institution of Dr. Ayata has received research support from Takeda. The institution of Dr. Ayata has received research support from Neurelis.
Sean I. Savitz, MD	Dr. Savitz has nothing to disclose.
Kunal Agrawal, MD	Dr. Agrawal has nothing to disclose.
Makoto Yoneda	The institution of Makoto Yoneda has received research support from Cosmic Corporation.
Adam J. Darby, MD	No disclosure on file
Rena Sukhdeo Singh, MD	No disclosure on file
Advait Mahulikar, MD	No disclosure on file
Jeffrey B. Peel, MD	Dr. Peel has nothing to disclose.
Steven R. Dunham, Jr., MD	Dr. Dunham has nothing to disclose.
Hae Young Baang, MD	Dr. Baang has nothing to disclose.
Amy W. Amara, MD PhD	The institution of Dr. Amara has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Photopharmics, Inc. The institution of Dr. Amara has received research support from Michael J Fox Foundation for Parkinson's Research . The institution of Dr. Amara has received research support from Biogen Idec. The institution of Dr. Amara has received research support from NIH.
Susan E. Duberstein Coad, MD	Dr. Duberstein Coad has nothing to disclose.
Deanna Saylor, MD, MHS	Dr. Saylor has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for ��ɫ��. The institution of Dr. Saylor has received research support from National Institutes of Health. The institution of Dr. Saylor has received research support from ��ɫ��. Dr. Saylor has a non-compensated relationship as a Member of multiple committees and task forces focused on improving access to MS medications to people across the world with Multiple Sclerosis International Federation that is relevant to AAN interests or activities. Dr. Saylor has a non-compensated relationship as a Member of the Neurology and COVID19 committee with World Health Organization that is relevant to AAN interests or activities. Dr. Saylor has a non-compensated relationship as a Member of the International Outreach Committee, Junior and Early Career Membership Committee, and ��ɫ��al Innovation Commitees with American Neurological Association that is relevant to AAN interests or activities.
Cynthia L. Comella, MD, FAAN	Dr. Comella has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Ipsen. Dr. Comella has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Vima. Dr. Comella has received publishing royalties from a publication relating to health care. Dr. Comella has received publishing royalties from a publication relating to health care.
Yan Zhang, MD, PhD	Dr. Zhang has nothing to disclose.
George Perry, PhD	Dr. Perry has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Synaptogenix. Dr. Perry has received personal compensation in the range of $50,000-$99,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for SAGE. Dr. Perry has stock in Synaptogenix.
Monica Lee	No disclosure on file
Crystal J. Yeo, MD, PhD	Dr. Yeo has nothing to disclose.
Lauren Tardo, MD	Dr. Tardo has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EMD Serono. Dr. Tardo has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for NeurologyLive. Dr. Tardo has received personal compensation in the range of $500-$4,999 for serving as a consultant with CanDoMS. Dr. Tardo has a non-compensated relationship as a Tardo with The MOG Project that is relevant to AAN interests or activities.
Benjamin Carroll	No disclosure on file
Ehad Afreen, MD	Dr. Afreen has nothing to disclose.
Mohammad Ridha, MD	No disclosure on file
Matthew K. Banks, DO	No disclosure on file
Jumana T. Alshaikh, MD	Dr. Alshaikh has nothing to disclose.
Christine Shrock, MD	Dr. Shrock has nothing to disclose.
Kyna Schreiber, MD	No disclosure on file
Jonathan Lauritsen, DO	No disclosure on file
Alexa M. King, MD	Dr. King has received research support from American Neurologic Association. The institution of Dr. King has received research support from Esai Pharmaceuticals.
Arsalan Hashemi Aghdam, MD	No disclosure on file
Karlla Danielle Ferreira Lima	Karlla Danielle Ferreira Lima has nothing to disclose.
Joyce A. Jimenez Zambrano, MD	Dr. Jimenez Zambrano has nothing to disclose.
Hong Lin, PhD	No disclosure on file
Jonathan Castillo	No disclosure on file
Guillaume Robert	No disclosure on file
Guido J. Falcone, MD	The institution of Dr. Falcone has received research support from NIH. The institution of Dr. Falcone has received research support from AHA.
Gregory A. Jicha, MD, PhD	Dr. Jicha has nothing to disclose.
David A. Wolk, MD, FAAN	Dr. Wolk has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eli Lilly. Dr. Wolk has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Functional Neuromodulation. Dr. Wolk has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for GSK. The institution of Dr. Wolk has received research support from Biogen. Dr. Wolk has received publishing royalties from a publication relating to health care. Dr. Wolk has received personal compensation in the range of $5,000-$9,999 for serving as a CME speaker with Eli Lilly.
Mandip S. Dhamoon, MD, MPH	Dr. Dhamoon has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Faegre Baker Daniels LLP. Dr. Dhamoon has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Wellstar Health System Inc. Dr. Dhamoon has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Fabiani Cohen & Hall, LLP. Dr. Dhamoon has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Kramer, Dillof, Livingston & Moore. Dr. Dhamoon has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Robins Kaplan. Dr. Dhamoon has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Parker Waichman LLP. Dr. Dhamoon has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Heidell, Pittoni, Murphy & Bach, LLP.
Rima Dafer, MD	Dr. Dafer has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eli Lilly. Dr. Dafer has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Eli Lilly. Dr. Dafer has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Anderson, Rasor, and partners.
Ira M. Turner, MD	Dr. Turner has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Allergan, Amgen, Novartis, Teva, Lilly, Lundbeck, Biohaven,Impel. Dr. Turner has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amgen, Teva, Allergan, Biohaven, Lilly, Lundbeck, Theranica, Revance. Dr. Turner has received personal compensation in the range of $100,000-$499,999 for serving on a Speakers Bureau for Allergan, Amgen, Biohaven, Teva, Novartis, Lundbeck, Lilly. The institution of Dr. Turner has received research support from Allergan, Amgen, Biohaven, Lilly, Lundbeck, Theranica.
Anand Venkatraman, MBBS	No disclosure on file
Minyoul Baik, Jr., MD	Dr. Baik has nothing to disclose.
Ann L. Bullinger, PharmD	No disclosure on file
Lauren McCollum, MD	No disclosure on file
Mohammad Abbas, MD	No disclosure on file
Louis M. Beers, MD	Mr. Beers has nothing to disclose.
Alexandria Valdrighi, MD	Dr. Valdrighi has nothing to disclose.
Dhaval Trivedi	No disclosure on file
Samuel Fallon	No disclosure on file
Andrea Calvo, MD, PhD, FAAN	Dr. Calvo has nothing to disclose.
Sushil S. Lakhani, MD	Dr. Lakhani has nothing to disclose.
Nicole B. Sur, MD	Dr. Sur has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Stroke. The institution of Dr. Sur has received research support from Florida Stroke Registry. The institution of Dr. Sur has received research support from Miami CTSI & NIH/NINDS.
Aparna Vaddiparti, MD	Dr. Vaddiparti has nothing to disclose.
Leila Parand, MD	Dr. Parand has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Eli Lily. Dr. Parand has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Esai. Dr. Parand has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Peer view . Dr. Parand has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Speaker Bureau .
Oleg Y. Yerstein, MD	Dr. Yerstein has nothing to disclose.
Neel Fotedar, MD	Dr. Fotedar has received research support from NINDS.
Nurose Karim, MD	Dr. Karim has nothing to disclose.
Jorge Torres, MD	No disclosure on file
Ausaf Ahmed, MD	No disclosure on file
Mohammad Rauf A. Chaudhry, MD	Dr. Chaudhry has nothing to disclose.
Sydney Moseley, MD	Dr. Moseley has nothing to disclose.
Abhijeet Jakate, PhD	No disclosure on file
Kyoo Ho Cho	No disclosure on file
Julia Drattell	No disclosure on file
Justin T. Jordan, MD, MPH, FAAN	Dr. Jordan has received personal compensation for serving as an employee of City of Beverly. An immediate family member of Dr. Jordan has received personal compensation for serving as an employee of Genesis HR Solutions. An immediate family member of Dr. Jordan has received personal compensation for serving as an employee of Children's Hospital. Dr. Jordan has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Shepherd Therapeutics. Dr. Jordan has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Alexion Pharmaceuticals. Dr. Jordan has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Springworks Therapeutics. Dr. Jordan has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for AstraZeneca. Dr. Jordan has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Continental Casualty Company. Dr. Jordan has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for HennLesperance. Dr. Jordan has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Rhoades McKee. Dr. Jordan has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Wheeler Trigg O'Donnell. Dr. Jordan has or had stock in Navio Theragnostics. An immediate family member of Dr. Jordan has or had stock in OldGate.Dr. Jordan has or had stock in Shepherd Therapeutics.Dr. Jordan has or had stock in Khora TX. The institution of Dr. Jordan has received research support from NIH. The institution of Dr. Jordan has received research support from Department of Defense. The institution of Dr. Jordan has received research support from PCORI. Dr. Jordan has received publishing royalties from a publication relating to health care. Dr. Jordan has received publishing royalties from a publication relating to health care.
Mario F. Mendez, MD, PhD, FAAN	Dr. Mendez has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Medical ��ɫ�� Speakers' Bureau. Dr. Mendez has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for UpToDate. The institution of Dr. Mendez has received research support from NIH. Dr. Mendez has received publishing royalties from a publication relating to health care.
Laszlo Mechtler, MD, FEAN, FASN, FAHS, FAAN	Dr. Mechtler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Impel Pharma. Dr. Mechtler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie. Dr. Mechtler has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Abbvie. Dr. Mechtler has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for Genomate Health. The institution of Dr. Mechtler has received research support from The Harry Dent Family Foundation, Inc. The institution of Dr. Mechtler has received research support from Alpheus medical. The institution of Dr. Mechtler has received research support from Shiratronics. The institution of Dr. Mechtler has received research support from Abbvie Inc. The institution of Dr. Mechtler has received research support from Amgen. The institution of Dr. Mechtler has received research support from Eli Lilly Company. The institution of Dr. Mechtler has received research support from H. Lundbeck HS. The institution of Dr. Mechtler has received research support from Pfizer. Dr. Mechtler has received personal compensation in the range of $100,000-$499,999 for serving as a Ownership interest with Neurology Practce Consortium GPO. Dr. Mechtler has a non-compensated relationship as a Board member with International Headache Society that is relevant to AAN interests or activities.
Stewart J. Tepper, MD	Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Aeon. Dr. Tepper has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Abbvie. Dr. Tepper has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Amgen. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Aruene. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Atheneum. Dr. Tepper has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Axsome Therapeutics. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Becker Pharmaceutical Consulting. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Clearview Healhcare Partners. Dr. Tepper has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for CoolTech. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for CRG. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Decision Resources. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Defined Health. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for DRG. Dr. Tepper has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Eli Lilly. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for ExpertConnect. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for FCB Health. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Fenix. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for GLG. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Guidepoint Global. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Health Advances. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Health Science Communications. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for HMP Communications. Dr. Tepper has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Impel. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for InteractiveForums. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Keyquest. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Krog and Partners. Dr. Tepper has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Lundbeck. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for M3 Global Research. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Magnolia Innovation. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for MJH Holdings. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurolief. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for P Value Communications. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Pain Insights Inc. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Palion Medical. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Pulmatrix. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Putnam Associates. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for SAI MedPartners. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Satsuma. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Slingshot Insights. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Spherix Global Insights. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Strategy Inc. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for System Analytic. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Taylor and Francis. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Teva. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Theranica. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Trinity Partners. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UnityHA. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for XOC. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Click Therapeutics. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Miravo. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurofront Therapeutics. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Rehaler. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Synapse Medical Communications. Dr. Tepper has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Pfizer. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alphasights. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Perfood. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for M3 Global Research. Dr. Tepper has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Scilex. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Synapse Medical Communication. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Tegus. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Catch Therapeutics. Dr. Tepper has received personal compensation in the range of $0-$499 for serving as a Consultant for DocDelta. Dr. Tepper has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Dr Reddy's. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for FCB Health. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Gilmartin Capital. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Initiator Pharma. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for IQVIA. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Magellan Health. Dr. Tepper has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Nocira. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Slingshot Insights. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Third Bridge. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Tonix. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Vial . Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for DocDelta. The institution of Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bausch Health. Dr. Tepper has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Dr Reddy's. The institution of Dr. Tepper has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biohaven. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Aeon. Dr. Tepper has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abbvie. Dr. Tepper has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ClickTherapeutics. Dr. Tepper has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for CoolTech. Dr. Tepper has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lundbeck. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Miravo Healthcare. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pulmatrix. Dr. Tepper has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Satsuma. Dr. Tepper has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for AbbVie. Dr. Tepper has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Lundbeck. Dr. Tepper has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Pfizer. Dr. Tepper has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Scilex. Dr. Tepper has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Teva. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Tonix. Dr. Tepper has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Dr Reddy's. Dr. Tepper has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Eli Lilly. Dr. Tepper has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Anneal. Dr. Tepper has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Axsome. The institution of Dr. Tepper has received research support from Abbvie. The institution of Dr. Tepper has received research support from Aeon. The institution of Dr. Tepper has received research support from Amgen. The institution of Dr. Tepper has received research support from Annovis. The institution of Dr. Tepper has received research support from Axsome. The institution of Dr. Tepper has received research support from Cassava. The institution of Dr. Tepper has received research support from Cognition. The institution of Dr. Tepper has received research support from Eli Lilly. The institution of Dr. Tepper has received research support from Inibikase. The institution of Dr. Tepper has received research support from Ipsen. The institution of Dr. Tepper has received research support from Lundbeck. The institution of Dr. Tepper has received research support from Merz. The institution of Dr. Tepper has received research support from Pfizer. The institution of Dr. Tepper has received research support from PrecisionMed. The institution of Dr. Tepper has received research support from Revance. The institution of Dr. Tepper has received research support from Suven. The institution of Dr. Tepper has received research support from UCB. The institution of Dr. Tepper has received research support from Biohaven. The institution of Dr. Tepper has received research support from Johnson and Johnson/Intracellular. The institution of Dr. Tepper has received research support from Karuna. The institution of Dr. Tepper has received research support from Neurocrine. Dr. Tepper has received publishing royalties from a publication relating to health care. Dr. Tepper has received personal compensation in the range of $10,000-$49,999 for serving as a CME Speaker with Diamond Headache Clinic. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a CME Speaker with Medical Learning Institute Peerview. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a CME Speaker with Medical ��ɫ�� Speakers Network. Dr. Tepper has received personal compensation in the range of $5,000-$9,999 for serving as a CME Speaker with Miller Medical Communications. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a CME Speaker with Physicians' ��ɫ�� Resource. Dr. Tepper has received personal compensation in the range of $10,000-$49,999 for serving as a CME Speaker with WebMD/Medscape. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a CME speaker with American Headache Society. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a CME speaker with Vindico Medical ��ɫ��. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a CME speaker with HMP Global. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a CMe speaker with Medical Learning Institute Peerview. Dr. Tepper has received personal compensation in the range of $5,000-$9,999 for serving as a Speaker with Consortium for Research ��ɫ�� Social Awareness and Training In Neurosciences.
Laurice T. Yang, MD, MHA, FAAN	The institution of Dr. Yang has received research support from Alzheimer's Disease Research Center (ADRC). The institution of Dr. Yang has received research support from Pacific Northwest Udall Center . The institution of Dr. Yang has received research support from Biogen/Parkinson's Study Group . The institution of Dr. Yang has received research support from Eli Lily . The institution of Dr. Yang has received research support from Michael J. Fox Foundation For Parkinson's Research . The institution of Dr. Yang has received research support from Sanofi . Dr. Yang has received personal compensation in the range of $500-$4,999 for serving as a Chair, Workgroup with ��ɫ�� .
Kevin M. Kelly, MD, PhD	Dr. Kelly has nothing to disclose.
Simon Hawke	No disclosure on file
Bennett H. Myers, MD	No disclosure on file
Inga K. Koerte, MD, PhD	An immediate family member of Prof. Koerte has stock in Siemens Healthineers. The institution of Prof. Koerte has received research support from NINDS. The institution of Prof. Koerte has received research support from Abbott Inc.. The institution of Prof. Koerte has received research support from European Research Council. The institution of Prof. Koerte has received research support from German Ministry of Research and ��ɫ�� . Prof. Koerte has received publishing royalties from a publication relating to health care. Prof. Koerte has a non-compensated relationship as a Vice President with European Neurotrauma Organization that is relevant to AAN interests or activities. Prof. Koerte has a non-compensated relationship as a European Editor with Journal of Neurotrauma that is relevant to AAN interests or activities.
Max Wintermark, MD	No disclosure on file
Raul G. Nogueira, MD	Dr. Nogueira has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for for advisory roles with Anaconda, Biogen, Cerenovus, Genentech, Hybernia, Imperative Care, Medtronic, Phenox, Philips, Prolong Pharmaceuticals, Stryker Neurovascular, Shanghai Wallaby, and Synchron (consulting fees) as well as for advisory roles with Astrocyte, Brainomix, Cerebrotech, Ceretrieve, Corindus Vascular Robotics, Vesalio, Viz-AI, RapidPulse and Perfuze ( stock options). Dr. Nogueira has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Law Firms. Dr. Nogueira has received stock or an ownership interest from Viz-AI, Perfuze, Cerebrotech, Reist/Q'Apel Medical, Truvic, and Viseon. The institution of Dr. Nogueira has received research support from Cerenovus.
Jaren W. Landen, PhD	No disclosure on file
Rushabh Modi	No disclosure on file
Aline Herlopian, MD	Dr. Herlopian has nothing to disclose.
Sourabh Lahoti, MD	No disclosure on file
Richard Zweifler, MD, FAAN	No disclosure on file
Marcus Ng, MD	The institution of Dr. Ng has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Paladin Canada. The institution of Dr. Ng has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Paladin Canada. Dr. Ng has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Journal of Clinical Neurophysiology. The institution of Dr. Ng has received research support from Eisai. The institution of Dr. Ng has received research support from Paladin Canada. Dr. Ng has received publishing royalties from a publication relating to health care.
L. Nicolas Gonzalez Castro, MD, PhD	Dr. Gonzalez Castro has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Servier. Dr. Gonzalez Castro has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier. Dr. Gonzalez Castro has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Oakstone Publishing. Dr. Gonzalez Castro has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for BMJ Best Practice. Dr. Gonzalez Castro has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Medscape. An immediate family member of Dr. Gonzalez Castro has or had stock in Takeda. The institution of Dr. Gonzalez Castro has received research support from Merck & Co.
Yvo A. Rodriguez-Linares, MD	Dr. Rodriguez-Linares has nothing to disclose.
Stephanie E. MacIver, MD	No disclosure on file
Priyanka Chilakamarri, MD	Dr. Chilakamarri has nothing to disclose.
Lucas Alessandro, Sr., MD	Dr. Alessandro has nothing to disclose.
Claudia L. Satizabal, PhD	The institution of Dr. Satizabal has received research support from NIH and TARCC.
Roger Cady, MD	Dr. Cady has received personal compensation for serving as an employee of Lundbeck. Dr. Cady has stock in Alder Biopharmaceutical.
Eric Kassel, PharmD	No disclosure on file
Tara D. Von Kleist, MBBS	No disclosure on file
Hema Viswanathan	Ms. Viswanathan has received personal compensation for serving as an employee of Allergan plc. Ms. Viswanathan has received personal compensation for serving as an employee of Precision Medicine Group. Ms. Viswanathan has received stock or an ownership interest from Allergan plc. Ms. Viswanathan has received stock or an ownership interest from Precision Medicine Group.
Alice Edwards, DO	The institution of Dr. Rutatangwa has received research support from NIH.
Neeja V. Desai, MD	No disclosure on file
Colby A. Richardson, MD	Dr. Richardson has nothing to disclose.
Yanan Wang	No disclosure on file
Laura Baugh, MD	No disclosure on file
Rebecca Spiegel, MD	No disclosure on file
James R. Lupski, MD, PhD	Dr. Lupski has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis. Dr. Lupski has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Regeneron Genetics Center.
Naveen George, DO	No disclosure on file
Joshua Lukas, MD	Dr. Lukas has nothing to disclose.
Erin M. Okazaki, MD	Dr. Okazaki has nothing to disclose.
Smit D. Patel, MD, MPH	Dr. Patel has nothing to disclose.
Allen Joop, MS	Mr. Joop has nothing to disclose.
Sajid Suriya, MD	Dr. Suriya has nothing to disclose.
Omar Akhand, MD	No disclosure on file
Nidhi Kasatwar, MD	No disclosure on file
Amy Delambo	No disclosure on file
Romana Hoeftberger	Romana Hoeftberger has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurology: Neuroimmunology and Neuroinflammation. Romana Hoeftberger has received personal compensation in the range of $500-$4,999 for serving as a speaker with BMS and UCB Biopharma.
Shinei Kato, MD	No disclosure on file
Miyabi Tanaka	No disclosure on file
Dasul Jin, MD	No disclosure on file
Ran Reshef	Ran Reshef has nothing to disclose.
Aleksandra Podlewska, PhD	Miss Podlewska has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Bial . The institution of Miss Podlewska has received research support from Wellcome Trust.
Clara Arndtsen	No disclosure on file
Janet C. Rucker, MD	Dr. Rucker has nothing to disclose.
Sanjeev V. Kothare, MD, FAAN	Dr. Kothare has nothing to disclose.
Michael Greicius, MD	Dr. Greicius has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Acelot.
Lauren Phillips, MD	Dr. Phillips has nothing to disclose.
Peter Jin, MD	Dr. Jin has nothing to disclose.
Danielle Takacs, MD	Dr. Takacs has received publishing royalties from a publication relating to health care.
Colin McLeod, MD	No disclosure on file
Julie Shawver	No disclosure on file
Margaret Blattner, MD	Dr. Blattner has nothing to disclose.
Juan Pablo Pauta Martinez, MD	Dr. Pauta Martinez has nothing to disclose.
Farah Shah	No disclosure on file
Elie Sader, MD	No disclosure on file
Stanley Zimba, MBBS	Dr. Zimba has nothing to disclose.
Masumeh Hatami, MD	No disclosure on file
Liu Ming	No disclosure on file
Adarsh Menon	No disclosure on file
Justin Barber	No disclosure on file
Ravyn Cash, NP	No disclosure on file
Nitasha Goyal, MD	No disclosure on file
Deepaneeta Sarmah, M Pharm	Miss Sarmah has nothing to disclose.
Alexander Merkler, MD	Dr. Merkler has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for The Neurohospitalist. Dr. Merkler has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for n/a.
C. W. Olanow, MD	Dr. Olanow has received personal compensation for serving as an employee of Clintrex Research Corporation. Dr. Olanow has received personal compensation in the range of $1,000,000+ for serving as an officer or member of the Board of Directors for Clintrex Research Corporation. Dr. Olanow has received personal compensation in the range of $100,000-$499,999 for serving as an Expert Witness for Chevron/Syngenta. Dr. Olanow has stock in Clintrex Research Corporation.
Kristen Johnson, PhD	No disclosure on file
Thiago S. Carneiro, MD	Dr. Carneiro has nothing to disclose.
Mahesh Jayaraman	No disclosure on file
Jason L. Siegel, MD	Dr. Siegel has nothing to disclose.
Sneha Mantri, MD, MS, FAAN	Dr. Mantri has received personal compensation for serving as an employee of Parkinson's Foundation. Dr. Mantri has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie. The institution of Dr. Mantri has received research support from The Michael J Fox Foundation for Parkinson Research.
Tafline Kao, MD	No disclosure on file
Katherine Breedlove, PhD	No disclosure on file
Oguntunde F. Olapeju, MBBS	No disclosure on file
Sergio A. Castillo-Torres, MD	No disclosure on file
Ryan K. Jones, MD	No disclosure on file
Page B. Pennell, MD, FAAN	The institution of Dr. Pennell has received research support from NIH.
David L. Perez, MD, FAAN	Dr. Perez has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Wiley: Brain and Behavior. Dr. Perez has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Psychiatric Association Publishing. The institution of Dr. Perez has received research support from NIH. The institution of Dr. Perez has received research support from Sidney R. Baer Jr. Foundation. The institution of Dr. Perez has received research support from Warren Alpert Foundation. Dr. Perez has received publishing royalties from a publication relating to health care. Dr. Perez has received publishing royalties from a publication relating to health care.
William B. Young, MD, FAAN	Dr. Young has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Theranica. Dr. Young has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Allergan. Dr. Young has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biohaven Pharmaceuticals. Dr. Young has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eli Lilly and Company. Dr. Young has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Teva. Dr. Young has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biohaven Pharmaceuticals Inc. Dr. Young has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Eli Lilly and Company. Dr. Young has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Teva. Dr. Young has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Coalition for Headache and Migraine Patients. Dr. Young has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Miles for Migraine. The institution of Dr. Young has received research support from Amgen. The institution of Dr. Young has received research support from Cumberland. The institution of Dr. Young has received research support from Eli Lilly. The institution of Dr. Young has received research support from Novartis. The institution of Dr. Young has received research support from PCORI. The institution of Dr. Young has received research support from Satsuma. The institution of Dr. Young has received research support from Scion. The institution of Dr. Young has received research support from Teva. The institution of Dr. Young has received research support from Zosano.
Arielle M. Kurzweil, MD, FAAN	Dr. Kurzweil has nothing to disclose.
Gian Marco De Marchis, MD	No disclosure on file
Roberta J. Seidman, MD	Dr. Seidman has nothing to disclose.
Danish Ghazali, MD	No disclosure on file
Morad Nasseri, MD	No disclosure on file
Rachna Malani, MD	Dr. Malani has nothing to disclose.
Anthony K. Savino, MD	No disclosure on file
Christopher Harp	Christopher Harp has received personal compensation for serving as an employee of Genentech. Christopher Harp has received stock or an ownership interest from Genentech, Inc..
Zahra Sadat-Hossieny, MD	No disclosure on file
Brooke Hartenstein	Ms. Hartenstein has nothing to disclose.
Bert A. Hart, PhD	No disclosure on file
Jeffrey W. Cooney, MD	No disclosure on file
Anshu Rohatgi, MD, DM, FAAN	No disclosure on file
Poonam Bansal, MD	Dr. Bansal has nothing to disclose.
Sachin M. Kokane	No disclosure on file
Carla F. Bolano Diaz, MD	Dr. Bolano Diaz has nothing to disclose.
Francesca M. Cali	No disclosure on file
Kara Stavros, MD, FAAN	Dr. Stavros has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Springer Healthcare LLC. Dr. Stavros has received personal compensation in the range of $500-$4,999 for serving as an officer or member of the Board of Directors for Rhode Island Medical Society.
Jacqueline French, MD, FAAN	Dr. French has received personal compensation in the range of $50,000-$99,999 for serving as an officer or member of the Board of Directors for Epilepsy Foundation. The institution of Dr. French has received research support from Epilepsy Study Consortium/ Epilepsy Foundation (Funded by UCB). The institution of Dr. French has received research support from GW/One8 Foundation/FACES. The institution of Dr. French has received research support from NINDS. The institution of Dr. French has received research support from Xenon. The institution of Dr. French has received research support from Cerevel. The institution of Dr. French has received research support from FACES. The institution of Dr. French has received research support from UCB. The institution of Dr. French has received research support from Epilepsy Study Consortium. The institution of Dr. French has received research support from UCB. The institution of Dr. French has received research support from Praxis. Dr. French has received personal compensation in the range of $50,000-$99,999 for serving as a Chief Medical/Innovation Officer with Epilepsy Foundation. Dr. French has a non-compensated relationship as a Consultant with Acadia Pharmaceuticals Inc that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a consultant with Access Industries that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a consultant with Acuta Capital Partners LLC that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with AFASCI Inc that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant, Advisory Board with Agrithera, Inc. that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Alkermes that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a consultant with Alterity Therapeutics Limited that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant, Advisory Board with Angelini Pharma S.p.A. that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Autifony Therapeutics Limited that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Axonis Therapeutics that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Bain Capital that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant, Advisory Board with Beacon Biosciences that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant, Advisory Board with Biogen that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant, Advisory Board with Biohaven Pharma that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant, Advisory Board with Bloom Science, Inc that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Bright Minds Biosciences, Inc. that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Capsidia Biotherapeutics that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant, Advisory Board with Cerebral Therapeutics that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Cerecin, Inc that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant, SAB with Cerevel that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consulting, SAB with Cognizance Biomarkers that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consulting with Ceribell that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Cowen that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Crossject that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Advisory Board with EcoR1 Capital that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with EG 427 that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a consultant, Advisory Board with Eisai that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Encoded Therapeutics that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant/Advisory Board with Engrail that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Epitel, Inc that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with EpiMinder that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Grin Therapeutics that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Harmony that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Advisory Board with Ionis Pharmaceutical that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with iQure Pharma, Inc that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with IQVIA that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant, Advisory Board with Janssen Pharma that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Jazz Pharmaceutical that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Leal Therapeutics that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant, with Livanova that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant, SAB with London Research & Pharmaceuticals that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant, Advisory Board with Longboard Pharmaceutical that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Maplight Therapeutics that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant, Advisory Board with Marinus that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Medscape/Web MD that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a consultant with Modulight Bio that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Montara Therapeutics that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Mosaica Therapeutics that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a consultant with Neumarker that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant, Advisory Board with Neumirna Therapeutics that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Neurelis that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a consulting, Advisory Board with Neurocrine that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a consultant with Neuropace that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with NeuroPro Therapeutics that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consulting with Neuroventis that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consulting with Neurona Therapeutics that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consulting, Advisory Board with Neuvarti that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant, Advisory Board with Noema that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consulting with Ono Pharmaceutical that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consulting, Advisory Board with Otsuka that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a consulting, Advisory Board with Ovid Therapeutics that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consulting with Praxis that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with PureTech LYT Inc that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with QurAlis Corp that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant, Advisory Board with Rapport Therapeutics that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Receptor Holdings, Inc that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Rivervest Venture Partners that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant, Advisory Board with Sage Therapeutics, Inc that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with SK Life Science that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant, Advisory Board with Stoke that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant, Advisory Board with Stream Neuroscience that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Supernus that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Takeda that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Taysha Gene Therapies that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant, Advisory Board with UCB, Inc that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with uniQure that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant, Advisory Board with Ventus Therapeutics that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Vida Ventures Management that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant, Advisory Board with Xenon Pharmaceuticals that is relevant to AAN interests or activities.
T. Scott Diesing, MD	Dr. Diesing has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Union Pacific Railroad.
Alan H. Yee, DO	Dr. Yee has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janux Therapeutics. The institution of Dr. Yee has received research support from American Osteopathic Association .
Annapoorna Bhat, MD	Dr. Bhat has nothing to disclose.
Virti D. Shah, Sr., MD, MBBS	No disclosure on file
Sanjay Gandhi, MD	Dr. Gandhi has received personal compensation for serving as an employee of Teva Pharmaceuticals.
Hisham G. Elkhider, MD	Dr. Elkhider has nothing to disclose.
Kwo Wei David Ho, MD, PhD	No disclosure on file
Audrey Leasure	Ms. Leasure has nothing to disclose.
Katarina B. Dakay, DO	No disclosure on file
Ana G. Cristancho, MD, PhD	Dr. Cristancho has nothing to disclose.
Tobias Loddenkemper, MD, FAAN	No disclosure on file
David N. Herrmann, MD, FAAN	Dr. Herrmann has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Acceleron. Dr. Herrmann has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Guidepoint global. Dr. Herrmann has received personal compensation in the range of $500-$4,999 for serving as a Consultant for GLG. Dr. Herrmann has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurogene. Dr. Herrmann has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sarepta. Dr. Herrmann has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Regenacy. Dr. Herrmann has received intellectual property interests from a discovery or technology relating to health care.
Alberto J. Espay, MD, FAAN	Dr. Espay has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Tanabe Pharma America (formerly, Neuroderm). Dr. Espay has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Avion. Dr. Espay has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Amneal. Dr. Espay has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Acadia. Dr. Espay has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Acorda. Dr. Espay has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Kyowa Kirin. Dr. Espay has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sunovion. Dr. Espay has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Herantis Pharma. Dr. Espay has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Supernus (formerly USWorldMeds). Dr. Espay has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Acadia. Dr. Espay has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Synaps Dx. Dr. Espay has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Bial. Dr. Espay has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for NeuroDiagnostics, Inc (SYNAPS Dx). Dr. Espay has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Intrance Medical Systems, Inc.. Dr. Espay has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Merz. Dr. Espay has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Praxis Precision Medicines. Dr. Espay has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Citrus Health. Dr. Espay has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AskBio. The institution of Dr. Espay has received research support from NIH. The institution of Dr. Espay has received research support from Michael J Fox Foundation for Parkinson's Research. Dr. Espay has received intellectual property interests from a discovery or technology relating to health care. Dr. Espay has received publishing royalties from a publication relating to health care. Dr. Espay has received publishing royalties from a publication relating to health care. Dr. Espay has received publishing royalties from a publication relating to health care.
Christopher Giza, MD, FAAN	Dr. Giza has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Medical Network Speakers Bureau. Dr. Giza has stock in Highmark Interactive. The institution of Dr. Giza has received research support from UCLA: Brain Injury Research Center, Steve Tisch BrainSPORT Program, Easton Clinic for Brain Health. Dr. Giza has received publishing royalties from a publication relating to health care. Dr. Giza has a non-compensated relationship as a Advisory Board with Major League Soccer that is relevant to AAN interests or activities. Dr. Giza has a non-compensated relationship as a Advisory Board with National Basketball Association that is relevant to AAN interests or activities. Dr. Giza has a non-compensated relationship as a Consultant with United States Soccer Federation that is relevant to AAN interests or activities. Dr. Giza has a non-compensated relationship as a Co-founder & Advisor with Symptomwise that is relevant to AAN interests or activities.
James R. White, MD	No disclosure on file
Leo Bonati, MD	No disclosure on file
Michael Reznik, MD	Dr. Reznik has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Morrison Mahoney. The institution of Dr. Reznik has received research support from NIDUS.
Brian Mac Grory, MB BCh BAO	An immediate family member of Dr. Mac Grory has received personal compensation for serving as an employee of Sanofi. Dr. Mac Grory has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Stroke. The institution of Dr. Mac Grory has received research support from National Institutes of Health. The institution of Dr. Mac Grory has received research support from American Heart Association.
Talal Aboud, MD	No disclosure on file
Alfredo Quinones-Hinojosa	Alfredo Quinones-Hinojosa has nothing to disclose.
Jason A. Friedman, MD	No disclosure on file
Jessica Choe, MD	No disclosure on file
Alexander C. Lehn, MD	No disclosure on file
Meghana S. Kinariwala, MD	Dr. Srinivas has nothing to disclose.
Claire P. Hogue	No disclosure on file
Katie Alex	No disclosure on file
Massimo Filippi, MD, FAAN	Dr. Filippi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Alexion, Almirall, Biogen, Merck, Novartis, Roche, Sanofi. Dr. Filippi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion, Biogen, Bristol-Myers Squibb, Merck, Novartis, Roche, Sanofi, Sanofi-Aventis, Sanofi-Genzyme, Takeda. Dr. Filippi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Bayer, Biogen, Celgene, Chiesi Italia SpA, Eli Lilly, Genzyme, Janssen, Merck-Serono, Neopharmed Gentili, Novartis, Novo Nordisk, Roche, Sanofi, Takeda, and TEVA. Dr. Filippi has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Springer Nature. The institution of Dr. Filippi has received research support from Biogen Idec, Merck-Serono, Novartis, Roche, the Italian Ministry of Health, the Italian Ministry of University and Research, and Fondazione Italiana Sclerosi Multipla.
Daniel L. Murman, MD, FAAN	The institution of Dr. Murman has received research support from Biogen. The institution of Dr. Murman has received research support from EIP Pharma. The institution of Dr. Murman has received research support from Eli Lilly & Co.. The institution of Dr. Murman has received research support from Functional Neuromodulation. The institution of Dr. Murman has received research support from Roche Pharmaceuticals.
Karin Woodman, MD	Dr. Woodman has nothing to disclose.
Vera Bril, MD	Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for CSL. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alnylam. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Grifols. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Takeda. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Octapharma. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Pfizer. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Powell Mansfield. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Akcea. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ionis. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Immunovant. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Momenta (now J&J). Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for NovoNordisk. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Takeda. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Immunovant. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Bril has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Akcea. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alnylam. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for CSL. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenx. The institution of Dr. Bril has received research support from UCB. The institution of Dr. Bril has received research support from Argenx. The institution of Dr. Bril has received research support from Momenta (now J&J). The institution of Dr. Bril has received research support from Immunovant. The institution of Dr. Bril has received research support from Alexion. The institution of Dr. Bril has received research support from Takeda. The institution of Dr. Bril has received research support from Grifols. The institution of Dr. Bril has received research support from CSL. The institution of Dr. Bril has received research support from Octapharma. The institution of Dr. Bril has received research support from Akcea. The institution of Dr. Bril has received research support from Ionis. The institution of Dr. Bril has received research support from Viela Bio (now Horizon). Dr. Bril has received intellectual property interests from a discovery or technology relating to health care.
Masako Kinoshita, MD, PhD	Dr. Kinoshita has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Otsuka Pharmaceutical Co., Ltd.. Dr. Kinoshita has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Eisai Co., Ltd.. Dr. Kinoshita has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for UCB Japan Co. Ltd. . Dr. Kinoshita has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Daiichi Sankyo Company, Limited.. The institution of Dr. Kinoshita has received research support from Japan Society for the Promotion of Science. The institution of Dr. Kinoshita has received research support from Nakatani Foundation for Advancement of Measuring Technologies in Biomedical Engineering .
Connie Lau, MS, CCRC	No disclosure on file
James F. Morley, MD, PhD	Dr. Morley has nothing to disclose.
Lan Qin, MD, PhD, FAAN	No disclosure on file
Lawrence M. Samkoff, MD, FAAN	Dr. Samkoff has nothing to disclose.
Marisela E. Dy-Hollins, MD, MSCR, FAAN	The institution of Dr. Dy-Hollins has received research support from CNCDP-K12.
Ugur Sener, MD	Dr. Sener has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Servier Pharmaceuticals. Dr. Sener has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Dr. Sener has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion.
Weredes Olango, MD	No disclosure on file
Jonathan Baskin, MBBS	No disclosure on file
Tej Stead	No disclosure on file
Casey J. Judge, DO	Dr. Judge has nothing to disclose.
Ching Tsao, MD	Dr. Tsao has nothing to disclose.
Jeremy Abramson	Jeremy Abramson has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for BMS. Jeremy Abramson has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Interius. Jeremy Abramson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Seagen. Jeremy Abramson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Gilead. Jeremy Abramson has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Genentech. Jeremy Abramson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for AbbVie. Jeremy Abramson has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Astra-Zeneca. Jeremy Abramson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Jeremy Abramson has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Roche. Jeremy Abramson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Foresight Diagnostics. Jeremy Abramson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Miltenyi Biotec. Jeremy Abramson has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for BeiGene. Jeremy Abramson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lilly. The institution of Jeremy Abramson has received research support from Allogene. The institution of Jeremy Abramson has received research support from BMS. The institution of Jeremy Abramson has received research support from Genentech. Jeremy Abramson has received research support from Cellectis. The institution of Jeremy Abramson has received research support from Merck.
Pashtun Shahim, MD, PhD	No disclosure on file
Farinaz Safavi, MD, PhD	The institution of Dr. Safavi has received research support from NMSS/ABF.
Rachel Beekman, MD	Dr. Beekman has nothing to disclose.
Jung Bin Kim, MD	No disclosure on file
Hajere Gatollari	No disclosure on file
Jeff Smith	No disclosure on file
Kavneet Kaur, MD	Dr. Kaur has nothing to disclose.
MacLean Nasrallah	The institution of an immediate family member of MacLean Nasrallah has received research support from NIH.
Tomotaka Mizoguchi	Tomotaka Mizoguchi has nothing to disclose.
Ryka Ashenden, MD	Ms. Sehgal has nothing to disclose.
Gabriel Martino	No disclosure on file
Jeyaraj D. Pandian, MD, DM	Dr. Pandian has nothing to disclose.
Shadi Yaghi, MD	Dr. Yaghi has nothing to disclose.
Ugur Uygunoglu	Ugur Uygunoglu has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche Turkey . The institution of Ugur Uygunoglu has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. The institution of Ugur Uygunoglu has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen Idec/Gen Pharma of Turkey. The institution of Ugur Uygunoglu has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck-Serono of Turkey. The institution of Ugur Uygunoglu has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanovel of Turkey. The institution of Ugur Uygunoglu has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Genveon of Turkey.
Amy Hellman, MD, FAAN	The institution of Dr. Hellman has received research support from COBRE-NIH. The institution of Dr. Hellman has received research support from Neurocrine.
Harry Alexopoulos	No disclosure on file
Cem Kucukali	No disclosure on file
Aidan Azher, MD	Dr. Azher has nothing to disclose.
Shani Peter, MD	No disclosure on file
Serena J. Shimshak, BA	No disclosure on file
Yohei Harada, MD	Dr. Harada has nothing to disclose.
Paul P. Yeung, MD, PhD	No disclosure on file
Alexander Allen, MD	No disclosure on file
Raymond V. Mirasol, MD	Dr. Mirasol has stock in PGE Poland. Dr. Mirasol has stock in Exxon Mobil. Dr. Mirasol has stock in EQT. The institution of Dr. Mirasol has received research support from Robert Wood Johnson Medical School. The institution of Dr. Mirasol has received research support from Jannsen Pharmaceutical.
Delphine Bernard	No disclosure on file
Cynthia L. Harden, MD	Dr. Harden has received personal compensation for serving as an employee of Xenon Pharmaceuticals Inc.. Dr. Harden has stock in Xenon Pharmaceuticals Inc.. Dr. Harden has received intellectual property interests from a discovery or technology relating to health care.
Nils Peters	No disclosure on file
Andrea Tettamanti	No disclosure on file
Amro Stino, MD	Dr. Stino has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for CSL Behring. Dr. Stino has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Argenx. Dr. Stino has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Takeda. Dr. Stino has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi. Dr. Stino has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Annexon. The institution of Dr. Stino has received research support from GBS-CIDP Foundation. The institution of Dr. Stino has received research support from Bristol Myers Squibb.
Billy Gao, MD	No disclosure on file
Ajaz Sheikh, MD	Dr. Sheikh has nothing to disclose.
Robert J. Marquardt, DO	Dr. Marquardt has nothing to disclose.
Ann Herman	Ann Herman has received personal compensation for serving as an employee of Genentech, Inc. Ann Herman has received stock or an ownership interest from F. Hoffman-La Roche Ltd.
Amin Sanei Moghaddam, MD	Dr. Sanei Moghaddam has nothing to disclose.
Alexandra L. Tse, BS	No disclosure on file
Aditi Trivedi, MD	Dr. Trivedi has nothing to disclose.
Erin C. Conrad, MD	Dr. Conrad has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Epiminder. Dr. Conrad has stock in Humana. Dr. Conrad has stock in Lilly Eli. Dr. Conrad has stock in Medtronic. Dr. Conrad has stock in Merck. Dr. Conrad has stock in Nevro. Dr. Conrad has stock in Sanofi. Dr. Conrad has stock in United Health Group.
Sasha Aleksander F. Dionisio, MD	No disclosure on file
Robert Fuino, MD	No disclosure on file
Dinushi Weerasinghe, MBBS	No disclosure on file
James E. Eaton III, MD	Dr. Eaton has received personal compensation in the range of $0-$499 for serving as a Consultant for Uniqure. Dr. Eaton has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Law Practices. Dr. Eaton has received personal compensation in the range of $0-$499 for serving as a Speaker with Can Do MS.
Lisa Gillinder, FRACP	The institution of Dr. Gillinder has received research support from Mater Research Institute. The institution of Dr. Gillinder has received research support from Metro South Health Study, ��ɫ�� and Research Trust Account (SERTA). The institution of Dr. Gillinder has received research support from Royal Brisbane and Women's Hospital Foundation. The institution of Dr. Gillinder has received research support from Herston Imaging Research Facility Project Support Scheme. The institution of Dr. Gillinder has received research support from Health Innovation, Investment and Research Office (HIIRO).
Luay Mrad, MD	No disclosure on file
William F. Taber	No disclosure on file
Maria Dimitriadou	No disclosure on file
Brian Silver, MD, FAAN	Dr. Silver has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Various legal firms. Dr. Silver has received intellectual property interests from a discovery or technology relating to health care. Dr. Silver has received publishing royalties from a publication relating to health care. Dr. Silver has received publishing royalties from a publication relating to health care. Dr. Silver has received publishing royalties from a publication relating to health care. Dr. Silver has received personal compensation in the range of $500-$4,999 for serving as a Consultant with Women's Health Initiative. Dr. Silver has received personal compensation in the range of $500-$4,999 for serving as a Consultant with Best Doctors, Inc./Teladoc, Inc.. Dr. Silver has a non-compensated relationship as a Consultant with ABPN that is relevant to AAN interests or activities. Dr. Silver has a non-compensated relationship as a Member, Regional Board of Directors with American Heart Association that is relevant to AAN interests or activities.
Siddharama Pawate, MD	The institution of Dr. Pawate has received research support from Genentech. The institution of Dr. Pawate has received research support from Biogen.
Zulfi Haneef, MD, MBBS, MRCP, FAAN	Dr. Haneef has received publishing royalties from a publication relating to health care.
Thomas F. Tropea, DO	Dr. Tropea has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bial. The institution of Dr. Tropea has received research support from NINDS. The institution of Dr. Tropea has received research support from Parkinson Foundation. The institution of Dr. Tropea has received research support from Michael J Fox Foundation.
Navid Seraji-Bozorgzad, MD	No disclosure on file
Sung-Min Cho, DO	Dr. Cho has nothing to disclose.
Aman Deep, MD	Dr. Deep has nothing to disclose.
Laura McGarry, MD, PhD	No disclosure on file
Ashutosh Kaushal, MD	No disclosure on file
Mihir Kakara, MD	Dr. Kakara has nothing to disclose.
Ryan M. Edelbrock	No disclosure on file
Lina Vadlamani	No disclosure on file
David M. Greer, MD, FAAN	Dr. Greer has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Thieme, Inc. Dr. Greer has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for multiple. Dr. Greer has received publishing royalties from a publication relating to health care. Dr. Greer has received publishing royalties from a publication relating to health care. Dr. Greer has received publishing royalties from a publication relating to health care. Dr. Greer has a non-compensated relationship as a Treasurer-Elect with American Neurological Association that is relevant to AAN interests or activities. Dr. Greer has a non-compensated relationship as a President with Neurocritical Care Society that is relevant to AAN interests or activities.
Ann H. Tilton, MD, FAAN	Dr. Tilton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ipsen. Dr. Tilton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie. Dr. Tilton has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Ipsen. Dr. Tilton has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abbvie. Dr. Tilton has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Ipsen. Dr. Tilton has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Abbvie. Dr. Tilton has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Up to Date.
Emmanuelle Waubant, MD, PhD, FAAN	The institution of Dr. Waubant has received research support from NIH. The institution of Dr. Waubant has received research support from NMSS. The institution of Dr. Waubant has received research support from PCORI. The institution of Dr. Waubant has received research support from Race to Erase MS. The institution of Dr. Waubant has received research support from Roche. The institution of Dr. Waubant has received research support from Department of Defense. Dr. Waubant has received publishing royalties from a publication relating to health care.
John R. Absher, MD, FAAN	Dr. Absher has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Rehabilitation Alternative Services, Inc.. Dr. Absher has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Butler, Means, Evins and Browne, P.A..
Nilika S. Singhal, MD	Dr. Singhal has received personal compensation in the range of $0-$499 for serving as a Consultant for Guidepoint Global. Dr. Singhal has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ceribell.
Kazunori Toyoda, MD, PhD	No disclosure on file
Annie L. Hsieh, MD, PhD	An immediate family member of Dr. Hsieh has received personal compensation for serving as an employee of Pfizer.
Pyay San	No disclosure on file
Kaitlin M. Snyder	No disclosure on file
Sarah A. Engkjer, RN	No disclosure on file
Jenny Lee	No disclosure on file
Sarah R. Durica, MD	An immediate family member of Dr. Durica has received personal compensation in the range of $100,000-$499,999 for serving as a Employee with Federal Aviation Administration.
Arthur Ramalho Monfredinho, MD	Dr. Ramalho Monfredinho has nothing to disclose.
Fabio Adrian Barroso, MD	Fabio Adrian Barroso, MD has nothing to disclose.
Rameshwar N. Chaurasia, MD, DM, FRCP (Edin), FAMS	Dr. Chaurasia has nothing to disclose.
Shailee S. Shah, MD	Dr. Shah has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon Therapeutics. Dr. Shah has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Shah has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Shah has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Shah has received publishing royalties from a publication relating to health care.
Carolyn Bernstein, MD	Dr. Bernstein has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Ogletree. Dr. Bernstein has or had stock in Percept. The institution of Dr. Bernstein has received research support from Crimson Lion foundation. The institution of Dr. Bernstein has received research support from teva. Dr. Bernstein has received publishing royalties from a publication relating to health care.
Khalil Husari, MD	The institution of Dr. Husari has received research support from Maryland Innovation Initiative.
Sarah Ingersoll, RN, PHN	Ms. Ingersoll has nothing to disclose.
Ezgi Tiryaki, MD, FAAN	Dr. Tiryaki has or had stock in HITIT Leadership Coaching.Dr. Tiryaki has a non-compensated relationship as a Professor of Neurology with University of Minnesota that is relevant to AAN interests or activities. Dr. Tiryaki has a non-compensated relationship as a Clinic Director of a Center of Excellence with The ALS Association that is relevant to AAN interests or activities. Dr. Tiryaki has a non-compensated relationship as a Volunteer Clinical Neurologist at ALS Clinic with Minneapolis VA Healthcare System that is relevant to AAN interests or activities.
Stephen G. Reich, MD, FAAN	Dr. Reich has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Best Doctors. Dr. Reich has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UpToDate. Dr. Reich has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Various law firms. Dr. Reich has received publishing royalties from a publication relating to health care. Dr. Reich has received publishing royalties from a publication relating to health care.
Sherri A. Braksick, MD, FAAN	Dr. Braksick has nothing to disclose.
Jeffrey Z. Shije, MD	Dr. Shije has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alnylam Pharmaceuticals. Dr. Shije has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alnylam Pharmaceuticals. The institution of Dr. Shije has received research support from University of Florida College of Medicine.
Babak Razavi, MD, PhD	Dr. Razavi has stock in CortexXus. The institution of Dr. Razavi has received research support from Neuropace.
Milton Biagioni, MD	No disclosure on file
Harald Pruss	Harald Pruss has nothing to disclose.
Derek L. Hill, PhD	No disclosure on file
Rui Li	Mr. Li has nothing to disclose.
Behnaz Jarrahi, PhD	No disclosure on file
Andrew E. Budson, MD	Dr. Budson has received personal compensation for serving as an employee of Boston Center for Memory. Dr. Budson has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genentech. Dr. Budson has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AbbVie. Dr. Budson has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Eli Lilly. The institution of Dr. Budson has received research support from Department of Veterans Affairs. The institution of Dr. Budson has received research support from NIH. The institution of Dr. Budson has received research support from Bristol Myers Squibb. The institution of Dr. Budson has received research support from VoxNeuro. The institution of Dr. Budson has received research support from Eisai. Dr. Budson has received publishing royalties from a publication relating to health care. Dr. Budson has received publishing royalties from a publication relating to health care. Dr. Budson has a non-compensated relationship as a Alzheimer's Advisory Panel with Commonwealth of Massachusetts that is relevant to AAN interests or activities.
Dawn C. Buse, PhD	Dr. Buse has received personal compensation for serving as an employee of Vector Psychometric Group. Dr. Buse has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie-Allergan. Dr. Buse has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amgen. Dr. Buse has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lilly. Dr. Buse has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lundbeck. Dr. Buse has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Teva. Dr. Buse has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Theranicsa. Dr. Buse has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lilly. Dr. Buse has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abbvie-Allergan. Dr. Buse has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lundbeck. Dr. Buse has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Current Pain and Headache Reports. The institution of Dr. Buse has received research support from Amgen. The institution of Dr. Buse has received research support from FDA. The institution of Dr. Buse has received research support from National Headache Foundation.
Jessica Ailani, MD, FAAN	Dr. Ailani has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Abbvie. Dr. Ailani has received personal compensation in the range of $0-$499 for serving as a Consultant for Eli Lilly. Dr. Ailani has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Lundbeck. Dr. Ailani has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Pfizer. Dr. Ailani has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ipsen. Dr. Ailani has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Merz. Dr. Ailani has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Aspya. Dr. Ailani has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Axsome. Dr. Ailani has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bausch. Dr. Ailani has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amneal. Dr. Ailani has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Satsuma. Dr. Ailani has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Kallyope. Dr. Ailani has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Self Magazine. The institution of Dr. Ailani has received research support from Ipsen. The institution of Dr. Ailani has received research support from Parema. The institution of Dr. Ailani has received research support from Lundbeck. The institution of Dr. Ailani has received research support from Merz. The institution of Dr. Ailani has received research support from Pfizer. Dr. Ailani has received research support from Mi-Helper. The institution of Dr. Ailani has received research support from ShiraTronic. Dr. Ailani has a non-compensated relationship as a Executive Board Member with American Headache Society that is relevant to AAN interests or activities.
Amer Malik, MD	Dr. Malik has nothing to disclose.
Diana M. Barratt, MD, MPH, FAAN	Dr. Barratt has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Legally Pink, LLC. Dr. Barratt has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Vlantis Law, LLC. Dr. Barratt has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Traub Lieberman. Dr. Barratt has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Callahan Fusco. Dr. Barratt has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Chane Socarras. Dr. Barratt has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Conroy Simberg. Dr. Barratt has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Crandall & Katt. Dr. Barratt has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Kelley Kronenberg. Dr. Barratt has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Plakas Mannos. Dr. Barratt has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Marshall Denehey. Dr. Barratt has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Pritt & Spano. Dr. Barratt has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Russo Law.
Maryam Shakir, MPH	No disclosure on file
Christopher Tarolli, MD, FAAN	Dr. Tarolli has received personal compensation for serving as an employee of University of Rochester. The institution of Dr. Tarolli has received research support from National Institutes of Health. The institution of Dr. Tarolli has received research support from Biogen. The institution of Dr. Tarolli has received research support from Neuron23. Dr. Tarolli has received personal compensation in the range of $500-$4,999 for serving as a Speaker, Committee Member with ��ɫ��. Dr. Tarolli has received personal compensation in the range of $500-$4,999 for serving as a Committee member with National Board of Medical Examiners. Dr. Tarolli has a non-compensated relationship as a Committee Member with ��ɫ�� that is relevant to AAN interests or activities.
Etienne Laverse, MBBS, BSc, MRCP(Neurol), AICSM	Dr. Laverse has nothing to disclose.
Nidhi Kapoor, MD, MBBS	Dr. Kapoor has nothing to disclose.
Elysia James, MD	Dr. James has nothing to disclose.
Andreas N. Neophytides, MD	No disclosure on file
Elise P. Kayson, RN	Elise Paulin Kayson, RN has nothing to disclose.
Amy Z. Crepeau, MD	Dr. Crepeau has nothing to disclose.
Joohi Jimenez Shahed, MD, FAAN	Dr. Jimenez Shahed has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Teva. Dr. Jimenez Shahed has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Medtronic. Dr. Jimenez Shahed has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie. Dr. Jimenez Shahed has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amneal. Dr. Jimenez Shahed has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for BlueRock. Dr. Jimenez Shahed has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Treefrog. Dr. Jimenez Shahed has received personal compensation in the range of $500-$4,999 for serving as a Consultant for RebrAIn. Dr. Jimenez Shahed has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for BlueRock Therapeutics. Dr. Jimenez Shahed has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for PhotoPharmics. Dr. Jimenez Shahed has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Emalex. Dr. Jimenez Shahed has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biohaven. The institution of Dr. Jimenez Shahed has received research support from Amneal. The institution of Dr. Jimenez Shahed has received research support from Annovis. The institution of Dr. Jimenez Shahed has received research support from SAGE. The institution of Dr. Jimenez Shahed has received research support from Ono Pharmaceuticals. The institution of Dr. Jimenez Shahed has received research support from BlueRock. The institution of Dr. Jimenez Shahed has received research support from Neuron23. Dr. Jimenez Shahed has received personal compensation in the range of $0-$499 for serving as a Faculty with Movement Disorders Society. Dr. Jimenez Shahed has received personal compensation in the range of $500-$4,999 for serving as a Faculty with ��ɫ��. Dr. Jimenez Shahed has received personal compensation in the range of $500-$4,999 for serving as a Grant Reviewer with Parkinson Foundation.
Steven Vernino, MD, PhD, FAAN	Dr. Vernino has received personal compensation in the range of $500-$4,999 for serving as a Consultant for antag. Dr. Vernino has received personal compensation in the range of $500-$4,999 for serving as a Consultant for CSL Behring. Dr. Vernino has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for argenx. Dr. Vernino has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Kyverna. Dr. Vernino has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Autonomic Neuroscience (Elsevier). The institution of Dr. Vernino has received research support from Takeda. The institution of Dr. Vernino has received research support from NIH/NHLBI. The institution of Dr. Vernino has received research support from Lundbeck. The institution of Dr. Vernino has received research support from Regeneron.
Jeff Guptill, MD, FAAN	Dr. Guptill has received personal compensation for serving as an employee of argenx. Dr. Guptill has or had stock in argenx.
Julie E. Hammack, MD, FAAN	Dr. Hammack has nothing to disclose.
David Y. Chung, MD	The institution of Dr. Chung has received research support from NIH/NINDS. The institution of Dr. Chung has received research support from Brain Aneurysm Foundation. The institution of Dr. Chung has received research support from Angea Biotherapeutics.
Peter E. Morrison, DO	Dr. Morrison has nothing to disclose.
Omar S. Shah, MD	No disclosure on file
Nidhiben A. Anadani, MD	Dr. Anadani has nothing to disclose.
Sebastiano Galantucci	Mr. Galantucci has nothing to disclose.
Melissa S. DiFabio	No disclosure on file
Rocio Vazquez Do Campo, MD	Dr. Vazquez Do Campo has received personal compensation in the range of $5,000-$9,999 for serving as a Advisor with US Department of Health, vaccine compensation program.
Abdul Rahman Alchaki, MD	Dr. Alchaki has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amgen.
Stephanie Allien, PA	Mrs. Allien has nothing to disclose.
Angela Parsons, DO	Dr. Parsons has nothing to disclose.
Bastiaan R. Bloem, MD, PhD	No disclosure on file
Amy E. Sanders, MD, FAAN	Dr. Sanders has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ionis Pharmaceuticals. Dr. Sanders has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Adlarity. Dr. Sanders has a non-compensated relationship as a Medical and Scientific Advisory Board with Alzheimer's Association (CT Chapter) that is relevant to AAN interests or activities. Dr. Sanders has a non-compensated relationship as a Board Member with UCNS that is relevant to AAN interests or activities.
Olajumoke Oshinaike, MD	Dr. Oshinaike has nothing to disclose.
Naresh Mullaguri, MD	Dr. Mullaguri has nothing to disclose.
Andrei A. Vakhtin	No disclosure on file
Daniel Schwartz	No disclosure on file
Lisa M. Shulman, MD, FAAN	The institution of Dr. Shulman has received research support from NIH. Dr. Shulman has received publishing royalties from a publication relating to health care. Dr. Shulman has received publishing royalties from a publication relating to health care.
Rocio C. Garcia Santibanez, MD, FAAN	Dr. Garcia Santibanez has nothing to disclose.
Mona Bahouth, MD, PhD, FAAN	The institution of Dr. Bahouth has received research support from NIH.
Ignacio Valencia, MD	No disclosure on file
Vijay Renga, MD	Dr. Renga has nothing to disclose.
Ole Graff, MD	Dr. Graff has received personal compensation for serving as an employee of AbbVie. Dr. Graff has stock in AbbVie.
David G. Wright, MD	Dr. Wright has nothing to disclose.
Christine Holmstedt, DO	The institution of Dr. Holmstedt has received research support from NIH. The institution of Dr. Holmstedt has received research support from Patient-Centered Outcomes Research Institute.
Michelle M. Mielke, PhD	Dr. Mielke has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Dr. Mielke has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eisai. Dr. Mielke has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eli Lilly. Dr. Mielke has received personal compensation in the range of $500-$4,999 for serving as a Consultant for LabCorp. Dr. Mielke has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Roche. Dr. Mielke has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Siemens Healthineers. Dr. Mielke has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sunbird Bio. Dr. Mielke has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eisai. Dr. Mielke has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Roche. Dr. Mielke has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novo Nordisk.
Joseph Zachariah, DO	Dr. Zachariah has nothing to disclose.
Leighton Mohl, MD	Dr. Mohl has nothing to disclose.
Alberto Cucca, MD	No disclosure on file
Robert Hendricks	No disclosure on file
Harmanpreet Tiwana, MD	No disclosure on file
William H. Mays III, MD	Dr. Mays has nothing to disclose.
Nida Akram, MBBS	No disclosure on file
Jeffrey B. Schachter, MD	Dr. Schachter has nothing to disclose.
Michelle Finnegan	Michelle Finnegan has received personal compensation for serving as an employee of AbbVie.
Austin Baltensperger, MD	No disclosure on file
Emma M. Loebel, MD	Ms. Loebel has nothing to disclose.
Zulfiqar Sheikh	No disclosure on file
Roque Villagra, MD	No disclosure on file
Krisna S. Maddy	Ms. Maddy has nothing to disclose.
Erin D. Bigler, PhD	Dr. Bigler has received personal compensation in the range of $50,000-$99,999 for serving as an Expert Witness for Erin D. Bigler, Ph.D., Private Consulting Practice. Dr. Bigler has received publishing royalties from a publication relating to health care.
Kapil Arya, MBBS, DA, FAAP, FACNS, FAAN	Dr. Arya has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Dr. Arya has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Arya has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Scholar Rock.
Natalie P. Witek, MD	Dr. Witek has nothing to disclose.
Kalea L. Colletta, DO	Dr. Colletta has nothing to disclose.
Devin E. Prior, MD	No disclosure on file
Svetlana Eckert, MD	Dr. Eckert has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pfizer. Dr. Eckert has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for EMD Serono. Dr. Eckert has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for TG Therapeutics.
Michele Hu, MD	The institution of Dr. Hu has received personal compensation in the range of $0-$499 for serving as a Consultant for Lundbeck. The institution of Dr. Hu has received personal compensation in the range of $0-$499 for serving as a Consultant for ESCAPE Bio. The institution of Dr. Hu has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Evidera. The institution of Dr. Hu has received research support from Parkinson's UK. The institution of Dr. Hu has received research support from Oxford BRC.
Gary S. Gronseth, MD, FAAN	Dr. Gronseth has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Brain & Life. Dr. Gronseth has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurology. Dr. Gronseth has received personal compensation in the range of $0-$499 for serving as a Member/EBM consultant Guideline Development Subcommittee with AAN.
Miya Bernson-Leung, MD, FAAN	An immediate family member of Dr. Bernson-Leung has received personal compensation in the range of $500-$4,999 for serving as a Consultant for GLG Consulting. Dr. Bernson-Leung has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BioMarin. Dr. Bernson-Leung has stock in Abbott Labs. Dr. Bernson-Leung has stock in Abbvie Inc.
Robert Fishman, MD	Dr. Fishman has nothing to disclose.
Salman Aljarallah, MD	Dr. Aljarallah has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Aljarallah has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Aljarallah has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Sanofi Genzyme.
Mehari Gebreyohanns, MD, FAAN	Dr. Gebreyohanns has nothing to disclose.
Deepak Reddy, MD	Dr. Reddy has nothing to disclose.
Tamra I. Ranasinghe, MD	Dr. Ranasinghe has nothing to disclose.
David A. Discua	No disclosure on file
Daniel Garbin Di Luca, MD	Dr. Garbin Di Luca has nothing to disclose.
Yazan Al-Hasan, MD, PhD	Dr. Al-Hasan has nothing to disclose.
Michael Haboubi, DO	Dr. Haboubi has nothing to disclose.
Michael Guo, MD, PhD	Dr. Guo has nothing to disclose.
Steven C. Swavely, MD	No disclosure on file
Sonali Sen, MD	No disclosure on file
Mahya Beheshti, MBBS	No disclosure on file
Holland Detke	Holland Detke has received personal compensation for serving as an employee of Eli Lilly and Company. Holland Detke has received stock or an ownership interest from Eli Lilly and Company.
Jeffrey M. Gelfand, MD, MS, FAAN	Dr. Gelfand has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Arialys. Dr. Gelfand has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ventyx Bio. An immediate family member of Dr. Gelfand has received personal compensation in the range of $50,000-$99,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Headache: The Journal of Head and Face Pain. The institution of Dr. Gelfand has received research support from Genentech/Roche. The institution of Dr. Gelfand has received research support from Vigil Neurosciences. An immediate family member of Dr. Gelfand has received publishing royalties from a publication relating to health care. Dr. Gelfand has received publishing royalties from a publication relating to health care. Dr. Gelfand has received publishing royalties from a publication relating to health care. Dr. Gelfand has a non-compensated relationship as a Trial Steering Committee Chairperson and member with Roche / Genentech that is relevant to AAN interests or activities.
Jorg Dietrich, MD, PhD, FAAN	Dr. Dietrich has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Dietrich has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ono Pharmaceuticals. Dr. Dietrich has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Johnson & Johnson. Dr. Dietrich has received publishing royalties from a publication relating to health care.
Michael Christiansen, MD	No disclosure on file
Ibrahim Binalsheikh, MD	No disclosure on file
Monica M. Diaz, MD, MS	The institution of Dr. Diaz has received research support from CorEvitas. The institution of Dr. Diaz has received research support from Novartis. The institution of Dr. Diaz has received research support from Bodford Family Transverse Myelitis Center Fund.
Tracy Brandt, PhD	No disclosure on file
Tina Oakes	Tina Oakes has received personal compensation for serving as an employee of Eli Lilly. Tina Oakes has received stock or an ownership interest from Eli Lilly.
Andrew J. Zhang, MD	Dr. Zhang has nothing to disclose.
Shreya Nayak, MD	Dr. Nayak has nothing to disclose.
Sania Atta, MBBS	No disclosure on file
Syeda Maria Muzammil, MD	Dr. Muzammil has nothing to disclose.
Paul B. Hart	Mr. Hart has nothing to disclose.
Khemissa Bejaoui, PhD	No disclosure on file
Martin A. Myers, MD	No disclosure on file
Michelle Rainka, PharmD	Dr. Rainka has stock in Abbvie. Dr. Rainka has stock in acadia. Dr. Rainka has stock in alon. Dr. Rainka has stock in biogen. Dr. Rainka has stock in bristol myers squib. Dr. Rainka has stock in eisai. Dr. Rainka has stock in Lilly. Dr. Rainka has stock in novartis. Dr. Rainka has stock in pfizer. Dr. Rainka has stock in roche. Dr. Rainka has stock in Sage. Dr. Rainka has stock in alkermes.
Dongchul Lee	No disclosure on file
Matthew Chung, MD	No disclosure on file
Muhammad Affan, MD	Dr. Affan has nothing to disclose.
Noushin Jazebi, MD	Dr. Jazebi has nothing to disclose.
Jonathan Duskin, MD	Dr. Duskin has nothing to disclose.
Elizabeth Pedowitz, MD	No disclosure on file
Charles Oh, MD	No disclosure on file
Priti Gros, MD	Dr. Gros has nothing to disclose.
George N. Ansoanuur, MD	No disclosure on file
Amina Nasri, MD	Dr. Nasri has nothing to disclose.
Chirag N. Savani, MD	No disclosure on file
Deborah Steiner, MD	No disclosure on file
Harpreet Kaur, MD	No disclosure on file
Yolanda Reyes-Iglesias, MD, FAAN	Dr. Reyes-Iglesias has received personal compensation in the range of $500-$4,999 for serving as a Member Neuroscience Test Development Material Committee with National Board medical examiners (NBME). Dr. Reyes-Iglesias has received personal compensation in the range of $500-$4,999 for serving as a Lecturer with Harvard Prime Med Series.
Joseph Snow, PhD	Dr. Snow has received research support from NIH/NIMH.
Seth N. Levin, MD	Dr. Levin has received personal compensation for serving as an employee of Biogen. Dr. Levin has received stock or an ownership interest from Biogen.
Natasha Hameed, MD	Dr. Hameed has nothing to disclose.
Jeanna West-Miles, DO	No disclosure on file
Shreya Agarwal	No disclosure on file
Nikita Shukla, MD	The institution of Dr. Shukla has received research support from Roche.
Michael L. Morgan, MD, PhD	Dr. Morgan has nothing to disclose.
Tahsin Khan, MD	Dr. Khan has nothing to disclose.
Cory Blaiss	No disclosure on file
John P. Holton-Burke, MD	No disclosure on file
Arushi Tripathy	No disclosure on file
Animesh Gupta, MD	Dr. Gupta has nothing to disclose.
Timothy J. Ainger, PhD	Dr. Ainger has nothing to disclose.
Daniel van Wamelen	No disclosure on file
Gustavo C. Roman, MD, FAAN	The institution of Dr. Roman has received research support from Brain Chamistry Labs.
Sanjeev V. Thomas, MD, FAAN	Dr. Thomas has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Wiley India. The institution of Dr. Thomas has received research support from Government of India.
William F. Schmalstieg, MD	No disclosure on file
Luigi Ferini-Strambi, MD	Dr. Ferini-Strambi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bioprojet. Dr. Ferini-Strambi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for lundbeck. Dr. Ferini-Strambi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for idorsia. Dr. Ferini-Strambi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Italfarmaco. Dr. Ferini-Strambi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi. Dr. Ferini-Strambi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Bruno Farmaceutici. Dr. Ferini-Strambi has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier Sleep Medicine.
Stephen J. Marks, MD	No disclosure on file
Hongyan Li, MD, PhD, FAAN	Dr. Li has nothing to disclose.
Laurel J. Cherian, MD, FAAN	The institution of Dr. Cherian has received research support from NIH.
Yuichi Hayashi	Yuichi Hayashi has nothing to disclose.
Jonathan R. Galli, MD	Dr. Galli has nothing to disclose.
Naomi Nevler, MD	No disclosure on file
Andrew Lin, MD	No disclosure on file
Mary Clare McKenna, MB BCh BAO PhD	Dr. McKenna has nothing to disclose.
Tracey H. Fan, DO	Dr. Fan has nothing to disclose.
Gisbert Weckbecker	No disclosure on file
Meaghan Berns, MD	Dr. Berns has nothing to disclose.
Alessandro Bombaci, MD	Dr. Bombaci has nothing to disclose.
Yajun Cheng	No disclosure on file
Bradford Dickerson, MD, FAAN	Dr. Dickerson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Dickerson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Acadia. Dr. Dickerson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Arkuda. Dr. Dickerson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eisai. Dr. Dickerson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lantheus. Dr. Dickerson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lilly. Dr. Dickerson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Dr. Dickerson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novo Nordisk. Dr. Dickerson has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Dr. Dickerson has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Arkuda. Dr. Dickerson has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Acadia. Dr. Dickerson has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lilly. Dr. Dickerson has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier. Dr. Dickerson has received publishing royalties from a publication relating to health care. Dr. Dickerson has received publishing royalties from a publication relating to health care.
Linda C. Wendell, MD, FAAN	Dr. Wendell has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Various. An immediate family member of Dr. Wendell has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Various. Dr. Wendell has stock in Apple. An immediate family member of Dr. Wendell has stock in Apple.
Dale Gamble	No disclosure on file
Cynthia Gonzalez, MD	Dr. Gonzalez has nothing to disclose.
Nicholas S. Potter, MD, PhD	Dr. Potter has nothing to disclose.
Bhavani Kashyap, MBBS, PhD	Dr. Kashyap has nothing to disclose.
Nicholas J. Silvestri, MD, FAAN	Dr. Silvestri has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for argenx. Dr. Silvestri has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Regeneron. Dr. Silvestri has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Silvestri has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. Dr. Silvestri has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Immunovant. Dr. Silvestri has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amgen. Dr. Silvestri has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for argenx. Dr. Silvestri has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion. The institution of an immediate family member of Dr. Silvestri has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for UCB. Dr. Silvestri has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Takeda. Dr. Silvestri has received publishing royalties from a publication relating to health care.
Susan Hutchinson	Susan Hutchinson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alder Pharmaceutical. Susan Hutchinson has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Allergan Pharmaceutical . Susan Hutchinson has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Amgen Pharmaceutical. Susan Hutchinson has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biohaven . Susan Hutchinson has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Currax Pharmaceutical . Susan Hutchinson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for electroCore. Susan Hutchinson has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Lilly Pharmaceutical . Susan Hutchinson has received personal compensation in the range of $0-$499 for serving as a Consultant for Lundbeck Pharmaceutical. Susan Hutchinson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Susan Hutchinson has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Teva. Susan Hutchinson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Theranica. Susan Hutchinson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Upsher Smith. Susan Hutchinson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Impel Pharmaceutical . Susan Hutchinson has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Allergan . Susan Hutchinson has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lilly Pharmaceutical . Susan Hutchinson has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Allergan/AbbVie. Susan Hutchinson has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Amgen. Susan Hutchinson has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biohaven . Susan Hutchinson has received personal compensation in the range of $100,000-$499,999 for serving on a Speakers Bureau for Lilly Pharmaceutical . Susan Hutchinson has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Lundbeck . Susan Hutchinson has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Teva . Susan Hutchinson has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for Headache Cooperative of the Pacific . Susan Hutchinson has received publishing royalties from a publication relating to health care.
Chris Hackett, MA	Mr. Hackett has nothing to disclose.
Chaitanya Amrutkar, MD	No disclosure on file
Xiao Weng, MD	Dr. Weng has nothing to disclose.
Xiaoping Ning	Ms. Ning has received personal compensation for serving as an employee of Teva Pharmaceutical . Ms. Ning has received personal compensation for serving as an employee of Teva Pharmaceutical.
Beatriz Parra	Beatriz Parra has nothing to disclose.
John C. Morris, MD, FAAN	Dr. Morris has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for CBR International Advisory Board. Dr. Morris has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cure Alzheimers Fund. Dr. Morris has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for LEADS Steering Commitee. The institution of Dr. Morris has received research support from NIH grants. Dr. Morris has received intellectual property interests from a discovery or technology relating to health care. Dr. Morris has received intellectual property interests from a discovery or technology relating to health care.
E. Ray Dorsey, MD, MBA	Dr. Dorsey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Seelos Therapeutics. Dr. Dorsey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eden McCallum, LLP. Dr. Dorsey has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Genentech/Roche. Dr. Dorsey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biohaven Pharmaceuticals. Dr. Dorsey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for WebMD. Dr. Dorsey has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for BioSensics. Dr. Dorsey has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Mediflix. Dr. Dorsey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cerevance. Dr. Dorsey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Kairos Cinema, LLC. Dr. Dorsey has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Mitsubishi Tanabe Pharma America Inc.. Dr. Dorsey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for HanAll. Dr. Dorsey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Dorsey has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Dorsey has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Advarra. Dr. Dorsey has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Medrhythms. Dr. Dorsey has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for ANA. Dr. Dorsey has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for HMP ��ɫ��, LLP. Dr. Dorsey has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for ADIVO Associates France. Dr. Dorsey has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for University of Toronto. Dr. Dorsey has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Philadelphia Neurological Society. Dr. Dorsey has stock in Included Health. Dr. Dorsey has stock in Mediflix. Dr. Dorsey has stock in SemCap. Dr. Dorsey has stock in Synapticure. The institution of Dr. Dorsey has received research support from NIH/NINDS. The institution of Dr. Dorsey has received research support from Burroughs Wellcome . The institution of Dr. Dorsey has received research support from Michael J. Fox Foundation - Fox Insight. The institution of Dr. Dorsey has received research support from Michael J. Fox Foundation - Emerald. The institution of Dr. Dorsey has received research support from B. Thomas Golisano Foundation. The institution of Dr. Dorsey has received research support from Emerald Innovations, Inc.. The institution of Dr. Dorsey has received research support from Photopharmics Inc.. The institution of Dr. Dorsey has received research support from Averitas Pharma Inc.. The institution of Dr. Dorsey has received research support from DOD/Army Medical Research Acquisition Activity. The institution of Dr. Dorsey has received research support from NIH/NINDS.
David Dolezil	No disclosure on file
Yasir N. Jassam, MD, FRCP, FAAN	Dr. Jassam has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Jassam has received research support from Roche, Chugai Pharmaceutical MedImmune LLC.Novartis, MedDay. Actelion, Alexion Pharmaceuticals,TG Therapeutics Alexion Pharmaceuticals, Teva Pharmaceuticals, Genentech phamarcetucal companies..
Jorge G. Ortiz-Garcia, MD, FAAN	Dr. Ortiz-Garcia has nothing to disclose.
Tamer Abdelhak, MD	Dr. Abdelhak has nothing to disclose.
Timothy Bernard, MD	The institution of Dr. Bernard has received research support from NIH.
Bassel Raad, MD	No disclosure on file
Sandra Jimenez, MD	Dr. Jimenez has nothing to disclose.
Sahil Gupta, MD	Dr. Gupta has nothing to disclose.
Menorca Chaturvedi	No disclosure on file
Mohammad A. Kabir, MD	Dr. Kabir has received personal compensation for serving as an employee of Hamilton Physician Group. Dr. Kabir has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Inlightened Inc. . Dr. Kabir has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for UCB Pharma. Dr. Kabir has received personal compensation in the range of $0-$499 for serving as a Consultant for Livanova Inc. Dr. Kabir has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eisai. Dr. Kabir has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Jazz Pharmaceuticals. Dr. Kabir has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Jazz Pharma. Dr. Kabir has stock in ArgenX. Dr. Kabir has stock in Lilly. Dr. Kabir has stock in Pfizer.
Tracy Ander, DO	No disclosure on file
Christine E. Yeager, MD	Dr. Yeager has nothing to disclose.
Muhammad Z. Memon, MD	Dr. Memon has nothing to disclose.
Mohamed T. Shabana, MD	Dr. Shabana has nothing to disclose.
Safa Kaleem, MD	Dr. Kaleem has nothing to disclose.
Alyssa Chao	No disclosure on file
Sarah Tisserand	No disclosure on file
Mady Hornig	No disclosure on file
Eoin P. Flanagan, MBBCh, FAAN	The institution of Dr. Flanagan has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Flanagan has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Pharmacy times. The institution of Dr. Flanagan has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for UCB. The institution of Dr. Flanagan has received research support from UCB. The institution of Dr. Flanagan has received research support from Roche. The institution of Dr. Flanagan has received research support from UCB. The institution of Dr. Flanagan has received research support from Merck. The institution of Dr. Flanagan has received research support from Roche. Dr. Flanagan has received publishing royalties from a publication relating to health care. Dr. Flanagan has received publishing royalties from a publication relating to health care. Dr. Flanagan has a non-compensated relationship as a Member of medical Advisory Board with The MOG Project that is relevant to AAN interests or activities. Dr. Flanagan has a non-compensated relationship as a Editorial board member with Journal of The Neurologic Sciences that is relevant to AAN interests or activities. Dr. Flanagan has a non-compensated relationship as a Editorial board member with Neuroimmunology Reports that is relevant to AAN interests or activities. Dr. Flanagan has a non-compensated relationship as a Editorial Board Member with Neurology, Neuroimmunology Neuroinflammation (N2) Journal that is relevant to AAN interests or activities. Dr. Flanagan has a non-compensated relationship as a Editorial Board Member with Neurology that is relevant to AAN interests or activities.
Angela Aziz-Donnelly, MD	No disclosure on file
Sean Mackey, MD, PhD	No disclosure on file
Gerald D. Podskalny, DO	No disclosure on file
Dorthea Juul, PhD	Dr. Juul has received personal compensation for serving as an employee of American Board of Psychiatry and Neurology.
Karisa C. Schreck, MD, PhD	Dr. Schreck has received personal compensation in the range of $0-$499 for serving as a Consultant for Nurix. Dr. Schreck has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Schreck has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Advarra LLC. The institution of Dr. Schreck has received research support from Springworks Therapeutics. Dr. Schreck has received personal compensation in the range of $500-$4,999 for serving as a speaker with Springworks Therapeutics.
Amr H. Ewida, MD	Dr. Ewida has nothing to disclose.
Asma Malik, MD	Dr. Malik has nothing to disclose.
Eufrosina I. Young, MD	The institution of Dr. Young has received research support from Mitsubishi Tanabe Pharma America.
Lyda Osorio	Lyda Osorio has nothing to disclose.
Kristen R. Joseph, MA	No disclosure on file
Maryamnaz Zaribaf, MD	No disclosure on file
Laura Dresser, MD	Dr. Dresser has nothing to disclose.
Ilavarasy Maran, MD	Dr. Maran has nothing to disclose.
Richard Monti, Jr., MD	No disclosure on file
Neil Suryadevara, MD	Dr. Suryadevara has nothing to disclose.
Jacob Manske, MD	No disclosure on file
Imane Abdelmoumen, MD	Dr. Abdelmoumen has nothing to disclose.
Xiaoye Ma	Xiaoye Ma has received personal compensation for serving as an employee of Genentech.
Akash Virupakshaiah, MD	Dr. Virupakshaiah has nothing to disclose.
Robert De Santis, MD	No disclosure on file
Sushanth R. Aroor, MD	Dr. Aroor has stock in Gravity.
Jeffrey B. Ratliff, MD, FAAN	Dr. Ratliff has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for the journal Neurology. The institution of Dr. Ratliff has received research support from Scion NeuroStim, LLC.
Carlos R. Camara-Lemarroy, MD	Dr. Camara-Lemarroy has received personal compensation in the range of $500-$4,999 for serving as a Consultant for emd serono. Dr. Camara-Lemarroy has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for novartis. Dr. Camara-Lemarroy has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for amgen. Dr. Camara-Lemarroy has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for novartis.
Mohammed H. Alkuwaiti, MD	No disclosure on file
Anjali Gera, MD	Dr. Gera has nothing to disclose.
Rafia Shafqat, MD	No disclosure on file
Maria V. Diaz Rojas, MD	Dr. Diaz Rojas has nothing to disclose.
Somayeh Meysami, MD	Dr. Meysami has nothing to disclose.
Jeffrey Barnes, MD	No disclosure on file
Carla M. Francisco, MD	Dr. Francisco has nothing to disclose.
Parneet K. Grewal, MD	The institution of Dr. Grewal has received research support from Bristol Myer Squibb Foundation. The institution of Dr. Grewal has received research support from IPSEN Global.
Sammita Satyanarayan, MD	Dr. Satyanarayan has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Health Monitor. Dr. Satyanarayan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono .
Riadh Gouider, MD, FAAN	Dr. Gouider has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Dr. Gouider has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Gouider has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Gouider has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Gouider has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Hikma. The institution of Dr. Gouider has received research support from Clinical Investigation Center. The institution of Dr. Gouider has received research support from Menactrims.
Isabel Arrillaga-Romany, MD	Dr. Arrillaga-Romany has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Boehringer Ingelheim. The institution of Dr. Arrillaga-Romany has received research support from Astex Pharmaceuticals. The institution of Dr. Arrillaga-Romany has received research support from Gsk.
Gabriel Vidal, MD	Dr. Vidal has nothing to disclose.
Andrea S. Synowiec, DO, FAAN	Dr. Synowiec has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Amgen. Dr. Synowiec has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Lilly. Dr. Synowiec has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Allergan. Dr. Synowiec has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Biohaven.
Valentina Leta	No disclosure on file
Lindsey R. Kuohn, MD	Dr. Kuohn has nothing to disclose.
Kelsey Satterly	Kelsey Satterly has received personal compensation for serving as an employee of Impel NeuroPharma . Kelsey Satterly has received intellectual property interests from a discovery or technology relating to health care.
Takayoshi Shimohata, MD, FAAN	Dr. Shimohata has nothing to disclose.
Antonio V. Delgado-Escueta, MD	Dr. Delgado-Escueta has nothing to disclose.
Jose G. Romano, MD, FAAN	Dr. Romano has stock in Vycor Medical/NovaVision. The institution of Dr. Romano has received research support from NIH/NINDS. The institution of Dr. Romano has received research support from NIH/NHLBI.
Xue Ming, MD	Dr. Ming has nothing to disclose.
Maria Trojano	Maria Trojano has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Maria Trojano has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Maria Trojano has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Maria Trojano has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Maria Trojano has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi_Genzyme. Maria Trojano has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Janssen. Maria Trojano has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sandoz. Maria Trojano has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. Maria Trojano has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck. Maria Trojano has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Maria Trojano has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi-Genzyme. Maria Trojano has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Maria Trojano has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Janssen.
Alberto Maud, MD	Dr. Maud has nothing to disclose.
Catherine Maurice, MD	No disclosure on file
Rebecca G. Straus Farber, MD	Dr. Straus Farber has received personal compensation in the range of $500-$4,999 for serving as a Consultant for TG Therapeutics.
Danielle Sandsmark, MD	The institution of Dr. Sandsmark has received research support from NINDS. The institution of Dr. Sandsmark has received research support from BrainBox Solutions Inc. The institution of Dr. Sandsmark has received research support from Department of Defense.
Sarah Lapointe, MD	Dr. Lapointe has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion.
Niyatee Samudra, MD	Dr. Samudra has nothing to disclose.
Leila Montaser-Kouhsari, MD, PhD	Dr. Montaser-Khousari has received personal compensation in the range of $0-$499 for serving as a Consultant for Darmyian, Trinity Life Sciences, Guidepoint and Techspert. Dr. Montaser-Khousari has received research support from DoD.
Ferdinand Schweser, PhD	Dr. Schweser has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier.
Isaac Molinero, MD	Dr. Molinero has nothing to disclose.
Melissa Cook, MD	Dr. Cook has nothing to disclose.
Zachary King	No disclosure on file
Salvatore A. D'Amato, MD	No disclosure on file
Ryan Kammeyer, MD	The institution of Dr. Kammeyer has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Amgen. The institution of Dr. Kammeyer has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Dr. Kammeyer has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Ogborn-Mihm Trial Lawyers. The institution of Dr. Kammeyer has received research support from Rocky Mountain Multiple Sclerosis Center.
Tarrant McPherson	Tarrant McPherson has received research support from Myasthenia Gravis Foundation of America.
Jonpaul Bonsignore	No disclosure on file
Lorraine Chishimba, MBChB, MMED	Dr. Chishimba has nothing to disclose.
Ravish Keni	No disclosure on file
Carol L. Koski, MD	No disclosure on file
M. M. Paz Soldan, MD, PhD	Dr. Paz Soldan has received personal compensation in the range of $500-$4,999 for serving as a Consultant for TG Therapeutics. The institution of Dr. Paz Soldan has received research support from National Institutes of Health. The institution of Dr. Paz Soldan has received research support from National Multiple Sclerosis Society. The institution of Dr. Paz Soldan has received research support from Western Institute for Biomedical Research. The institution of Dr. Paz Soldan has received research support from Biogen. The institution of Dr. Paz Soldan has received research support from Novartis. The institution of Dr. Paz Soldan has received research support from Clene Nanomedicine.
Shefali Karkare, MD	Dr. Karkare has nothing to disclose.
Susan Shin, MD	Dr. Shin has nothing to disclose.
Aaron M. Carlson, MD	Dr. Carlson has received research support from Horizon Therapeutics (Amgen).
Annie S. Daniel, MBBS	Dr. Daniel has nothing to disclose.
Buse Sengul, MD	Dr. Sengul has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Horizon Therapeutics . Dr. Sengul has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for EMD Serano. Dr. Sengul has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genentech. Dr. Sengul has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for EMD Serano. Dr. Sengul has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biogen.
Audrey Arango, RN	No disclosure on file
Thomas R. Haven, PhD	Dr. Haven has nothing to disclose.
Smeer Salam, MD, MBBS	No disclosure on file
Rajanigandhi Hanumanthu, MD	No disclosure on file
Padmavati R. Eksambe, MD	Dr. Eksambe has nothing to disclose.
Tsubasa Tomoto, PhD	Dr. Tomoto has nothing to disclose.
Caitlin D'Souza, DO	No disclosure on file
Julian Agin-Liebes, MD	Dr. Agin-Liebes has nothing to disclose.
Beau Billings	No disclosure on file
Dwayne O. Brown, MD	Dr. Brown has nothing to disclose.
Lisa Brooks	Lisa Brooks has received personal compensation for serving as an employee of Nevro. Lisa Brooks has received stock or an ownership interest from Nevro.
Ludivine Chamard Witkowski	Ludivine Chamard Witkowski has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Ludivine Chamard Witkowski has received personal compensation in the range of $500-$4,999 for serving as a Consultant for merck Serono. The institution of Ludivine Chamard Witkowski has received research support from CFMNB. The institution of Ludivine Chamard Witkowski has received research support from Cantrain.
Mitchell S. Elkind, MD, MS, FAAN	Dr. Elkind has received personal compensation for serving as an employee of American Heart Association. Dr. Elkind has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Atria Academy.
Rajesh Pahwa, MD, FAAN	Dr. Pahwa has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Abbott. Dr. Pahwa has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for AbbVie. Dr. Pahwa has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for ACADIA. Dr. Pahwa has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Amneal. Dr. Pahwa has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Lundbeck. Dr. Pahwa has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Supernus. Dr. Pahwa has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Insightec. Dr. Pahwa has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Jaaz. Dr. Pahwa has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Fasikl. Dr. Pahwa has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genetech. Dr. Pahwa has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Merz. Dr. Pahwa has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Mitsubishi Tanabe. Dr. Pahwa has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Photopharmics. The institution of Dr. Pahwa has received research support from Abbott. The institution of Dr. Pahwa has received research support from Abbvie. The institution of Dr. Pahwa has received research support from Biogen. The institution of Dr. Pahwa has received research support from Parkinson Foundation. The institution of Dr. Pahwa has received research support from Roche. The institution of Dr. Pahwa has received research support from Sage. The institution of Dr. Pahwa has received research support from Sun Pharma. The institution of Dr. Pahwa has received research support from Theravance. The institution of Dr. Pahwa has received research support from Neuroderm. The institution of Dr. Pahwa has received research support from Ask Bio. The institution of Dr. Pahwa has received research support from Blue Rock. The institution of Dr. Pahwa has received research support from Cerevance. The institution of Dr. Pahwa has received research support from Fasikl. The institution of Dr. Pahwa has received research support from Scion. The institution of Dr. Pahwa has received research support from UCB. The institution of Dr. Pahwa has received research support from Ono. The institution of Dr. Pahwa has received research support from Intra-cellular Therapies. The institution of Dr. Pahwa has received research support from Ask Bio. The institution of Dr. Pahwa has received research support from Michael J Fox Foundation . The institution of Dr. Pahwa has received research support from Neuron 23. The institution of Dr. Pahwa has received research support from Roche.
David E. Blum, MD	Dr. Blum has received personal compensation for serving as an employee of Neurona Therapeutics. Dr. Blum has stock in Neurona Therapeutics.
Bakri Elsheikh, MD, FAAN	Dr. Elsheikh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen . Dr. Elsheikh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Argnex . The institution of Dr. Elsheikh has received research support from Biogen. The institution of Dr. Elsheikh has received research support from Cure SMA.
Bradford B. Thompson, MD	Dr. Thompson has nothing to disclose.
Xuling Lin, MD	The institution of Dr. Lin has received research support from National Health Innovation Center.
Eric Thouvenot, MD, PhD	Dr. Thouvenot has received personal compensation in the range of $0-$499 for serving as a Consultant for Biogen. Dr. Thouvenot has received personal compensation in the range of $0-$499 for serving as a Consultant for Merck. Dr. Thouvenot has received personal compensation in the range of $0-$499 for serving as a Consultant for Teva. Dr. Thouvenot has received personal compensation in the range of $0-$499 for serving as a Consultant for Novartis. Dr. Thouvenot has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Thouvenot has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. The institution of Dr. Thouvenot has received research support from Biogen. The institution of Dr. Thouvenot has received research support from Novartis. The institution of Dr. Thouvenot has received research support from Roche.
Farhaan S. Vahidy, MBBS, PhD	Dr. Vahidy has nothing to disclose.
Betsy N. Williams, PhD	Dr. Williams has received personal compensation for serving as an employee of IQVIA.
Caroline Arquizan	No disclosure on file
Ellen Huang	No disclosure on file
Kenneth Hayashida	Kenneth Hayashida has nothing to disclose.
C Romano	No disclosure on file
Nishant K. Mishra, MD, MBBS, PhD, FESO	Dr. Mishra has nothing to disclose.
Kate E. Therkelsen, MD	Dr. Therkelsen has nothing to disclose.
Jacob Soumerai	No disclosure on file
Camilo Garcia	No disclosure on file
Joel Kramer, PhD	The institution of Dr. Kramer has received research support from tau consortium. Dr. Kramer has received publishing royalties from a publication relating to health care.
Katherine T. Dawson, MD	No disclosure on file
Joachim M. Baehring, MD, FAAN	Dr. Baehring has nothing to disclose.
Becky J. Parks, MD	Dr. Parks has received personal compensation for serving as an employee of Alexion Pharmaceuticals. An immediate family member of Dr. Parks has received personal compensation for serving as an employee of Edward P. Evans Foundation. Dr. Parks has stock in Biogen. An immediate family member of Dr. Parks has stock in Regeneron. Dr. Parks has stock in Blueprint Medicines. Dr. Parks has stock in Sanofi. An immediate family member of Dr. Parks has stock in Vertex. Dr. Parks has stock in AstraZeneca. The institution of an immediate family member of Dr. Parks has received research support from NIH/NCI. The institution of an immediate family member of Dr. Parks has received research support from Leukemia & Lymphoma Society. The institution of an immediate family member of Dr. Parks has received research support from AstraZeneca Scholar Award.
Melanie Glenn, MD	No disclosure on file
Thomas M. Aune, PhD	No disclosure on file
Devangi S. Mehta, PhD	No disclosure on file
Mary Jane Lim-Fat, MD, FRCPC	Dr. Lim Fat has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Servier. Dr. Lim Fat has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novocure. The institution of Dr. Lim Fat has received research support from Brain Cancer Canada.
Elaine Su, MD	No disclosure on file
Meghan Purohit, DO	Dr. Purohit has nothing to disclose.
Claire E. Delpirou Nouh, MD	The institution of Dr. Delpirou Nouh has received research support from Oklahomas Nathan Shock Center. Dr. Delpirou Nouh has a non-compensated relationship as a Volunteer/Board member with Oklahoma Alzheimer Association that is relevant to AAN interests or activities.
Muhammad U. Jahngir, MD	No disclosure on file
Mohamed Elfil, MBBCh	Dr. Elfil has nothing to disclose.
Ahmed Chenna, PhD	Dr. Chenna has received personal compensation for serving as an employee of LabCorp-monogram Biosciences. Dr. Chenna has or had stock in LabCorp.
Ethan Edmondson, MD	Dr. Edmondson has nothing to disclose.
Chao Xu	Chao Xu has nothing to disclose.
L C. Pettigrew, MD, MPH, FAAN	No disclosure on file
Hamza I. Maqsood, MD	Dr. Qureshi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for AstraZeneca.
Mercedes P. Jacobson, MD	The institution of Dr. Jacobson has received research support from Engage. The institution of Dr. Jacobson has received research support from XENON. The institution of Dr. Jacobson has received research support from SK Life Sciences.
Richard A. Macdonell, MD, FAAN	Dr. Macdonell has nothing to disclose.
Fabrizio Giuliani, MD	Dr. Giuliani has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Giuliani has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Hoffman-LaRoche. The institution of Dr. Giuliani has received research support from Canadian Institute of Health Research. The institution of Dr. Giuliani has received research support from University of Alberta Hospital Foundation. The institution of Dr. Giuliani has received research support from Hoffman-LaRoche. The institution of Dr. Giuliani has received research support from Novartis.
Natalia Murinova, MD, FAAN	Dr. Murinova has nothing to disclose.
Jung E Park, MD, PhD	No disclosure on file
Maria Pilar Sanchez de Paz	No disclosure on file
Peter Lynch	No disclosure on file
Luca Marsili, MD, PhD	Dr. Marsili has received personal compensation in the range of $500-$4,999 for serving as a Consultant for IAPRD. Dr. Marsili has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Acadia.
Paul C. Chang, MD	No disclosure on file
Brittany L. Heckel, MD	Dr. Heckel has nothing to disclose.
Neena Cherayil, MD	Dr. Cherayil has nothing to disclose.
Robert Davis	No disclosure on file
Tasneem F. Hasan, MD	Dr. Hasan has nothing to disclose.
Sally I. Othman	No disclosure on file
Christopher Melinosky, MD	Dr. Melinosky has nothing to disclose.
Morgan Jordan, DO	Dr. Jordan has nothing to disclose.
Ellen Michelle Gibson, MD	Dr. Gibson has nothing to disclose.
Sabeena I. Malik, MD	Dr. Malik has nothing to disclose.
Maria Jeleva	Maria Jeleva has received personal compensation for serving as an employee of Impel NeuroPharma.
Popianna Tsiortou	Popianna Tsiortou has nothing to disclose.
Mya C. Schiess, MD, FAAN	Dr. Schiess has nothing to disclose.
Benjamin H. Eidelman, MB, FAAN	Dr. Eidelman has nothing to disclose.
Mirjam Korporal-Kuhnke, MD	Dr. Korporal-Kuhnke has nothing to disclose.
H.-Christian C. von Büdingen, MD, FAAN	Dr. von Büdingen has received personal compensation for serving as an employee of F. Hoffmann-La Roche Ltd. Dr. von Büdingen has stock in F. Hoffmann-La Roche Ltd.
Simon Borghs	No disclosure on file
Josephine F. Huang, MD	Dr. Huang has nothing to disclose.
Sofia Akrivou	No disclosure on file
Robert K Heaton	The institution of Robert K Heaton has received research support from NIH. Robert K Heaton has received intellectual property interests from a discovery or technology relating to health care. Robert K Heaton has received intellectual property interests from a discovery or technology relating to health care.
Michaela H. Schwaiblmair	No disclosure on file
Ali Basher Alanazi, MD, FAAN	Dr. Alanazi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pfizer. Dr. Alanazi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Jamjoom Pharma .
Matthew Varon, MD	Dr. Varon has nothing to disclose.
Ahmer Asif, MD	Dr. Asif has nothing to disclose.
Gregory W. Albers, MD	No disclosure on file
Elena Ratti, MD	Dr. Ratti has received personal compensation for serving as an employee of Takeda. Dr. Ratti has received personal compensation for serving as an employee of Biogen. Dr. Ratti has stock in Takeda. Dr. Ratti has stock in Biogen.
Prerak Juthani	Mr. Juthani has nothing to disclose.
Brett C. Meyer, MD	Dr. Meyer has received personal compensation in the range of $0-$499 for serving as a Consultant for Sevaro Health. An immediate family member of Dr. Meyer has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Chiesi.
Hideto Nakajima, MD	No disclosure on file
Sven O. Jarius, MD	Dr. Jarius has nothing to disclose.
Anne R. Davis, MD	Dr. Davis has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Exeltis. Dr. Davis has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Mylan . Dr. Davis has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for ACLU. Dr. Davis has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Planned Parenthood Federation of America .
Timothy M. Ellmore, PhD	Prof. Ellmore has nothing to disclose.
Machteld E. Hillen, MD, FAAN	The institution of Dr. Hillen has received research support from Genentech.
Adam MacLellan, MD, BSch	No disclosure on file
Nitin Goyal, MD	No disclosure on file
Matthew Schrag, MD	No disclosure on file
Hyungsub Shim	No disclosure on file
Mohammad K. Ali, MD	No disclosure on file
Saloua Mrabet, MD	Dr. Mrabet has nothing to disclose.
Yazan Radaideh, MD	No disclosure on file
Ankur Bhargava, MD	No disclosure on file
Ahmed A. Alqahtani	No disclosure on file
Ephraim Hochberg	No disclosure on file
Jorge D. Correale, MD	Dr. Correale has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Correale has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Dr. Correale has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Correale has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Correale has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi-Genzyme. Dr. Correale has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ROche. Dr. Correale has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Dr. Correale has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Correale has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Correale has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi-Genzyme. The institution of Dr. Correale has received research support from Merck. The institution of Dr. Correale has received research support from Biogen. The institution of Dr. Correale has received research support from Novartis .
Paul Maruff, PhD	Dr. Maruff has received personal compensation for serving as an employee of Cogstate .
Patrick Cossette, MD	No disclosure on file
Camila Pupe, MD	Dr. Pupe has nothing to disclose.
Luis F. Maia	No disclosure on file
Umer Akbar, MD	Dr. Akbar has received personal compensation in the range of $500-$4,999 for serving as a Consultant for LANGaware.
Amelia K. Boehme, PhD	Dr. Boehme has nothing to disclose.
Charles F. Spurlock III, PhD	Dr. Spurlock has received personal compensation for serving as an employee of Decode Health. Dr. Spurlock has received personal compensation for serving as an employee of New York University. Dr. Spurlock has received personal compensation for serving as an employee of IQuity Labs. Dr. Spurlock has stock in Decode Health. Dr. Spurlock has stock in IQuity Labs. The institution of Dr. Spurlock has received research support from National Institutes of Health.
Gabriela Tantillo, MD	Dr. Tantillo has received personal compensation in the range of $500-$4,999 for serving as a faculty honorarium for educational symposium with American Epilepsy Society.
Christos J. Petropoulos, PhD	Dr. Petropoulos has received personal compensation for serving as an employee of Labcorp-Monogram Biosciences. Dr. Petropoulos has stock in Laboratory Corporation of America Holdings. Dr. Petropoulos has received intellectual property interests from a discovery or technology relating to health care.
Clemens Goedel, MD	Dr. Goedel has nothing to disclose.
Victor Mantelatto Bonsi	Victor Mantelatto Bonsi has nothing to disclose.
Kevin Nolasco	Kevin Nolasco has nothing to disclose.
Henry J. Kaminski, MD, FAAN	Dr. Kaminski has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Dr. Kaminski has received personal compensation in the range of $0-$499 for serving as a Consultant for Cabaletta Bio. The institution of Dr. Kaminski has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Dr. Kaminski has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Canopy Immunotherapeutics. Dr. Kaminski has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Curie.bio. Dr. Kaminski has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Samsung. Dr. Kaminski has received personal compensation in the range of $0-$499 for serving as a Consultant for Care Constitution. Dr. Kaminski has stock in mimivax. The institution of Dr. Kaminski has received research support from National Institutes of Health. Dr. Kaminski has received publishing royalties from a publication relating to health care.
Robert Zivadinov, MD, PhD, FAAN	The institution of Dr. Zivadinov has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BMS. The institution of Dr. Zivadinov has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Omnicuris. The institution of Dr. Zivadinov has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Myrobalan. Dr. Zivadinov has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi. Dr. Zivadinov has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for EMD Serono. Dr. Zivadinov has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Bristol Myers Squibb. The institution of Dr. Zivadinov has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Biogen.
Ken Uchino, MD	Dr. Uchino has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Aboott Laboratories, Inc.. Dr. Uchino has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for ACP JOURNAL CLUB. The institution of Dr. Uchino has received research support from NIH.
Damiano Paolicelli	Damiano Paolicelli has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck Serono. Damiano Paolicelli has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi.
David Z. Rose, MD	Dr. Rose has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Boston Scientific. Dr. Rose has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Chiesi USA. Dr. Rose has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Medtronic. Dr. Rose has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Boehringer Ingelheim . Dr. Rose has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for CSL-Behring .
Okeanis Vaou, MD, FAAN	Dr. Vaou has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for ABBVIE. Dr. Vaou has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abbvie. Dr. Vaou has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Medtronic . Dr. Vaou has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for medtronic. An immediate family member of Dr. Vaou has stock in SAGE. The institution of Dr. Vaou has received research support from Medtronic.
David Leppert, MD	Dr. Leppert has received personal compensation for serving as an employee of GeNeuro. Dr. Leppert has received personal compensation for serving as an employee of GeNeuro. Dr. Leppert has received personal compensation for serving as an employee of Geneuro. Dr. Leppert has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Leppert has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Roche. Dr. Leppert has received personal compensation in the range of $0-$499 for serving as a Consultant for Orion. Dr. Leppert has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi. Dr. Leppert has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Quanterix. Dr. Leppert has stock in Novartis.
Roop Gursahani, MD, FAAN	Dr. Gursahani has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for DR REDDY'S LABS.
Stacy C. Brown, MD	Dr. Brown has nothing to disclose.
Robert C. Stowe, MD	Dr. Stowe has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Neurocrine Biosciences. Dr. Stowe has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Takeda Pharmaceuticals. Dr. Stowe has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Kherkher Garcia, LLP.
Julia Klein, NP	An immediate family member of Ms. Klein has received personal compensation for serving as an employee of Amgen. An immediate family member of Ms. Klein has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Amgen.
Ashmanie Mahatoo, MD	No disclosure on file
Lisa K. Peterson, PhD	Dr. Peterson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Werfen. Dr. Peterson has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Werfen. Dr. Peterson has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AliveDx. Dr. Peterson has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Clinical Biochemistry. Dr. Peterson has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Lab Q for ASCP. Dr. Peterson has a non-compensated relationship as a President with Association of Medical Laboratory Immunologists that is relevant to AAN interests or activities.
Reyna M. Duron, MD	No disclosure on file
Ilana Green, MD	Dr. Green has nothing to disclose.
Philipp Karschnia	Philipp Karschnia has nothing to disclose.
Edgar Carnero Contentti	Edgar Carnero Contentti has nothing to disclose.
Nada Ahmed, MD	Dr. Ahmed has nothing to disclose.
Lithey Poveda	No disclosure on file
Michael Comisac III	Mr. Comisac has nothing to disclose.
Maria A. Vera, MD	Dr. Vera Silva has nothing to disclose.
Sun Ju Chung, MD, PhD, FAAN	Dr. Chung has nothing to disclose.
Igor Grant, MD	No disclosure on file
Sudha Seshadri, MD, FAAN	Dr. Seshadri has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eisai. Dr. Seshadri has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. The institution of Dr. Seshadri has received research support from NIH. The institution of Dr. Seshadri has received research support from Alzheimer Association.
Rakesh Khatri, MD, FAAN	Dr. Khatri has received personal compensation in the range of $0-$499 for serving as a Survey consultant with Alpha insight . Dr. Khatri has received personal compensation in the range of $0-$499 for serving as a Survey consultant with Survey company .
Subramaniam Sriram, MD	Dr. Sriram has nothing to disclose.
Samia J. Khoury, MD, FAAN	Dr. Khoury has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merk. Dr. Khoury has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Khoury has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for ANA. Dr. Khoury has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Clinical Immunology. The institution of Dr. Khoury has received research support from MENACTRIMS. The institution of Dr. Khoury has received research support from NMSS. The institution of Dr. Khoury has received research support from Office of Naval Research USA. An immediate family member of Dr. Khoury has received intellectual property interests from a discovery or technology relating to health care.
Catherine Lomen-Hoerth, MD, PhD, FAAN	Dr. Lomen-Hoerth has nothing to disclose.
Michael J. Polydefkis, MD, FAAN	Dr. Polydefkis has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alnylam Pharmaceuticals. Dr. Polydefkis has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Akcea. Dr. Polydefkis has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Vertex Pharmaceutical . Dr. Polydefkis has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen-Idec. Dr. Polydefkis has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Pfizer.
Anna D. Hohler, MD, FAAN	Dr. Hohler has nothing to disclose.
Scott L. Letendre, MD	The institution of Dr. Letendre has received research support from National Institutes of Health. The institution of Dr. Letendre has received research support from University at Buffalo. Dr. Letendre has received publishing royalties from a publication relating to health care.
Gustavo J. Rodriguez, MD	Dr. Rodriguez has nothing to disclose.
Darine Kassar, MD	Dr. Kassar has nothing to disclose.
Anila Thomas, MD	Dr. Thomas has nothing to disclose.
Ugonma N. Chukwueke, MD	Dr. Chukwueke has nothing to disclose.
Patricia Pozo-Rosich, MD, PhD	Dr. Pozo-Rosich has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for AbbVie. Dr. Pozo-Rosich has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Teva Pharmaceuticals. Dr. Pozo-Rosich has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lundbeck. Dr. Pozo-Rosich has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Pfizer. Dr. Pozo-Rosich has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Organon. Dr. Pozo-Rosich has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Dr. Reddy's. Dr. Pozo-Rosich has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Sociedad Española Neurologia.
Mallory N. Luckey, MD	Dr. Roberts has nothing to disclose.
Supriya Kairamkonda, MD	No disclosure on file
Nicholas Capaldo	No disclosure on file
Malcolm Horne	No disclosure on file
Jonah Fox, MD	No disclosure on file
Argirios Moustakas, MD	No disclosure on file
Kelley Humbert, MD	Dr. Humbert has nothing to disclose.
Kasser Saba, MD	Dr. Saba has nothing to disclose.
Michael Todinca, MD	Dr. Todinca has nothing to disclose.
Arthur E. Warrington, PhD	No disclosure on file
Gopika Hari	No disclosure on file
Tao Qin	No disclosure on file
Stuart H. Isaacson, MD, FAAN	The institution of Dr. Isaacson has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Acadia. The institution of Dr. Isaacson has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sunovion. The institution of Dr. Isaacson has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for acorda. The institution of Dr. Isaacson has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Supernus. The institution of Dr. Isaacson has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Neurocrine. The institution of Dr. Isaacson has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Kyowa. The institution of Dr. Isaacson has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for adamas. The institution of Dr. Isaacson has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Lundbeck. The institution of Dr. Isaacson has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Teva. The institution of Dr. Isaacson has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Neuroderm. The institution of Dr. Isaacson has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Abbvie. The institution of Dr. Isaacson has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for amneal. Dr. Isaacson has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Teva. Dr. Isaacson has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Neurocrine. Dr. Isaacson has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for adamas. Dr. Isaacson has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Lundbeck. Dr. Isaacson has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Supernus. Dr. Isaacson has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Acadia. Dr. Isaacson has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Acorda. Dr. Isaacson has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Amneal. Dr. Isaacson has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Abbvie.
Aksel Siva, MD	Dr. Siva has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Siva has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Siva has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi-Genzyme. Dr. Siva has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen - TR. Dr. Siva has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. Siva has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ali Raif Pharmaceuticals, Turkiye. Dr. Siva has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanovel Pharmaceuticals, Turkiye. Dr. Siva has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Siva has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abdi Ibrahim Ilac - TR. Dr. Siva has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck Serono . The institution of Dr. Siva has received research support from Turkish MS Society. The institution of Dr. Siva has received research support from The Scientific and Technological Research Council Of Turkey - Health Sciences Research Grants.
John F. Rothrock, MD	Dr. Rothrock has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie. Dr. Rothrock has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for AbbVie. Dr. Rothrock has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Lundbeck. The institution of Dr. Rothrock has received research support from AbbVie. The institution of Dr. Rothrock has received research support from Ipsen. The institution of Dr. Rothrock has received research support from Lundbeck.
Siobhan Hutchinson, MD	Dr. Hutchinson has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Hutchinson has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Teva. Dr. Hutchinson has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Teva.
Sachin Agarwal, MD, MPH	Dr. Agarwal has nothing to disclose.
Andrea Boon, MD	Dr. Boon has received personal compensation in the range of $500-$4,999 for serving as a Consultant for HPE cosmetics .
Jonathan Howard, MD	Dr. Howard has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for MCE Conferences. Dr. Howard has received publishing royalties from a publication relating to health care. Dr. Howard has received publishing royalties from a publication relating to health care. Dr. Howard has received publishing royalties from a publication relating to health care. Dr. Howard has a non-compensated relationship as a Test writer with ABPN that is relevant to AAN interests or activities.
Sabahattin Saip	Sabahattin Saip has nothing to disclose.
Traci Aladeen, PharmD	Dr. Aladeen has nothing to disclose.
Chad J. Stuckey, MD	No disclosure on file
Neil Mehdiratta, MD	No disclosure on file
Laura Qi, MD	No disclosure on file
James R. Ghattas, DO	No disclosure on file
Sama Astani, MD	Dr. Astani has nothing to disclose.
Molly Knox, MD	Dr. Knox has nothing to disclose.
Rucha Bahekar, MBBS	Dr. Bahekar has nothing to disclose.
Thiago A. Rodrigues, MD	Dr. Rodrigues has nothing to disclose.
David M. Biondi, DO, FAAN	Dr. Biondi has received personal compensation for serving as an employee of Cohen Veterans Bioscience, Inc. Dr. Biondi has received personal compensation for serving as an employee of Alder Biopharmaceuticals, Inc. Dr. Biondi has received stock or an ownership interest from Johnson & Johnson . The institution of Dr. Biondi has received research support from US Department of Defense .
Ronald J. Ellis, MD, PhD, FAAN	Dr. Ellis has nothing to disclose.
Eric S. Farbman, MD, FAAN	Dr. Farbman has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Supernus. Dr. Farbman has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Teva. Dr. Farbman has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Acorda.
Luanne Metz, MD	The institution of Dr. Metz has received research support from Multiple Sclerosis Society of Canada. The institution of Dr. Metz has received research support from Calgary Health Trust. The institution of Dr. Metz has received research support from Government of Alberta.
Alyx B. Porter, MD, FAAN	Dr. Porter has a non-compensated relationship as a Board Member with American Brain Foundation that is relevant to AAN interests or activities.
Delaram Safarpour, MD, MSCE, FAAN	Dr. Safarpour has received personal compensation in the range of $500-$4,999 for serving as a Consultant for 2nd MD. Dr. Safarpour has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Boston Scientific. Dr. Safarpour has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Medtronic. Dr. Safarpour has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Insightec. Dr. Safarpour has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for BlueRock. Dr. Safarpour has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Acadia. Dr. Safarpour has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Boston Scientific. The institution of Dr. Safarpour has received research support from Medtronic. The institution of Dr. Safarpour has received research support from Amneal. The institution of Dr. Safarpour has received research support from CND life science.
Aditi V. Varma-Doyle, MD	Dr. Varma-Doyle has nothing to disclose.
Demelio A. Urbano	Mr. Urbano has nothing to disclose.
Matthew Frigault	No disclosure on file
Sihui Zhao	No disclosure on file
Cheryl H. Waters, MD, FAAN	Dr. Waters has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Acadia. Dr. Waters has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Kyowa. Dr. Waters has received personal compensation in the range of $500-$4,999 for serving as a Consultant for US world meds. Dr. Waters has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexza. Dr. Waters has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Acorda. Dr. Waters has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Acadia. Dr. Waters has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Neurocrine. Dr. Waters has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Bial. Dr. Waters has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for US world meds. Dr. Waters has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Lundbeck. Dr. Waters has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Adamas. Dr. Waters has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sunovion. Dr. Waters has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Amneal.
Amit Bar-Or, MD, FRCPC	Dr. Bar-Or has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche Genentech. Dr. Bar-Or has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Bar-Or has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Bar-Or has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merk/EMD Serono. Dr. Bar-Or has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi-Genzyme. Dr. Bar-Or has received personal compensation in the range of $500-$4,999 for serving as a Consultant for cabaletta. Dr. Bar-Or has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche/Genentech. Dr. Bar-Or has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Bar-Or has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck/EMD Serono. Dr. Bar-Or has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi/Genzyme. The institution of Dr. Bar-Or has received research support from Novartis. The institution of Dr. Bar-Or has received research support from Biogen. The institution of Dr. Bar-Or has received research support from Roche/Genentech.
David L. Gordon, MD, FAHA, FANA, FAAN	Dr. Gordon has nothing to disclose.
Michael Cartwright, MD	Dr. Cartwright has received publishing royalties from a publication relating to health care.
Yang Mao-Draayer, MD	Dr. Mao-Draayer has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen Idec. Dr. Mao-Draayer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genzyme-Sanofi. Dr. Mao-Draayer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Dr. Mao-Draayer has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genzyme-Sanofi. Dr. Mao-Draayer has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Mao-Draayer has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizone. Dr. Mao-Draayer has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen Idec. The institution of Dr. Mao-Draayer has received research support from NIH .
Yuko Shimizu, MD, PhD	Dr. Shimizu has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Biogen Japan.. Dr. Shimizu has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Novartis Pharma. Dr. Shimizu has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Chigai Pharma CoLtd.
Muriel Stoppe	Muriel Stoppe has nothing to disclose.
Recai Turkoglu	Recai Turkoglu has nothing to disclose.
Giuliana Petri	No disclosure on file
Shefali Dujari, MD	Dr. Dujari has nothing to disclose.
Samer Riaz, DO	No disclosure on file
Owais Khadem Alsrouji, MD	No disclosure on file
Paul J. Maccabee, MD	No disclosure on file
Haley Huggins, MD	Dr. Huggins has nothing to disclose.
Sonya E. Zhou, MD	Sonya Zhou has nothing to disclose.
Sidney Hinds, MD, FAAN	An immediate family member of Dr. Hinds has received personal compensation for serving as an employee of Henry Jackson Foundation. Dr. Hinds has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Otolith. Dr. Hinds has received personal compensation in the range of $500-$4,999 for serving as a Consultant for ICON. Dr. Hinds has received personal compensation in the range of $500-$4,999 for serving as a Consultant for The Conafay Group. Dr. Hinds has received research support from Uniformed Service University. Dr. Hinds has received personal compensation in the range of $500-$4,999 for serving as a Panel member with Congressionally Directed Medical Research Program. Dr. Hinds has a non-compensated relationship as a Ex Offcio Board member with NINDS/NANDS that is relevant to AAN interests or activities.
Anand R. Shewale	Anand R. Shewale has received personal compensation for serving as an employee of AbbVie. Anand R. Shewale has stock in AbbVie.
Diaa Hamouda	No disclosure on file
Shayan A. Gates, DO	No disclosure on file
Tanya Geist, PA	No disclosure on file
Matthew Gusler, DO	Dr. Gusler has nothing to disclose.
Raghad Alharthi	No disclosure on file
Scott Vota, DO, FAAN	No disclosure on file
Panayiotis Mitsias, MD	The institution of Dr. Mitsias has received research support from European Union.
Anna Marin	Mrs. Marin has nothing to disclose.
Esau G. Mbewe	Esau G. Mbewe has received research support from Research was supported by the National Institute Of Neurological Disorders And Stroke of the National Institutes of Health under Award Number K23NS117310. .
Gretchen L. Birbeck, MD, MPH, DTMH, FAAN	An immediate family member of Dr. Birbeck has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Various. Dr. Birbeck has a non-compensated relationship as a Ambassador for Zambia with RSTMH that is relevant to AAN interests or activities.
Kevin R. Chysna, MD	No disclosure on file
Christa B. Swisher, MD	Dr. Swisher has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for UCB.
Saima Chaudhry, MD	Dr. Chaudhry has nothing to disclose.
Alexandria E. Matic, MD	No disclosure on file
Jimmy Suh, MD	Dr. Suh has received publishing royalties from a publication relating to health care.
Thanujaa Subramaniam, MD	Dr. Subramaniam has nothing to disclose.
Ahmad Mahadeen, MD	Dr. Mahadeen has nothing to disclose.
Owen Dean	No disclosure on file
Mark J. Kelly, MBBS	The institution of Dr. Kelly has received research support from The Health Research Board / Wellcome Trust.
Glenn Lopate, MD	Dr. Lopate has nothing to disclose.
Florian Hatz, MD	No disclosure on file
Stefan Bittner	Stefan Bittner has received personal compensation in the range of $500-$4,999 for serving as a Honoria with Biogen Idec. Stefan Bittner has received personal compensation in the range of $500-$4,999 for serving as a Honoria with Merck Healthcare. Stefan Bittner has received personal compensation in the range of $500-$4,999 for serving as a Honoria with Novartis. Stefan Bittner has received personal compensation in the range of $500-$4,999 for serving as a Honoria with Roche. Stefan Bittner has received personal compensation in the range of $500-$4,999 for serving as a Honoria with Sanofi. Stefan Bittner has received personal compensation in the range of $500-$4,999 for serving as a Honoria with Bristol-Meyer-Squibbs. Stefan Bittner has received personal compensation in the range of $500-$4,999 for serving as a Honoria with Teva.
Janice Wong, MD	Dr. Wong has received personal compensation for serving as an employee of Janssen Research & Development. Dr. Wong has received personal compensation for serving as an employee of Biogen. Dr. Wong has stock in Biogen. Dr. Wong has stock in Janssen Research & Development.
Amy Chan, MD	Dr. Chan has nothing to disclose.
Roshni A. Patel, MD	Dr. Patel has nothing to disclose.
Muhammad Niazi, MD	No disclosure on file
Dipen P. Sangurdekar, PhD	No disclosure on file
Iris Martinez	Iris Martinez has nothing to disclose.
Vinothkumar Rajendran	Mr. Rajendran has nothing to disclose.
Juan Pablo Ospina Botero, MD	No disclosure on file
Justin Hoskin, MD	Dr. Hoskin has nothing to disclose.
Rohit Swarnkar, MD	No disclosure on file
Leah Zuroff, MD	Dr. Zuroff has received personal compensation in the range of $500-$4,999 for serving as a Speaker with EMD Serono.
Celine Leung, DO	No disclosure on file
Anke Post	No disclosure on file
Elizabeth Herries	No disclosure on file
Karl D. Kieburtz, MD	Dr. Kieburtz has received personal compensation for serving as an employee of Clintrex Research Corporation. Dr. Kieburtz has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Kieburtz has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lilly. Dr. Kieburtz has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Janssen. Dr. Kieburtz has stock in Clintrex Research Corp. Dr. Kieburtz has stock in Hoover Brown. An immediate family member of Dr. Kieburtz has stock in Hoover Brown. Dr. Kieburtz has stock in Safe Therapeutics. The institution of Dr. Kieburtz has received research support from NIH. The institution of Dr. Kieburtz has received research support from Michae J Fox Foundation.
Joel I. Shenker, MD, PhD, FAAN	Dr. Shenker has received personal compensation for serving as an employee of R3 continuum. Dr. Shenker has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for attorneys.
Robert G. Holloway, MD, MPH, FAAN	Dr. Holloway has nothing to disclose.
Frauke Zipp, MD	Dr. Zipp has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Celgene. Dr. Zipp has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Janssen. Dr. Zipp has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Octapharma. Dr. Zipp has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Dr. Zipp has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Zipp has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TEVA. The institution of Dr. Zipp has received research support from BMBF. The institution of Dr. Zipp has received research support from DFG. The institution of Dr. Zipp has received research support from PMSA. The institution of Dr. Zipp has received research support from Sanofi Genzyme. The institution of Dr. Zipp has received research support from UCB. The institution of Dr. Zipp has received research support from Eisai. The institution of Dr. Zipp has received research support from SK Life Science. The institution of Dr. Zipp has received research support from Abbott. The institution of Dr. Zipp has received research support from Actelion. The institution of Dr. Zipp has received research support from Bayer. The institution of Dr. Zipp has received research support from Servier. Dr. Zipp has received personal compensation in the range of $500-$4,999 for serving as a Reviewer with Novartis. Dr. Zipp has received personal compensation in the range of $0-$499 for serving as a Reviewer with Universite de Geneve. Dr. Zipp has received personal compensation in the range of $5,000-$9,999 for serving as a Reviewer with Oppenheim Förderpreis für Multiple Sklerose. Dr. Zipp has received personal compensation in the range of $500-$4,999 for serving as a Reviewer with EKFS. Dr. Zipp has a non-compensated relationship as a Associate Editor with Brain that is relevant to AAN interests or activities. Dr. Zipp has a non-compensated relationship as a Advisor with Science Translational Medicine that is relevant to AAN interests or activities.
Peter Fuhr, MD, FAAN	The institution of Dr. Fuhr has received research support from Roche.
Shingo Konno, MD	Dr. Konno has nothing to disclose.
Raffaele Iorio, MD	Dr. Iorio has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Iorio has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenx. Dr. Iorio has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. Dr. Iorio has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Dianthus Therapeutics. Dr. Iorio has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Johnson & Johnson. Dr. Iorio has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amgen. Dr. Iorio has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion. Dr. Iorio has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Argenx. Dr. Iorio has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Johnson&Johnson.
Sandeep S. Rana, MD, FAAN	Dr. Rana has received personal compensation in the range of $500-$4,999 for serving as a Consultant for CSI. Dr. Rana has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Pharmawrite. Dr. Rana has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biohaven. Dr. Rana has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Argenx. Dr. Rana has received personal compensation in the range of $500-$4,999 for serving as a Consultant for amylyx. Dr. Rana has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion.
Emily J. Gilmore, MD	Dr. Gilmore has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for carpl.ai. Dr. Gilmore has received personal compensation in the range of $0-$499 for serving as a Consultant for AAN. Dr. Gilmore has received research support from NIH.
V. Wee Yong	No disclosure on file
Adil Iqbal, MD	No disclosure on file
Joshua Santucci, MD	Dr. Santucci has nothing to disclose.
G.M. Terwindt	G.M. Terwindt has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis, Teva, Allergan, Lilly, Lundbeck. The institution of G.M. Terwindt has received research support from Dutch Research Council, Dutch Brain Council, IRRF, Dioraphte.
Carlos F. Muniz, MD	Dr. Muniz has received intellectual property interests from a discovery or technology relating to health care.
Chris Hollen, MD	Dr. Hollen has nothing to disclose.
Oluwatosin Akintola, MD	Dr. Akintola has nothing to disclose.
Andrew Dhawan, MD	Dr. Dhawan has nothing to disclose.
Natalie Thom	Ms. Thom has nothing to disclose.
Nicholas P. Constant	No disclosure on file
Ronald Takvorian	No disclosure on file
Stephen D. Silberstein, MD, FAAN	Dr. Silberstein has received publishing royalties from a publication relating to health care.
Jeremy Moeller, MD, FAAN	Dr. Moeller has received publishing royalties from a publication relating to health care.
Pelekelo Kabundula	Pelekelo Kabundula has nothing to disclose.
Daniele Bravi, MD	No disclosure on file
Catherine Salussolia, MD, PhD	No disclosure on file
Marina Kushnirsky, MD	Dr. Kushnirsky has nothing to disclose.
Nadia N. Bowling, MD	No disclosure on file
Gregorio Spagni	Gregorio Spagni has nothing to disclose.
Martha Moyano	Martha Moyano has nothing to disclose.
Cole D. Stang	Mr. Stang has nothing to disclose.
Erin K. O'Ferrall, MD	The institution of Dr. O'Ferrall has received research support from Sanofi Genzyme. The institution of Dr. O'Ferrall has received research support from Harmony Biosciences. The institution of Dr. O'Ferrall has received research support from Fulcrum Therapeutics. The institution of Dr. O'Ferrall has received research support from Roche Pharmaceuticals. The institution of Dr. O'Ferrall has received research support from VERTEX. The institution of Dr. O'Ferrall has received research support from Novartis. Dr. O'Ferrall has received publishing royalties from a publication relating to health care.
Michael Schwarzschild, MD, PhD	The institution of Dr. Schwarzschild has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bial Biotech (indirectly, as a service of the Parkinson Study Group service). The institution of Dr. Schwarzschild has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen (indirectly, as a service of the Parkinson Study Group service). The institution of Dr. Schwarzschild has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for UCB (indirectly, as a service of the Parkinson Study Group service). Dr. Schwarzschild has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eli Lilly. The institution of Dr. Schwarzschild has received research support from NIH. The institution of Dr. Schwarzschild has received research support from Parkinson's Foundation. The institution of Dr. Schwarzschild has received research support from Michael J Fox Foundation. The institution of Dr. Schwarzschild has received research support from Farmer Family Foundation. Dr. Schwarzschild has a non-compensated relationship as a Chair, Executive Committee with the Parkinson Study Group that is relevant to AAN interests or activities.
Valentina Damato	Valentina Damato has nothing to disclose.
Deepmala Nandanwar, MD	Dr. Nandanwar has nothing to disclose.
Paul Van Donkelaar	No disclosure on file
Kelsey Bryk, MSc	No disclosure on file
Gustavo E. Ramos, MD	Dr. Ramos has nothing to disclose.
Larsson Omberg	Larsson Omberg has nothing to disclose.
Cindy Beltran	No disclosure on file
Rahul H. Rahangdale, MD	Dr. Rahangdale has nothing to disclose.
Umar A. Shuaib, MBBS	Dr. Shuaib has nothing to disclose.
Lisa Brown, ScD	No disclosure on file
Dana B. Harrar, MD	The institution of Dr. Harrar has received research support from NIH. Dr. Harrar has received publishing royalties from a publication relating to health care.
Juan Francisco Idiaquez, Jr., MD	No disclosure on file
Aditya V. Boddu, MD	Dr. Boddu has nothing to disclose.
Magdalena Stepien, MD	No disclosure on file
Alexandra Buda	Ms. Buda has nothing to disclose.
Amir A. Mbonde, MD	Dr. Mbonde has nothing to disclose.
Shawn Allen, MD	Dr. Allen has nothing to disclose.
Richard Butterfield	No disclosure on file
Ashley Petrone	No disclosure on file
Bart Demaerschalk, MD, MSc, FRCPC, FAAN	Dr. Demaerschalk has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Dr. Demaerschalk has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Shionogi. Dr. Demaerschalk has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for The Neurologist . The institution of Dr. Demaerschalk has received research support from NICHD.
Stephen B. Shrewsbury, MD	Dr. Shrewsbury has received personal compensation for serving as an employee of Impel NeuroPharma. Dr. Shrewsbury has received stock or an ownership interest from Impel NeuroPharma.
Philip De Jager, MD, PhD	Dr. De Jager has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Puretech. Dr. De Jager has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for roche. Dr. De Jager has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for biogen. The institution of Dr. De Jager has received research support from roche. The institution of Dr. De Jager has received research support from puretech.
Iram Zaman, DO, FAAN	Dr. Zaman has nothing to disclose.
Huw R. Morris, MD, PhD	Dr. Morris has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Morris has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Aprinoia. Dr. Morris has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Morris has received personal compensation in the range of $50,000-$99,999 for serving as an Expert Witness for Personal injury / Negligence cases. The institution of Dr. Morris has received research support from Parkinson's UK. The institution of Dr. Morris has received research support from Michael J Fox Foundartion. The institution of Dr. Morris has received research support from Cure Parkinson's Trust. The institution of Dr. Morris has received research support from PSP Association. The institution of Dr. Morris has received research support from CBD Solutions. The institution of Dr. Morris has received research support from Drake Foundation. The institution of Dr. Morris has received research support from Medical Research Council. Dr. Morris has received intellectual property interests from a discovery or technology relating to health care. Dr. Morris has a non-compensated relationship as a Scientific Advisory Board with Cure PSP that is relevant to AAN interests or activities. Dr. Morris has a non-compensated relationship as a Scientific Advisory Board with Parkinson's UK that is relevant to AAN interests or activities.
Jacqueline Rick	No disclosure on file
Warren P. Mason, MD, FAAN	Dr. Mason has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novocure. Dr. Mason has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Dr. Mason has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Servier. Dr. Mason has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Boeringher Ingelheim. Dr. Mason has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Ono Therapeutics.
Jignesh J. Shah, MD	No disclosure on file
Pierpaolo Turcano, MD	Dr. Turcano has nothing to disclose.
Victor Lira, MD	No disclosure on file
Caroline L. Medeiros, Jr., MD	Dr. Medeiros has nothing to disclose.
Julie Benavides	Julie Benavides has nothing to disclose.
Elizabeth Rappa	No disclosure on file
Andrew G. Herzog, MD, MSc, FAAN	Dr. Herzog has nothing to disclose.
David C. Tong, MD, FAHA	No disclosure on file
James F. Meschia, MD, FAAN	The institution of Dr. Meschia has received research support from NINDS. The institution of Dr. Meschia has received research support from NINDS.
Vittorio Martinelli	Dr. Martinelli has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis, Biogen, Sanofi Genzyme, TEVA and Merck. Dr. Martinelli has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck .
Peter B. Forgacs, MD	Dr. Forgacs has received personal compensation for serving as an employee of Xenon Pharmaceuticals. Dr. Forgacs has or had stock in Xenon Pharmaneuticals.
Nimish Thakore, MD	No disclosure on file
Dalia Rotstein, MD	Dr. Rotstein has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. The institution of Dr. Rotstein has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Rotstein has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis. Dr. Rotstein has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amgen/Horizon . Dr. Rotstein has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion . Dr. Rotstein has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Rotstein has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi Aventis. Dr. Rotstein has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis . Dr. Rotstein has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono. Dr. Rotstein has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Dr. Rotstein has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Alexion . Dr. Rotstein has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Dr. Rotstein has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Amgen. The institution of Dr. Rotstein has received research support from MS Canada. The institution of Dr. Rotstein has received research support from National MS Society. Dr. Rotstein has received research support from Li Ka Shing Knowledge Institute. The institution of Dr. Rotstein has received research support from University of Toronto Division of Neurology. The institution of Dr. Rotstein has received research support from Canada's Drug Agency. The institution of Dr. Rotstein has received research support from Amgen. The institution of Dr. Rotstein has received research support from Alexion. The institution of Dr. Rotstein has received research support from Guthy Jackson Foundation .
Peyman Shirani, MD	No disclosure on file
Danielle M. Andrade, MD	The institution of Dr. Andrade has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Dr. Andrade has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Jazz Pharmaceutical. The institution of Dr. Andrade has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Stoke Therapeutics. The institution of Dr. Andrade has received research support from Epilepsy Canada. The institution of Dr. Andrade has received research support from SynGAP Research Fund. Dr. Andrade has received publishing royalties from a publication relating to health care. Dr. Andrade has a non-compensated relationship as a Former Chair of task force on Transition with International League Against Epilepsy that is relevant to AAN interests or activities. Dr. Andrade has a non-compensated relationship as a President with Canadian League Against Epilepsy that is relevant to AAN interests or activities.
Ashkan Mowla, MD, FAAN	No disclosure on file
Ryotaro Ikeguchi	Ryotaro Ikeguchi has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Chugai Pharmaceutical Co., Ltd.. Ryotaro Ikeguchi has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis Pharma K.K.. Ryotaro Ikeguchi has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Mitsubishi Tanabe Pharma Corporation. Ryotaro Ikeguchi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for argenx Japan K.K.. Ryotaro Ikeguchi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion Pharma GK. Ryotaro Ikeguchi has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Chugai Pharmaceutical Co., Ltd.. Ryotaro Ikeguchi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Mitsubishi Tanabe Pharma Corporation. Ryotaro Ikeguchi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for UCB Japan Co., Ltd.. Ryotaro Ikeguchi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis Pharma K.K.. Ryotaro Ikeguchi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen Japan Ltd..
Mahnaz Asgharnejad, PharmD	Mahnaz Asgharnejad, PharmD has received personal compensation for serving as an employee of Takeda Pharmaceuticals. Mahnaz Asgharnejad, PharmD has stock in GlaxoSmithKline. Mahnaz Asgharnejad, PharmD has stock in Takeda Pharmaceuticals.
Anusha Yeshokumar, MD	Dr. Yeshokumar has nothing to disclose.
Himanshu Chokhawala, MD	Dr. Chokhawala has nothing to disclose.
Marta Ruiz Lopez, MD	Dr. Ruiz Lopez has nothing to disclose.
Cora Ormseth	No disclosure on file
Nina Bozinov, MD	Dr. Bozinov has nothing to disclose.
Leslie Shinobu, MD, PhD	No disclosure on file
Zichen Li	No disclosure on file
Tresa McGranahan, MD	Dr. McGranahan has nothing to disclose.
Abigail M. Taylor, PA	Ms. Taylor has nothing to disclose.
Ephrem Teklemariam, MD	Dr. Teklemariam has nothing to disclose.
Sheyar Amin, MD	Dr. Amin has nothing to disclose.
Robert A. Hauser, MD, MBA, FAAN	Dr. Hauser has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Supernus. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Stoparkinson. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Revance. Dr. Hauser has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Abbvie. Dr. Hauser has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Neurocrine. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Mitsubishi Tanabe. Dr. Hauser has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Amneal. Dr. Hauser has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Intrance. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Zambon. Dr. Hauser has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for NanoPharmasolutions. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for HanAll BioPharma. Dr. Hauser has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Cerevance. Dr. Hauser has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Dr. Hauser has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Clario. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Dr. Hauser has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for ABLi Therapeutics. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sumitomo. Dr. Hauser has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Taurus Therapeutics. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sorriddi Therapeutics. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Contera. Dr. Hauser has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Lundbeck. Dr. Hauser has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Alterity Therapeutics. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Convatec Inc. Dr. Hauser has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Knight Therapeutics. Dr. Hauser has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Acadia. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biorasi. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medicure Pharma. Dr. Hauser has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for BlueRock. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Inhibikase. The institution of Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Stoparkinson. The institution of Dr. Hauser has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Photopharmics. The institution of Dr. Hauser has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ABLi Therapeutics. Dr. Hauser has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Amneal . Dr. Hauser has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Neurocrine Biosciences. Dr. Hauser has received personal compensation in the range of $100,000-$499,999 for serving on a Speakers Bureau for Supernus. Dr. Hauser has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Abbvie. Dr. Hauser has or had stock in Inhibikase.Dr. Hauser has or had stock in Axial Therapeutics.Dr. Hauser has or had stock in Enterin.Dr. Hauser has or had stock in Photopharmics. The institution of Dr. Hauser has received research support from Annovis Bio, Inc.. The institution of Dr. Hauser has received research support from Inhibikase Therapeutics. The institution of Dr. Hauser has received research support from AbbVie, Inc.. The institution of Dr. Hauser has received research support from Biogen MA. The institution of Dr. Hauser has received research support from Cavion, Inc.. The institution of Dr. Hauser has received research support from Cerevance Beta, Inc.. The institution of Dr. Hauser has received research support from Cerevel Therapeutics. The institution of Dr. Hauser has received research support from Enterin, Inc.. The institution of Dr. Hauser has received research support from Genentech. The institution of Dr. Hauser has received research support from Global Kinetics Corporation. The institution of Dr. Hauser has received research support from Hoffman-La Roche Inc. The institution of Dr. Hauser has received research support from Michael J. Fox Foundation for Parkinson's Research. The institution of Dr. Hauser has received research support from National Parkinson's Foundation. The institution of Dr. Hauser has received research support from Neuroderm. The institution of Dr. Hauser has received research support from Sage Therapeutics. The institution of Dr. Hauser has received research support from Scion NeuroStim. The institution of Dr. Hauser has received research support from UCB BioPharma. The institution of Dr. Hauser has received research support from UCB. The institution of Dr. Hauser has received research support from Amneal Pharmaceuticals. The institution of Dr. Hauser has received research support from Motric Bio, Inc.. The institution of Dr. Hauser has received research support from Sun Pharma Advanced Research Company. The institution of Dr. Hauser has received research support from Teva Branded Pharmaceuticals. The institution of Dr. Hauser has received research support from Truebinding, Inc.. The institution of Dr. Hauser has received research support from Jazz Pharmaceuticals. The institution of Dr. Hauser has received research support from Ipsen. Dr. Hauser has received intellectual property interests from a discovery or technology relating to health care.
Osvaldo J. Nascimento, MD, PhD, FAAN	Dr. Nascimento has nothing to disclose.
Martin Berghoff, MD, FAAN	Dr. Berghoff has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen Idec. Dr. Berghoff has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Berghoff has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen. Dr. Berghoff has received personal compensation in the range of $500-$4,999 for serving as a Consultant for MerckSerono. Dr. Berghoff has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bristol Myers Squibb.
John H. Herndon, MD	No disclosure on file
Matthew J. Wodziak, MD	No disclosure on file
Yuko Takahashi	No disclosure on file
Tammy L. Smith, MD, PhD	Dr. Smith has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono. The institution of Dr. Smith has received research support from Alexion/AstraZeneca.
Marwa A. Elnazeir, MD	Dr. Elnazeir has nothing to disclose.
Fahd Baig, MBBS	No disclosure on file
Nucike Khezri	No disclosure on file
Jaime Quintero	No disclosure on file
Yunxia Wang, MD, FAAN	Dr. Wang has nothing to disclose.
Sayona John, MD, FAAN	Dr. John has nothing to disclose.
Chad Carlson, MD, FAAN	Dr. Carlson has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant with US Department of Justice.
Arayamparambil Anilkumar, MD, FAAN	Dr. Anilkumar has received publishing royalties from a publication relating to health care.
Dinesh V. Jillella, MD	Dr. Jillella has nothing to disclose.
Mariano Marrodan, MD	Dr. Marrodan has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Dr. Marrodan has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck, Astra Zeneca, Gador, Biogen, Roche and Novartis.
Daniel Krashin, MD	Dr. Krashin has nothing to disclose.
Genevieve K. Gabriel, MD	No disclosure on file
Nicholas Crump, MD	No disclosure on file
Amanda Sandoval Karamian, MD	The institution of Dr. Sandoval Karamian has received research support from Pediatric Epilepsy Research Foundation.
Sanskriti Sasikumar, MD	Dr. Sasikumar has nothing to disclose.
Rory Abrams, MD	Dr. Abrams has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Averitas Pharmaceutical.
Shashika Rodrigo, MD	Dr. Rodrigo has nothing to disclose.
Deepa Gautam	No disclosure on file
Martha Shenton	Martha Shenton has nothing to disclose.
Marino Bianchini	No disclosure on file
Thais Secchi	No disclosure on file
Bruce L. Miller, MD, FAAN	Dr. Miller has nothing to disclose.
Marinos C. Dalakas, MD, FAAN	Dr. Dalakas has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Grifols, . Dr. Dalakas has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Dysimmune Diseases Foundation. Dr. Dalakas has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Octapharma. Dr. Dalakas has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ARGENX. Dr. Dalakas has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for AAN. Dr. Dalakas has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Therapeutic Advances in Neurology (TAND). Dr. Dalakas has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Medlink.
Morris Freedman, MD, FAAN	No disclosure on file
Marco Salvetti, MD	Dr. Salvetti has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for sanofi. Dr. Salvetti has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for biogen. The institution of Dr. Salvetti has received research support from bms.
Jacob S. Elkins, MD	No disclosure on file
Jeffrey Statland, MD	Dr. Statland has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Arrowhead. Dr. Statland has received personal compensation in the range of $500-$4,999 for serving as a Consultant for ML Bio. Dr. Statland has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Epic Bio. Dr. Statland has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Armatus . Dr. Statland has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Kate Therapeutics. Dr. Statland has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Vita Therapeutics. Dr. Statland has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Dyne Therapeutics. Dr. Statland has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Avidity . Dr. Statland has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Fulcrum Therapeutics. Dr. Statland has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Statland has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Vertex . The institution of Dr. Statland has received research support from NIH. The institution of Dr. Statland has received research support from FSHD Society. The institution of Dr. Statland has received research support from Friends of FSH Research. The institution of Dr. Statland has received research support from FSHD Canada. The institution of Dr. Statland has received research support from MDA.
Douglas P. Larsen, MD	Dr. Larsen has received personal compensation in the range of $500-$4,999 for serving as a Grant Reviewer with National Board of Medical Examiners.
Caroline Gentile Kruse, MD	Dr. Gentile Kruse has nothing to disclose.
Samuel Ludwin, MD	No disclosure on file
John Q. Trojanowski, MD, PhD	Dr. Trojanowski has nothing to disclose.
Jan Klatt, MD	No disclosure on file
Anvi Gadani, MD	No disclosure on file
Charles S. Venuto, MD	No disclosure on file
Nicholas Swingle, MD	No disclosure on file
Igal Mirman, MD	Dr. Mirman has nothing to disclose.
Jack P. Antel, MD, FAAN	Dr. Antel has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for sanofi, roche, biogen, wave,nervgen. The institution of Dr. Antel has received research support from Novartis canada bristol myers squib. Dr. Antel has a non-compensated relationship as a past president with ACTRIMS that is relevant to AAN interests or activities.
Keith A. Josephs, Jr., MD, FAAN	Dr. Josephs has nothing to disclose.
Ann Gruber-Baldini	No disclosure on file
Glenn T. Stebbins, PhD	Dr. Stebbins has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Dr. Stebbins has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Partners Healthcare System. Dr. Stebbins has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for CHDI. The institution of Dr. Stebbins has received research support from Department of Defense. Dr. Stebbins has received research support from Cleveland Clinic Health Systems. Dr. Stebbins has received personal compensation in the range of $500-$4,999 for serving as a Course Director with MDS.
Samuel J. Maiser, MD	Dr. Maiser has nothing to disclose.
Ruth Schneider, MD, FAAN	Dr. Schneider has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Escape Bio. The institution of Dr. Schneider has received research support from The Michael J. Fox Foundation. The institution of Dr. Schneider has received research support from NIH. The institution of Dr. Schneider has received research support from Acadia Pharmaceuticals. The institution of Dr. Schneider has received research support from CHDI. The institution of Dr. Schneider has received research support from Biohaven Pharmaceuticals. The institution of Dr. Schneider has received research support from Parkinson Study Group. The institution of Dr. Schneider has received research support from The Michael J. Fox Foundation. The institution of Dr. Schneider has received research support from Bial. Dr. Schneider has received personal compensation in the range of $500-$4,999 for serving as a Telemedicine Evaluator with Parkinson's Foundation.
Abbas Jowkar, MD	No disclosure on file
Diane Stephenson	Diane Stephenson has received personal compensation for serving as an employee of Critical Path Institute.
Muniza Sheikh	Ms. Sheikh has received personal compensation for serving as an employee of The Emmes Company.
Kalyan Yarraguntla, MD	Dr. Yarraguntla has nothing to disclose.
Mina Lobbous, MD	Dr. Lobbous has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Servier . Dr. Lobbous has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion Pharmaceuticals . Dr. Lobbous has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Telix pharmaceuticals . Dr. Lobbous has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Springworks Pharmaceuticals . Dr. Lobbous has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Springworks Pharmaceuticals . Dr. Lobbous has received publishing royalties from a publication relating to health care.
Abdallah O. Amireh, MD	Dr. Amireh has nothing to disclose.
Shaun Ajinkya, MD	No disclosure on file
Mohammad Anadani, MD	Dr. Anadani has nothing to disclose.
Sishir Mannava, MD	Dr. Mannava has nothing to disclose.
Michael Leffler-McCabe, MD	No disclosure on file
Amandeep Dolla, MBBS	Dr. Dolla has nothing to disclose.
Sarah R. Ahmad	Ms. Ahmad has nothing to disclose.
Mahmood Shbeb, MD	Dr. Shbeb has nothing to disclose.
Joachim Fladt, MD	No disclosure on file
J. E. Ahlskog, MD, PhD	Dr. Ahlskog has received publishing royalties from a publication relating to health care.
O. C. Snead III, MD, FAAN	Dr. Snead has nothing to disclose.
Sheena K. Aurora, MD	Dr. Aurora has received personal compensation for serving as an employee of Alzheimer's Association.
Marwan N. Sabbagh, MD, FAAN	Dr. Sabbagh has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Eisai. Dr. Sabbagh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genetech=Roche. Dr. Sabbagh has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novo Nordisk. Dr. Sabbagh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lilly. Dr. Sabbagh has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Synaptogenix. Dr. Sabbagh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Signant Health. Dr. Sabbagh has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Anavex. Dr. Sabbagh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cognito Therapeutics. Dr. Sabbagh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for GSK. Dr. Sabbagh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie. Dr. Sabbagh has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for CervoMed. Dr. Sabbagh has stock in Neurotau. Dr. Sabbagh has stock in Seq Biomarque. Dr. Sabbagh has stock in uMethod Health. Dr. Sabbagh has stock in Athira. Dr. Sabbagh has stock in Lighthouse Pharmaceuticals. Dr. Sabbagh has stock in Alzheon. The institution of Dr. Sabbagh has received research support from NIH. The institution of Dr. Sabbagh has received research support from ADDF.
Suraj Muley, MD, FAAN	Dr. Muley has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Argenx. Dr. Muley has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Alexion. Dr. Muley has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for CSL Behring. Dr. Muley has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Takeda. Dr. Muley has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Catalyst. Dr. Muley has received publishing royalties from a publication relating to health care.
Craig S. Moore, PhD	Dr. Moore has nothing to disclose.
Ashis H. Tayal, MD	Dr. Tayal has nothing to disclose.
Kerry L. Knievel, DO	Dr. Knievel has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Abbvie . Dr. Knievel has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biohaven . Dr. Knievel has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Lundbeck . Dr. Knievel has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Lilly. Dr. Knievel has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Pfizer. Dr. Knievel has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lundbeck . Dr. Knievel has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for AbbVie . Dr. Knievel has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Amgen . Dr. Knievel has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biohaven . Dr. Knievel has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Lundbeck . Dr. Knievel has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for Headache Cooperative of the Pacific . The institution of Dr. Knievel has received research support from Abbvie .
Ghazala Hayat, MBBS, FAAN	Dr. Hayat has received personal compensation in the range of $500-$4,999 for serving as a Consultant for kabafusion. Dr. Hayat has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for csl. Dr. Hayat has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for alexion. Dr. Hayat has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for MTPA. Dr. Hayat has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for alexion. Dr. Hayat has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for kabafusion.
Rohit A. Marawar, MD, FAAN	Dr. Marawar has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Jazz Pharmaceuticals. Dr. Marawar has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for SK Pharma. Dr. Marawar has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Xenon. Dr. Marawar has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Neurelis.
Amelia K. Adcock, MD	The institution of an immediate family member of Dr. Adcock has received research support from NIH.
Jose G. Cea Munoz, MD	No disclosure on file
Nan Zhang	Nan Zhang has nothing to disclose.
Hennan S. Teixeira, MD	Dr. Teixeira has nothing to disclose.
Faddi G. Saleh Velez, MD	Dr. Saleh Velez has nothing to disclose.
Setty M. Magana, MD, PhD	Dr. Magana has nothing to disclose.
Carole Ho, MD	No disclosure on file
Yu Zhang, PhD	No disclosure on file
Rana Moosavi, MD	Dr. Moosavi has nothing to disclose.
Samir Belal	No disclosure on file
Khaled Abdalla, MD	Dr. Abdalla has nothing to disclose.
Robert Alexander, MD	Dr. Alexander has received personal compensation for serving as an employee of Takeda .
Louisa G. Keith, MD	No disclosure on file
Poornachand Veerapaneni, MD	Dr. Veerapaneni has nothing to disclose.
Jani Hegarty	No disclosure on file
Murtadha Hssayeni	No disclosure on file
Yatin Sagvekar	No disclosure on file
Nicholas D. Schiff, MD	Dr. Schiff has received publishing royalties from a publication relating to health care. Dr. Schiff has received personal compensation in the range of $500-$4,999 for serving as a study section member with NIH. Dr. Schiff has a non-compensated relationship as a Guidelines Panel Member with AAN that is relevant to AAN interests or activities.
Kelly E. Lyons, PhD	Dr. Lyons has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Praxis. Dr. Lyons has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sage. Dr. Lyons has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Parkinson's Foundation. Dr. Lyons has a non-compensated relationship as a President with International Essential Tremor Foundation that is relevant to AAN interests or activities.
H. C. Diener, MD, FAAN	Dr. Diener has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lundbeck. Dr. Diener has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for TEVA. Dr. Diener has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Lundbeck. Dr. Diener has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Springer. Dr. Diener has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Thieme. The institution of Dr. Diener has received research support from German Research Council.
Njide Okubadejo, MD, FAAN	The institution of Dr. Okubadejo has received research support from United Kingdom National Institute for Health and Care Research . The institution of Dr. Okubadejo has received research support from Michael J Fox Foundation for Parkinson's Research.
Aaron Ellenbogen, DO	Dr. Ellenbogen has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for allergan. Dr. Ellenbogen has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for allergan. Dr. Ellenbogen has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Teva. Dr. Ellenbogen has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Supernus. Dr. Ellenbogen has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for ipsen. Dr. Ellenbogen has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Acorda.
Gabriel Persi	Gabriel Persi has nothing to disclose.
Nathan P. Young, DO	Dr. Young has nothing to disclose.
Shawna M. Cutting, MD, FAAN	The institution of Dr. Cutting has received research support from Genentech.
Andrew L. Lin, MD	The institution of Dr. Lin has received research support from Bristol Myers Squibb. The institution of Dr. Lin has received research support from NantOmics. The institution of Dr. Lin has received research support from Society of Memorial Sloan Kettering Cancer Center.
Divisha Raheja, MD, FAAN	Dr. Raheja has nothing to disclose.
Neil E. Schwartz, MD, PhD	Dr. Schwartz has nothing to disclose.
Aaron Hadley	Aaron Hadley has received personal compensation for serving as an employee of Great Lakes NeuroTechnologies.
Antonino Giordano	Mr. Giordano has nothing to disclose.
Andrew D. Chang, MS	No disclosure on file
Filip Bergquist	The institution of Filip Bergquist has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Abbvie. Filip Bergquist has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for Arvid Carlsson Research AB. The institution of Filip Bergquist has received research support from Swedish Government. The institution of Filip Bergquist has received research support from Parkinsonfonden. The institution of Filip Bergquist has received research support from Neuro Sweden. The institution of Filip Bergquist has received research support from Swedish Research Council. Filip Bergquist has received publishing royalties from a publication relating to health care. Filip Bergquist has received publishing royalties from a publication relating to health care. Filip Bergquist has a non-compensated relationship as a Advisor with Sense4Care that is relevant to AAN interests or activities.
Androniki Plomaritoglou, MD, PhD, MSc	No disclosure on file
Carlos A. Pardo-Villamizar, MD	The institution of Dr. Pardo-Villamizar has received research support from National Institutes of Health. The institution of Dr. Pardo-Villamizar has received research support from Bart McLean Fund for Neuroimmunology Research .
Daniel D. Mikol, MD, PhD	Dr. Mikol has received personal compensation for serving as an employee of NervGen. Dr. Mikol has received personal compensation for serving as an employee of Amgen. Dr. Mikol has received personal compensation in the range of $100,000-$499,999 for serving as an officer or member of the Board of Directors for NervGen. Dr. Mikol has stock in NervGen. Dr. Mikol has stock in Amgen. Dr. Mikol has received personal compensation in the range of $100,000-$499,999 for serving as a Employee with NervGen.
Rebecca O'Dwyer, MD	Dr. O'Dwyer has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB Pharma. Dr. O'Dwyer has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for SK Life Sciences.
Christopher R. Newey, DO	Dr. Newey has nothing to disclose.
Bob Bucelli, MD, PhD	Dr. Bucelli has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen . Dr. Bucelli has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Bucelli has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Regeneron. Dr. Bucelli has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Hamilton Weber. Dr. Bucelli has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for O'Bryan Brown and Toner. Dr. Bucelli has stock in Neuroquestions.com. An immediate family member of Dr. Bucelli has stock in Neuroquestions.com. The institution of Dr. Bucelli has received research support from Biogen. The institution of Dr. Bucelli has received research support from Ionis.
Amre Nouh, MD, FAAN	Dr. Nouh has stock in Openwater.
Devanshi Dharaiya, MD	No disclosure on file
Uwe Reuter	Uwe Reuter has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Allergan. Uwe Reuter has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Abbvie. Uwe Reuter has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis. Uwe Reuter has received personal compensation in the range of $500-$4,999 for serving as a Consultant for TEVA. Uwe Reuter has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Liily Deutschland. Uwe Reuter has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amgen. Uwe Reuter has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Allergan/Abbvie. Uwe Reuter has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lilly. Uwe Reuter has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TEVA. Uwe Reuter has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. The institution of Uwe Reuter has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lundbeck. Uwe Reuter has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Allergan. Uwe Reuter has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Lilly. Uwe Reuter has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Medscape . Uwe Reuter has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Novartis. Uwe Reuter has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for StreaMEdUp. Uwe Reuter has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Teva. The institution of Uwe Reuter has received research support from Novartis.
Sridhara S. Yaddanapudi, MD	Dr. Yaddanapudi has nothing to disclose.
Kalyan C. Sajja, MD	No disclosure on file
Robin S. Feldman	No disclosure on file
Sunfa Cheng	Sunfa Cheng has received personal compensation for serving as an employee of Amgen. Sunfa Cheng has received stock or an ownership interest from Amgen.
Kush Sharma, MBBS	Dr. Sharma has nothing to disclose.
Takanori Yokota, MD, PhD	Dr. Yokota has nothing to disclose.
Katherine E. Heaton, MD	No disclosure on file
Andrea Parks, MD	No disclosure on file
Bridget L. Ostrem, MD, PhD	No disclosure on file
Charles Sanky	No disclosure on file
Pavan Patel, DO	Dr. Patel has nothing to disclose.
Josefine Waldthaler, MD	No disclosure on file
Laura Baratta	No disclosure on file
Andrew S. Feigin, MD	Dr. Feigin has received personal compensation for serving as an employee of Rho, Inc.. Dr. Feigin has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Kenai. Dr. Feigin has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ADCS/ATRI. Dr. Feigin has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for PTC. Dr. Feigin has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. Dr. Feigin has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lundbeck. The institution of Dr. Feigin has received research support from Huntngton Study Group. The institution of Dr. Feigin has received research support from Prilenia.
Saud Sadiq, BS, FAAN	Ms. Brewi has nothing to disclose.
Federica Agosta	Federica Agosta has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Philips. Federica Agosta has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier INC.
Philippe A. Lyrer, MD	No disclosure on file
Patricia Musolino, MD, PhD	An immediate family member of Dr. Musolino has received personal compensation for serving as an employee of EMD Sorono. Dr. Musolino has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Minoryx Pharmaceuticals. Dr. Musolino has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for IONIS Pharmaceuticals . Dr. Musolino has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Inozyme Pharma. Dr. Musolino has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Vertex Pharmaceuticals. An immediate family member of Dr. Musolino has or had stock in 2seventy Bio. An immediate family member of Dr. Musolino has or had stock in Editas Medicine. An immediate family member of Dr. Musolino has or had stock in Generation Bio. An immediate family member of Dr. Musolino has or had stock in Beam Therapeutics. An immediate family member of Dr. Musolino has or had stock in Ebotec . An immediate family member of Dr. Musolino has or had stock in Novonordisk. An immediate family member of Dr. Musolino has or had stock in Morphosys. The institution of Dr. Musolino has received research support from National Institute of Health-NINDS-R01. The institution of Dr. Musolino has received research support from Angea Biotherapeutics. The institution of Dr. Musolino has received research support from Minoryx Pharmaceuticals. The institution of Dr. Musolino has received research support from Belanger Foundation. The institution of Dr. Musolino has received research support from Rozwat Family Foundation. The institution of Dr. Musolino has received research support from Dooley Family Foundation. Dr. Musolino has received intellectual property interests from a discovery or technology relating to health care. Dr. Musolino has received publishing royalties from a publication relating to health care.
Kerri S. Remmel, MD, PhD	Dr. Remmel has nothing to disclose.
Edwin B. George, MD, PhD, FAAN	No disclosure on file
Laura S. Munoz-Arcos, MD	No disclosure on file
Babawale Arabambi, MBBS	Dr. Arabambi has nothing to disclose.
Carissa C. Dioquino	No disclosure on file
Sen Sheng, MD	Dr. Sheng has nothing to disclose.
Jorge Angarita, MD	Dr. Angarita has nothing to disclose.
Fallon Schloemer, DO	Dr. Schloemer has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Lilly . Dr. Schloemer has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Abbvie .
Marjorie Ho, MD	Dr. Ho has nothing to disclose.
Christopher Traenka, MD	No disclosure on file
Kimberly Laxton, MD	No disclosure on file
Harathi Bandaru, MD	Dr. Bandaru has nothing to disclose.
Pamela Ramseier	No disclosure on file
Jessica Frey, MD	The institution of Dr. Frey has received research support from Tourette Association of America.
Mehila Zebenigus, MD	Dr. Zebenigus has a non-compensated relationship as a Director with Global NeuroCare that is relevant to AAN interests or activities.
Moein Amin, MD	Dr. Amin has nothing to disclose.
Erin Barnes, MD	An immediate family member of Dr. Barnes has received personal compensation for serving as an employee of Go2For Lung Cancer. The institution of Dr. Barnes has received research support from NIH.
Lucas Cofer	No disclosure on file
Emilia M. Gatto, MD, FAAN	Dr. Gatto has received personal compensation in the range of $0-$499 for serving as a Consultant for UCB. Dr. Gatto has received personal compensation in the range of $0-$499 for serving as a Consultant for Bago Argentina. Dr. Gatto has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bago. Dr. Gatto has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for UCB. Dr. Gatto has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Janssen. Dr. Gatto has received research support from Roche. The institution of Dr. Gatto has received research support from CHDI.
Dustin A. Heldman, PhD	Dr. Heldman has received personal compensation for serving as an employee of Great Lakes NeuroTechnologies Inc.. Dr. Heldman has stock in Great Lakes NeuroTechnologies. The institution of Dr. Heldman has received research support from NIH.
William D. Arnold, MD	Dr. Arnold has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Arnold has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for La Hoffmann Roche. Dr. Arnold has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cadent Therapeutics . Dr. Arnold has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. The institution of Dr. Arnold has received research support from NIH. The institution of Dr. Arnold has received research support from NMD Pharma. The institution of Dr. Arnold has received research support from Gilead Sciences. The institution of Dr. Arnold has received research support from CureSMA. Dr. Arnold has received intellectual property interests from a discovery or technology relating to health care.
Facundo Manes	No disclosure on file
Yvonne Langan	Yvonne Langan has nothing to disclose.
Oluwadamilola O. Ojo, MD	Dr. Ojo has nothing to disclose.
Elizabeth A. Mauricio, MD, FAAN	Dr. Mauricio has nothing to disclose.
Elisabetta Sarasso	Elisabetta Sarasso has nothing to disclose.
Henrik Gensicke, MD	No disclosure on file
Stanley Levy, FRACP	No disclosure on file
Benjamin P. Trewin, MBBS, PhD, FRACP	Dr. Trewin has received research support from University of Sydney.
Kenneth A. Morris, MD, PhD	No disclosure on file
Melih Tutuncu, MD	Dr. Tutuncu has nothing to disclose.
Nadia Foskett	No disclosure on file
Franco E. Appiani, MD	Dr. Appiani has nothing to disclose.
Greg Owendoff	Greg Owendoff has nothing to disclose.
Eyad Almallouhi, MD	Dr. Almallouhi has nothing to disclose.
Reydmar Lopez	Reydmar Lopez has nothing to disclose.
Sushma Kola, MD	Dr. Kola has nothing to disclose.
Jae Eun Lee, MD	Dr. Lee has nothing to disclose.
Paola G. Bronson, PhD, MPH	Dr. Bronson has received personal compensation for serving as an employee of Biogen.
Agnieszka Kielian, MD	Dr. Kielian has nothing to disclose.
Yoichiro Nishida	Yoichiro Nishida has nothing to disclose.
Paul Winner, DO, FAAN	Dr. Winner has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Teva. Dr. Winner has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Allergan. Dr. Winner has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lundbeck . Dr. Winner has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Amgen. Dr. Winner has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Allergan. Dr. Winner has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Lundbeck. Dr. Winner has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Teva. Dr. Winner has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for lilly. The institution of Dr. Winner has received research support from Amgen. The institution of Dr. Winner has received research support from Allergan. The institution of Dr. Winner has received research support from Lundbeck . The institution of Dr. Winner has received research support from Novartis. The institution of Dr. Winner has received research support from Lilly. The institution of Dr. Winner has received research support from Teva. The institution of Dr. Winner has received research support from Supernus. The institution of Dr. Winner has received research support from Biogen. The institution of Dr. Winner has received research support from Avinar. The institution of Dr. Winner has received research support from SAMUS.
Giuseppe Magnani	Giuseppe Magnani has nothing to disclose.
Zbigniew K. Wszolek, MD, FAAN	Dr. Wszolek has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Polish Neurological Society/Via Medica. Dr. Wszolek has received intellectual property interests from a discovery or technology relating to health care.
P. James B. Dyck, MD, FAAN	Dr. Dyck has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Akcea/Ionis.
Jerry Lin, BS	Mr. Lin has nothing to disclose.
Jeremiah M. Scharf, MD, PhD	The institution of Dr. Scharf has received research support from the TLC Foundation for Body-Focused Repetitive Behaviors. Dr. Scharf has received personal compensation in the range of $500-$4,999 for serving as a Speaker for a TAA/CDC Family Day Symposium with the Tourette Association of America. Dr. Scharf has a non-compensated relationship as a Scientific Advisory Board Member with the Tourette Association of America that is relevant to AAN interests or activities.
Doris Kung, DO, FAAN	Dr. Kung has received personal compensation for serving as an employee of Aquifer. The institution of Dr. Kung has received research support from RxFunction. Dr. Kung has received publishing royalties from a publication relating to health care. Dr. Kung has received personal compensation in the range of $0-$499 for serving as a Workgroup member with NBME. Dr. Kung has received personal compensation in the range of $500-$4,999 for serving as a Editor with Aquifer.
Elliot Dimberg, MD, FAAN	Dr. Dimberg has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Academic CME.
Royya F. Modir, MD	Dr. Modir has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Medtronic .
Guido D. Vazquez II, PhD	Dr. Vazquez has nothing to disclose.
Tina M. Burton, MD	Dr. Burton has nothing to disclose.
Chrysanthi Barba	No disclosure on file
Sonia Koul	No disclosure on file
Imad M. Najm, MD	Dr. Najm has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Eisai Inc. Dr. Najm has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eisai Inc. Dr. Najm has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Eisai Inc.
Bernard Brais, MD	Dr. Brais has nothing to disclose.
Daniel T. Laskowitz, MD	No disclosure on file
Ilana Spokoyny, MD	Dr. Spokoyny has nothing to disclose.
Thomas A. Buckley, PhD	The institution of Dr. Buckley has received research support from Highmark Bluecross Blue Prints. The institution of Dr. Buckley has received research support from NIH/NINDS. The institution of Dr. Buckley has received research support from StateSpace, Inc.
Devashish D. Ruikar, MD	Dr. Ruikar has nothing to disclose.
Luca Giancardo	Luca Giancardo has received personal compensation for serving as an employee of AWS. Luca Giancardo has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Rutgers University. Luca Giancardo has received intellectual property interests from a discovery or technology relating to health care. Luca Giancardo has received intellectual property interests from a discovery or technology relating to health care.
Sona Mistry, MD, MBBS	No disclosure on file
Yue Jiang, MD	No disclosure on file
Chen Yan, MD	Dr. Yan has nothing to disclose.
Torge Rempe, MD	Dr. Rempe has nothing to disclose.
Cecilia Fernandes, MD	No disclosure on file
Anvita Potluri, MD	Dr. Potluri has nothing to disclose.
Charles E. Argoff, MD	Dr. Argoff has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Nevro. Dr. Argoff has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for XGene. Dr. Argoff has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Vertex. Dr. Argoff has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Scilex. Dr. Argoff has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Colllegium. Dr. Argoff has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Vertex. Dr. Argoff has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Allergan/Abbvie. Dr. Argoff has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Lundbeck. Dr. Argoff has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Scilex. Dr. Argoff has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Scilex. The institution of Dr. Argoff has received research support from Lilly. The institution of Dr. Argoff has received research support from Lundbeck. The institution of Dr. Argoff has received research support from Abbvie. The institution of Dr. Argoff has received research support from Vertex. Dr. Argoff has received publishing royalties from a publication relating to health care.
Haitham Hussein, MD, FAAN	Dr. Hussein has nothing to disclose.
Sandra Magalhaes	No disclosure on file
Aubrey Adams, PhD	Dr. Manack Adams has received personal compensation for serving as an employee of Abbvie. Dr. Manack Adams has stock in Abbvie.
Eric Lancaster, MD, PhD	Dr. Lancaster has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for merck. Dr. Lancaster has received intellectual property interests from a discovery or technology relating to health care. Dr. Lancaster has received personal compensation in the range of $50,000-$99,999 for serving as a Expert and Witness with US Vaccine Injury Compensation Program.
Messoud Ashina, MD, PhD	Dr. Ashina has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for AbbVie. Dr. Ashina has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eli Lilly. Dr. Ashina has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Lundbeck. Dr. Ashina has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Ashina has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Teva. Dr. Ashina has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Pfizer. Dr. Ashina has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Astra Zeneca. Dr. Ashina has received personal compensation in the range of $500-$4,999 for serving as a Consultant for GlaxoSmithKline. Dr. Ashina has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Incyte. The institution of Dr. Ashina has received research support from The Lundbeck Foundation. The institution of Dr. Ashina has received research support from Novo Nordisk Foundation . The institution of Dr. Ashina has received research support from Danish National Research Foundation . Dr. Ashina has received publishing royalties from a publication relating to health care.
Brittany Lapin	No disclosure on file
Makoto Hara, MD	Dr. Hara has nothing to disclose.
Mahsa Sadeghi, MD	Dr. Sadeghi has nothing to disclose.
Eve Taylor, PhD	No disclosure on file
Bradford A. Navia, MD, PhD	No disclosure on file
Karen Craig	Karen Craig has received personal compensation for serving as an employee of Impel NeuroPharma.
Brett L. Cucchiara, MD	Dr. Cucchiara has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Elseiver. Dr. Cucchiara has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Bayer. Dr. Cucchiara has received publishing royalties from a publication relating to health care.
Erdem Tuzun	Erdem Tuzun has nothing to disclose.
Stefan T. Engelter, MD	No disclosure on file
Ramon R. Diaz-Arrastia, MD, PhD, FAAN	Dr. Diaz-Arrastia has stock in BrainBox, LLC. Dr. Diaz-Arrastia has stock in Nia Therpeutics. The institution of Dr. Diaz-Arrastia has received research support from National Institutes of Health. The institution of Dr. Diaz-Arrastia has received research support from Department of Defense.
Scott Przybelski	Scott Przybelski has nothing to disclose.
Raima A. Memon, MBBS	Dr. Memon has nothing to disclose.
Alfred Balasa, MD	Dr. Balasa has nothing to disclose.
Paul M. Elsbernd, MD	Dr. Elsbernd has nothing to disclose.
Hans Hundemer, MD	No disclosure on file
Casey S. Albin, MD, FAAN	Dr. Albin has received personal compensation in the range of $0-$499 for serving as a Consultant for Azurity Pharmaceutical. Dr. Albin has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Continuum: Life Long Learning in Neurology. Dr. Albin has received research support from ��ɫ��. Dr. Albin has received publishing royalties from a publication relating to health care.
Michael F. La Fountaine, EdD, ATC	Dr. La Fountaine has nothing to disclose.
Nicholas D. Henkel	No disclosure on file
Brianna J. Sennott, MD	An immediate family member of Dr. Sennott has received personal compensation for serving as an employee of Abbott Laboratories.
Ana C. Villegas	Ms. Villegas has nothing to disclose.
Iakov Rudenko, MD, PhD	No disclosure on file
Jennifer Meeks	No disclosure on file
Bade Gulec	Bade Gulec has nothing to disclose.
Michela Leocadi, MSc	Dr. Leocadi has nothing to disclose.
Mustapha A. Danesi, MD	No disclosure on file
nobl barazangi, MD, PhD	Dr. Barazangi has nothing to disclose.
Randi Hagerman	Randi Hagerman has received publishing royalties from a publication relating to health care.
Carolina Barnett Tapia, MD	Dr. Barnett Tapia has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Argenx. Dr. Barnett Tapia has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen. Dr. Barnett Tapia has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for UCB. Dr. Barnett Tapia has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Barnett Tapia has received personal compensation in the range of $500-$4,999 for serving as a Consultant for NMD pharma. Dr. Barnett Tapia has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Barnett Tapia has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for argenx. Dr. Barnett Tapia has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Janssen. Dr. Barnett Tapia has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. Dr. Barnett Tapia has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for argenx. The institution of Dr. Barnett Tapia has received research support from Department of defense. The institution of Dr. Barnett Tapia has received research support from Muscular dystrophy canada. The institution of Dr. Barnett Tapia has received research support from MgNet. The institution of Dr. Barnett Tapia has received research support from NIH. The institution of Dr. Barnett Tapia has received research support from Cartesian. The institution of Dr. Barnett Tapia has received research support from Alexion. Dr. Barnett Tapia has received intellectual property interests from a discovery or technology relating to health care.
Charlene Chen, MD	No disclosure on file
Assad M. Ali	No disclosure on file
James A. Mastrianni, MD, PhD	Dr. Mastrianni has received personal compensation in the range of $500-$4,999 for serving as a Consultant for CVS Caremark. Dr. Mastrianni has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. The institution of Dr. Mastrianni has received research support from Brain Research Foundation.
Erik K. St. Louis, MD	The institution of Dr. St. Louis has received research support from NIH. Dr. St. Louis has received publishing royalties from a publication relating to health care. Dr. St. Louis has received publishing royalties from a publication relating to health care.
Jeffrey A. Allen, MD	Dr. Allen has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Argenx. Dr. Allen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for csl behring. Dr. Allen has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Takeda. Dr. Allen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Grifols. Dr. Allen has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Alnylam. Dr. Allen has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi. Dr. Allen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Astra Zeneca. Dr. Allen has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Johnson and Johnson. Dr. Allen has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Alexion. Dr. Allen has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Annexon. Dr. Allen has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Immunovant. Dr. Allen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amgen. Dr. Allen has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Dianthus. Dr. Allen has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for CSL Behring. Dr. Allen has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Annexon. Dr. Allen has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Takeda. Dr. Allen has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenx. Dr. Allen has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Dianthus. Dr. Allen has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for CSL behring. Dr. Allen has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Takeda. Dr. Allen has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Alnylam. Dr. Allen has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Alexion. Dr. Allen has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Johnson and Johnson.
Gary R. Cutter, PhD	Dr. Cutter has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for onsulting or Advisory Boards: Alexion, Antisense Therapeutics/Percheron, Avotres, Biogen, Clene Nanomedicine, Clinical Trial Solutions LLC, Endra Life Sciences, Cognito Therapeutics, Genzyme, Genentech, Immunic, Klein-Buendel Incorporated, Kyverna Therapeutics, Inc. , Linical, Merck/Serono, Noema, Neurogenesis, Perception Neurosciences, Protalix Biotherapeutics, Regeneron, Revelstone Consulting, Roche, SAB Biotherapeutics, Sapience Therapeutics, Scott&Scott LLP, Tenmile.. Dr. Cutter has received personal compensation in the range of $50,000-$99,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Data and Safety Monitoring Boards: Applied Therapeutics, AI therapeutics, AMO Pharma, Argenx, Astra-Zeneca, Avexis Pharmaceuticals, Bristol Meyers Squibb, CSL Behring, Cynata Therapeutics, DiamedicaTherapeutics, Horizon Pharmaceuticals, Immunic, Inhibrix, Karuna Therapeutics, Kezar Life Sciences, Medtronic, Merck, Meiji Seika Pharma, Mitsubishi Tanabe Pharma Holdings, Prothena Biosciences, Novartis, Pipeline Therapeutics (Contineum), Regeneron, Sanofi-Aventis, Teva Pharmaceuticals, United BioSource LLC, University of Texas Southwestern.. Dr. Cutter has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for JASN.
Kimbra L. Kenney, MD, FAAN	Dr. Kenney has nothing to disclose.
Maitreyi Murthy, MD	Dr. Murthy has nothing to disclose.
Fiona Chan, MBBS	Dr. Chan has nothing to disclose.
Victoria L. Wu, MD	Dr. Wu has nothing to disclose.
Nicholas L. Shawen	No disclosure on file
Karen L. Furie, MD	The institution of Dr. Furie has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Janssen/BMS. Dr. Furie has received personal compensation in the range of $50,000-$99,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for BMJ/JNNP. The institution of Dr. Furie has received research support from NINDS.
Tamara Vyshkina, PhD	No disclosure on file
Jorge Sepulcre	No disclosure on file
Moses Rodriguez, MD, FAAN	Dr. Rodriguez has received intellectual property interests from a discovery or technology relating to health care.
Nicte Mejia, MD, MPH, FAAN	Dr. Mejia has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Mejia has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurology. The institution of Dr. Mejia has received research support from Biogen Foundation.
Brigitte Wildemann, MD	The institution of Dr. Wildemann has received research support from Roche. The institution of Dr. Wildemann has received research support from Novartis. The institution of Dr. Wildemann has received research support from Argenx. Dr. Wildemann has received personal compensation in the range of $500-$4,999 for serving as a Conference participant with Neuraxpharm. Dr. Wildemann has received personal compensation in the range of $0-$499 for serving as a Speaker with Roche. Dr. Wildemann has received personal compensation in the range of $0-$499 for serving as a Soeaker with Instand.
Violaine K. Harris, PhD	No disclosure on file
Latha Ganti, MD, MS, MBA, FACEP	Dr. Ganti has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Springer. Dr. Ganti has received publishing royalties from a publication relating to health care.
Pariwat Thaisetthawatkul, MD, FAAN	Dr. Thaisetthawatkul has nothing to disclose.
Charles Maitland	No disclosure on file
Christine S. Wong, MD	No disclosure on file
Rebecca A. Harrison, MD	No disclosure on file
Balaji Krishnaiah, MD, FAAN	Dr. Krishnaiah has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for ACP. Dr. Krishnaiah has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Merck Manual. Dr. Krishnaiah has received publishing royalties from a publication relating to health care.
Sheila Oren, MD, MBA	Sheila Oren, MD, MBA has received personal compensation for serving as an employee of Neuroderm. Sheila Oren, MD, MBA has received personal compensation in the range of $0-$499 for serving as a Consultant for Neuroderm.
Seward B. Rutkove, MD, FAAN	Dr. Rutkove has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Myolex, Inc. Dr. Rutkove has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Academy of Neuorlogy . The institution of Dr. Rutkove has received research support from NIH. The institution of Dr. Rutkove has received research support from NASA. The institution of Dr. Rutkove has received research support from Blavatnik Family Foundation. Dr. Rutkove has received intellectual property interests from a discovery or technology relating to health care. Dr. Rutkove has received intellectual property interests from a discovery or technology relating to health care. Dr. Rutkove has received publishing royalties from a publication relating to health care. Dr. Rutkove has received publishing royalties from a publication relating to health care. Dr. Rutkove has received personal compensation in the range of $500-$4,999 for serving as a Grant Reviewer with NIH.
Felicia Goldstein	No disclosure on file
Jennifer A. Frontera, MD	Dr. Frontera has received personal compensation in the range of $500-$4,999 for serving as a Consultant for FirstKindMedical. Dr. Frontera has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Physician ��ɫ�� Resource. The institution of Dr. Frontera has received research support from NIH. The institution of Dr. Frontera has received research support from Alexion. Dr. Frontera has received publishing royalties from a publication relating to health care.
Prashanthi Vemuri, PhD	The institution of Dr. Vemuri has received research support from NIH.
Gustavo A. Patino, MD, PhD	Dr. Patino has nothing to disclose.
Christopher Schwarz	The institution of Christopher Schwarz has received research support from NIH.
Elizabeth Gerard, MD	Dr. Gerard has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Xenon. The institution of Dr. Gerard has received research support from NIH/NINDS. The institution of Dr. Gerard has received research support from Xenon Pharmaceuticals. The institution of an immediate family member of Dr. Gerard has received research support from NIH. The institution of Dr. Gerard has received research support from Eisai, Inc. (via Stanford University). Dr. Gerard has received publishing royalties from a publication relating to health care.
Umberto Manera, MD	Dr. Manera has nothing to disclose.
Giovanni Meola, MD, FAAN	No disclosure on file
Val J. Lowe, MD	Dr. Lowe has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for AVID Radiopharmaceutical. Dr. Lowe has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eisai Inc. The institution of Dr. Lowe has received research support from AVID Radiopharmaceuticals.
Timothy E. Lotze, MD, FAAN	Dr. Lotze has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Department of Justice VICP. The institution of Dr. Lotze has received research support from NIH. The institution of Dr. Lotze has received research support from National MS Society. The institution of Dr. Lotze has received research support from Sarepta Therapeutics. The institution of Dr. Lotze has received research support from PTC THERAPEUTICS. The institution of Dr. Lotze has received research support from Avexis. Dr. Lotze has received publishing royalties from a publication relating to health care. Dr. Lotze has received publishing royalties from a publication relating to health care.
Judith E. Warner, MD	Dr. Warner has received intellectual property interests from a discovery or technology relating to health care.
Prachi Mehndiratta, MD	Dr. Mehndiratta has nothing to disclose.
Sahar Zafar, MD	Dr. Zafar has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Springer. Dr. Zafar has received research support from NIH. Dr. Zafar has received personal compensation in the range of $5,000-$9,999 for serving as a Speaker for a lecture with Marinus.
John Winslow, PhD	Dr. Winslow has received personal compensation for serving as an employee of Labcorp/Monogram Biosciences. Dr. Winslow has received personal compensation for serving as an employee of Labcorp/Monogram Biosciences. Dr. Winslow has stock in Labcorp. Dr. Winslow has received intellectual property interests from a discovery or technology relating to health care.
Kristina Maselli, MD	Dr. Maselli has nothing to disclose.
Ram Mani, MD	No disclosure on file
Murray Grossman, MD, FAAN	Dr. Grossman has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurology. The institution of Dr. Grossman has received research support from NIH.
Claire Riley, MD, FAAN	Dr. Riley has received personal compensation for serving as an employee of AstraZeneca. Dr. Riley has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Dr. Riley has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono. Dr. Riley has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics. Dr. Riley has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon. Dr. Riley has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Riley has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amgen. Dr. Riley has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Immunic AG. Dr. Riley has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cabaletta Bio. Dr. Riley has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bristol Myers Squibb. Dr. Riley has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Riley has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics.
Petra W. Duda, MD, PhD	Dr. Duda has received personal compensation for serving as an employee of UCB. Dr. Duda has stock in UCB.
John H. Krege	John H. Krege has received personal compensation for serving as an employee of Eli Lilly. John H. Krege has received stock or an ownership interest from Eli Lilly.
Roland Grenningloh	Roland Grenningloh has received personal compensation for serving as an employee of EMD Serono.
Phebe Kemmer, PhD	Dr. Kemmer has received personal compensation for serving as an employee of Eli Lilly and Company. Dr. Kemmer has received stock or an ownership interest from Eli Lilly and Company.
Carlos Singer, MD	Dr. Singer has nothing to disclose.
Michael G. Dwyer III, MD, PhD	Dr. Dwyer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bristol Myers Squibb. Dr. Dwyer has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Keystone Heart, Ltd. Dr. Dwyer has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. The institution of Dr. Dwyer has received research support from Novartis. The institution of Dr. Dwyer has received research support from Keystone Heart, Ltd. The institution of Dr. Dwyer has received research support from Bristol Myers Squibb. The institution of Dr. Dwyer has received research support from Roche.
Heinz Reichmann, MD, FAAN	Dr. Reichmann has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bial. Dr. Reichmann has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Zambon. Dr. Reichmann has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Kyowa. Dr. Reichmann has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bial. Dr. Reichmann has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Zambon. Dr. Reichmann has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Kyowa. Dr. Reichmann has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Bial. Dr. Reichmann has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Zambon. Dr. Reichmann has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for UCB. Dr. Reichmann has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Thieme. Dr. Reichmann has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Wissenschaftsverlag.
David Q. Beversdorf, MD, FAAN	Dr. Beversdorf has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Yamo pharmaceuticals. Dr. Beversdorf has received personal compensation in the range of $500-$4,999 for serving as an officer or member of the Board of Directors for Autism Research Institute. Dr. Beversdorf has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier (Research in Autism Spectrum Disorders). The institution of Dr. Beversdorf has received research support from Autism Research Institute. Dr. Beversdorf has received personal compensation in the range of $5,000-$9,999 for serving as a Case Consultant with Best Doctors.
Syed F. Zaidi, MD	Dr. Zaidi has nothing to disclose.
Spozhmy Panezai, MD	Dr. Panezai has nothing to disclose.
Bhavesh Trikamji, MD	Dr. Trikamji has nothing to disclose.
Hesham A. Abboud, MD	Dr. Abboud has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. The institution of Dr. Abboud has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genentech . Dr. Abboud has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. Abboud has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Horizon. Dr. Abboud has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BMS. Dr. Abboud has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alpine Pharma. Dr. Abboud has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Abboud has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon. Dr. Abboud has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cycle Pharma. Dr. Abboud has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Axonics. Dr. Abboud has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics. Dr. Abboud has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. Dr. Abboud has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Genentech. Dr. Abboud has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for BMS. Dr. Abboud has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Horizon. Dr. Abboud has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for TG Therapeutics. The institution of Dr. Abboud has received research support from Genentech . The institution of Dr. Abboud has received research support from Novartis. The institution of Dr. Abboud has received research support from BMS. The institution of Dr. Abboud has received research support from Sanofi-Genzyme. The institution of Dr. Abboud has received research support from The Guthy-Jackson Charitable Foundation. The institution of Dr. Abboud has received research support from UCB. Dr. Abboud has received publishing royalties from a publication relating to health care.
Alejandro Vargas, MD, MS, FAAN	Dr. Vargas has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bayer U.S. LLC Pharmaceuticals.
Nicholas D. Osteraas, MD	Dr. Osteraas has nothing to disclose.
Kunakorn Atchaneeyasakul, MD	No disclosure on file
Omar Jawdat, MD	Dr. Jawdat has nothing to disclose.
Betul B. Gundogdu, MD	Dr. Gundogdu has nothing to disclose.
Siddhart K. Mehta, MD	Dr. Mehta has nothing to disclose.
Vasu Saini, MD	Dr. Saini has nothing to disclose.
Avinash Prasad, MD	No disclosure on file
Hanna Czarkowska, MD	No disclosure on file
Ashish Kulhari, MD	No disclosure on file
Christopher S. Nance, MD	No disclosure on file
Niraj A. Arora, MD	Dr. Arora has nothing to disclose.
Irine Siraj, MD	Dr. Siraj has nothing to disclose.
Grace Kim	Mr. Kim has nothing to disclose.
Chloe E. Super, MD	No disclosure on file
Jennifer Iudicello	No disclosure on file
Morgan Fretwell	No disclosure on file
Noor A. Pirzada, MD, FAAN	Dr. Pirzada has nothing to disclose.
Joey English, MD, PhD	No disclosure on file
Andrei V. Alexandrov, MD	The institution of Dr. Alexandrov has received personal compensation in the range of $500-$4,999 for serving as a Consultant for NovaSignal. Dr. Alexandrov has received personal compensation in the range of $500-$4,999 for serving as a Consultant for NovoNordisc. Dr. Alexandrov has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for AstraZeneca. Dr. Alexandrov has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for American Society of Neuroimaging. Dr. Alexandrov has received publishing royalties from a publication relating to health care.
Andrew M. Blumenfeld, MD, FAAN	Dr. Blumenfeld has received personal compensation for serving as an employee of The Los Angeles Headache Center. Dr. Blumenfeld has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Allergan/Abbvie. Dr. Blumenfeld has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Best Doctors. Dr. Blumenfeld has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Guidepoint. Dr. Blumenfeld has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for GLG. Dr. Blumenfeld has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Theranica. Dr. Blumenfeld has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Aeon. Dr. Blumenfeld has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Revance. Dr. Blumenfeld has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Lilly. Dr. Blumenfeld has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Pfizer. Dr. Blumenfeld has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Lundbeck. Dr. Blumenfeld has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Teva. Dr. Blumenfeld has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Axsome. Dr. Blumenfeld has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Axon. Dr. Blumenfeld has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Cedar Sinai. Dr. Blumenfeld has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Allergan/Abbvie. Dr. Blumenfeld has received personal compensation in the range of $100,000-$499,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Aeon. Dr. Blumenfeld has received personal compensation in the range of $100,000-$499,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Revance. Dr. Blumenfeld has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Theranica. Dr. Blumenfeld has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Axsome. Dr. Blumenfeld has received personal compensation in the range of $100,000-$499,999 for serving on a Speakers Bureau for Allergan/Abbvie. Dr. Blumenfeld has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Amgen. Dr. Blumenfeld has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Teva. Dr. Blumenfeld has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Lilly. Dr. Blumenfeld has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biohaven. Dr. Blumenfeld has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Lundbeck. Dr. Blumenfeld has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for AXSOME.
Deidre J. Devier, PhD	No disclosure on file
Jesus Lovera, MD	Dr. Lovera has nothing to disclose.
Chokri A. Mhiri, MD	Prof. Mhiri has received personal compensation for serving as an employee of Hikma. Prof. Mhiri has received personal compensation for serving as an employee of Sanofi Genzyme. Prof. Mhiri has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Prof. Mhiri has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche.
Jessie Oldham	No disclosure on file
Galen V. Henderson, MD	No disclosure on file
Cristina Moglia	Cristina Moglia has nothing to disclose.
Lonni Schultz, PhD	Dr. Schultz has nothing to disclose.
Wendy Chao, DO	No disclosure on file
Barbara Fossati, MD	No disclosure on file
Shaneela Malik, MD	Dr. Malik has nothing to disclose.
Babak Boroojerdi, MD	Dr. Boroojerdi has received personal compensation for serving as an employee of UCB Biosciences. Dr. Boroojerdi has stock in UCB Biosciences.
Celia H. Tengan, MD	No disclosure on file
Joel M. Trugman, MD, FAAN	Dr. Trugman has received personal compensation for serving as an employee of AbbVie. Dr. Trugman has stock in AbbVie.
Rami Massie, MD	Dr. Massie has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Gowlingwlg. Dr. Massie has received personal compensation in the range of $500-$4,999 for serving as a Lecturer with Pfizer. Dr. Massie has received personal compensation in the range of $500-$4,999 for serving as a Advisory Board with Argenx.
Larry R. Faulkner, MD	Dr. Faulkner has received personal compensation for serving as an employee of ABPN.
Alice Chen-Plotkin, MD	Dr. Chen-Plotkin has received intellectual property interests from a discovery or technology relating to health care.
Elena Pentsova, MD	The institution of Dr. Pentsova has received research support from YmAbs Therapeutics, Inc.
Muhib Khan, MD, FAAN	The institution of Dr. Khan has received research support from Mayo Clinic ��ɫ�� Grant . The institution of Dr. Khan has received research support from Mayo Clinic Small Grants .
Iva Stankovic	Iva Stankovic has nothing to disclose.
Katherine Turk, MD	The institution of Dr. Turk has received research support from Alzheimer's Association. The institution of Dr. Turk has received research support from US Department of Veterans Affairs.
Adrienne Boire, MD, PhD, FAAN	The institution of Dr. Boire has received research support from National Cancer Institute. The institution of Dr. Boire has received research support from Center for Experimental Therapeutics. The institution of Dr. Boire has received research support from STARR Cancer Consortium. The institution of Dr. Boire has received research support from National Cancer Institute. The institution of Dr. Boire has received research support from Break Through Cancer. The institution of Dr. Boire has received research support from Mary Kay Ash Foundation. The institution of Dr. Boire has received research support from American Cancer Society. The institution of Dr. Boire has received research support from Melanoma Research Alliance. Dr. Boire has received intellectual property interests from a discovery or technology relating to health care. Dr. Boire has received intellectual property interests from a discovery or technology relating to health care. Dr. Boire has received intellectual property interests from a discovery or technology relating to health care.
Elisa Canu	The institution of Elisa Canu has received research support from Italian Ministry of Health .
Stephanie M. Roses, MD	Dr. Roses has nothing to disclose.
Cuyler Huffman	No disclosure on file
Sylvia Mwanza-Kabaghe	No disclosure on file
Jesse M. Cedarbaum, MD, FAAN	No disclosure on file
Peter A. Calabresi, MD, FAAN	Dr. Calabresi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis. Dr. Calabresi has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lilly. Dr. Calabresi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Idorsia. An immediate family member of Dr. Calabresi has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for MyMD. Dr. Calabresi has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Myelin Repair Foundation. The institution of Dr. Calabresi has received research support from Genentech. Dr. Calabresi has received publishing royalties from a publication relating to health care. Dr. Calabresi has received personal compensation in the range of $500-$4,999 for serving as a Study Section Member with NIH. Dr. Calabresi has received personal compensation in the range of $500-$4,999 for serving as a Grant reveiwer with Myelin Repair Foundation. Dr. Calabresi has received personal compensation in the range of $500-$4,999 for serving as a Speaker for CME with NYAS. Dr. Calabresi has received personal compensation in the range of $500-$4,999 for serving as a Speaker with Academic CME.
Christine Stadelmann-Nessler	No disclosure on file
Thomas Brannagan III, MD, FAAN	Dr. Brannagan has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Brannagan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Intellia. Dr. Brannagan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Astra Zenica. Dr. Brannagan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Annexon. The institution of Dr. Brannagan has received research support from Alnylam. The institution of Dr. Brannagan has received research support from Abcuro. The institution of Dr. Brannagan has received research support from Ionis. The institution of Dr. Brannagan has received research support from Vertex. The institution of Dr. Brannagan has received research support from NMD Pharma.
Maurizio Facheris, MD, MSc	Dr. Facheris has received personal compensation for serving as an employee of Vanqua Bio. Dr. Facheris has stock in Vanqua Bio.
Toshiki Fujioka, MD	Dr. Fujioka has nothing to disclose.
Elizabeth Donner, MD, FRCPC	Dr. Donner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eisai. Dr. Donner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Dr. Donner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Pendopharm. Dr. Donner has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Seizure. The institution of Dr. Donner has received research support from SickKids Centre for Brain and Mental Health. The institution of Dr. Donner has received research support from Ontario Brain Institute. The institution of Dr. Donner has received research support from CIHR.
Eduardo R. Davidovich	Dr. Davidovich has nothing to disclose.
James Gordon, MD, FRCPC, FAAN	No disclosure on file
Sharon Ash	No disclosure on file
A. Hauber	No disclosure on file
Kan Ding, MD	The institution of Dr. Ding has received research support from National Institute of Aging. The institution of Dr. Ding has received research support from NINDS.
Erika Silverman	Ms. Silverman has nothing to disclose.
Tirisham Gyang, MD	Dr. Gyang has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for EMD Serono.
Berge A. Minassian, MD	Dr. Minassian has nothing to disclose.
Zachary Miller, MD	Dr. Miller has nothing to disclose.
Raja Mehanna, MD	Dr. Mehanna has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Teva. Dr. Mehanna has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Kyowa Kirin. The institution of Dr. Mehanna has received research support from Cerevel. The institution of Dr. Mehanna has received research support from Neurocrine.
Aaron Deykin, MD	No disclosure on file
Ahmad Abulaban, MD, FAAN	Dr. Abulaban has nothing to disclose.
Alan Pestronk, MD, FAAN	The institution of Dr. Pestronk has received research support from Jain. The institution of Dr. Pestronk has received research support from Fulcrum. The institution of Dr. Pestronk has received research support from Argenyx. The institution of Dr. Pestronk has received research support from NeuroNext.
Stephen L. Hauser, MD	Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for NGM Bio. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Moderna. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BD. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Pheno Therapeutics. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Nurix Therapeutics. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Gilead. Dr. Hauser has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Accure. Dr. Hauser has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alector. Dr. Hauser has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Hinge Therapeutics. Dr. Hauser has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for Neurona. Dr. Hauser has a non-compensated relationship as a Clinical Trial/Primary Investigator with Roche that is relevant to AAN interests or activities. Dr. Hauser has a non-compensated relationship as a Clinical Trial/Primary Investigator with Novartis that is relevant to AAN interests or activities.
Vladimir S. Kostic, MD, PhD	Dr. Kostic has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Roche. An immediate family member of Dr. Kostic has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Alkaloid. The institution of Dr. Kostic has received research support from Ministry of ��ɫ��, Science and Technological Development of Serbia.
Donald Grosset	Donald Grosset has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Glasgow Memory Clinic. Donald Grosset has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for IQVIA. Donald Grosset has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for AbbVie. Donald Grosset has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Britannia. Donald Grosset has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for GE Healthcare. The institution of Donald Grosset has received research support from Parkinson's UK. Donald Grosset has received personal compensation in the range of $10,000-$49,999 for serving as a Clinical Director Excellence Network with Parkinson's UK.
F. Rainer Von Coelln, MD	The institution of Dr. Von Coelln has received research support from University of Maryland and Maryland State Goverment. Dr. Von Coelln has received intellectual property interests from a discovery or technology relating to health care.
Richard R. Murphy, MBChB, FAAN	Dr. Murphy has nothing to disclose.
Danielle S. Shpiner, MD	An immediate family member of Dr. Shpiner has received personal compensation for serving as an employee of University of Miami. Dr. Shpiner has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Mission MSA. The institution of Dr. Shpiner has received research support from American Parkinson's Disease Association. The institution of Dr. Shpiner has received research support from CurePSP. The institution of Dr. Shpiner has received research support from Parkinson's Foundation. Dr. Shpiner has a non-compensated relationship as a COE Medical Director with Parkinson's Foundation that is relevant to AAN interests or activities. Dr. Shpiner has a non-compensated relationship as a Fellowship Co-Director with Medtronic that is relevant to AAN interests or activities. Dr. Shpiner has a non-compensated relationship as a Fellowship Co-Director with Boston Scientific that is relevant to AAN interests or activities. Dr. Shpiner has a non-compensated relationship as a Fellowship Co-Director with Abbott that is relevant to AAN interests or activities. Dr. Shpiner has a non-compensated relationship as a Fellowship Co-Director with Abbvie that is relevant to AAN interests or activities. Dr. Shpiner has a non-compensated relationship as a Fellowship Co-Director with Ipsen that is relevant to AAN interests or activities. Dr. Shpiner has a non-compensated relationship as a Fellowship Co-Director with Amneal that is relevant to AAN interests or activities. Dr. Shpiner has a non-compensated relationship as a Fellowship Co-Director with Michael J. Fox Foundation that is relevant to AAN interests or activities. Dr. Shpiner has a non-compensated relationship as a CoC Medical Director with CurePSP that is relevant to AAN interests or activities. Dr. Shpiner has a non-compensated relationship as a COE Medical Director with Mission MSA that is relevant to AAN interests or activities. Dr. Shpiner has a non-compensated relationship as a Fellowship Co-Director with Merz that is relevant to AAN interests or activities.
John-Ross Rizzo	No disclosure on file
Maria A. Garcia-Dominguez, MD	Dr. Garcia-Dominguez has nothing to disclose.
Scott S. Zamvil, MD, PhD, FAAN	Dr. Zamvil has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sanofi-Genzyme. Dr. Zamvil has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion. Dr. Zamvil has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Genzyme. Dr. Zamvil has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Horizon. The institution of Dr. Zamvil has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for AAN. The institution of Dr. Zamvil has received research support from Sumaira Foundation. Dr. Zamvil has received personal compensation in the range of $5,000-$9,999 for serving as a Advisory Board with Genzyme. Dr. Zamvil has received personal compensation in the range of $500-$4,999 for serving as a Advisory Board with Genentech. Dr. Zamvil has received personal compensation in the range of $500-$4,999 for serving as a Advisory Board with Alexion.
Kenneth L. Marek, MD	Dr. Marek has received personal compensation for serving as an employee of IND. Dr. Marek has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for invicro. Dr. Marek has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Roche. Dr. Marek has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi. Dr. Marek has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biohaven. Dr. Marek has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for takeda. Dr. Marek has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Denali. Dr. Marek has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Koneksa. Dr. Marek has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Xingimaging. Dr. Marek has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neuron23. Dr. Marek has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lilly. Dr. Marek has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biohaven. Dr. Marek has received research support from Michael J Fox Foundation.
Nizar Souayah, MD, FAAN	Dr. Souayah has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Takeda. Dr. Souayah has received publishing royalties from a publication relating to health care.
Amelia Evoli, MD	No disclosure on file
Beatriz H. Kiyomoto	No disclosure on file
Alexandre Prat, MD	The institution of Dr. Prat has received research support from CIHR and MSSC.
Henrik Zetterberg	Henrik Zetterberg has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie, Acumen, Alector, Alzinova, ALZpath, Amylyx, Annexon, Apellis, Artery Therapeutics, AZTherapies, Cognito Therapeutics, CogRx, Denali, Eisai, LabCorp, Merry Life, Nervgen, Novo Nordisk, Optoceutics, Passage Bio, Pinteon Therapeutics, Prothena, Quanterix, Red Abbey Labs, reMYND, Roche, Samumed, Siemens Healthineers, Triplet Therapeutics, and Wave. Henrik Zetterberg has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alzecure, BioArctic, Biogen, Cellectricon, Fujirebio, Lilly, Novo Nordisk, Roche, and WebMD. Henrik Zetterberg has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Wiley and Elsevier. Henrik Zetterberg has stock in Brain Biomarker Solutions.
Max R. Lowden, MD, FAAN	Dr. Lowden has nothing to disclose.
Laura Guilhoto, MD	No disclosure on file
Elka Stefanova	No disclosure on file
Pravin George, DO	Dr. George has nothing to disclose.
Wataru Hagiwara	No disclosure on file
Paula Barreras, MD	Dr. Barreras has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. The institution of Dr. Barreras has received research support from Foundation for Sarcoidosis Research. The institution of Dr. Barreras has received research support from ��ɫ��.
Charles W. Brock, MD	No disclosure on file
Tracy T. Batchelor, MD, MPH	Dr. Batchelor has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Up To Date, Inc. An immediate family member of Dr. Batchelor has received publishing royalties from a publication relating to health care. Dr. Batchelor has received publishing royalties from a publication relating to health care.
Paul M. Thompson, PhD	No disclosure on file
Kaj Blennow	Kaj Blennow has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie. Kaj Blennow has received personal compensation in the range of $500-$4,999 for serving as a Consultant for AC Immune. Kaj Blennow has received personal compensation in the range of $500-$4,999 for serving as a Consultant for ALZPath. Kaj Blennow has received personal compensation in the range of $500-$4,999 for serving as a Consultant for AriBio. Kaj Blennow has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Beckman-Coulter. Kaj Blennow has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BioArctic. Kaj Blennow has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Kaj Blennow has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eisai. Kaj Blennow has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lilly. Kaj Blennow has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Moleac Pte. Ltd. Kaj Blennow has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurimmune. Kaj Blennow has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Kaj Blennow has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ono Pharma. Kaj Blennow has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Prothena. Kaj Blennow has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Quanterix. Kaj Blennow has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche Diagnostics. Kaj Blennow has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi. Kaj Blennow has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Siemens Healthineers. Kaj Blennow has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abbvie. Kaj Blennow has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AC Immune. Kaj Blennow has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ALZPath. Kaj Blennow has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AriBio. Kaj Blennow has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Beckman-Coulter. Kaj Blennow has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for BioArctic. Kaj Blennow has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Kaj Blennow has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eisai. Kaj Blennow has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lilly. Kaj Blennow has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Moleac Pte. Ltd. Kaj Blennow has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Neurimmune. Kaj Blennow has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Kaj Blennow has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Ono Pharma. Kaj Blennow has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Prothena. Kaj Blennow has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Quanterix. Kaj Blennow has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche Diagnostics. Kaj Blennow has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Kaj Blennow has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Siemens Healthineers. Kaj Blennow has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Julius Clinical. Kaj Blennow has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for AC Immune. Kaj Blennow has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. Kaj Blennow has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Celdara Medical. Kaj Blennow has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Eisai. Kaj Blennow has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche Diagnostics. Kaj Blennow has received personal compensation in the range of $500-$4,999 for serving as a Co-founder with Brain Biomarker Solutions.
Scott Mintzer, MD	No disclosure on file
Jan Drappatz, MD	Dr. Drappatz has stock in Pfizer. Dr. Drappatz has stock in Vertex. Dr. Drappatz has stock in GSK. The institution of Dr. Drappatz has received research support from Servier. Dr. Drappatz has received publishing royalties from a publication relating to health care.
Imen Kacem, MD	Dr. Kacem has nothing to disclose.
Brij M. Ahluwalia-Singh, MD, FAAN	No disclosure on file
Maya Katz, MD	Dr. Katz has received research support from NIH.
Lester Y. Leung, MD	Dr. Leung has received research support from NIH.
Michael Mlynash	No disclosure on file
Licia Grazzi, MD	Dr. Grazzi has received personal compensation in the range of $0-$499 for serving as a Consultant for EliLilly. Dr. Grazzi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for allergan-abbvie.
Bradford B. Worrall, MD, MSc, FAAN	The institution of Dr. Worrall has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for AAN. The institution of Dr. Worrall has received research support from NIH. The institution of Dr. Worrall has received research support from AHA/ASA.
John E. Duda, MD	Dr. Duda has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Nature Publishing Group. The institution of Dr. Duda has received research support from Department of Veterans Affairs. The institution of Dr. Duda has received research support from Michael J. Fox Foundation. The institution of Dr. Duda has received research support from Innervace, Incorporated. The institution of Dr. Duda has received research support from National Institutes of Health.
Florian Then Bergh, MD	Dr. Then Bergh has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Then Bergh has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Dr. Then Bergh has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Then Bergh has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon. Dr. Then Bergh has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. Dr. Then Bergh has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Actelion. Dr. Then Bergh has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion. Dr. Then Bergh has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. Dr. Then Bergh has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Bayer. Dr. Then Bergh has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Genzyme. Dr. Then Bergh has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Dr. Then Bergh has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Fresenius. Dr. Then Bergh has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Merck. Dr. Then Bergh has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Takeda. The institution of Dr. Then Bergh has received research support from Actelion. The institution of Dr. Then Bergh has received research support from Novartis. The institution of Dr. Then Bergh has received research support from DFG (German Science Fund). The institution of Dr. Then Bergh has received research support from Fresenius. The institution of Dr. Then Bergh has received research support from Diamed. Dr. Then Bergh has received personal compensation in the range of $10,000-$49,999 for serving as a Member of the Institutional Ethics Board with University of Leipzig, Medical Faculty.
Bradley Molyneaux, MD, PhD	Dr. Molyneaux has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Molyneaux has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Billing, Cochran, Lyles, Mauro and Ramsey. The institution of Dr. Molyneaux has received research support from NIH. Dr. Molyneaux has received publishing royalties from a publication relating to health care.
Paisith Piriyawat, MD	Dr. Piriyawat has nothing to disclose.
Mauricio F. Farez, MD	Dr. Farez has received personal compensation for serving as an employee of Entelai. Dr. Farez has stock in Entelai. The institution of Dr. Farez has received research support from Fundación Sadosky.
Chinwe Nwadiogbu	No disclosure on file
Jamie Greenfield	No disclosure on file
Ahmed Eldokla	No disclosure on file
Tammam Dayyoub, MD	No disclosure on file
Elisabeth Wilde	Elisabeth Wilde has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neuropsychology. The institution of Elisabeth Wilde has received research support from CDMRP/DoD. The institution of Elisabeth Wilde has received research support from VA. The institution of Elisabeth Wilde has received research support from NIH. The institution of Elisabeth Wilde has received research support from Cohen Veteran Biosciences.
Corey McMillan, PhD	Dr. McMillan has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier. The institution of Dr. McMillan has received research support from Biogen. The institution of Dr. McMillan has received research support from NIH.
Constantine Farmakidis, MD, FAAN	Dr. Farmakidis has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Dr. Farmakidis has received personal compensation in the range of $500-$4,999 for serving as a Consultant for J&J. Dr. Farmakidis has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Muscular Dystrophy Association.
Helena W. Lau	No disclosure on file
Helen Shih	No disclosure on file
Duaa Jabari, MD	Dr. Jabari has nothing to disclose.
Joshua Makepeace	No disclosure on file
Kara A. Sands, MD	Dr. Sands has nothing to disclose.
Richard J. Barohn, MD, FAAN	Dr. Barohn has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for NuFactor. The institution of Dr. Barohn has received research support from FDA OPD R01. Dr. Barohn has received intellectual property interests from a discovery or technology relating to health care.
Mohamad Rostami, MD, PhD, FAAN	No disclosure on file
Mark F. Lew, MD, FAAN	Dr. Lew has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Supernus. Dr. Lew has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for kyowa. Dr. Lew has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for neurocrine. Dr. Lew has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Acorda. Dr. Lew has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Acadia. Dr. Lew has received personal compensation in the range of $500-$4,999 for serving as a Consultant for RegenXBio. Dr. Lew has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Neurocrine. Dr. Lew has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Kyowa. Dr. Lew has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for acorda. The institution of Dr. Lew has received research support from MJFF. Dr. Lew has received research support from NIH.
Mamatha Pasnoor, MD, FAAN	Dr. Pasnoor has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Argenx BVBA. Dr. Pasnoor has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen Pharmaceutical. Dr. Pasnoor has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Immunovant. Dr. Pasnoor has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Dr. Pasnoor has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Annexon. Dr. Pasnoor has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Grifols. Dr. Pasnoor has received personal compensation in the range of $500-$4,999 for serving as a Consultant for amgen.
Eric T. Wong, MD, FAAN	Dr. Wong has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novocure. Dr. Wong has received personal compensation in the range of $500-$4,999 for serving as a Consultant for ZaiLab. Dr. Wong has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Turning Point Therapeutics. Dr. Wong has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Imvax. The institution of Dr. Wong has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novocure. The institution of Dr. Wong has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Turning Point Therapeutics. The institution of Dr. Wong has received research support from Novocure. Dr. Wong has received intellectual property interests from a discovery or technology relating to health care. Dr. Wong has received publishing royalties from a publication relating to health care.
Edward Huey	No disclosure on file
Christopher Streib, MD	Dr. Streib has nothing to disclose.
Tigran Kesayan, MD	Dr. Kesayan has nothing to disclose.
Natarajan Visvanathan, MD, DM, FAAN	No disclosure on file
Lauren M. Massimo, PhD	No disclosure on file
Heather Adams	The institution of Heather Adams has received research support from Current: NIH; Past: Abeona; Batten Research Alliance; American University Centers on Disabilities. An immediate family member of Heather Adams has received publishing royalties from a publication relating to health care. Heather Adams has received personal compensation in the range of $500-$4,999 for serving as a Consultant with Critical Path Institute.
John P. Seibyl, MD	Dr. Seibyl has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Invicro. Dr. Seibyl has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biogen. Dr. Seibyl has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Life Molecular Imaging. Dr. Seibyl has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Roche. Dr. Seibyl has received stock or an ownership interest from Invicro.
Xiaoyan Sun, MD, PhD	The institution of Dr. Sun has received research support from NIH. The institution of Dr. Sun has received research support from Dr. M. Lee Pearce Foundation.
Erik V. Burton, MD	Dr. Burton has nothing to disclose.
David Bearden, MD	Dr. Bearden has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Bearden has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Praxis. Dr. Bearden has received personal compensation in the range of $100,000-$499,999 for serving as an Expert Witness for law firms.
Mohamed Kazamel, MD	Dr. Kazamel has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Alnylam Pharamceuticals. Dr. Kazamel has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Akcea Therapeutics.
Elizabeth H. Wise, APRN	Ms. Wise has nothing to disclose.
David R. Cornblath, MD	Dr. Cornblath has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Octapharma. Dr. Cornblath has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Annexon. Dr. Cornblath has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Pfizer. Dr. Cornblath has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Grifols. Dr. Cornblath has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cigna. Dr. Cornblath has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alnylam. Dr. Cornblath has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Anavex. Dr. Cornblath has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Hansa. Dr. Cornblath has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for MPTP. Dr. Cornblath has received intellectual property interests from a discovery or technology relating to health care.
Daniel Weintraub	Daniel Weintraub has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Clintrex. Daniel Weintraub has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eisai. Daniel Weintraub has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen. Daniel Weintraub has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sage. Daniel Weintraub has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Scion. Daniel Weintraub has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Signant. Daniel Weintraub has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sunovion. Daniel Weintraub has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Modality.ai. Daniel Weintraub has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cerevel. Daniel Weintraub has received personal compensation in the range of $500-$4,999 for serving as a Consultant for CuraSen. Daniel Weintraub has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Takeda. Daniel Weintraub has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Boehringer Ingelheim. Daniel Weintraub has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Daniel Weintraub has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Acadia. Daniel Weintraub has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Movement Disorder Society. The institution of Daniel Weintraub has received research support from NIH. The institution of Daniel Weintraub has received research support from Fox Foundation. The institution of Daniel Weintraub has received research support from IPMDS. Daniel Weintraub has received intellectual property interests from a discovery or technology relating to health care.
Olha Taraschenko, MD, PhD	The institution of Dr. Taraschenko has received research support from NIH. The institution of Dr. Taraschenko has received research support from DHSS LB606 Nebraska Stem Cell Grant . Dr. Taraschenko has received personal compensation in the range of $0-$499 for serving as a Speaker with AES.
Nicholas Milano, MD	Dr. Milano has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Jackson kelly.
Dianalee McKnight, PhD	Dr. McKnight has nothing to disclose.
Wei Liu, MD	Dr. Liu has nothing to disclose.
David S. Russell, MD, PhD	Dr. Russell has received personal compensation for serving as an employee of Invicro. Dr. Russell has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Neurocrine. The institution of Dr. Russell has received research support from Biogen. The institution of Dr. Russell has received research support from Roche. The institution of Dr. Russell has received research support from Voyager. The institution of Dr. Russell has received research support from Eisai. The institution of Dr. Russell has received research support from Neuraly. The institution of Dr. Russell has received research support from Michael J. Fox Foundation. The institution of Dr. Russell has received research support from National Institutes for Health. The institution of Dr. Russell has received research support from Eli Lilly. The institution of Dr. Russell has received research support from Aprinoia.
Eric A. Macklin, PhD	The institution of Dr. Macklin has received personal compensation in the range of $500-$4,999 for serving as a Consultant for AI Therapeutics. Dr. Macklin has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Chase Therapeutics. Dr. Macklin has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bial Biotech. Dr. Macklin has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Macklin has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Stoparkinson Healthcare LLC. Dr. Macklin has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Macklin has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Macklin has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. The institution of Dr. Macklin has received research support from Biohaven. The institution of Dr. Macklin has received research support from Clene Nanomedicine. The institution of Dr. Macklin has received research support from Mitsubishi Tanabe Pharmaceuticals America. The institution of Dr. Macklin has received research support from Prilenia. The institution of Dr. Macklin has received research support from UCB Ra Pharma. The institution of Dr. Macklin has received research support from Revalesio. The institution of Dr. Macklin has received research support from Seelos. The institution of Dr. Macklin has received research support from Calico. The institution of Dr. Macklin has received research support from Denali. The institution of Dr. Macklin has received research support from NeuroDex. The institution of Dr. Macklin has received research support from Alector. The institution of Dr. Macklin has received research support from ITB-Med.
Michael J. Rivkin, MD	No disclosure on file
Ranjithkumar Rajendran	Mr. Rajendran has nothing to disclose.
Suresh Kumar, MD	Dr. Kumar has nothing to disclose.
Juliann M. Paolicchi, MD	No disclosure on file
Marc Verin	Mr. Verin has nothing to disclose.
Wolfgang Brueck, PhD	Dr. Brueck has nothing to disclose.
Henry P. Moore, MD	Dr. Moore has received personal compensation in the range of $0-$499 for serving as a Consultant for Abbvie. Dr. Moore has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Ipsen Pharma. The institution of Dr. Moore has received research support from Sage Therapeutics. The institution of Dr. Moore has received research support from Bukwang Pharmaceutical. The institution of Dr. Moore has received research support from Neurocrine. The institution of Dr. Moore has received research support from CDHI Foundation. The institution of Dr. Moore has received research support from MODUS Outcomes LLC. The institution of Dr. Moore has received research support from University of Kansas Center for Research.
Lucas Schirmer, MD	No disclosure on file
Ninad Desai, MBBS	Dr. Desai has nothing to disclose.
Venugopalan Y. Vishnu, MD	The institution of Dr. Vishnu has received research support from Department of Health Research.
Per Odin	Per Odin has received personal compensation in the range of $500-$4,999 for serving as a Consultant for AbbVie. Per Odin has received personal compensation in the range of $0-$499 for serving as a Consultant for Britannia. Per Odin has received personal compensation in the range of $0-$499 for serving as a Consultant for Convatec. Per Odin has received personal compensation in the range of $0-$499 for serving as a Consultant for UCB.
Georgia D. Montouris, MD	No disclosure on file
Bruno Stankoff, MD, PhD	The institution of Bruno Stankoff, MD, PhD has received research support from Roche, Sanofi, Serono . The institution of Bruno Stankoff, MD, PhD has received research support from Novartis.
Corneliu C. Luca, MD	Dr. Luca has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Boston Scientific. Dr. Luca has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Signant Health. Dr. Luca has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Abbott.
Tatjana Rundek, MD, PhD	The institution of Dr. Rundek has received research support from NIH.
Daniel Anthony, PhD, MA	Dr. Anthony has received personal compensation for serving as an employee of University of Oxford. Dr. Anthony has received personal compensation for serving as an employee of Somerville College Oxford. Dr. Anthony has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Dr. Anthony has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Neuroplast. Dr. Anthony has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Oxomics. The institution of Dr. Anthony has received research support from Numares. The institution of Dr. Anthony has received research support from MRC UK.
Nobuaki Yoshikura, MD, PhD	Dr. Yoshikura has nothing to disclose.
Antonio Canosa	Antonio Canosa has nothing to disclose.
Mouhammad A. Jumaa, MD	Dr. Jumaa has nothing to disclose.
Karlo J. Lizarraga, MD, MS, FAAN	Dr. Lizarraga has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for FHC. The institution of Dr. Lizarraga has received research support from BlueRock. The institution of Dr. Lizarraga has received research support from Roche. The institution of Dr. Lizarraga has received research support from NIH/NINDS. Dr. Lizarraga has received personal compensation in the range of $500-$4,999 for serving as a Speaker with International Parkinson and Movement Disorders Society. Dr. Lizarraga has received personal compensation in the range of $0-$499 for serving as a Reviewer with National Institutes of Health. Dr. Lizarraga has a non-compensated relationship as a Editorial Board Member for Brain & Life with ��ɫ�� that is relevant to AAN interests or activities.
Lisena Hasanaj	Ms. Hasanaj has nothing to disclose.
Acary S. Oliveira, MD	No disclosure on file
Ann Helms, MD	Dr. Helms has nothing to disclose.
Rodolfo Savica, MD, PhD, FAAN	The institution of Dr. Savica has received research support from ACADIA Pharmaceuticals, Inc.
David J. Burn, MD	No disclosure on file
Marc Bigaud	Marc Bigaud has received personal compensation for serving as an employee of Novartis Pharma.
Tara A. Kimbrough, MD	Dr. Kimbrough has nothing to disclose.
Simon Cronin, PhD	Prof. Cronin has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis.
Elisabeth Maillart	No disclosure on file
Hisham Salahuddin, MD	Dr. Salahuddin has nothing to disclose.
Indira R. Garcia Cordero, PhD	No disclosure on file

��ɫ����

��ɫ����

��ɫ��

��ɫ��